Giovedì, il 13 gennaio 2022, la Corte Suprema degli Stati Uniti ha bloccato il mandato alla vaccinazione contro SarsCov2 promulgato dall’Amministrazione di J. Biden, in particolare l’obbligo di mandato ai datori di lavori con più di cento lavoratori.

Il 4 novembre 2021, Occupational Health and Safety Administration (OSHA) ha stipulato che tutte le imprese e società con più di 100 dipendenti avevano l’obbligo di assicurare che i dipendenti fossero vaccinati o testati settimanalmente. L’ordine ha subito incontrato resistenza e un’opposizione risoluta, anche grazie alla determinazione della DAILY WIRE, la prima società a fare causa contro l’Amministrazione Biden nei tribunali della 6th Circuit.

Questa è la prima volta da 1970 che la Corte Suprema ascolta una richiesta di interruzione di un ‘stay’ (un’interruzione immediata di una procedura legale), e la maggioranza dei giudici ha segnalato la propria opposizione durante le udienze di venerdì scorso.

Il giovedì, la Corte Suprema ha bloccato il mandato alla vaccinazione in una decisione 6-3, con l’accordo di tutte e 6 i giudici conservatori e il dissenso dei 3 giudici liberali.  

Leggete la decisione e l’opinione della maggioranza qui sotto:

The Secretary of Labor, acting through the Occupational Safety and Health Administration, recently enacted a vaccine mandate for much of the Nation’s work force. The mandate, which employers must enforce, applies to roughly 84 million workers, covering virtually all employers with at least 100 employees. It requires that covered workers receive a COVID–19 vaccine, and it pre-empts contrary state laws. The only exception is for workers who obtain a medical test each week at their own expense and on their own time, and also wear a mask each workday. OSHA has never before imposed such a mandate. Nor has Congress. Indeed, although Congress has enacted significant legislation addressing the COVID–19 pandemic, it has declined to enact any measure similar to what OSHA has promulgated here.

Many States, businesses, and nonprofit organizations challenged OSHA’s rule in Courts of Appeals across the country. The Fifth Circuit initially entered a stay. But when the cases were consolidated before the Sixth Circuit, that court lifted the stay and allowed OSHA’s rule to take effect. Applicants now seek emergency relief from this Court, arguing that OSHA’s mandate exceeds its statutory authority and is otherwise unlawful. Agreeing that applicants are likely to prevail, we grant their applications and stay the rule.

Congress enacted the Occupational Safety and Health Act in 1970. 84 Stat. 1590, 29 U. S. C. §651 et seq. The Act created the Occupational Safety and Health Administration (OSHA), which is part of the Department of Labor and under the supervision of its Secretary. As its name suggests, OSHA is tasked with ensuring occupational safety— that is, “safe and healthful working conditions.” §651(b). It does so by enforcing occupational safety and health standards promulgated by the Secretary. §655(b). Such standards must be “reasonably necessary or appropriate to provide safe or healthful employment.” §652(8) (emphasis added). They must also be developed using a rigorous process that includes notice, comment, and an opportunity for a public hearing. §655(b).

The Act contains an exception to those ordinary noticeand-comment procedures for “emergency temporary standards.” §655(c)(1). Such standards may “take immediate effect upon publication in the Federal Register.” Ibid. They are permissible, however, only in the narrowest of circumstances: the Secretary must show (1) “that employees are exposed to grave danger from exposure to substances or agents determined to be toxic or physically harmful or from new hazards,” and (2) that the “emergency standard is necessary to protect employees from such danger.” Ibid. Prior to the emergence of COVID–19, the Secretary had used this power just nine times before (and never to issue a rule as broad as this one). Of those nine emergency rules, six were challenged in court, and only one of those was upheld in full. See BST Holdings, L.L.C. v. Occupational Safety and Health Admin., 17 F. 4th 604, 609 (CA5 2021). 

On September 9, 2021, President Biden announced “a new plan to require more Americans to be vaccinated.” Remarks on the COVID–19 Response and National Vaccination Efforts, 2021 Daily Comp. of Pres. Doc. 775, p. 2. As part of that plan, the President said that the Department of Labor would issue an emergency rule requiring all employers with at least 100 employees “to ensure their workforces are fully vaccinated or show a negative test at least once a week.” Ibid. The purpose of the rule was to increase vaccination rates at “businesses all across America.” Ibid. In tandem with other planned regulations, the administration’s goal was to impose “vaccine requirements” on “about 100 million Americans, two-thirds of all workers.” Id., at 3.

After a 2-month delay, the Secretary of Labor issued the promised emergency standard. 86 Fed. Reg. 61402 (2021). Consistent with President Biden’s announcement, the rule applies to all who work for employers with 100 or more employees. There are narrow exemptions for employees who work remotely “100 percent of the time” or who “work exclusively outdoors,” but those exemptions are largely illusory. Id., at 61460. The Secretary has estimated, for example, that only nine percent of landscapers and groundskeepers qualify as working exclusively outside. Id., at 61461. The regulation otherwise operates as a blunt instrument. It draws no distinctions based on industry or risk of exposure to COVID–19. Thus, most lifeguards and linemen face the same regulations as do medics and meatpackers. OSHA estimates that 84.2 million employees are subject to its mandate. Id., at 61467.

Covered employers must “develop, implement, and enforce a mandatory COVID–19 vaccination policy.” Id., at 61402. The employer must verify the vaccination status of each employee and maintain proof of it. Id., at 61552. The mandate does contain an “exception” for employers that require unvaccinated workers to “undergo [weekly] COVID– 19 testing and wear a face covering at work in lieu of vaccination.” Id., at 61402. But employers are not required to offer this option, and the emergency regulation purports to pre-empt state laws to the contrary. Id., at 61437. Unvaccinated employees who do not comply with OSHA’s rule must be “removed from the workplace.” Id., at 61532. And employers who commit violations face hefty fines: up to $13,653 for a standard violation, and up to $136,532 for a willful one. 29 CFR §1903.15(d) (2021). 

OSHA published its vaccine mandate on November 5, 2021. Scores of parties—including States, businesses, trade groups, and nonprofit organizations—filed petitions for review, with at least one petition arriving in each regional Court of Appeals. The cases were consolidated in the Sixth Circuit, which was selected at random pursuant to 28 U. S. C. §2112(a).

Prior to consolidation, however, the Fifth Circuit stayed OSHA’s rule pending further judicial review. BST Holdings, 17 F. 4th 604. It held that the mandate likely exceeded OSHA’s statutory authority, raised separation-ofpowers concerns in the absence of a clear delegation from Congress, and was not properly tailored to the risks facing different types of workers and workplaces.

When the consolidated cases arrived at the Sixth Circuit, two things happened. First, many of the petitioners—nearly 60 in all—requested initial hearing en banc. Second, OSHA asked the Court of Appeals to vacate the Fifth Circuit’s existing stay. The Sixth Circuit denied the request for initial hearing en banc by an evenly divided 8-to-8 vote. In re MCP No. 165, 20 F. 4th 264 (2021). Chief Judge Sutton dissented, joined by seven of his colleagues. He reasoned that the Secretary’s “broad assertions of administrative power demand unmistakable legislative support,” which he found lacking. Id., at 268. A three-judge panel then dissolved the Fifth Circuit’s stay, holding that OSHA’s mandate was likely consistent with the agency’s statutory and constitutional authority. See In re MCP No. 165, 2021 WL 5989357, ___ F. 4th ___ (CA6 2021). Judge Larsen dissented.

Various parties then filed applications in this Court requesting that we stay OSHA’s emergency standard. We consolidated two of those applications—one from the National Federation of Independent Business, and one from a coalition of States—and heard expedited argument on January 7, 2022. 

The Sixth Circuit concluded that a stay of the rule was not justified. We disagree.

Applicants are likely to succeed on the merits of their claim that the Secretary lacked authority to impose the mandate. Administrative agencies are creatures of statute. They accordingly possess only the authority that Congress has provided. The Secretary has ordered 84 million Americans to either obtain a COVID–19 vaccine or undergo weekly medical testing at their own expense. This is no “everyday exercise of federal power.” In re MCP No. 165, 20 F. 4th, at 272 (Sutton, C. J., dissenting). It is instead a significant encroachment into the lives—and health—of a vast number of employees. “We expect Congress to speak clearly when authorizing an agency to exercise powers of vast economic and political significance.” Alabama Assn. of Realtors v. Department of Health and Human Servs., 594 U. S. ___, ___ (2021) (per curiam) (slip op., at 6) (internal quotation marks omitted). There can be little doubt that OSHA’s mandate qualifies as an exercise of such authority.

The question, then, is whether the Act plainly authorizes the Secretary’s mandate. It does not. The Act empowers the Secretary to set workplace safety standards, not broad public health measures. See 29 U. S. C. §655(b) (directing the Secretary to set “occupational safety and health standards” (emphasis added)); §655(c)(1) (authorizing the Secretary to impose emergency temporary standards necessary to protect “employees” from grave danger in the workplace). Confirming the point, the Act’s provisions typically speak to hazards that employees face at work. See, e.g., §§651, 653, 657. And no provision of the Act addresses public health more generally, which falls outside of OSHA’s sphere of expertise.

The dissent protests that we are imposing “a limit found no place in the governing statute.” Post, at 7 (joint opinion of BREYER, SOTOMAYOR, and KAGAN, JJ.). Not so. It is the text of the agency’s Organic Act that repeatedly makes clear that OSHA is charged with regulating “occupational” hazards and the safety and health of “employees.” See, e.g., 29 U. S. C. §§652(8), 654(a)(2), 655(b)–(c).

The Solicitor General does not dispute that OSHA is limited to regulating “work-related dangers.” Response Brief for OSHA in No. 21A244 etc., p. 45 (OSHA Response). She instead argues that the risk of contracting COVID–19 qualifies as such a danger. We cannot agree. Although COVID– 19 is a risk that occurs in many workplaces, it is not an occupational hazard in most. COVID–19 can and does spread at home, in schools, during sporting events, and everywhere else that people gather. That kind of universal risk is no different from the day-to-day dangers that all face from crime, air pollution, or any number of communicable diseases. Permitting OSHA to regulate the hazards of daily life—simply because most Americans have jobs and face those same risks while on the clock—would significantly expand OSHA’s regulatory authority without clear congressional authorization.

The dissent contends that OSHA’s mandate is comparable to a fire or sanitation regulation imposed by the agency. See post, at 7–9. But a vaccine mandate is strikingly unlike the workplace regulations that OSHA has typically imposed. A vaccination, after all, “cannot be undone at the end of the workday.” In re MCP No. 165, 20 F. 4th, at 274 (Sutton, C. J., dissenting). Contrary to the dissent’s contention, imposing a vaccine mandate on 84 million Americans in response to a worldwide pandemic is simply not “part of what the agency was built for.” Post, at 10.

That is not to say OSHA lacks authority to regulate occupation-specific risks related to COVID–19. Where the virus poses a special danger because of the particular features of an employee’s job or workplace, targeted regulations are plainly permissible. We do not doubt, for example, that OSHA could regulate researchers who work with the COVID–19 virus. So too could OSHA regulate risks associated with working in particularly crowded or cramped environments. But the danger present in such workplaces differs in both degree and kind from the everyday risk of contracting COVID–19 that all face. OSHA’s indiscriminate approach fails to account for this crucial distinction— between occupational risk and risk more generally—and accordingly the mandate takes on the character of a general public health measure, rather than an “occupational safety or health standard.” 29 U. S. C. §655(b) (emphasis added).

In looking for legislative support for the vaccine mandate, the dissent turns to the American Rescue Plan Act of 2021, Pub. L. 117–2, 135 Stat. 4. See post, at 8. That legislation, signed into law on March 11, 2021, of course said nothing about OSHA’s vaccine mandate, which was not announced until six months later. In fact, the most noteworthy action concerning the vaccine mandate by either House of Congress has been a majority vote of the Senate disapproving the regulation on December 8, 2021. S. J. Res. 29, 117th Cong., 1st Sess. (2021).

It is telling that OSHA, in its half century of existence, has never before adopted a broad public health regulation of this kind—addressing a threat that is untethered, in any causal sense, from the workplace. This “lack of historical precedent,” coupled with the breadth of authority that the Secretary now claims, is a “telling indication” that the mandate extends beyond the agency’s legitimate reach. Free Enterprise Fund v. Public Company Accounting Oversight Bd., 561 U. S. 477, 505 (2010) (internal quotation marks omitted). 

The equities do not justify withholding interim relief. We are told by the States and the employers that OSHA’s mandate will force them to incur billions of dollars in unrecoverable compliance costs and will cause hundreds of thousands of employees to leave their jobs. See Application in No. 21A244, pp. 25–32; Application in No. 21A247, pp. 32– 33; see also 86 Fed. Reg. 61475. For its part, the Federal Government says that the mandate will save over 6,500 lives and prevent hundreds of thousands of hospitalizations. OSHA Response 83; see also 86 Fed. Reg. 61408.

It is not our role to weigh such tradeoffs. In our system of government, that is the responsibility of those chosen by the people through democratic processes. Although Congress has indisputably given OSHA the power to regulate occupational dangers, it has not given that agency the power to regulate public health more broadly. Requiring the vaccination of 84 million Americans, selected simply because they work for employers with more than 100 employees, certainly falls in the latter category.

The applications for stays presented to JUSTICE KAVANAUGH and by him referred to the Court are granted.

OSHA’s COVID–19 Vaccination and Testing; Emergency Temporary Standard, 86 Fed. Reg. 61402, is stayed pending disposition of the applicants’ petitions for review in the United States Court of Appeals for the Sixth Circuit and disposition of the applicants’ petitions for writs of certiorari, if such writs are timely sought. Should the petitions for writs of certiorari be denied, this order shall terminate automatically. In the event the petitions for writs of certiorari are granted, the order shall terminate upon the sending down of the judgment of this Court.

It is so ordered.

Albert Bourla in an interview on Yahoo! Finance: “Everything has very quickly deteriorated because of the Omicron. It has been very quick. It is a disease which manifests itself with greater mildness, but because of the high infectious rates, the absolute numbers of hospitals are increased. We know that the full dose of the vaccine offers VERY LIMITED PROTECTION, IF ANY, the booster MAY add reasonable protection against hospitalization and death, less protection against infection. We are working on a new version of the vaccine 1.1, which will cover Omicron as well. We are waiting for results, so the vaccine will be ready in March (when it will no longer be needed).”

Pfizer CEO: New Covid-19 vaccine that covers Omicron ‘will be ready in March’ Yahoo! Finance https://youtu.be/IhMbKy Dq9_w (Youtube will not permit me to post this video).

With this statement, the pretext for any mandate just completely collapsed. No government can force an individual to be injected with an unknown substance which is non only potentially harmful, but has been scientifically demonstrated to be ineffective, declaration made by the manufacturers themselves. The full vaccination does not protect against Omicron. It does not attenuate the disease, which manifests itself in a relatively similar manner amongst the vaccinated and unvaccinated, although at least anecdotally the unvaccinated seem to have far milder symptoms, or none at all.

In South Africa, where Omicron was first detected, and there is a low level of vaccination (Africa’s vaccination average is 1.2%, with a death rate of 14:1,000,000, thanks to the regular profilactic use of Hydroxychloroquine against Malaria and Ivermectin against River Blindness) it is described as displaying symptoms “so mild, they may easily be missed.” and a 4 out of 10 on the sliding scale of severity of influenza symptoms.

Source: Great Britain News

In Spain, with cases of Omicron on the rise, Spain has adapted an Influenza Surveillance system to Covid-19 which clearly reflects their understanding of the lesser severity of this particular variant. Monitoring will no longer rely on exhaustive counts of ‘positive cases’, but rather on a network of experts (family doctors and hospital workers). Spanish authorities are finalizing a plan for a new Covid-19 surveillance system that will mirror the one that has been used for years to monitor the flu. The new system will extrapolate numbers from a statistically significant sample, rather than rely on daily reporting of each and every diagnosed infection.

The system comes as case counts in Spain continue to hit new records: on Friday, the Health Ministry reported 242,440 new infections. More than seven million coronavirus cases have now been detected since the beginning of the pandemic. Speaking on Friday, Spanish Prime Minister Pedro Sánchez said that most of the cases being registered were ASYMPTOMATIC, adding: “We are going to have to learn to live with it [the coronavirus] as we do with many other viruses,”

Health officials have been working for months on adapting what is known as influenza sentinel surveillance. Under the new system, there will be no more reporting of every single diagnosed infection, nor will tests be carried out at the slightest symptom. The coronavirus will be monitored just like any other respiratory illness, and close contacts of positive cases will no longer need to get tested unless displaying clear symptoms.

Source. ElPais

Nike, Coca-Cola, and American Airlines are just a few of the companies Consumers’ Research is targeting over their woke business practices. Consumers’ Research, an educational organization seeking to highlight issues concerning to consumers, now has a new target: American investment firm BlackRock and their ties to the Chinese Communist Party.

“Where [is BlackRock] investing your money? China. Pouring in billions, propping up Chinese communist leaders, putting money into surveillance companies used by the Chinese military. Even left-wing billionaire George Soros knows BlackRock is harming U.S. national security,” says Will Hild, executive director of Consumers’ Research.

Doug Blair: Our guest today is Will Hild, executive director of Consumers’ Research, an educational organization seeking to highlight issues concerning to consumers. Will, thank you so much for joining me today.

Will Hild: Thanks for having me.

Blair: Your organization, Consumers’ Research, is in the process of launching a campaign about U.S. investment firm BlackRock and their connections to the Chinese Communist Party. So, what do you want us to know specifically about this relationship?

Hild: Absolutely. Two things, namely that BlackRock is taking American investment dollars and they’re funneling them into companies controlled by the Communist Party in many cases. And as many people know, China’s become our greatest geopolitical adversary.

At the same time that they are funding investments for Chinese companies, sometimes Chinese companies that are being used to oppress the Chinese people, they’re hamstringing U.S. corporations here in the United States, bullying them, trying to get them to divest of, in some cases, their main product—oil and gas.

In other cases, just getting involved and bean counting around race and gender, board diversity quotas, that kind of thing. At the same time that they’re advantaging foreign corporations, namely Chinese corporations that we’re competing with, they’re hamstringing U.S. corporations here at home.

Blair: And why should this matter then? You mentioned that some of the corporations here are being hamstrung. Americans here being hamstrung. But what about this relationship to the Chinese Communist Party should concern Americans?

Hild: Absolutely. Well, let me take a step back just to say Consumers’ Research is the nation’s oldest consumer protection organization. We try to protect and educate consumers in all ways. And there’s actually twofold problems here for U.S. consumers. Let me start with the most important one.

The effect of all these things that BlackRock is doing to U.S. corporations, trying to get them to divest their oil, gas, trying to distract them from their business model and focus on, like I said, bean counting our own race and gender, it’s going to drive up the price and drive down the quality of the goods that these companies are producing.

Let me give you a specific example. BlackRock was just instrumental in getting elected three activist board members to Exxon’s board. Those directors’ stated purpose is to get Exxon to focus on meeting the Paris accord agreement targets, which would effectively get them out of the oil and gas business within the next few years.

Well, this is a time, obviously, when we’re seeing energy prices skyrocket in an unprecedented way. The American consumers are already having to tighten their budget because of inflation. And this is only going to make things worse.

Energy is a cost of production for pretty much every good or service. And so, if the price of oil and gas goes up because of lack of exploration or recovery, we’re going to see prices go up across the board. And so, that’s No. 1. We’d like BlackRock to cut that out because we think it’s really bad for the American consumer.

But No. 2, often American consumers are also American investors. That’s why they call them retail investors. And we thought that they needed to know how their money was being used in ways against their own interests, as I just noted. Their money as investors was being used against their interest as consumers, but also as Americans.

We’re obviously locked in sort of a frenemy situation with China that’s growing in its bellicosity, and it doesn’t look like it’s going to slow down anytime soon. And the Chinese seem bent on making sure that’s the case. So we don’t think it’s wise, at a time like this, that the American dollars, investment dollars, BlackRock would be taking those and betting on China. Sometimes they’re hamstringing U.S. corporations.

Blair: Now, we do have that ad and we’re going to actually play it right now for our listeners.

Ad: BlackRock, the biggest American money manager. Where are they investing your money? China. Pouring in billions, propping up Chinese communist leaders, putting money into surveillance companies used by the Chinese military. Even left-wing billionaire George Soros knows BlackRock is harming U.S. national security. CEO Larry Fink loves to tell Americans how to live, but he negotiated against America, sucking up to China. BlackRock, taking your money, betting on China.

Blair: Having heard the ad, who are you targeting with the campaign? Is it specifically BlackRock? Is it the consumers? Is it both? Sort of what—

Hild: Absolutely. That’s a great question. There’s, again, two intentions here with the ad. One is to send a message to BlackRock, that we’re paying attention, they’re being named and shamed.

BlackRock is a company that most Americans have never heard of, and we didn’t want them to get away with what they were doing because of their obscurity. In other words, because of how little known they were, they were sort of getting away with virtue signaling on Wall Street, here in the U.S., and yet cozying up to one of the most authoritarian regimes. U.N. would say, “Worst human rights abuser in the world.”

The second one is to educate consumers, so that they know what’s going on, how their money’s being used.

There’s a number of different states that have pension dollars that are managed by BlackRock. So in some cases you may have citizens of states whose own pension money is being invested in China, risky investments. And then here, it’s being used against their interest as consumers. They’re being double ripped off by BlackRock. And so, we just thought it was very important that consumers be aware of this because up till now, it’s sort of been an inside secret in Wall Street and the average American needs to know that.

Blair: It’s a dual-pronged approach.

Hild: Absolutely.

Blair: I’m curious as to how you became and your organization became aware of the dealings between BlackRock and China. What was the process like to get that information?

Hild: Right. Well, let me take a quick step back. We launched the Consumers First Initiative, which is aimed at telling corporations to stop cozying up to woke politicians and focus on their consumers. We launched that in June.

And then the lead-up to that campaign, we spent over a year just really digging in to the ecosystem, what was happening, why did we see so many weird things going on in corporate America, what were the incentives. And we kept coming back to this one company that seemed to be pushing this and the one CEO, Larry Fink, who was mentioned in the ad, of course.

And we looked at what they were doing and lo and behold, just like some of the American corporations here that are going woke in order to cozy up to woke politicians, and namely distract from the bad things they’re doing—the failures, their misdeeds, their mistreatments of their customers, in cases like American and Coca-Cola and Nike—sure enough, BlackRock is doing the same thing.

Here in America, they’re virtue signaling. They’re talking about all the things they’re going to make American corporations do, they say are great things. But you look at their dealings in China, they’re investing in companies like iFLYTEK and Hikvision. These are two surveillance companies that have actually been blacklisted by the American government.

Is it legal for U.S. persons to trade with these companies? Because they are surveillance companies being used to oppress the Chinese people on behalf of the Communist Party. And yet BlackRock actually increased their investment in these companies after they were blacklisted.

So you have at the same time, like I said, they’re virtue signaling here. They’re out in China, cozying up to one of the most authoritarian regimes in world history.

Blair: The campaign has been out for a little bit now. Have you received any responses to it? Are people resonating with it? How is it going?

Hild: Well, we’ve just been floored by the overwhelming feedback. There seems to be a real reservoir of anger at this type of action. We’ve received thousands and thousands of emails and support from across the country and really from across the political divide.

Some people would like to say, “This is a political action.” We actually think it’s the opposite. We’ve gotten feedback from people left, right, middle, up, down. No matter who you are in America, no American consumer likes to be preached at by the company that supposedly worked for them, producing the goods and services them. They don’t want to be told what to think or how to think or how to talk about politics. And so, we’ve just really been floored.

Now, some of the companies have come back. On Friday, BlackRock responded. They attacked us. I will note, they didn’t deny a single fact in the ad. They can’t, none of it, all of it’s been cited by very reputable mainstream media stories. So they completely ignore that and just go ad hominem against us. And I think that, to me, is the most telling thing, that they couldn’t quibble about a single fact that we allege.

Blair: It was more that they were just, “Hey, why did you expose this information?”

Hild: Right. Well, basically, they said I don’t care about the issues that they care about. And they’re right, I don’t care about growing their profits and aggrandizing their power at the cost of the American consumer.

Blair: So given that this is getting results, it seems like you’ve gotten people engaged, you’ve gotten people responding to this ad campaign relatively positively. BlackRock themselves came out and gave a response to it. What would be the successful resolution to this campaign? What would you like to see?

Hild: Well, there’s a lot of different options there, depending on who you’re talking about. Obviously, in a perfect world, I’d like to see BlackRock cut it out. I’d like to see them focus on providing good investment management advice and services to their clientele that doesn’t involve cozying up to an authoritarian human rights-violating regime, and doesn’t put this country at a disadvantage long term against that regime, as we compete, and doesn’t drive up costs for consumers, some of the very consumers whose money they’re investing.

So that would be namely No. 1, to get, obviously, them to just stop being villainous.

But short of that, I would like the American people to really understand what’s going on. I think there’s a lot of growing frustration. You see some of the results of BlackRock’s activities and don’t know … where is this coming from? Why is there less oil and gas expiration driving up energy costs? Well, we hope to explain that. And that’s one of these things that’s going on that I would hope, coming out of this ad campaign, people would understand.

Blair: Now, beyond the BlackRock campaign, Consumers’ Research has also run campaigns on other companies that have been doing woke capital, as you refer to it—Coke, Nike, American Airlines. What results came from those campaigns? Are we seeing similar things coming from this one as well?

Hild: Well, it’s interesting. Again, been floored by the amount of feedback we’ve gotten, positive feedback. I don’t know everything that the companies have done since, but I’m pretty sure most of them have more or less stayed out of issues of politics that are not germane to their business and that they have no expertise in, which was always our goal.

Say, “Listen, we understand there are issues that you may talk to politicians about related to sugar taxes or in the case of Coca-Cola or shoe rubber or whatever, but you’re wading into issues that you don’t know anything about. And it’s clear that you’re only doing this to cozy up to woke politicians for favors and for virtue signaling to cover.” And we’ve seen that decrease to a large extent with a lot of these companies. So we’re happy to see that.

At the same time, sadly, some of what we haven’t seen is them fixing their problems. So you look at an airline like American, who was already struggling and was going woke to cover from that, basically, since we’ve launched our campaign, it’s been an unending string of bad news for that company, mainly focused on their incompetence and their inability to run an airline.

Just over the weekend, they had to cancel thousands of flights. And the pilots union representative that spoke on the topics said, basically, they are failing at the most basic aspects of running an airline, which is attach staff and pilots to these flights and get them in the air.

So it makes you question, is the COO, [David] Seymour, and the CEO, Doug Parker, are they in a room somewhere talking about woke politics when they should be running the airline or what?

But we hope that they will, either them or their board—or ultimately, the shareholders—will take more seriously the management of that company and get them focused away from politics and back to the task at hand, which is running an airline.

Blair: Now, you mentioned that certain businesses maybe aren’t responding in the ways that we’d like, but there are certain responses that are coming out at all. Are you saying that maybe it’s more the consumers that are responding to these campaigns then?

Hild: Yeah, we’ve had overwhelming response from consumers, thanking us for speaking up for them. That’s one of our missions at Consumers’ Research, is to speak up for the consumer in the marketplace and to educate them about issues that are important to their interests.

But I don’t want to downplay it. I think when the campaign launched back in the summer, it seemed like every day some corporation or group of corporations was coming out and speaking on some issue that wasn’t germane to their business. And that does seem to have decreased, I think, fairly significantly.

I’m not in those rooms. Obviously, they’re not going to invite me in anytime soon. But it does seem … tempo and volume of politic speech on these issues coming out of corporate America has decreased since we launched.

Blair: I feel like we scratched the surface on some of the issues that are resulting from companies that are going woke like American Airlines. Obviously, you said there’s quite a bit of problems going on right now, but sort of at a larger level, what are the real dangers in companies like Nike, American Airlines, BlackRock engaging in woke capitalism?

Hild: Absolutely. Well, I mean, it’s the same danger that exists anytime you have bad actors who try to use grandstanding and virtue signaling to cover from what should be the focus, which is fixing their problems.

I think, broadly speaking, we have a free market system here in the United States, and that’s based on the idea of calling balls and strikes. In other words, instead of a planned economy, state economy, like our frenemy China, you don’t really have much of a say if you don’t like what a company’s doing, not just in the services they’re providing, but what they’re doing to your community or doing to your society, or that kind of thing. You have to go to some political official and hope that he’ll hear you out, and then he’ll issue some dictate.

Here in America, the idea is that we have a right as Americans to not just not buy the goods, I think too much of a focus gets made on that, where it was always, “It’s just all about money.” It’s not, you have a right in a democracy to discuss whether you think something’s a moral decision or whether a company should be shamed for doing something.

And I think that’s an important aspect that has been not lost, but certainly not been fully represented in the American marketplace’s idea that consumers can come together and say, “You know what? We really just can’t stand listening to you bloviate from your ivory tower.”

In the case of Doug Parker, they got a guy whose airline required a multibillion-dollar taxpayer-funded bailout. The same year, he gets a 10 million-plus paycheck in the form of stock options, courtesy of the American taxpayer. And then he’s bloviating on politics and weighing in on issues he doesn’t know anything about.

And I think that is something that at a higher level, Americans are kind of waking up and saying, “You know what? We’re sick of this. And we are going to tell you that we don’t like the cut of your jib. You should be ashamed of what you’re doing. It’s not seemly.”

Blair: Now, I want to highlight something you just said, is that they’re bloviating about politics and morality. Does politics have any place in business at all? I’m curious if the problem here is that woke capitalism is the issue, or it’s just that politics and business should not mix?

Hild: That’s a good question. The phenomenon that we saw was that woke politics was being used as a shiny object to shake, while you were using forced labor in China, or subsisting only on government payouts, while eight-figure paychecks go to your CEO, Doug Parker. And so, to us, that was the focus.

And a lot of times we get interviewed, and say, “Well, what … ” They kind of want me to write a whole list of rules for corporate America. And it’s sort of like, I just want them to cut out this fraud. Just stop doing this thing where you got really shady stuff, you got skeletons in your closet. You may actively have your business model failing in the case of American Airlines, and yet, you won’t just deal with the problems.

So I would say, generally, as a rule, consumers should have this expectation. Companies should be focused on politics as it pertains to their business model. Is it something that they need to talk to a congressman [about] because, like I said, there’s a sugar tax issue or a tariff or something like that? That is in the mission of serving the consumer, because they’re trying to figure out, “How do I produce the highest quality good for the lowest price for the most amount of people?” Every business is trying to basically do that.

What is very suspicious, and in this case I think very villainous, is when they get into politics, not anything to do with serving the consumer, only to serve themselves at the expense of the consumer.

Blair: So if American Airlines is talking about Black Lives Matter, that really has nothing to do with the airline business, it’s more—

Hild: Right. Absolutely. Let me put it this way, it is extremely suspicious if they are. … Doug Parker loves to brag about the fact that he does not get a salary, he gets a stock option. His bonus is based on stock compensation. So at least in theory, his compensation is performance-based. Doesn’t seem to work out that way, but whatever.

Let’s take another example of something that’s performance-based. Most car dealers, when you go in to buy a car, you say, “Hey, I’m here to buy a car.” They don’t go, “Well, let me tell you about Black Lives Matter for the next 15 minutes.” Because their paycheck is reliant on the fact of them getting you into the vehicle on that dealership.

Every company in America is effectively a car dealer because they don’t have somebody like, I guess, Doug does. He’s got the U.S. taxpayer. But absent government bailout, most companies are that car dealer. They have to sell you a good or service that you want in order to stay in business.

And so, it should be really suspicious when you walk up to the car dealership, and I mean that metaphoric, like if you walk into any business in America and they suddenly just want to talk to you about something completely unrelated. It makes you question, it’s like, “Well, do you really have faith in your cars? Are they breaking down back there and you’re trying to hide something?”

And so, I think that’s the issue, is it seems to be a problem that is recent. And every time you look into it, these companies have a real issue that they really don’t want to talk about. And in some cases, it’s like strangely related to the thing that they’re bloviating about.

Like BlackRock’s got all these environmental rules they’re trying to pose from the top-down on American corporations. But then in China, it’s just like freewheeling, they’re invested in … PetroChina and all these crazy polluting companies. It seems they’re covering for that specific thing so they have something they can hold up and be like, “Oh, look how good we are.”

Blair: Interesting. I want to go back to Consumers’ Research as an organization. As we mentioned at the top, you guys highlight issues that affect consumers and then offer them sort of like guidance on how to consume better. How do you guys do that? What’s the work that you guys do to educate the consumer?

Hild: That’s a great question. Well, historically, the organization was founded in 1929. We’re the oldest consumer protection organization. I wasn’t there, obviously, which is probably for the best, because then I wouldn’t be here. And it started out as pretty much your first product testing organization.

We had a lab of about 500 people in Washington, New Jersey put out the Consumers Bulletin, which is now a website, by the way, consumersbulletin.org. And it existed because there really was no product testing in America.

The founder, Frederick Schlink, had written a book called “100,000,000 Guinea Pigs,” which was a reference to the population of the United States at that time. It’s basically saying companies were just putting out products and, “We’ll see what happens.” And that continued for a good portion of the life of the organization.

However, luckily, the market actually provided new products and services like Yelp and Google Reviews. And you don’t really need that as much anymore. Even websites like Lifehacker and Wirecutter are having trouble because there’s just so much aggregated, crowdsourced reviews of things.

And so, we moved into a space of trying to go from kind of a shotgun blast approach to more of a rifle shot, where we would look for real issues that consumers kind of were missing, that aren’t going to show up in a Google Review for American Airlines, or certainly not for BlackRock, and try to educate them on an issue that maybe isn’t right at the surface level, but is affecting their experiences as consumers. And so, we’ve kind of shifted focus over time as sort of the product testing has been taken over by the sort of crowdsourcing internet age.

Blair: Your campaigns target quite a few different businesses. Coke, obviously, the drink company and food; Nike, sports apparel; American Airlines, a plane; and then BlackRock. We got all that stuff. How do you guys determine which issues you direct your consumers to sort of look at?

Hild: That’s great question. Well, it really just depends on what we see as the sort of greatest factor going into this. So like for American Airlines and Coca-Cola and Nike, they were all companies that had massive hypocrisy at the same time that they were bloviating on subject after subject. And so, it seemed like something where people needed to understand—we’re sort of introducing the consumer to this trick that these [companies] were pulling.

It’s sort of like you’re walking down the street in New York or Chicago, whatever, and you see someone doing like a Three-card Monte scam on somebody like that. There’s a crowd of people gathering. They’re moving the cards around or whatever. And you walk up and you just explain, “Actually, the card’s in his—he’s moved it … none of the three is the card that you’re looking for. You’re never going to win.” Well, you’ve effectively beat him. You don’t have to arrest the guy at that point, because you don’t have the power to, we’ll say. But you’ve destroyed his scam because you’ve explained the trick.

So, initially, for the Consumers First Initiative, we just wanted to explain the trick to consumers, that what’s going on here is when you see them take this weird stance on something that’s not related to their business model—and I will note, I know I keep hammering on American Airlines, because it’s such a great example of this. It was so oddly ironic that they would take a position at the time they were really getting involved in some election integrity legislation that was going through Texas.

And one of the big things they hit upon was that you were going to need an ID to vote. What’s really weird about that is you need an ID to use their product. So not only are they out here getting involved in something that’s not germane to them and they have no expertise in it, they’re sort of taking a position that’s in direct contradiction to their own business model. And so, we wanted to explain to consumers that were mystified by this, “Well, here’s what’s really going on.”

And then with BlackRock, we wanted to show, to stretch the Three-card Monte metaphor way farther than I should, that the Three-card Monte operator has a boss and you may not know who he is, but he’s the guy putting all these guys out there. And he’s the one pushing them to do this.

And BlackRock plays a significant role in pushing American corporations away from their main focus, which should be producing value to consumers in order to return value to their shareholders. And they’ve instead hijacked the management class and provided all these perverse incentives for them to serve their own interests, either to be punished or rewarded for sort of engaging in woke politics and cozying up to woke politicians. So we’re trying to explain the street-level trick, and then explain the sort of boss guy and where he’s at and what he’s doing.

Blair: Let’s say you’re given the opportunity to maybe sit down with the CEO of American Airlines or BlackRock. And you are going to explain to them what Consumers’ Research is trying to do? What do you say to them?

Hild: What I would say we’re trying to get them to do is just to cut it out and just focus on flying a good airline. American Airlines used to be my airline. I always flew. And I just watched the quality go down and down and down.

And then you look into a little bit of what Doug Parker’s been doing during the management cycle—I think in 2016, there’s a good Forbes letter on this. It talked about in 2016, I think the company started off with like $5.5 billion in cash, just sitting in the bank.

By the time the pandemic had rolled around, they had spent $5 billion of the cash and then borrowed more, I don’t remember the exact amount, to do stock buybacks—which, remember I noted that Doug Parker’s compensation is exclusively based on stock compensation, which he claims keeps him honest about his performance. Because it’s all, “I don’t get just paid for sitting in the seat. I have to produce value.”

Well, what he’s done over his tenure is effectively just use stock buybacks to goose the price. And then when the pandemic rolled around, there was no money in the bank. It’s sort of like spending all your rainy day fund. And he had to run to the U.S. government for a bailout.

I bring this up because what I’d say is, “You spend all that money putting stock options in your pocket. You either could have returned more value to shareholders or my preference is you could have invested in newer planes, more leg room, given your workers a wage so that they’re happier on the job and more training so that they can handle issues better.”

I mean, $5 billion could have gone into improving that airline. Instead, it’s sort of like they stripped it for parts and then sold it so that they could goose his compensation. And then they pretended as if COVID was the entirety of why they needed a bailout. And that just isn’t true. They wouldn’t have needed one had they been saving that money instead of spending it.

I mean, obviously, it’s a long way of saying a very simple message, “Just get back to serving your consumers and stop cozying up to woke politicians because we’re done playing that game. We’re going to name and shame you when you do that.”

Blair: So as we wrap-up here, if our listeners would like to learn more about your campaign against BlackRock or American Airlines or Nike or Coke, where should they go?

Hild: Absolutely. Well, I’m going to shill exclusively here for our website on BlackRock. People can visit blackrockloveschina.com and find out all the dirty details that CEO, Larry Fink, doesn’t want you to know about. And we hope you’ll come watch the ad there.

Blair: Very good. That was Will Hild, executive director of Consumers’ Research, an educational organization seeking to highlight issues concerning to consumers. Will, very much appreciate you joining us.

Hild: Thank you so much for having me.

A Note for our Readers: Stay alert for next week’s info regarding Morgan Stanley.

On Sunday, a car plowed through a Waukasha Christmas parade, killing five and injuring over 40, many of whom are children. The heartbreaking footage is extremely explicit in its revelation that the criminal was purposely avoiding some people whilst pro-actively seeking to hit other individuals. Obviously, the media has immediately leapt to the defense of the black, career criminal in order to establish a narrative regarding this brutal and racist mass homicide: the criminal was fleeing another crime scene and drove across the parade “by accident” in order to avoid  .  .  .  what, we do not know, and this has already been debunked by knowledge of the direction from which he was driving, the alleged previous crime scene, and the location of the parade.

As if the Rittenhouse trial was not sufficient proof that there is no neutral media: CNN at 9:30 Eastern on Monday the 22^nd of November, was still refusing to provide a profile of the criminal, alternately calling him he/she, then accusing an SUV of being responsible, although they had access to the police scanner audio broadcast description of the perp., available to the public. The description runs thus: “The guy is Durell Brooks, lighter skinned black male with dreadlocks”. He was released on a 1000$ bond, two days prior to the mass killings, for domestic abuse and bail-jumping. He is also a registered sex offender (pedophile), and a pimp, his social media is full of BLM nonsense which in a sane world would be defined as domestic terrorism. The media is covering for the perpetrator of the crime because of the colour of his skin, and therefor does not fit their narrative. Lies get amplified, truth is smothered in silence.

Research on the criminal suspect have established his racially motivated disdain for white people, bodily animus towards the police, criticism of the Kyle Rittenhouse verdict, his lamenting of the death of George Floyd, his quoting of Malcolm X, his black supremacist sympathies, invocations to kill white people, his openly admitting in social media videos to having sex trafficked underage girls, his creation of rap songs in which he raps about being a terrorist and killing white people, his being charged with 11 crimes dating back to 1999, substantial battery and bodily harm, strangulation and suffocation, statutory sexual seduction, obstructing of an officer, 2 recent accounts of recklessly endangering safety with a dangerous weapon, 1 count of illegal possession of a firearm, , domestic violence, bail jumping, attempt to run over the mother of his child with his car.

 Not only does this tragic event shed further light on the sad state of race relations in America; it has opened a Pandora’s box of details regarding the radical left’s intervention in the judicial process, with George Soros leading the way of private funding to radical prosecutorial nominees.

Durell Brooks was released on Nov 11^th for questions of “court congestion” on a thousand- dollar bail provided by DA and progressivist hero John Chisholm.  This Durell Brooks has a list of crimes as long as your arm, but he had been incarcerated in Milwaukee, which has a serious backlog of criminal cases, exacerbated by this notion that if you are poor, you should not be held in jail because you cannot pay the bail, and therefore criminals get rereleased onto the street for a minimum amount of money. With this perversive logic, we have criminals back on the streets, with this tragic slaughter being a case in point. Judge Mary Triggiano: “We’ve taken this pandemic very seriously, including the variants. We’re being very careful,”, with regards to the backlogs and their unwillingness to keep people in jail. But the case of Durrell Brooks demonstrates that the tendency to dismiss crimes and misdemeanors executed by the black community dates back prior to the Covid emergency, all the way back to 1999.  This man quite simply should not have been put back on the street.

But this is part of a broader prosecutorial strategy embraced by the left, imposed in major cities across the US and Europe.  And this is the reason for which a major increase in crime has been observed over the last few years. Prosecutorial strategy has changed dramatically. Individuals like Soros have poured millions of dollars over the past 7-8 years into electing left wing prosecutors across the country. Jeffery Tubin, previously well- known legal commentator (now infamous for not being able to keep his hands out of his pants whilst participating in Zoom calls with colleagues), wrote a gushing piece in 2015 for the New Yorker Magazine, called “the Milwaukee Experiment: What can one prosector do about the mass incarceration of African Americans?”  “Like many people in the criminal justice system, John Chisholm, the DA in Milwaukee County, has been concerned for a long time about the racial imbalance in American prisons. the issue is especially salient in Wisconsin, where African Americans constitute only 6% of the population,  but 37% of the residents of state prisons. According to the University of Wisconsin, in Milwaukee, as of 2010, 13% of the state’s African American men of working age were behind bars, nearly double the national average of 6.7%. the figures were especially stark for Milwaukee County, here more than half of black men in their thirties had served time in state prison. How, Chisholm wondered, did the work of his own office contribute to this situation?” (Here comes the motivating logic of the Left, and the animating philosophy of the present day Democratic Party:  if a disproportionate number of people of a certain race or ethnicity are in jail, it must be because the SYSTEM is evil and corrupt. The problem is that the result of this kind of rationale means letting criminals out of jail. If you desire to have fewer black people in jail, you either have to identify who is innocent, or solve the festering problems with the black community, or you’re going to have to release criminals onto the street.   

So Chisholm decided that his office would exercise prosecutorial discretion by taking initiatives to send fewer black people to prison, while maintaining public safety (Wisconsin residents should demand this idiot’s head on a platter). What is the idiotic logic behind this decision? Do not release confirmed criminals based on race, colour or ethnicity! It is not permissible to release criminals form jail in order to “even out the numbers”. Chisholm said that prosecutors should be judged by their ability to reduce numbers of mass incarceration and achieving racial equality. Wrong again. Prosecutors should be judged solely on the reduction of crime rates. Americans have an adversarial system. It is not the job of prosecutors to determine whether mass incarceration is an issue, or achieving racial equality in outcome.This is the reason why there has been a spike in murders in Milwaukee over the past few years. Chisholm’s efforts have drawn attention across the country. Cyrus Vance, Manhatten’s DA, says “ John is a national leader in law enforcement, because he is trying to achieve the right results, not only in individual cases, but also in larger policy issues as well.” Chisholm reflects a growing national sentiment that the system has failed African Americans!”

In the US, that is the propaganda emanated from the Ministry of Truth: that left wing prosecutors are doing a great job at evening out the numbers, and that is what is most significant. So the entire basis for criminal justice in Wisconsin has been rooted in this “New Jim Crow”: “ if black people are in prison, America must be racist” philosophy , as opposed to : you are a prosecutor, lower the crime rate by  prosecuting criminals who commit crime. Digest this: there were 941 victims of homicides in Milwaukee alone in 2020.

This is case in point of one of several DOZEN rogue prosecutors elected to public office, thanks in most part to Soros (or his political action committees or wealthy liberal friends). Their goal, as written in a major research paper on the rogue prosecutor movement, is to fundamentally reverse-engineer the criminal justice system by replacing independent law-and-order prosecutors with pro-criminal, anti-victim zealots who flout the rule of law, abuse their offices, and as a result, see crime explode in their cities.

This strategy is dear to the withered heart of George Soros. By the way: we’re not supposed to nominate Soros with regards to his funding of wild, left-wing causes because it would be considered anti-Semitic, but it is quite simply the truth. And he certainly cannot claim the sympathies of Orthodox Jews, nor is he in any way a Believer.  He is a radical left-wing fanatic who has spent billions of dollars on various radical causes around the globe. This is a very bad man who does very, very bad things. And the Left celebrates him for it as a ‘philathropist’.

Politico reported, back in 2016:” George Soro’s quiet overhaul of the U.S. Justice System”: “ While America’s political king makers invest their money into high profile presidential and congressional candidates, Democratic mega-donor G.Soros has directed his wealth into an under-the-radar 2016 campaign to advance one of the progressive movement’s goals: reshaping the American justice system. The multi-billion dollar financeer has channeled more than 3 million dollars into 7 local district attorneys receiving money directly from Soros (Florida, Illinois, Louisiana, Mississippi, New Mexico and Texas) campaigns in 6 states over the past year, a sum that exceeds the total spends on the 2016 presidential campaign by all but a handful of rival super donors. His money has supported A.A and Hispanic candidates for these local, powerful roles, all of whom ran on platforms of major goals of Soros, like reducing major disparities in sentencing, directing some drug offenders to diversion programs instead of to trial. It is by far the most tangible action by a progressive push to find, prepare and finance criminal justice reform-oriented candidates for the jobs by long term incumbents.”

Politico, 2021: “Four Wealthy Donors fuel Overhaul of California’s Political Justice System”: “The Social Justice movement has never lacked for energy. Last year’s death of G.Floyd sparked waves of support for BLM. Progressive donors have strategically targeted prosecutor races in major cities, because DAs wield power over sentencing and investigations. In California, social justice advocates are preparing to defend the State’s top prosecutor AG Rob Banta, who is closely aligned with the reform movement, and was one of the nation’s most liberal AGs.” “The last 10 years have been the biggest change I’ve seen in terms of philanthropic interest in these issues”, say Lenore Anderson, who speaks for “Californians for Safety and Justice” when you have that shift then the door is open because you have the winds of change. In California, few causes get far without a pile of money. 4 donors channeled 22 million dollars for criminal justice ballot measures, and LA candidates for the past 2 years. In 2018, an organization of G.Soros funded the DA campaign.

It will not however be possible to find common ground in any discussion, if the Left refuses to acknowledge the difference between Kyle Rittenhouse cleaning up graffiti, providing medical care, and then being chased down by child rapists and wife-beaters, serial criminals and antifa thugs, only shooting people who violently attacked him and attempted to kill him, and a career criminal who deliberately plows through a crowd of innocent women and children at a parade. If, in these two cases, the Left acts as if the only differentiator is race, then they are not only ignorant and racist but also completely demented. The American media is intensely racist, anti-white as a rule with a bias against whites, paternalistically condescending to blacks, and they perceive and interpret everything through the lens of race, distorting reality.

Transcription of an hour of interview with Catherine Austin-Fitts

Catherine Austin-Fitts, Planet Lockdown, Solari Investment Advisor Services

“For many decades the American dollar has been the reserve currency, whose function and stability is somewhat long in the tooth, and central bankers are  trying to bring in a new system, but it is not yet ready to be implemented. We are in a period of great change and uncertainty, during which central bankers are trying to keep the dollar system going, lengthening its period of use whilst accelerating the bringing in of the new system. They have to bring in the new system without anyone quite realizing exactly what it is. So we’ve had this global reserve system, the dollar, and it needs to evolve and change. The central bankers are trying to bring in the new system and to do it they are extending the old and accelerating the new, meeting at a very chaotic center, since much of the new is being tested and tried and prototyped, and involves many diferent industries.

The New System might best be described as the end of currencies. We are not bringing in a new currency, we are bringing in a new transaction system that will be all digital. This involves essentially all the money on the planet, therefore it’s big, complicated, messy, and the challenge to them is this: how do you market a system that no one would want if they were to fully understand it? And of course, the way you do that is with a health care crisis. This is because if a few people want to control the many, they have to have a strategy to herd all of the sheep into the slaughterhouse without them realizing and resisting. The perfect solution is the ‘Invisible Enemy’, such as the War on Terrorism (leading to Patriot Act), and now we have the War on the Virus, which is truly invisible. The Invisible Enemy is the perfect solution, allowing the Few to introduce fear in order to lead people to believe they require more gov’t to combat the invisible enemy. The other Age-old strategy is ‘divide and conquer’: if you can use the media to turn women against men, blacks against whites, immigrants against the general population, getting gov’t in the middle, that is ploy of distraction. The invisible virus provides extraordinary control mechanisms: you can prohibit individuals from gathering, you can stop people from getting together and talking about what is going on, if you digitize it with contact tracing, you can control who is talking to whom, can control their work, and with education on- line you can literally listen in on everything they are saying. You can institute extraordinary amounts of surveillance and control, justified by the belief that the population is being protected from ‘the virus’.

I am not underestimating the gov’ts capacity to introduce pathogens which can kill people, nor am I denying that people are getting sick. But essentially, what is happening is that we are being set up to buy into a solution, without seeing ultimately where these measures may be heading. We are talking about a transaction system which is no longer a currency, it is a control system. It is like a credit at the company store. If your company or your banks come up with a digital central bank currency, they have the ability to  turn your money on and off, so if you don’t behave, that’s it. And we know they want to combine this with tras-humanism, which means literally that I take injections that can institute the equivalent of an operating system in my body, and so I’m hooked up to the financial system literally physically.

The “Concentration in Control of Cash flow Act” aka. “The Patriotic Act” is a very similar process.  It is the dramatic centralization of political and economic control. Let’s take an example: You have 100 small businesses on Main Street, you declare them non-essential, you shut them down, but Amazon, Walmart and BigBox  multiNationals can continue to work, coming in and taking away the market share of these small businesses. In the meantime, the owners of small businesses on Main Street have to continue paying off their credit cards and mortgages, so they are in a debt entrapment CREATED BY THEIR OWN GOVERNMENT. They are desperate to get cash flow for their regular expenses. In the meantime, you have the Federal Reserve institute a form of Quantitative Easing, whereby they are buying up corporate bonds and the guys who are taking up the market share can basically finance at 0-0.1% while everyone on mainstreet is paying 16-17% on their credit cards without income. At this point they have the mainstreet entrepeneurs over a barrel and can take away their market share,  because though they try to fight back, they are generally  too busy trying to survive.

The Globalists realized that they had a problem with the results of the 2016 elections, which pointed towards a changing tendency towards populism (Trump, Sanders): the global capitalist class realized that they had a problem, and that they would have to destroy the independent income of small practitioners, businesses and people who have independent forms of income due to their supporting of a anti-globalist figure such as Trump: If you are a doctor working as a single practitioner, a lawyer, a Cpa, you are going to support the populist candidate for obvious reasons. The way to shut the populist candidates down is to shut down their support: put mainstreet out of business, there is then no one to finance a Bernie Sanders or a Donald Trump.

We are in an economic war. Since April 2020, we have seen global billionaires increase their net worth by 27%. This tells us that this has been a very successful global economic war for them thus far. The global ‘capitalist’ class, although they would be better described as “economic totalitarian”, they have been able to consolidate fantastic amounts of economic wealth, not just by deleting the income and wealth of the middle class and consolidating it into their companies, but by significantly improving the economic power of the largest of the G7 countries and China vis à vis the emerging markets. The countries with the most advanced technology and access to AI and software,  including digital systems working in Space, are dramatically consolidating power vis-à-vis the developing nations. We can see a consolidation of economic power, a centralization, both into the wealthier and more powerful nations, and the top 1% who control them.

I would describe COVID19 as the institution of controls necessary to convert the planet from democratic process to technocracy. What we’re observing is a change in control. And an engineering of new control systems. We can think of this as a coup-d’etat, rather than a pandemic of a virus. For 20 years in the US there has been a financial coup-d’etat. We knew that at the end of 1995 a decision was made to move much of the assets and wealth out of the country, which was part of bubbling the global economy. And they knew that once they moved all of those assets they would have to consolidate and change the fundamental system, so after the financial coup, you’ve stolen all the money in the pension funds, you’ve stolen all the money in the government, and now, rather then turn to people and say “We stole your money”, you need an excuse to consolidate and change the system, and so you have a magic virus. Because of the magic virus, we have to suddenly change the system, thanks to the magic virus there is no money in social security, thanks to the magic virus there’s no money in the Treasury: you have your perfect, magic excuse! it is evident, because every implication of the financial coup has been magically solved by the magic virus. If you are involved in finance and you look at events through the perspective of time and money, it’s quite amazing that anyone would believe this, but they do!

The technocracy that they are pushing towards is what is called transhumanism. Essentially what you do is you use injections to inject materials into the body that create the equivalent of an operating system. We are all familiar with the Microsoft Operating Systems which permit Microsoft a backdoor into your private computer, and every few months it has to be updated because there are ‘viruses’ (we’re back to the magic virus). It would be a similar system for your body, and you can literally hook everybody up to the cloud. That includes hooking up a transaction system, which the Book of Revelation defines as the Sign of the Beast. We are talking about being able to digitally identify and track people in connection with their financial transactions. There is 0 privacy, but more importantly, what is important to understand is that if you then institute one or more Central bank crypts, you’re now talking about a system where every Central Bank in the World can now shut you off individually from transacting if they don’t like the way you’re behaving. So, many people are familiar with the social credit system in China. it is extremely similar. You install a smartgrid in their community, then in their homes, then literally in their body, you’ve got 24/7 surveillance and if people don’t do what you say or desire, they can be shut off from their money. If you say they cannot travel more than 5 miles, that’s it, because you are in a complete digital control system, and it is control by the central bankers through the money.

We’re digitizing everything, but this includes the human body and mind, this system comes with control of your ability to transact financially, which is hooked up to your body, but also very sophisticated mind control technology through the media and those cloud connections. Like hooking up into the Borg. Transhumanism and technocracy go hand in hand, best described as a slavery system. We are talking about shifting out of freedom of movement and speech into a complete control system 24 /7, including mind control. Now, the challenge before us is if the Committee that runs the World (“Mr.Global”) wants to transit to a slavery system, then we have a fundamental disagreement.

Firstly, we have the military placing strategic satellites, then we get operation Warp Speed, followed by BigPharma preparing these mysterious injections which modify your DnA and make you infertile. Then we have the media pouring out the propaganda, then we have the Central Bankers engineering to the crypt currency systems. In the daily media, news regarding these pillars which will sustain the New System are purposefully disassociated and kept apart so that the general population is unable to observe that this is an integrated system controlling your body and your mind, for the purpose of instituting the slavery system. If I am going to do everything through a smart grid, and I am going to run the smart grid into your neighbourhood, then into your body, the question is:  how am I going to build all of this without you seeing the trap? Central bankers attempt to stay far away from the aforementioned conversations, because – at least in the US – there are 329million Americans and +329 million guns, so they don’t want people to see this until the trap is thrown.

We have been put in a trap this year. But the door hasn’t shut. Transparency can blow the game. At the beginning of the year, when I wrote the article stating that Bill Gates is trying to download an operating system in your body and mind, using the virus as an excuse to update the system. In the autumn, Yahoo did a poll which revealed that 44% of Repubblicans are convinced that Gates wants to chip them, and so I thought, ‘Ok, we’re making progress!’ That is the moment in which Gates disappeared and they came out with Operation Warp Speed (led by an expert  – former Glaxo-Smith – Kline – in injectible brain-machine interface), because they needed to improve credibility.

One of the most important developments that happened in 2019 in addition to the approval of the GOING Direct plan by the central bankers and Jackson Hall, was the issuance by the Dep’t of Defence of the Jedi Cloud contract to Microsoft. So you had Amazon receive . . . (Amazon is essentially a CIA and Intelligence agency contractor. They started making major profits when they entered into contracts with the CIA, providing clouds not only to the CIA but all 17 US Intelligence Agencies through that umbrella cloud contract).

So you now have Amazon running the Intelligence agency’s contract, this year Ledos did a big contract with the Navy, and then DOD did the Jedi contract. So those 3 huge Cloud contracts give you the ability, once you get everybody hooked up into them, to radically influence how the cashflows work. You can literally shut down all small business, put everybody on a universal basic income (A CONTROL SYSTEM), and run it all through the military clouds.

The reason is simple: technology gives you the ability to institute a complete control system, and the ability to centralize economic and political control. A perfect example: the reason the African American slave trade ended 1) you couldn’t perfect collateral so the banks in London would lose money because the plantation owners who were in the commodities market, when it went down would sell their slaves west, and the banks couldn’t get their collateral. So they would finance the purchase of a slave at 50% loan to value ratio, and when the commodities markets were down they would sell the slave, say he ran away and the bank would be hung. The banks couldn’t prove that  so-and-so was their slave, because they had no way of perfecting their collateral. 2) the Haitians rebelled, and though the military was sent in, they were never able to quell the rebellion. Now, with this new technology, you can perfect the collateral. And with this new space weapon technology and the kind of weaponry you have from space surveillance, you can suppress any rebellion.

So, the reason that the slave trade – trading in slaves is unbelievably profitable – the history of the world has taught that slavery is the most profitable business. More than mining, than narcotics and all the addictions. (Just look at the Narcos who have transferred their business to illegal immigration!) So, if you now have the technological ability for the implementation of slavery, their attitude is : “Ok, let’s do it!” Technology also makes it much easier for a small group of people to get together and be very powerful. So if they bring in breakthrough energy technology, the danger is that a small group of people can weaponize it. Technology is powerful. The more powerful tech you integrate, the greater the danger of losing control. Now, there are other theories as to why people would want complete control. Given the challenges of feeding a population that is getting ever larger, if you now have biotechnology that allows Mr. Global to live 150 years, you can’t keep that secret. If they are living much longer than we, that can’t be kept a secret. So why not downsize the population, integrate robotics, use robots for everything and yet have a very luxurious life without the management headaches? Imagine a small uber class and a larger peasantry mixed with robotics. Mr.Global is using technology to move to a system where, between robotics, Ai and software, you can control the many with far fewer headaches and fear. Remember: Mr. Global is very fearful of the general population. The leadership in the US has gotten together to establish how they can undo the secrecy, and each time, they come to the conclusion that it is impossible. The liabilities are too enormous. If you are the Swamp, and you are guilty of all the things the Swamp is guilty of, and you try to open the window on the secrecy, you run tremendous risks. Our history teaches us that the general population has turned on its governments in the past and has killed the leadership. There are more that 325 million privately owned guns in the US. But the above described scenario is why the second amendment is such a fractious issue. Many people around the world don’t understand why in America the population is so strongly in favour of owning guns. The first reason why they don’t understand the importance of owning guns is because they don’t understand the power of mind control! if I can institute total mind control -which is what this system is, guns aren’t that dangerous to me, but for the leadership to do what they want to do, it would be very convenient if they could bring in the guns. If the Democrats win this election, that is the first thing they’re going to try to do, after making everyone wear face diapers. This is why Repubblicans holding the Senate has been such a big issue, because they cannot do this if Repubblicans hold the Senate.

There is an old tradition in America of voting fraud, and neither one of the presidential candidates would have been the candidate without the voting fraud to begin with. But the voting fraud has never been so blatant, and it is interesting to observe that even with voter fraud, they could not have stopped a Trump landslide without Covid19, so the question is : how much of the timing of the health care op. is designed to ensure they won’t get a populist president? Trump, by the way, is not a populist even in the widest sense of the word, but he is an outsider of the Swamp establishment. He was very much on board for the pro-centralization team, but he is, in Michael Moore’s words, the American peoples’ way of saying F!”? You to the leadership. It was very important to Mr. Global to get rid of Trump. The problem is, they’ve used massive voter fraud to do it, but they’ve used the fraud in a way that is obvious that the fraud is off the charts. It is almost as though they are turning to the population which they are trying to turn into a cult, saying “you have to pretend this guy is your president”, even though you know he is not.” So we have a fake virus and magic virus, and a fake president and a magical political system, and it really is getting very cult-like.

From the minute they began to steal the money, we moved into a bizarro world, the only difference is now as they moved all the money and the official reality moved away from actual reality further and further, which is part and parcel of the secrecy, many people thought they could stay in the middle of the road. Now what is clear is, you have to go with the cult, or you have to go with truth, the middle of the road is now a great divide. We are at a turning point, and everyone has to choose.

Let’s go to the riots (BLM). When the riots began, people were not permitted to go to Church because of the magic virus, but you could go to the riots and protest (and loot, destroy, burn and KILL). My team and I started to look at the riots. Firstly, the Solari team looked at the state, the cities, and whether or not the governor was Democrat or Repubblican, and what the COVID cases and deaths were. Then, the team checked a box for where riots had been. We started to look at the patterns of the riots vis-à-vis the political machine control of the covid magic virus op, and there was something wrong, when I was looking at the data, and I could intuit that something was up. We created a check box for the Federal Reserve, and check the box (there are 12 banks, 1 headquarters, and the branches, for a total of 37 locations). I wanted to check the box in any city where we have a branch or bank, or headquarters. What was discovered was that 34 of the 37 bank locations had riots, which is a pretty distinct pattern. Realizing that there was something to this pattern, we began to drill down. Starting with Minneapolis, we took the data of all the buildings and businesses which were harmed or burned, and we’d map it, to observe how close they were to the federal Reserve Bank, and draw in the ‘Opportunity Zones’ (a tax shelter mechanism created in 2018, to help the tech billionaires as they sold their stock, avoid capital gains. You can – if you’re Jeff Bezos, who sold 10 billion dollars of stock this year – if you were to roll over your proceeds into an opportunity in investments and handle it in a certain way, you can avoid all capital gains tax. So this is fantastically profitable. If you look at the riots, what I first saw, of all the buildings and businesses destroyed were right at the bottom of the opportunity zone, I started to laugh. I was assistant secretary of housing. That is not a riot pattern: that is a real estate acquisition plan. Here we had thriving businesses, many of which were owned by African Americans and Hispanics along a particular boulevard in the opportunity zone, if firstly I declare the businesses non-essential and shut them down (magic virus), then I have riots that burn and damage them (if I were really clever I would have pulled their insurance right before doing it). Now the businesses are shut down and they are hung on their debt, their buildings have been damaged and of course insurance would not cover all repairs. So it will be much easier and cheaper for someone like Bezos to go in and buy up all of those buildings. E voilà Disaster capitalism.

We then mapped Kenosha, Portland, and other cities, the pattern of where the damage is, speaking as assistant secretary of housing, those are real estate acquisition plans especially when it come on top of declaring those businesses non-essential and shutting them down. In San Francisco, 49% of businesses are expected to be bankrupt by the end of the year, that is so much real estate that can be picked up cheap, it is mind-boggling. When you realize that if they sell their tech stocks high, they can pick it up really cheap, this makes the economics of building the smart grid out in the Fed cities (34 of 37 riot cities have a Fed Banker Branch), this makes the building out of the smart grid around the Fed banks much cheaper, which I’m assuming you want to do if you’re coming out with a crypt system.

The defining characteristic of life on planet earth is that our real global governance system is a mystery. Incredibly, we live on this planet, and we don’t demand to know how our governance system really works.

So Mr. Global is now coming to the point where he is implementing robotics, and is deciding  – between humans and robots – which is more efficient at doing what. If I am supposed to manage the planet and all its natural resources, and harvest it to my benefit, reassuring that my risk is reduced, how much do I want to use robots for and how much do I want to use humans? One of the results of being hooked up to the cloud system is to provide software for humans to interface with AI and show them how to do all their jobs. So we have a hierarchy of systems: Mr. Global at the top, the cloud platform providing digital interface and software, as well as satellites system being put up in the orbital platform. And using telecommunications technology you have the ability 24/7 to track and monitor both you robots and your humans. Mr. Global wants to know: what is more efficient? If I can do everything with robots, then what do I do with the humans? I don’t need them anymore.

This would be described as resource management. if you look at the writing of technocracies, you perceive a completely different vision of the world. My vision of the world is that human beings are sovereign individuals whose freedom derives from Divine Authority. That is the belief expressed in the Bill of Rights, the Declaration of Independence, the Constitution. The image of a sovereign individual as someone who is free by Divine Authority. In the vision of technocracy, a human is a natural resource, like and oil deposit, and is to be used accordingly. They are not sovereign individuals, they are labour, and they are either more or less efficient than a robot at various functions. Mr. Global views the human race like livestock, not someone with whom they share empathy . They don’t view us as the same species as them. And with the new biotechnology, they assume they are also going to live far longer and far differently that we. One of the challenges with the secrecy as one group becomes more and more technologically advanced, they separate culturally, legally, financially from all the other groups. They have literally broken away and created a separate civilization. They don’t think of themselves as part of our civilization any more.

I have had much to do with people in this group, but it is unclear as to who is actually the Head. The world is governed by force, so ultimately the question is: who is the most powerful gun, and that comes down to space, who has the most space surveillance and weapons, as well as who controls the sea lanes. Traditionally control of the currency derived from control of the sea lanes, but as we have come into space, it has now become control of both the sea lanes and the satellite lanes. The question is. who controls what, and what kind of weapons do they have? One of the reasons you have seen a fairly interesting discussion in the US for the past two years, is that Trump has been very verbal and forceful about Space and has made allusions to certain magical weapons in space.

What we do know is that part of the competition between China and America is that the player who has the most dominant position in space has the power to control the whole planet. The Chinese have a social credit system to which their financial transactions are tied, as well as their abilities to travel. This is a world in which people are under 24/7 surveillance and then their financial powers and incentives are related to how well behaved they are. It is a slavery system, because there is no freedom. To a certain extent, what technocracy will do is move us to a similar system as the Chinese social credit system. Imagine working in order to be able to travel more than 10 miles from your home. To be allowed to fly. So there will be a pecking order that relates to your freedoms to either travel or roam, or even how much access you have to resources. How much money you are allowed to make. If they think they can automize everything with robotics and AI, it is going to be that much harder for you to share in the benefits of the system, because the central group extract so much more. They have a one way mirror. They can see everything you do, but we don’t even know who they are.

What is very important to understanding what is happening, is that the majority of people have been supporting and financing this transhumanist slave system without knowing it. Why are BigPharma heads building a system where their own children or grandchildren will be slaves? Why are the central Banks doing it? There is a theory in America amongst the monied classes that if only they make enough money, they can escape this tyranny, but if you look at who is implementing all these different activities, we are building our own slavery system, and therefore we have the power to stop. We don’t have to finance the companies that are doing this. We don’t have to work for the companies that are doing it. In fact, we don’t even have to pay our taxes, because the government is breaking all the laws relating to financial management. We have the ability to hold them accountable. So we are building and financing the prison, but this gives us the power to stop. That is why it is so important that we see where the system is going. There will be no exceptions.

Solution 1) Bring transparency to what is happening, understand where the system is going. Then stop building it. If you work for BigPharma, stop! Stop financing it. Begin the conversation of where this is going, and where we want to go. We are going to have to rebuild the economy bottom up, if we don’t want to be highly centralized. This comes down to “coming clean”: check your investments and disinvest from companies that are destroying communities, stop banking with criminals. If tomorrow everyone were to wake up and stop banking at certain places, and moved to local credit unions or community banks, it would be a revolution.

We have the power to change this, but we have to come clean, because we are all complicit in the building of this. You are either for the transhumanist slavery system, or you are for the human system, but you’re going to have to find a way to make money, and engage socially in the human system, and stop participating in the transhumanist system.

Don’t support military campaigns such as Operation Warp Speed,; don’t help tech guys figure out ways to inject nanoparticles into your body and hook you up to the Cloud; don’t let BigPharma make injections that are poisoning American children today, don’t let BigAg create food that is poisoning America to death. Don’t help the government institute corrupt regulations that are really disaster capital opportunites that are making the 1% richer.”

Oltre 1000 studi e/o rapporti scientifici sui pericoli legati alle iniezioni di Covid

Oltre 1000 studi e/o rapporti scientifici sui pericoli associati alle iniezioni di COVID legati a coagulazione del sangue, miocardite, pericardite, trombosi, trombocitopenia, anafilassi, paralisi di Bell, Guillain-Barre, decessi, ecc.

1. Trombosi venosa cerebrale dopo la vaccinazione COVID-19 nel Regno Unito: uno studio di coorte multicentrico: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01608-1/fulltext
2. Trombocitopenia trombotica immunitaria indotta da vaccino con coagulazione intravascolare disseminata e morte dopo la vaccinazione ChAdOx1 nCoV-19: https://www.sciencedirect.com/science/article/pii/S1052305721003414

3. Emorragia cerebrale fatale dopo il vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/33928772/
4. Miocardite dopo vaccinazione con mRNA contro SARS-CoV-2, una serie di casi: https://www.sciencedirect.com/science/article/pii/S2666602221000409
5. Tre casi di tromboembolismo venoso acuto nelle donne dopo la vaccinazione contro il COVID-19: https://www.sciencedirect.com/science/article/pii/S2213333X21003929
6. Trombosi acuta dell’albero coronarico dopo la vaccinazione contro il COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S1936879821003988
7. Casi clinici statunitensi di trombosi del seno venoso cerebrale con trombocitopenia dopo la vaccinazione con Ad26.COV2.S (contro covid-19), dal 2 marzo al 21 aprile 2020: https://pubmed.ncbi.nlm.nih.gov/33929487/
8. Trombosi della vena porta associata al vaccino ChAdOx1 nCov-19: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(21)00197-7/fullte xt
9. Gestione della trombosi venosa cerebrale e splancnica associata a trombocitopenia in soggetti precedentemente vaccinati con Vaxzevria (AstraZeneca): position statement della Società Italiana per lo Studio dell’Emostasi e della Trombosi (SISET): https://pubmed.ncbi.nlm.nih.gov / 33871350 /
10. Trombocitopenia trombotica immunitaria indotta da vaccino e trombosi del seno venoso cerebrale dopo la vaccinazione con COVID-19; una revisione sistematica: https://www.sciencedirect.com/science/article/pii/S0022510X21003014
11. Trombosi con sindrome da trombocitopenia associata a vaccini COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381
12. Trombosi e trombocitopenia indotte dal vaccino Covid-19: un commento su un dilemma clinico importante e pratico: https://www.sciencedirect.com/science/article/abs/pii/S0033062021000505
13. Trombosi con sindrome da trombocitopenia associata a vaccini vettoriali virali COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S0953620521001904
14. Trombocitopenia trombotica immuno-immune indotta dal vaccino COVID-19: una causa emergente di trombosi venosa splancnica: https://www.sciencedirect.com/science/article/pii/S1665268121000557
15. I ruoli delle piastrine nella coagulopatia associata a COVID-19 e nella trombocitopenia immunitaria trombotica immunitaria indotta da vaccino (covid): https://www.sciencedirect.com/science/article/pii/S1050173821000967
16. Radici dell’autoimmunità degli eventi trombotici dopo la vaccinazione COVID-19: https://www.sciencedirect.com/science/article/abs/pii/S1568997221002160
17. Trombosi del seno venoso cerebrale dopo la vaccinazione: l’esperienza nel Regno Unito: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01788-8/fulltext
18. Trombocitopenia immunitaria trombotica indotta dal vaccino SARS-CoV-2: https://www.nejm.org/doi/full/10.1056/nejme2106315

Miocardite dopo immunizzazione con vaccini mRNA COVID-19 in membri dell’esercito americano. Questo articolo riporta che in “23 pazienti maschi, inclusi 22 militari precedentemente sani, la miocardite è stata identificata entro 4 giorni dal ricevimento del vaccino”: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601

20. Trombosi e trombocitopenia dopo la vaccinazione con ChAdOx1 nCoV-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2104882?query=recirc_curatedRelated_article
21. Associazione di miocardite con il vaccino BNT162b2 messaggero RNA COVID-19 in una serie di casi di bambini: https://pubmed.ncbi.nlm.nih.gov/34374740/
22. Miocardite e pericardite dopo la vaccinazione contro il covid-19: https://jamanetwork.com/journals/jama/fullarticle/2782900?fbclid=IwAR06pFKNF Mfx7N6RbPK6bYUZ1y8xPnnCK9K5iZYlcwEzwp3X8B68syO
23. Trombocitopenia trombotica dopo la vaccinazione con ChAdOx1 nCov-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2104840?query=recirc_curatedRelated_article

24. Risultati post mortem nella trombocitopenia trombotica indotta da vaccino (covid-19): https://haematologica.org/article/view/haematol.2021.279075
25. Anticorpi patologici contro il fattore piastrinico 4 dopo la vaccinazione con ChAdOx1 nCoV-19. Questo articolo afferma: “In assenza di precedenti condizioni mediche protrombotiche, 22 pazienti presentavano trombocitopenia e trombosi acuta, principalmente trombosi venosa cerebrale, e 1 paziente presentava trombocitopenia isolata e un fenotipo emorragico”: https://www.nejm.org/doi /full/10.1056/NEJMoa2105385?query=TOC&fbclid=IwA R2ifm2TQjetAMb42YRRUlKEeqCQe-lDasIWvjMgzHHaItbuPbu6n7NlG3cic.
26. Trombocitopenia, inclusa la trombocitopenia immunitaria dopo aver ricevuto vaccini mRNA COVID-19 segnalati al Vaccine Adverse Event Reporting System (VAERS): https://www.sciencedirect.com/science/article/pii/S0264410X21005247
27. Miocardite acuta sintomatica in sette adolescenti dopo la vaccinazione Pfizer-BioNTech COVID-19: https://pediatrics.aappublications.org/content/early/2021/06/04/peds.2021-052478
28. Afasia sette giorni dopo la seconda dose di un vaccino SARS-CoV-2 a base di mRNA. La risonanza magnetica cerebrale ha rivelato un’emorragia intracerebrale (ICBH) nel lobo temporale sinistro in un uomo di 52 anni. https://www.sciencedirect.com/science/article/pii/S2589238X21000292#f0005
29. Confronto di episodi trombotici indotti da vaccino tra i vaccini ChAdOx1 nCoV-19 e Ad26.COV.2.S: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000895
30. Ipotesi dietro i rarissimi casi di trombosi con sindrome da trombocitopenia dopo la vaccinazione SARS-CoV-2: https://www.sciencedirect.com/science/article/abs/pii/S0049384821003315
31. Coaguli di sangue ed episodi emorragici dopo la vaccinazione BNT162b2 e ChAdOx1 nCoV-19: analisi dei dati europei: https://www.sciencedirect.com/science/article/pii/S0896841121000937
32. Trombosi venosa cerebrale dopo il vaccino BNT162b2 mRNA SARS-CoV-2: https://www.sciencedirect.com/science/article/abs/pii/S1052305721003098
33. Insufficienza surrenalica primaria associata a trombocitopenia immunitaria trombotica indotta dal vaccino Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT): https://www.sciencedirect.com/science/article/pii/S0953620521002363
34. Miocardite e pericardite dopo vaccinazione con mRNA COVID-19: considerazioni pratiche per gli operatori sanitari: https://www.sciencedirect.com/science/article/pii/S0828282X21006243
35. “Trombosi venosa portale che si verifica dopo la prima dose di vaccino mRNA SARS-CoV-2 in un paziente con sindrome da anticorpi antifosfolipidi”: https://www.sciencedirect.com/science/article/pii/S2666572721000389
36. Primi risultati del trattamento con bivalirudina per trombocitopenia trombotica e trombosi del seno venoso cerebrale dopo la vaccinazione con Ad26.COV2.S: https://www.sciencedirect.com/science/article/pii/S0196064421003425
37. Miocardite, pericardite e cardiomiopatia dopo la vaccinazione COVID-19: https://www.sciencedirect.com/science/article/pii/S1443950621011562
38. Meccanismi di immunotrombosi nella trombocitopenia trombotica indotta da vaccino (VITT) rispetto all’infezione naturale da SARS-CoV-2: https://www.sciencedirect.com/science/article/abs/pii/S0896841121000706
39. Trombocitopenia immunitaria protrombotica dopo la vaccinazione COVID-19: https://www.sciencedirect.com/science/article/pii/S0006497121009411
40. Trombocitopenia trombotica indotta da vaccino: il capitolo oscuro di una storia di successo: https://www.sciencedirect.com/science/article/pii/S2589936821000256
41. Trombosi del seno venoso cerebrale negativa per anticorpi anti-PF4 senza trombocitopenia dopo immunizzazione con vaccino COVID-19 in un uomo indiano anziano non comorbido trattato con anticoagulante convenzionale a base di eparina-warfarin: https://www.sciencedirect.com/science/article/ pii / S1871402121002046
42. Trombosi dopo vaccinazione COVID-19: possibile collegamento a percorsi ACE: https://www.sciencedirect.com/science/article/pii/S0049384821004369
43. Trombosi del seno venoso cerebrale nella popolazione statunitense dopo la vaccinazione SARS-CoV-2 con adenovirus e dopo COVID-19: https://www.sciencedirect.com/science/article/pii/S0735109721051949
44. Un raro caso di un maschio asiatico di mezza età con trombosi venosa cerebrale dopo la vaccinazione AstraZeneca COVID-19: https://www.sciencedirect.com/science/article/pii/S0735675721005714
45. Trombosi del seno venoso cerebrale e trombocitopenia dopo vaccinazione COVID-19: report di due casi nel Regno Unito: https://www.sciencedirect.com/science/article/abs/pii/S088915912100163X

46. Porpora trombocitopenica immunitaria dopo la vaccinazione con il vaccino COVID-19 (ChAdOx1 nCov-19): https://www.sciencedirect.com/science/article/abs/pii/S0006497121013963 .
47. Anticorpi antifosfolipidi e rischio di trombofilia dopo la vaccinazione COVID-19: la goccia che fa traboccare il vaso?: https://docs.google.com/document/d/1XzajasO8VMMnC3CdxSBKks1o7kiOLXFQ
48. Trombocitopenia trombotica indotta da vaccino, un raro ma grave caso di fuoco amico nella battaglia contro la pandemia di COVID-19: quale patogenesi?: https://www.sciencedirect.com/science/article/pii/S0953620521002314
49. Raccomandazioni diagnostico-terapeutiche del gruppo di lavoro di esperti ad hoc FACME sulla gestione della trombosi venosa cerebrale correlata alla vaccinazione COVID-19: https://www.sciencedirect.com/science/article/pii/S0213485321000839
50. Trombocitopenia e trombosi del seno venoso intracranico dopo esposizione al “vaccino AstraZeneca COVID-19”: https://pubmed.ncbi.nlm.nih.gov/33918932/
51. Trombocitopenia a seguito della vaccinazione Pfizer e Moderna SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33606296/
52. Trombocitopenia immunitaria grave e refrattaria che si verifica dopo la vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33854395/
53. Eruzione cutanea purpurica e trombocitopenia dopo il vaccino mRNA-1273 (moderno) COVID-19: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996471/
54. Vaccinazione COVID-19: informazioni sull’insorgenza di trombosi arteriosa e venosa utilizzando i dati di VigiBase: https://pubmed.ncbi.nlm.nih.gov/33863748/
55. Trombosi venosa cerebrale associata al vaccino covid-19 in Germania: https://onlinelibrary.wiley.com/doi/10.1002/ana.26172
56. Trombosi venosa cerebrale in seguito alla vaccinazione con mRNA BNT162b2 di BNT162b2 contro SARS-CoV-2: un evento da cigno nero: https://pubmed.ncbi.nlm.nih.gov/34133027/
57. L’importanza di riconoscere la trombosi venosa cerebrale dopo la vaccinazione anti-COVID-19: https://pubmed.ncbi.nlm.nih.gov/34001390/
58. Trombosi con trombocitopenia dopo vaccino RNA messaggero -1273: https://pubmed.ncbi.nlm.nih.gov/34181446/
59. Coaguli di sangue e sanguinamento dopo la vaccinazione BNT162b2 e ChAdOx1 nCoV-19: un’analisi dei dati europei: https://pubmed.ncbi.nlm.nih.gov/34174723/
60. Prima dose di vaccini ChAdOx1 e BNT162b2 COVID-19 ed eventi trombocitopenici, tromboembolici ed emorragici in Scozia: https://www.nature.com/articles/s41591-021-01408-4
61. Esacerbazione della trombocitopenia immunitaria dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34075578/
62. Primo rapporto di un episodio de novo iTTP associato a un vaccino anti-COVID-19 basato su mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34105244/
63. Saggi immunologici PF4 nella trombocitopenia trombotica indotta da vaccino: https://www.nejm.org/doi/full/10.1056/NEJMc2106383
64. Epitopi anticorpali nella trombocitopenia immunotrombotica immunitaria indotta da vaccino: https://www.nature.com/articles/s41586-021-03744-4
65. Frequenza dei test positivi per anticorpi anti-PF4/anticorpi polianinici dopo la vaccinazione COVID-19 con ChAdOx1 nCoV-19 e BNT162b2: https://ashpublications.org/blood/article-abstract/138/4/299/475972/Frequency-of- p ositive-anti-PF4-polianione-anticorpo? Redirectedfrom = full-text
66. Miocardite con vaccini mRNA COVID-19: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.056135
67. Miocardite e pericardite dopo la vaccinazione COVID-19: https://jamanetwork.com/journals/jama/fullarticle/2782900
68. Miocardite temporaneamente associata alla vaccinazione COVID-19: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.121.055891 .
69. Vaccinazione COVID-19 associata alla miocardite negli adolescenti: https://pediatrics.aappublications.org/content/pediatrics/early/2021/08/12/peds.2021-053427.full.pdf
70. Miocardite acuta dopo somministrazione del vaccino BNT162b2 contro COVID-19: https://pubmed.ncbi.nlm.nih.gov/33994339/
71. Associazione temporale tra vaccino COVID-19 Ad26.COV2.S e miocardite acuta: case report e revisione della letteratura: https://www.sciencedirect.com/science/article/pii/S1553838921005789
72. Miocardite indotta da vaccino COVID-19: un case report con revisione della letteratura: https://www.sciencedirect.com/science/article/pii/S1871402121002253
73. Potenziale associazione tra vaccino COVID-19 e miocardite: risultati clinici e CMR: https://www.sciencedirect.com/science/article/pii/S1936878X2100485X
74. Recidiva di miocardite acuta temporaneamente associata alla ricezione del vaccino contro la malattia dell’mRNA del coronavirus 2019 (COVID-19) in un adolescente maschio: https://www.sciencedirect.com/science/article/pii/S002234762100617X

75. Miocardite fulminante e iperinfiammazione sistemica temporalmente associate alla vaccinazione contro l’mRNA di BNT162b2 COVID-19 in due pazienti: https://www.sciencedirect.com/science/article/pii/S0167527321012286 .
76. Miocardite acuta dopo somministrazione del vaccino BNT162b2: https://www.sciencedirect.com/science/article/pii/S2214250921001530
77. Miocardite linfoistocitica dopo la vaccinazione con il vettore virale COVID-19 Ad26.COV2.S: https://www.sciencedirect.com/science/article/pii/S2352906721001573
78. Miocardite in seguito a vaccinazione con BNT162b2 in un maschio sano: https://www.sciencedirect.com/science/article/pii/S0735675721005362
79. Miocardite acuta dopo vaccinazione con Comirnaty (Pfizer) in un maschio sano con precedente infezione da SARS-CoV-2: https://www.sciencedirect.com/science/article/pii/S1930043321005549
80. Miopericardite dopo vaccinazione Pfizer mRNA COVID-19 negli adolescenti: https://www.sciencedirect.com/science/article/pii/S002234762100665X
81. Pericardite dopo somministrazione del vaccino mRNA BNT162b2 mRNA COVID-19: https://www.sciencedirect.com/science/article/pii/S1885585721002218
82. Miocardite acuta dopo la vaccinazione con SARS-CoV-2 mRNA-1273 mRNA: https://www.sciencedirect.com/science/article/pii/S2589790X21001931
83. Relazione temporale tra la seconda dose di vaccino BNT162b2 mRNA Covid-19 e coinvolgimento cardiaco in un paziente con precedente infezione da SARS-COV-2: https://www.sciencedirect.com/science/article/pii/S2352906721000622
84. Miopericardite dopo vaccinazione con mRNA COVID-19 in adolescenti di età compresa tra 12 e 18 anni: https://www.sciencedirect.com/science/article/pii/S0022347621007368
85. Miocardite acuta dopo vaccinazione SARS-CoV-2 in un uomo di 24 anni: https://www.sciencedirect.com/science/article/pii/S0870255121003243
86. Informazioni importanti sulla miopericardite dopo la vaccinazione con l’mRNA di Pfizer COVID-19 negli adolescenti: https://www.sciencedirect.com/science/article/pii/S0022347621007496
87. Una serie di pazienti con miocardite dopo la vaccinazione contro SARS-CoV-2 con mRNA-1279 e BNT162b2: https://www.sciencedirect.com/science/article/pii/S1936878X21004861
88. Cardiomiopatia Takotsubo dopo vaccinazione con mRNA COVID-19: https://www.sciencedirect.com/science/article/pii/S1443950621011331
89. Vaccinazione dell’mRNA COVID-19 e miocardite: https://pubmed.ncbi.nlm.nih.gov/34268277/
90. Vaccino COVID-19 e miocardite: https://pubmed.ncbi.nlm.nih.gov/34399967/
91. Epidemiologia e caratteristiche cliniche della miocardite/pericardite prima dell’introduzione del vaccino mRNA COVID-19 nei bambini coreani: uno studio multicentrico https://search.bvsalud.org/global-literature-on-novel-coronavirus-2019-ncov/resourc e / it / covidwho-1360706.
92. Vaccini COVID-19 e miocardite: https://pubmed.ncbi.nlm.nih.gov/34246566/
93. Miocardite e altre complicazioni cardiovascolari di-COVID 19 a base di mRNA COVID-19 vaccini https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp licazioni-of-the-mRNA-based-covid -19-vaccines https://www.cureus.com/articles/61030-myocarditis-and-other-cardiovascular-comp lications-of-the-mrna-based-covid-19-vaccines
94. Miocardite, pericardite e cardiomiopatia dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34340927/
95. Miocardite con vaccini mRNA covid-19: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056135
96. Associazione di miocardite con vaccino mRNA COVID-19 nei bambini: https://media.jamanetwork.com/news-item/association-of-myocarditis-with-mrna-co vid-19-vaccine-in-children /
97. Associazione di miocardite con il vaccino a RNA messaggero COVID-19 BNT162b2 in una serie di casi di bambini: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052
98. Miocardite dopo immunizzazione con vaccini mRNA COVID-19 in membri delle forze armate statunitensi: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781601%5C
99. Miocardite che si verifica dopo l’immunizzazione con vaccini COVID-19 basati su mRNA COVID-19: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781600
100. Miocardite dopo immunizzazione con mRNA Covid-19: https://www.nejm.org/doi/full/10.1056/NEJMc2109975
101. Pazienti con miocardite acuta dopo la vaccinazione con mRNA del COVID-19: https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602
102. Miocardite associata alla vaccinazione con mRNA COVID-19: https://pubs.rsna.org/doi/10.1148/radiol.2021211430

Miocardite acuta sintomatica in 7 adolescenti dopo la vaccinazione Pfizer-BioNTech COVID-19: https://pediatrics.aappublications.org/content/148/3/e2021052478

104. Risultati della risonanza magnetica cardiovascolare in pazienti giovani adulti con miocardite acuta dopo la vaccinazione con mRNA COVID-19: una serie di casi: https://jcmr-online.biomedcentral.com/articles/10.1186/s12968-021-00795-4

Guida clinica per giovani con miocardite e pericardite dopo la vaccinazione con mRNA COVID-19: https://www.cps.ca/en/documents/position/clinical-guidance-for-youth-with-myocar ditis-and-pericarditis

106. Imaging cardiaco della miocardite acuta dopo la vaccinazione con mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34402228/
107. Caso clinico: miocardite acuta dopo la seconda dose di vaccino mRNA-1273 SARS-CoV-2: https://academic.oup.com/ehjcr/article/5/8/ytab319/6339567
108. Miocardite/pericardite associata al vaccino COVID-19: https://science.gc.ca/eic/site/063.nsf/eng/h_98291.html
109. Danno cardiaco transitorio negli adolescenti che ricevono il vaccino BNT162b2 mRNA COVID-19: https://journals.lww.com/pidj/Abstract/9000/Transient_Cardiac_Injury_in_Adolesce nts_Receiving.95800.aspx
110. Perimiocardite negli adolescenti dopo il vaccino Pfizer-BioNTech COVID-19: https://academic.oup.com/jpids/advance-article/doi/10.1093/jpids/piab060/6329543
111. La nuova piattaforma del vaccino mRNA COVID-19 e la miocardite: indizi sul possibile meccanismo sottostante: https://pubmed.ncbi.nlm.nih.gov/34312010/
112. Danno miocardico acuto dopo la vaccinazione COVID-19: un caso clinico e una revisione delle prove attuali dal database del sistema di segnalazione degli eventi avversi del vaccino: https://pubmed.ncbi.nlm.nih.gov/34219532/
113. Prestare attenzione al rischio di eventi cardiovascolari avversi dopo la vaccinazione COVID-19: https://www.xiahepublishing.com/m/2472-0712/ERHM-2021-00033
114. Miocardite associata alla vaccinazione COVID-19: risultati di ecocardiografia, tomografia cardiaca e risonanza magnetica: https://www.ahajournals.org/doi/10.1161/CIRCIMAGING.121.013236
115. Valutazione approfondita di un caso di presunta miocardite dopo la seconda dose di vaccino mRNA COVID-19: https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.121.056038
116. Presenza di miocardite acuta simil-infartuale dopo la vaccinazione COVID-19: solo una coincidenza accidentale o meglio una miocardite autoimmune associata alla vaccinazione?: https://pubmed.ncbi.nlm.nih.gov/34333695/

Recidiva di miocardite acuta temporaneamente associata alla ricezione del vaccino contro la malattia dell’mRNA del coronavirus 2019 (COVID-19) in un adolescente maschio: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216855/

118. Miocardite dopo la vaccinazione SARS-CoV-2: una reazione indotta dal vaccino?: https://pubmed.ncbi.nlm.nih.gov/34118375/
119. Miocardite autolimitante che si presenta con dolore toracico ed elevazione del segmento ST negli adolescenti dopo la vaccinazione con il vaccino mRNA BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34180390/
120. Miopericardite in un maschio adolescente precedentemente sano dopo la vaccinazione COVID-19: Caso clinico: https://pubmed.ncbi.nlm.nih.gov/34133825/
121. Miocardite linfocitica provata da biopsia dopo la prima vaccinazione con mRNA COVID-19 in un uomo di 40 anni: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34487236/
122. Approfondimenti da un modello murino di miopericardite indotta da vaccino mRNA COVID-19: l’iniezione endovenosa accidentale di un vaccino potrebbe indurre miopericardite?

in. https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab741/6359059

123. Presentazione insolita della perimiocardite acuta dopo la moderna vaccinazione SARS-COV-2 mRNA-1237: https://pubmed.ncbi.nlm.nih.gov/34447639/
124. Perimiocardite dopo la prima dose di vaccino mRNA-1273 SARS-CoV-2 (Modern) mRNA-1273 in un giovane maschio sano: caso clinico: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-021-02183
125. Miocardite acuta dopo la seconda dose di vaccino SARS-CoV-2: serendipità o relazione causale: https://pubmed.ncbi.nlm.nih.gov/34236331/
126. Rabdomiolisi e fascite indotte dal vaccino mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34435250/
127. Rabdomiolisi indotta dal vaccino COVID-19: caso clinico con revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34186348/ .
128. Anticorpo ganglioside GM1 e sindrome di Guillain Barre correlata a COVID-19: caso clinico, revisione sistemica e implicazioni per lo sviluppo del vaccino: https://www.sciencedirect.com/science/article/pii/S2666354621000065

Sindrome di Guillain-Barré dopo vaccinazione AstraZeneca COVID-19: associazione causale o casuale: https://www.sciencedirect.com/science/article/pii/S0303846721004169

130. Sindrome sensoriale di Guillain-Barré dopo vaccino ChAdOx1 nCov-19: relazione di due casi e revisione della letteratura: https://www.sciencedirect.com/science/article/pii/S0165572821002186

Sindrome di Guillain-Barré dopo la prima dose di vaccino SARS-CoV-2: un evento temporaneo, non un’associazione causale: https://www.sciencedirect.com/science/article/pii/S2214250921000998 .

132. Sindrome di Guillain-Barré che si presenta come diplegia facciale dopo la vaccinazione con COVID-19: un caso clinico: https://www.sciencedirect.com/science/article/pii/S0736467921006442

Sindrome di Guillain-Barré dopo la prima iniezione del vaccino ChAdOx1 nCoV-19: primo rapporto: https://www.sciencedirect.com/science/article/pii/S0035378721005853 .

134. I vaccini SARS-CoV-2 non sono sicuri per quelli con la sindrome di Guillain-Barre dopo la vaccinazione: https://www.sciencedirect.com/science/article/pii/S2049080121005343
135. Encefalopatia iperattiva acuta a seguito di vaccinazione COVID-19 con risposta drammatica al metilprednisolone: ​​un caso clinico: https://www.sciencedirect.com/science/article/pii/S2049080121007536
136. Paralisi del nervo facciale in seguito alla somministrazione di vaccini mRNA COVID-19: analisi del database di autovalutazione: https://www.sciencedirect.com/science/article/pii/S1201971221007049
137. Sintomi neurologici e alterazioni neuroimaging relative al vaccino COVID-19: causa o coincidenza: https://www.sciencedirect.com/science/article/pii/S0899707121003557 .
138. Stato epilettico refrattario di nuova insorgenza dopo la vaccinazione ChAdOx1 nCoV-19: https://www.sciencedirect.com/science/article/pii/S0165572821001569
139. Mielite acuta e vaccino ChAdOx1 nCoV-19: associazione casuale o causale: https://www.sciencedirect.com/science/article/pii/S0165572821002137
140. Paralisi di Bell e vaccini SARS-CoV-2: una storia in divenire: https://www.sciencedirect.com/science/article/pii/S1473309921002735
141. Paralisi di Bell dopo la seconda dose del vaccino Pfizer COVID-19 in un paziente con una storia di paralisi di Bell ricorrente: bhttps: //www.sciencedirect.com/science/article/pii/S266635462100020X
142. Retinopatia sierosa centrale a esordio acuto dopo immunizzazione con vaccino mRNA COVID-19 :. https://www.sciencedirect.com/science/article/pii/S2451993621001456 .
143. La paralisi di Bell dopo la vaccinazione COVID-19: caso clinico: https://www.sciencedirect.com/science/article/pii/S217358082100122X .
144. Un’esperienza ospedaliera accademica che valuta il rischio del vaccino mRNA COVID-19 utilizzando la storia di allergia del paziente: https://www.sciencedirect.com/science/article/pii/S2213219821007972
145. Linfoadenopatia ascellare e pettorale indotta dal vaccino COVID-19 nella PET: https://www.sciencedirect.com/science/article/pii/S1930043321002612
146. Vasculite associata ad ANCA dopo il vaccino Pfizer-BioNTech COVID-19: https://www.sciencedirect.com/science/article/pii/S0272638621007423
147. Reazioni cutanee tardive dopo la somministrazione di vaccini mRNA COVID-19: https://www.sciencedirect.com/science/article/pii/S2213219821007996
148. Rabdomiolisi indotta da vaccino COVID-19: case report con revisione della letteratura: https://www.sciencedirect.com/science/article/pii/S1871402121001880
149. Correlazioni cliniche e patologiche delle reazioni cutanee al vaccino COVID-19, incluso V-REPP: uno studio basato sul registro: https://www.sciencedirect.com/science/article/pii/S0190962221024427
150. Trombosi con sindrome da trombocitopenia associata a vaccini COVID-19 :. https://www.sciencedirect.com/science/article/abs/pii/S0735675721004381 .
151. Anafilassi associata al vaccino COVID-19: una dichiarazione del Comitato per l’anafilassi dell’Organizzazione mondiale delle allergie:. https://www.sciencedirect.com/science/article/pii/S1939455121000119 .
152. Trombosi del seno venoso cerebrale negativa per anticorpi anti-PF4 senza trombocitopenia dopo immunizzazione con vaccino COVID-19 in un uomo indiano anziano, non comorbido, trattato con anticoagulante convenzionale a base di eparina-warfarin:. https://www.sciencedirect.com/science/article/pii/S1871402121002046 .
153. Miocardite acuta dopo somministrazione del vaccino BNT162b2 contro COVID-19 :. https://www.sciencedirect.com/science/article/abs/pii/S188558572100133X
154. Coaguli di sangue e sanguinamento dopo il vaccino BNT162b2 e ChAdOx1 nCoV-19: un’analisi dei dati europei :. https://www.sciencedirect.com/science/article/pii/S0896841121000937 .
155. trombocitopenia immunitaria associata al vaccino mRNA COVID-19 BNT162b2 di Pfizer-BioNTech:. https://www.sciencedirect.com/science/article/pii/S2214250921002018 .
156. Eruzione bollosa di farmaci dopo la seconda dose di vaccino COVID-19 mRNA-1273 (Moderna): Caso clinico: https://www.sciencedirect.com/science/article/pii/S1876034121001878 .

157. COVID-19 vaccini RNA-based e il rischio di malattia da prioni: https://scivisionpub.com/pdfs/covid19-rna-based-vaccines-and-the-risk-of-prion-dis facilità 1503.pdf
158. Questo studio rileva che 115 donne in gravidanza hanno perso i loro bambini, su 827 che hanno partecipato a uno studio sulla sicurezza dei vaccini covid-19: https://www.nejm.org/doi/full/10.1056/NEJMoa2104983 .
159. Impurità legate al processo nel vaccino ChAdOx1 nCov-19: https://www.researchsquare.com/article/rs-477964/v1
160. Vaccino COVID-19 mRNA che causa infiammazione del SNC: una serie di casi: https://link.springer.com/article/10.1007/s00415-021-10780-7
161. Reazioni allergiche, inclusa l’anafilassi, dopo aver ricevuto la prima dose del vaccino Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/33475702/
162. Reazioni allergiche al primo vaccino COVID-19: un potenziale ruolo del polietilenglicole: https://pubmed.ncbi.nlm.nih.gov/33320974/
163. Il vaccino Pfizer solleva problemi di allergia: https://pubmed.ncbi.nlm.nih.gov/33384356/
164. Reazioni allergiche, inclusa l’anafilassi, dopo aver ricevuto la prima dose del vaccino Pfizer-BioNTech COVID-19 – Stati Uniti, 14-23 dicembre 2020: https://pubmed.ncbi.nlm.nih.gov/33444297/

Reazioni allergiche, inclusa l’anafilassi, dopo aver ricevuto la prima dose del vaccino Modern COVID-19 – Stati Uniti, 21 dicembre 2020-10 gennaio 2021: https://pubmed.ncbi.nlm.nih.gov/33507892/

166. Rapporti di anafilassi dopo la vaccinazione contro il coronavirus 2019, Corea del Sud, 26 febbraio-30 aprile 2021: https://pubmed.ncbi.nlm.nih.gov/34414880/
167. segnalazioni di anafilassi dopo aver ricevuto vaccini mRNA COVID-19 negli Stati Uniti – 14 dicembre 2020 – 18 gennaio 2021: https://pubmed.ncbi.nlm.nih.gov/33576785/
168. Pratiche di immunizzazione e rischio di anafilassi: un aggiornamento attuale e completo dei dati sulla vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34269740/
169. Relazione tra allergie preesistenti e reazioni anafilattiche in seguito alla somministrazione del vaccino mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34215453/
170. Anafilassi associata ai vaccini mRNA COVID-19: approccio alla ricerca sulle allergie: https://pubmed.ncbi.nlm.nih.gov/33932618/
171. Reazioni allergiche gravi dopo la vaccinazione contro il COVID-19 con il vaccino Pfizer / BioNTech in Gran Bretagna e negli Stati Uniti: Posizione delle Società tedesche di allergie: Associazione medica tedesca degli allergologi (AeDA), Società tedesca di allergologia e immunologia clinica (DGAKI) e Società per Allergologia Pediatrica e Medicina Ambientale (GPA): https://pubmed.ncbi.nlm.nih.gov/33643776/
172. Reazioni allergiche e anafilassi ai vaccini COVID-19 basati su LNP: https://pubmed.ncbi.nlm.nih.gov/33571463/
173. Segnalati effetti avversi orofacciali dai vaccini COVID-19: il noto e l’ignoto: https://pubmed.ncbi.nlm.nih.gov/33527524/
174. Effetti avversi cutanei dei vaccini COVID-19 disponibili: https://pubmed.ncbi.nlm.nih.gov/34518015/
175. Rapporto cumulativo di eventi avversi di anafilassi a seguito di iniezioni di vaccino mRNA COVID-19 (Pfizer-BioNTech) in Giappone: il rapporto del primo mese: https://pubmed.ncbi.nlm.nih.gov/34347278/
176. I vaccini COVID-19 aumentano il rischio di anafilassi: https://pubmed.ncbi.nlm.nih.gov/33685103/
177. Anafilassi bifasica dopo esposizione alla prima dose del vaccino mRNA Pfizer-BioNTech COVID-19 COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/
178. Componenti allergeniche del vaccino mRNA-1273 per COVID-19: possibile coinvolgimento del polietilenglicole e attivazione del complemento mediata da IgG: https://pubmed.ncbi.nlm.nih.gov/33657648/
179. Il polietilenglicole (PEG) è una causa di anafilassi per il vaccino Pfizer / BioNTech mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/33825239/
180. Reazioni allergiche acute ai vaccini mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/33683290/
181. Allergia al polietilenglicole del destinatario del vaccino SARS CoV2: caso clinico di un giovane adulto ricevente e gestione dell’esposizione futura a SARS-CoV2: https://pubmed.ncbi.nlm.nih.gov/33919151/
182. Elevati tassi di anafilassi dopo la vaccinazione con il vaccino mRNA Pfizer BNT162b2 contro COVID-19 negli operatori sanitari giapponesi; un’analisi secondaria dei dati di sicurezza iniziali post-approvazione: https://pubmed.ncbi.nlm.nih.gov/34128049/

Reazioni allergiche ed eventi avversi associati alla somministrazione di vaccini a base di mRNA. Un’esperienza del sistema sanitario: https://pubmed.ncbi.nlm.nih.gov/34474708/

Reazioni allergiche ai vaccini COVID-19: dichiarazione della Società belga di allergie e immunologia clinica (BelSACI): https://www.tandfonline.com/doi/abs/10.1080/17843286.2021.1909447?journalCod e = yacb20.

185. Allergia IgE-mediata al polietilenglicole (PEG) come causa di anafilassi ai vaccini mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34318537/

Reazioni allergiche dopo la vaccinazione COVID-19: mettere il rischio in prospettiva: https://pubmed.ncbi.nlm.nih.gov/34463751/

Reazioni anafilattiche ai vaccini mRNA COVID-19: un invito a ulteriori studi: https://pubmed.ncbi.nlm.nih.gov/33846043/ 188.

188. Rischio di gravi reazioni allergiche ai vaccini COVID-19 tra i pazienti con malattie allergiche cutanee: raccomandazioni pratiche. Una presa di posizione dell’ETFAD con esperti esterni: https://pubmed.ncbi.nlm.nih.gov/33752263/
189. Vaccino COVID-19 e morte: algoritmo di causalità secondo la diagnosi di ammissibilità dell’OMS: https://pubmed.ncbi.nlm.nih.gov/34073536/
190. Emorragia cerebrale fatale dopo il vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/33928772/
191. Una serie di casi di reazioni cutanee al vaccino COVID-19 nel Dipartimento di Dermatologia della Loma Linda University: https://pubmed.ncbi.nlm.nih.gov/34423106/
192. Reazioni cutanee riportate dopo la vaccinazione COVID-19 di Moderna e Pfizer: uno studio basato su un registro di 414 casi: https://pubmed.ncbi.nlm.nih.gov/33838206/
193. Correlazioni cliniche e patologiche delle reazioni cutanee al vaccino COVID-19, incluso V-REPP: uno studio basato sul registro: https://pubmed.ncbi.nlm.nih.gov/34517079/

Reazioni cutanee dopo la vaccinazione contro SARS-COV-2: uno studio trasversale spagnolo a livello nazionale su 405 casi: https://pubmed.ncbi.nlm.nih.gov/34254291/

Riattivazione del virus varicella zoster e del virus herpes simplex dopo la vaccinazione con COVID-19: revisione di 40 casi in un registro dermatologico internazionale: https://pubmed.ncbi.nlm.nih.gov/34487581/

196. Trombosi immunitaria e trombocitopenia (VITT) associate al vaccino COVID-19: raccomandazioni diagnostiche e terapeutiche per una nuova sindrome: https://pubmed.ncbi.nlm.nih.gov/33987882/
197. Test di laboratorio per il sospetto di trombocitopenia trombotica (immune) indotta dal vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34138513/
198. Emorragia intracerebrale da trombosi con sindrome da trombocitopenia dopo la vaccinazione COVID-19: il primo caso fatale in Corea: https://pubmed.ncbi.nlm.nih.gov/34402235/
199. Rischio di trombocitopenia e tromboembolismo dopo vaccinazione covid-19 e test SARS-CoV-2 positivi: studio di serie di casi autocontrollati: https://pubmed.ncbi.nlm.nih.gov/34446426/

Trombocitopenia trombotica immunitaria indotta da vaccino e trombosi del seno venoso cerebrale dopo la vaccinazione contro il covid-19; una revisione sistematica: https://pubmed.ncbi.nlm.nih.gov/34365148/ .

201. Eventi avversi nervosi e muscolari dopo la vaccinazione con COVID-19: una revisione sistematica e una meta-analisi degli studi clinici: https://pubmed.ncbi.nlm.nih.gov/34452064/ .
202. Un raro caso di trombosi venosa cerebrale e coagulazione intravascolare disseminata temporaneamente associata alla somministrazione del vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/33917902/
203. Insufficienza surrenalica primaria associata a trombocitopenia immunitaria trombotica indotta dal vaccino Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT): https://pubmed.ncbi.nlm.nih.gov/34256983/

Trombosi venosa cerebrale acuta ed embolia dell’arteria polmonare associata al vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34247246/ .

205. Infusione di tromboaspirazione e fibrinolisi per trombosi portomesenterica dopo somministrazione del vaccino AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34132839/
206. Donna di 59 anni con trombosi venosa profonda estesa e tromboembolismo polmonare 7 giorni dopo una prima dose di vaccino mRNA Pfizer-BioNTech BNT162b2 COVID-19: https://pubmed.ncbi.nlm.nih.gov/34117206/
207. Trombosi venosa cerebrale e trombocitopenia indotta da vaccino.

in. Oxford-AstraZeneca COVID-19: un’occasione mancata per un rapido ritorno all’esperienza: https://pubmed.ncbi.nlm.nih.gov/34033927/

208. Miocardite e altre complicanze cardiovascolari dei vaccini COVID-19 basati su mRNA: https://pubmed.ncbi.nlm.nih.gov/34277198/
209. Pericardite dopo somministrazione del vaccino COVID-19 mRNA BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34364831/
210. Presentazione insolita di pericardite acuta dopo la vaccinazione contro SARS-COV-2 mRNA-1237 Modern: https://pubmed.ncbi.nlm.nih.gov/34447639/
211. Caso clinico: miocardite acuta dopo la seconda dose del vaccino mRNA-1273 SARS-CoV-2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34514306/

212. Focolai di malattie immuno-mediate o malattie di recente insorgenza in 27 soggetti dopo la vaccinazione con mRNA/DNA contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/
213. Approfondimenti da un modello murino di miopericardite indotta dal vaccino mRNA COVID-19: l’iniezione endovenosa accidentale di un vaccino potrebbe indurre miopericardite: https://pubmed.ncbi.nlm.nih.gov/34453510/
214. Trombocitopenia immunitaria in un vaccino post Covid-19 di 22 anni: https://pubmed.ncbi.nlm.nih.gov/33476455/
215. vasculite associata ad anticorpi anticitoplasmatici neutrofili indotta da propiltiouracile dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34451967/
216. Trombocitopenia immunitaria secondaria (ITP) associata al vaccino ChAdOx1 Covid-19: case report: https://pubmed.ncbi.nlm.nih.gov/34377889/
217. Trombosi con sindrome da trombocitopenia (TTS) dopo AstraZeneca ChAdOx1 nCoV-19 (AZD1222) Vaccinazione COVID-19: analisi rischio-beneficio per persone <60 anni in Australia: https://pubmed.ncbi.nlm.nih.gov/34272095/
218. Associazione di vaccinazione COVID-19 e paralisi del nervo facciale: uno studio caso-controllo: https://pubmed.ncbi.nlm.nih.gov/34165512/
219. L’associazione tra la vaccinazione COVID-19 e la paralisi di Bell: https://pubmed.ncbi.nlm.nih.gov/34411533/

Paralisi di Bell dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33611630/

Mielite trasversa acuta (ATM): revisione clinica di 43 pazienti con ATM associato a COVID-19 e 3 eventi avversi gravi di ATM post-vaccinazione con il vaccino ChAdOx1 nCoV-19 (AZD1222): https: //pubmed.ncbi.nlm.nih .gov / 33981305 /

222. Paralisi di Bell dopo 24 ore di vaccino mRNA-1273 SARS-CoV-2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34336436/
223. Paralisi sequenziale del nervo facciale controlaterale dopo la prima e la seconda dose di vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34281950/ .
224. Mielite trasversa indotta dalla vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34458035/
225. Paralisi del nervo facciale periferico dopo la vaccinazione con BNT162b2 (COVID-19): https://pubmed.ncbi.nlm.nih.gov/33734623/
226. Paralisi acuta del nervo abducente dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34044114/ .
227. Paralisi del nervo facciale dopo la somministrazione di vaccini mRNA COVID-19: analisi del database di autovalutazione: https://pubmed.ncbi.nlm.nih.gov/34492394/
228. Paralisi oculomotoria transitoria dopo la somministrazione del vaccino messaggero RNA-1273 per la diplopia SARS-CoV-2 dopo il vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34369471/
229. Paralisi di Bell dopo la vaccinazione Ad26.COV2.S COVID-19: https://pubmed.ncbi.nlm.nih.gov/34014316/
230. La paralisi di Bell dopo la vaccinazione COVID-19: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34330676/
231. Un caso di poliradicoloneuropatia demielinizzante acuta con paralisi facciale bilaterale a seguito della vaccinazione ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34272622/
232. Sindrome di Guillian Barré dopo la vaccinazione con mRNA-1273 contro COVID-19: https://pubmed.ncbi.nlm.nih.gov/34477091/
233. Paralisi facciale acuta come possibile complicanza della vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33975372/ .
234. Paralisi di Bell dopo la vaccinazione COVID-19 con elevata risposta anticorpale nel liquido cerebrospinale: https://pubmed.ncbi.nlm.nih.gov/34322761/ .
235. Sindrome di Parsonage-Turner associata alla vaccinazione SARS-CoV-2 o SARS-CoV-2. Commento su: “Amiotrofia nevralgica e infezione da COVID-19: 2 casi di paralisi del nervo spinale accessorio” di Coll et al. Colonna articolare 2021; 88: 10519: https://pubmed.ncbi.nlm.nih.gov/34139321/ .
236. Paralisi di Bell dopo una singola dose di mRNA del vaccino. SARS-CoV-2: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34032902/ .
237. Epatite autoimmune in via di sviluppo dopo il vaccino contro la malattia di coronavirus 2019 (COVID-19): causalità o vittima?: https://pubmed.ncbi.nlm.nih.gov/33862041/
238. Epatite autoimmune innescata dalla vaccinazione contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34332438/
239. Epatite acuta simil-autoimmune con anticorpo antimitocondriale atipico dopo vaccinazione con mRNA COVID-19: una nuova entità clinica: https://pubmed.ncbi.nlm.nih.gov/34293683/ .
240. Epatite autoimmune dopo il vaccino COVID: https://pubmed.ncbi.nlm.nih.gov/34225251/
241. Un nuovo caso di variante di diplegia bifacciale della sindrome di Guillain-Barré dopo la vaccinazione con Janssen COVID-19: https://pubmed.ncbi.nlm.nih.gov/34449715/

242. Confronto di eventi trombotici indotti da vaccino tra i vaccini ChAdOx1 nCoV-19 e Ad26.COV.2.S: https://pubmed.ncbi.nlm.nih.gov/34139631/ .
243. Trombosi venosa oftalmica superiore bilaterale, ictus ischemico e trombocitopenia immunitaria dopo la vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/33864750/
244. Diagnosi e trattamento della trombosi del seno venoso cerebrale con trombocitopenia trombotica immune-immune indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/33914590/
245. Trombosi del seno venoso dopo la vaccinazione con ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34420802/
246. Trombosi del seno venoso cerebrale a seguito di vaccinazione contro SARS-CoV-2: un’analisi dei casi segnalati all’Agenzia europea per i medicinali: https://pubmed.ncbi.nlm.nih.gov/34293217/
247. Rischio di trombocitopenia e tromboembolismo dopo vaccinazione covid-19 e test SARS-CoV-2 positivi: studio di serie di casi autocontrollati: https://pubmed.ncbi.nlm.nih.gov/34446426/
248. Coaguli di sangue e sanguinamento dopo la vaccinazione BNT162b2 e ChAdOx1 nCoV-19: un’analisi dei dati europei: https://pubmed.ncbi.nlm.nih.gov/34174723/
249. Eventi arteriosi, tromboembolismo venoso, trombocitopenia ed emorragie dopo la vaccinazione con Oxford-AstraZeneca ChAdOx1-S in Danimarca e Norvegia: studio di coorte basato sulla popolazione: https://pubmed.ncbi.nlm.nih.gov/33952445/
250. Prima dose di vaccini ChAdOx1 e BNT162b2 COVID-19 ed eventi trombocitopenici, tromboembolici ed emorragici in Scozia: https://pubmed.ncbi.nlm.nih.gov/34108714/
251. Trombosi venosa cerebrale associata al vaccino COVID-19 in Germania: https://pubmed.ncbi.nlm.nih.gov/34288044/
252. Infarto cerebrale maligno dopo la vaccinazione con ChAdOx1 nCov-19: una variante catastrofica della trombocitopenia trombotica immuno-mediata indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34341358/
253. trombosi dell’arteria celiaca e dell’arteria splenica complicata da infarto splenico 7 giorni dopo la prima dose di vaccino Oxford, relazione causale o coincidenza: https://pubmed.ncbi.nlm.nih.gov/34261633/ .
254. Insufficienza surrenalica primaria associata a trombocitopenia trombotica immunitaria indotta dal vaccino Oxford-AstraZeneca ChAdOx1 nCoV-19 (VITT): https://pubmed.ncbi.nlm.nih.gov/34256983/
255. Trombocitopenia dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34332437/ .
256. Trombosi del seno venoso cerebrale associata a trombocitopenia dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33845870/ .
257. Trombosi con sindrome da trombocitopenia dopo immunizzazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34236343/
258. Infarto miocardico acuto entro 24 ore dalla vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34364657/ .
259. Neuroretinopatia maculare acuta bilaterale dopo la vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34287612/
260. trombosi del seno venoso centrale con emorragia subaracnoidea dopo vaccinazione con mRNA COVID-19: questi rapporti sono semplicemente casuali: https://pubmed.ncbi.nlm.nih.gov/34478433/
261. Emorragia intracerebrale da trombosi con sindrome da trombocitopenia dopo la vaccinazione COVID-19: il primo caso fatale in Corea: https://pubmed.ncbi.nlm.nih.gov/34402235/
262. Trombosi del seno venoso cerebrale negativa per anticorpi anti-PF4 senza trombocitopenia dopo immunizzazione con vaccino COVID-19 in un uomo indiano anziano non comorbido trattato con anticoagulante convenzionale a base di eparina-warfarin: https://pubmed.ncbi.nlm.nih.gov / 34186376/263 .
263. Trombosi del seno venoso cerebrale 2 settimane dopo la prima dose di vaccino mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34101024/
264. Un caso di trombocitopenia multipla e trombosi in seguito alla vaccinazione con ChAdOx1 nCoV-19 contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34137813/

Trombocitopenia trombotica indotta da vaccino: il legame sfuggente tra trombosi e vaccini SARS-CoV-2 basati su adenovirus: https://pubmed.ncbi.nlm.nih.gov/34191218/ 266.

266. Ictus ischemico acuto che rivela trombocitopenia trombotica immunitaria indotta dal vaccino ChAdOx1 nCov-19: impatto sulla strategia di ricanalizzazione: https://pubmed.ncbi.nlm.nih.gov/34175640/
267. Stato epilettico refrattario di nuova insorgenza dopo il vaccino ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34153802/
268. Trombosi con sindrome da trombocitopenia associata a vaccini vettoriali virali COVID-19: https://pubmed.ncbi.nlm.nih.gov/34092488/
269. Embolia polmonare, attacco ischemico transitorio e trombocitopenia dopo il vaccino Johnson & Johnson COVID-19: https://pubmed.ncbi.nlm.nih.gov/34261635/

270. Infusione di tromboaspirazione e fibrinolisi per la trombosi portomesenterica dopo la somministrazione del vaccino AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34132839/ .
271. Sindrome HIT spontanea: sostituzione del ginocchio, infezione e parallelismi con trombocitopenia immunitaria indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34144250/
272. Trombosi venosa profonda (TVP) che si verifica poco dopo la seconda dose del vaccino mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33687691/
273. Piastrine procoagulanti mediate da anticorpi procoagulanti nella trombocitopenia trombotica immunitaria associata alla vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34011137/ .
274. Trombocitopenia trombotica immunitaria indotta da vaccino che causa una forma grave di trombosi venosa cerebrale con alto tasso di mortalità: una serie di casi: https://pubmed.ncbi.nlm.nih.gov/34393988/ .
275. Microparticelle procoagulanti: un possibile legame tra trombocitopenia immunitaria indotta da vaccino (VITT) e trombosi venosa del seno cerebrale: https://pubmed.ncbi.nlm.nih.gov/34129181/ .

Trombosi atipica associata al vaccino VaxZevria® (AstraZeneca): dati della rete francese dei centri regionali di farmacovigilanza: https://pubmed.ncbi.nlm.nih.gov/34083026/ .

277. Trombosi venosa cerebrale acuta ed embolia dell’arteria polmonare associata al vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34247246/ .
278. Trombosi e trombocitopenia indotte da vaccino con emorragia surrenalica bilaterale: https://pubmed.ncbi.nlm.nih.gov/34235757/ .
279. Trombosi venosa digitale palmare dopo la vaccinazione Oxford-AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34473841/ .
280. Trombosi cutanea associata a necrosi cutanea a seguito della vaccinazione Oxford-AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34189756/
281. Trombosi venosa cerebrale a seguito della vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34045111/ .
282. Ulcere di Lipschütz dopo la vaccinazione AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34366434/ .
283. Nevralgia amiotrofica secondaria al vaccino Vaxzevri (AstraZeneca) COVID-19: https://pubmed.ncbi.nlm.nih.gov/34330677/
284. Trombosi con trombocitopenia dopo il vaccino Messenger RNA-1273: https://pubmed.ncbi.nlm.nih.gov/34181446/
285. Emorragia intracerebrale dodici giorni dopo la vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34477089/
286. Trombocitopenia trombotica dopo vaccinazione con COVID-19: alla ricerca del meccanismo sottostante: https://pubmed.ncbi.nlm.nih.gov/34071883/
287. Coronavirus (COVID-19) Trombocitopenia trombotica immunitaria indotta da vaccino (VITT): https://pubmed.ncbi.nlm.nih.gov/34033367/
288. Confronto delle reazioni avverse ai farmaci tra quattro vaccini COVID-19 in Europa utilizzando il database EudraVigilance: Trombosi in siti insoliti: https://pubmed.ncbi.nlm.nih.gov/34375510/
289. Immunoglobulina adiuvante per trombocitopenia trombotica immunitaria indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34107198/
290. Grave trombocitopenia trombotica indotta da vaccino a seguito di vaccinazione con COVID-19: un caso clinico autoptico e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34355379/ .
291. Un caso di embolia polmonare acuta dopo immunizzazione con mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34452028/
292. Considerazioni neurochirurgiche sulla craniectomia decompressiva per emorragia intracerebrale dopo la vaccinazione SARS-CoV-2 nella trombocitopenia trombotica indotta da vaccino-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/
293. Vaccini contro la trombosi e SARS-CoV-2: trombocitopenia trombotica immunitaria indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34237213/ .
294. Porpora trombotica trombocitopenica trombocitopenica acquisita: una malattia rara associata al vaccino BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34105247/ .
295. Complessi immunitari, immunità innata e NETosi nella trombocitopenia indotta dal vaccino ChAdOx1: https://pubmed.ncbi.nlm.nih.gov/34405870/ .
296. Sindrome sensoriale di Guillain-Barré dopo il vaccino ChAdOx1 nCov-19: rapporto di due casi e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34416410/ .
297. Sindrome di Vogt-Koyanagi-Harada dopo la vaccinazione COVID-19 e ChAdOx1 nCoV-19 (AZD1222): https://pubmed.ncbi.nlm.nih.gov/34462013/ .
298. Riattivazione della malattia di Vogt-Koyanagi-Harada sotto controllo da più di 6 anni, dopo la vaccinazione anti-SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34224024/ .
299. Encefalite post-vaccinale dopo ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34324214/

Sintomi neurologici e alterazioni neuroimaging relative al vaccino COVID-19: causa o coincidenza?: https://pubmed.ncbi.nlm.nih.gov/34507266/

301. Sindrome da perdita capillare sistemica fatale dopo la vaccinazione SARS-COV-2 in un paziente con mieloma multiplo: https://pubmed.ncbi.nlm.nih.gov/34459725/
302. Sindrome di poliartralgia e mialgia dopo la vaccinazione con ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/
303. Tre casi di tiroidite subacuta dopo la vaccinazione SARS-CoV-2: sindrome ASIA post-vaccinazione: https://pubmed.ncbi.nlm.nih.gov/34043800/ .
304. Diplegia facciale: una variante rara e atipica della sindrome di Guillain-Barré e del vaccino Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34447646/
305. Associazione tra vaccinazione ChAdOx1 nCoV-19 ed episodi emorragici: ampio studio di coorte basato sulla popolazione: https://pubmed.ncbi.nlm.nih.gov/34479760/ .
306. miocardite fulminante e iperinfiammazione sistemica temporalmente associate alla vaccinazione contro l’mRNA di BNT162b2 COVID-19 in due pazienti: https://pubmed.ncbi.nlm.nih.gov/34416319/ .
307. Effetti avversi segnalati dopo la vaccinazione COVID-19 in un ospedale di cure terziarie, incentrato sulla trombosi del seno venoso cerebrale (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/
308. Induzione ed esacerbazione del lupus eritematoso cutaneo subacuto dopo vaccinazione SARS-CoV-2 basata su mRNA o vettore adenovirale: https://pubmed.ncbi.nlm.nih.gov/34291477/
309. Petecchie e desquamazione delle dita dopo l’immunizzazione con il vaccino COVID-19 a base di RNA messaggero BTN162b2 (mRNA): https://pubmed.ncbi.nlm.nih.gov/34513435/
310. Riattivazione del virus dell’epatite C dopo la vaccinazione COVID-19: un caso clinico: https://pubmed.ncbi.nlm.nih.gov/34512037/
311. Cheratolisi bilaterale immuno-mediata dopo immunizzazione con vaccino vettore virale ricombinante SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34483273/ .
312. Porpora trombocitopenica immuno-mediata dopo il vaccino Pfizer-BioNTech COVID-19 in una donna anziana: https://pubmed.ncbi.nlm.nih.gov/34513446/
313. Attivazione e modulazione piastrinica nella trombosi con sindrome da trombocitopenia associata al vaccino ChAdO × 1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34474550/
314. Artrite reattiva dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34033732/ .
315. Due casi di morbo di Graves dopo la vaccinazione SARS-CoV-2: una sindrome autoimmune/infiammatoria indotta da adiuvanti: https://pubmed.ncbi.nlm.nih.gov/33858208/
316. Recidiva acuta e immunizzazione compromessa dopo la vaccinazione COVID-19 in un paziente con sclerosi multipla trattato con rituximab: https://pubmed.ncbi.nlm.nih.gov/34015240/
317. Eruzione diffusa di farmaci bollosi fissati dopo la vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34482558/
318. Vaccino COVID-19 mRNA che causa infiammazione del SNC: una serie di casi: https://pubmed.ncbi.nlm.nih.gov/34480607/
319. Iperplasia timica dopo vaccinazione a base di mRNA Covid-19 con Covid-19: https://pubmed.ncbi.nlm.nih.gov/34462647/
320. Encefalomielite acuta disseminata a seguito di vaccinazione contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34325334/
321. Sindrome di Tolosa-Hunt che si verifica dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34513398/
322. Sindrome da stravaso capillare sistemico in seguito alla vaccinazione con ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/
323. Trombocitopenia immuno-mediata associata al vaccino Ad26.COV2.S (Janssen; Johnson & Johnson): https://pubmed.ncbi.nlm.nih.gov/34469919/ .
324. Trombocitopenia transitoria con autoanticorpi piastrinici specifici per glicoproteina dopo la vaccinazione con Ad26.COV2.S: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34516272/ .
325. Encefalopatia iperattiva acuta a seguito della vaccinazione COVID-19 con risposta drammatica al metilprednisolone: ​​caso clinico: https://pubmed.ncbi.nlm.nih.gov/34512961/
326. Danno cardiaco transitorio negli adolescenti che ricevono il vaccino BNT162b2 mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34077949/
327. Epatite autoimmune che si sviluppa dopo il vaccino ChAdOx1 nCoV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34171435/
328. Grave recidiva di sclerosi multipla dopo la vaccinazione COVID-19: un caso clinico: https://pubmed.ncbi.nlm.nih.gov/34447349/
329. Miocardite linfoistocitica dopo vaccinazione con il vettore virale COVID-19 Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34514078/
330. Linfoistiocitosi emofagocitica dopo vaccinazione con ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34406660/ .
331. Vasculite IgA in paziente adulto dopo la vaccinazione con ChadOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34509658/

332. Un caso di vasculite leucocitoclastica dopo la vaccinazione con un vaccino SARS-CoV2: case report: https://pubmed.ncbi.nlm.nih.gov/34196469/ .
333. Esordio / focolaio di psoriasi dopo il vaccino Corona virus ChAdOx1 nCoV-19 (Oxford-AstraZeneca / Covishield): rapporto di due casi: https://pubmed.ncbi.nlm.nih.gov/34350668/
334. Esacerbazione della malattia di Hailey-Hailey dopo la vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34436620/
335. Linfoadenopatia sopraclavicolare dopo la vaccinazione COVID-19 in Corea: follow-up seriale mediante ecografia: https://pubmed.ncbi.nlm.nih.gov/34116295/ .
336. Vaccino COVID-19, trombocitopenia trombotica immunitaria, ittero, iperviscosità: preoccupazione nei casi con problemi epatici sottostanti: https://pubmed.ncbi.nlm.nih.gov/34509271/ .
337. Rapporto dell’International Cerebral Venous Thrombosis Consortium sulla trombosi venosa cerebrale dopo la vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34462996/
338. Trombocitopenia immunitaria dopo la vaccinazione durante la pandemia di COVID-19: https://pubmed.ncbi.nlm.nih.gov/34435486/
339. COVID-19: gli insegnamenti della tragedia norvegese dovrebbero essere presi in considerazione nella pianificazione del lancio del vaccino nei paesi meno sviluppati/in via di sviluppo: https://pubmed.ncbi.nlm.nih.gov/34435142/
340. Linfolisi acuta e pancitopenia indotte da rituximab dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34429981/
341. Esacerbazione della psoriasi a placche dopo i vaccini mRNA e BNT162b2 inattivati ​​da COVID-19: rapporto di due casi: https://pubmed.ncbi.nlm.nih.gov/34427024/
342. Malattia polmonare interstiziale indotta da vaccino: una rara reazione al vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34510014/ .
343. Reazioni cutanee vescicolobollose indotte dal vaccino mRNA COVID-19: rapporto di quattro casi e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34236711/
344. Trombocitopenia indotta da vaccino con forte mal di testa: https://pubmed.ncbi.nlm.nih.gov/34525282/
345. Perimiocardite acuta dopo la prima dose di vaccino mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34515024/
346. Rabdomiolisi e fascite indotte dal vaccino mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34435250/ .
347. Rari effetti avversi cutanei dei vaccini COVID-19: una serie di casi e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34363637/
348. Trombocitopenia immunitaria associata al vaccino Pfizer-BioNTech COVID-19 mRNA BNT162b2: https://www.sciencedirect.com/science/article/pii/S2214250921002018
349. Trombocitopenia immunitaria secondaria presumibilmente attribuibile alla vaccinazione COVID-19: https://casereports.bmj.com/content/14/5/e242220.abstract .
350. Trombocitopenia immunitaria dopo il vaccino Pfizer-BioNTech BNT162b2 mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34155844/
351. Trombocitopenia idiopatica di nuova diagnosi dopo la somministrazione del vaccino COVID-19: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176657/ .
352. Porpora trombocitopenica idiopatica e vaccino moderno Covid-19: https://www.annemergmed.com/article/S0196-0644(21)00122-0/fulltext .
353. Trombocitopenia dopo la vaccinazione contro la SARS Pfizer e Moderna – CoV -2: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014568/ .
354. Porpora trombocitopenica immunitaria e danno epatico acuto dopo la vaccinazione COVID-19: https://casereports.bmj.com/content/14/7/e242678.full?int_source=trendmd&int_me dium = cpc & int_campaign = usage-042019
355. Raccolta di condizioni ematologiche mediate dal complemento e autoimmuni dopo la vaccinazione SARS-CoV-2: https://ashpublications.org/bloodadvances/article/5/13/2794/476324/Autoimmune-a nd-complement-mediated-hematologic? utm_source = TrendMD & utm_medium = cpc & utm_campaign = Blood_Advances_TrendMD_1.
356. Rash petecchiale associato alla vaccinazione CoronaVac: primo rapporto sugli effetti collaterali cutanei prima dei risultati della fase 3: https://ejhp.bmj.com/content/early/2021/05/23/ejhpharm-2021-002794?int_source=t rendmd & int_medium = cpc & int_campaign = utilizzo-042019
357. I vaccini COVID-19 inducono una grave emolisi nell’emoglobinuria parossistica notturna: https://ashpublications.org/blood/article/137/26/3670/475905/COVID-19-vaccines-i nduce-severe-hemolysis-in
358. Trombosi venosa cerebrale associata al vaccino COVID-19 in Germania: https://pubmed.ncbi.nlm.nih.gov/34288044/ .
359. Trombosi del seno venoso cerebrale dopo la vaccinazione COVID-19: gestione neurologica e radiologica: https://pubmed.ncbi.nlm.nih.gov/34327553/ .
360. Trombosi venosa cerebrale e trombocitopenia dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33878469/ .

361. Trombosi del seno venoso cerebrale e trombocitopenia dopo la vaccinazione COVID-19: rapporto di due casi nel Regno Unito: https://pubmed.ncbi.nlm.nih.gov/33857630/ .
362. Trombosi venosa cerebrale indotta dal vaccino SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34090750/ .
363. Trombosi immunitaria dell’arteria carotidea indotta dal vaccino COVID-19 con vettore di adenovirus: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34312301/ .
364. Trombosi del seno venoso cerebrale associata a trombocitopenia trombotica indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34333995/
365. I ruoli delle piastrine nella coagulopatia associata a COVID-19 e nella trombocitopenia trombotica immunoimmune indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34455073/
366. Trombosi venosa cerebrale dopo il vaccino BNT162b2 mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34111775/ .
367. Trombosi venosa cerebrale dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34045111/
368. Trombosi del seno venoso cerebrale letale dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33983464/
369. Trombosi del seno venoso cerebrale nella popolazione statunitense, dopo la vaccinazione SARS-CoV-2 con adenovirus e dopo COVID-19: https://pubmed.ncbi.nlm.nih.gov/34116145/

Trombosi venosa cerebrale dopo vaccinazione COVID-19: è il rischio di trombosi aumentato dalla somministrazione intravascolare del vaccino: https://pubmed.ncbi.nlm.nih.gov/34286453/ .

371. Trombosi del seno venoso centrale con emorragia subaracnoidea dopo vaccinazione con mRNA COVID-19: questi rapporti sono semplicemente casuali: https://pubmed.ncbi.nlm.nih.gov/34478433/
372. Trombosi del seno venoso cerebrale dopo la vaccinazione ChAdOx1 nCov-19 con una prima risonanza magnetica cerebrale fuorviante: https://pubmed.ncbi.nlm.nih.gov/34244448/
373. Primi risultati del trattamento con bivalirudina per trombocitopenia trombotica e trombosi del seno venoso cerebrale dopo la vaccinazione con Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34226070/
374. Trombosi del seno venoso cerebrale associata a trombocitopenia post-vaccinazione da COVID-19: https://pubmed.ncbi.nlm.nih.gov/33845870/ .
375. Trombosi del seno venoso cerebrale 2 settimane dopo la prima dose di vaccino mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34101024/ .
376. Trombocitopenia trombotica immunitaria indotta da vaccino che causa una forma grave di trombosi venosa cerebrale con un alto tasso di mortalità: una serie di casi: https://pubmed.ncbi.nlm.nih.gov/34393988/ .
377. Interazioni dell’adenovirus con piastrine e coagulazione e sindrome da trombosi trombocitopenica autoimmune associata al vaccino: https://pubmed.ncbi.nlm.nih.gov/34407607/ .
378. Mal di testa attribuita alla vaccinazione COVID-19 (SARS-CoV-2 coronavirus) con il vaccino ChAdOx1 nCoV-19 (AZD1222): uno studio di coorte osservazionale multicentrico: https://pubmed.ncbi.nlm.nih.gov/34313952/
379. Gli effetti avversi segnalati dopo la vaccinazione COVID-19 in un ospedale di cure terziarie, focus sulla trombosi del seno venoso cerebrale (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/
380. Trombosi del seno venoso cerebrale a seguito di vaccinazione contro SARS-CoV-2: un’analisi dei casi segnalati all’Agenzia europea per i medicinali: https://pubmed.ncbi.nlm.nih.gov/34293217/
381. Un raro caso di un maschio asiatico di mezza età con trombosi venosa cerebrale dopo la vaccinazione COVID-19 AstraZeneca: https://pubmed.ncbi.nlm.nih.gov/34274191/
382. Trombosi del seno venoso cerebrale negativa per anticorpi anti-PF4 senza trombocitopenia dopo immunizzazione con vaccino COVID-19 in un uomo indiano anziano non comorbido trattato con anticoagulante convenzionale a base di eparina-warfarin: https://pubmed.ncbi.nlm.nih.gov / 34186376 /
383. Eventi arteriosi, tromboembolismo venoso, trombocitopenia ed emorragie dopo la vaccinazione con Oxford-AstraZeneca ChAdOx1-S in Danimarca e Norvegia: studio di coorte basato sulla popolazione: https://pubmed.ncbi.nlm.nih.gov/33952445/
384. Microparticelle procoagulanti: un possibile legame tra trombocitopenia immunitaria indotta da vaccino (VITT) e trombosi venosa del seno cerebrale: https://pubmed.ncbi.nlm.nih.gov/34129181/
385. Casi clinici statunitensi di trombosi del seno venoso cerebrale con trombocitopenia dopo la vaccinazione con Ad26.COV2.S, 2 marzo-21 aprile 2021: https://pubmed.ncbi.nlm.nih.gov/33929487/ .
386. Infarto cerebrale maligno dopo la vaccinazione con ChAdOx1 nCov-19: una variante catastrofica della trombocitopenia trombotica immuno-mediata indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34341358/

387. Ictus ischemico acuto che rivela trombocitopenia trombotica immunitaria indotta dal vaccino ChAdOx1 nCov-19: impatto sulla strategia di ricanalizzazione: https://pubmed.ncbi.nlm.nih.gov/34175640/
388. Trombocitopenia immunitaria trombotica immunitaria indotta da vaccino (VITT): una nuova entità clinicopatologica con presentazioni cliniche eterogenee: https://pubmed.ncbi.nlm.nih.gov/34159588/ .
389. Reperti di imaging ed ematologici nella trombosi e trombocitopenia dopo la vaccinazione con ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/
390. Radici di autoimmunità di eventi trombotici dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34508917/
391. Trombosi del seno venoso cerebrale dopo la vaccinazione: l’esperienza nel Regno Unito: https://pubmed.ncbi.nlm.nih.gov/34370974/
392. Trombosi venosa cerebrale massiccia e infarto del bacino venoso come complicanze tardive di COVID-19: un caso clinico: https://pubmed.ncbi.nlm.nih.gov/34373991/
393. Approccio australiano e neozelandese alla diagnosi e al trattamento della trombosi immunitaria indotta da vaccino e della trombocitopenia immunitaria: https://pubmed.ncbi.nlm.nih.gov/34490632/
394. Uno studio osservazionale per identificare la prevalenza della trombocitopenia e degli anticorpi anti-PF4/polianione negli operatori sanitari norvegesi dopo la vaccinazione contro il COVID-19: https://pubmed.ncbi.nlm.nih.gov/33909350/

Mielite trasversa acuta (ATM): revisione clinica di 43 pazienti con ATM associato a COVID-19 e 3 eventi avversi gravi di ATM post-vaccinazione con vaccino ChAdOx1 nCoV-19 (AZD1222): https: //pubmed.ncbi.nlm.nih .gov / 33981305 / .

396. Un caso di poliradicoloneuropatia demielinizzante acuta con paralisi facciale bilaterale dopo il vaccino ChAdOx1 nCoV-19 :. https://pubmed.ncbi.nlm.nih.gov/34272622/
397. Trombocitopenia con ictus ischemico acuto ed emorragia in un paziente recentemente vaccinato con un vaccino COVID-19 a base di vettore adenovirale:. https://pubmed.ncbi.nlm.nih.gov/33877737/
398. Incidenza prevista e osservata di eventi tromboembolici tra i coreani vaccinati con il vaccino ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34254476/
399. Prima dose di vaccini ChAdOx1 e BNT162b2 COVID-19 ed eventi trombocitopenici, tromboembolici ed emorragici in Scozia: https://pubmed.ncbi.nlm.nih.gov/34108714/

Trombocitopenia associata al vaccino ChAdOx1 nCoV-19: tre casi di trombocitopenia immunitaria dopo 107.720 dosi di vaccinazione ChAdOx1 in Thailandia: https://pubmed.ncbi.nlm.nih.gov/34483267/ .

401. Embolia polmonare, attacco ischemico transitorio e trombocitopenia dopo il vaccino Johnson & Johnson COVID-19: https://pubmed.ncbi.nlm.nih.gov/34261635/
402. Considerazioni neurochirurgiche rispetto alla craniectomia decompressiva per emorragia intracerebrale dopo la vaccinazione SARS-CoV-2 nella trombocitopenia trombotica indotta da vaccino-VITT: https://pubmed.ncbi.nlm.nih.gov/34202817/
403. Grande ictus emorragico dopo la vaccinazione contro ChAdOx1 nCoV-19: un caso clinico: https://pubmed.ncbi.nlm.nih.gov/34273119/
404. Sindrome di poliartralgia e mialgia dopo la vaccinazione con ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/
405. Un raro caso di trombosi e trombocitopenia della vena oftalmica superiore dopo la vaccinazione ChAdOx1 nCoV-19 contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34276917/

Trombosi e sindrome respiratoria acuta grave Vaccini contro il coronavirus 2: trombocitopenia trombotica immunitaria indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34237213/ .

407. Trombosi venosa renale ed embolia polmonare secondarie a trombocitopenia immunitaria trombotica indotta da vaccino (VITT): https://pubmed.ncbi.nlm.nih.gov/34268278/ .
408. Ischemia degli arti e trombosi dell’arteria polmonare dopo il vaccino ChAdOx1 nCoV-19 (Oxford-AstraZeneca): un caso di trombocitopenia trombotica immunitaria indotta dal vaccino: https://pubmed.ncbi.nlm.nih.gov/33990339/ .
409. Associazione tra vaccinazione ChAdOx1 nCoV-19 ed episodi emorragici: ampio studio di coorte basato sulla popolazione: https://pubmed.ncbi.nlm.nih.gov/34479760/ .

Trombocitopenia secondaria dopo vaccinazione SARS-CoV-2: caso clinico di emorragia ed ematoma dopo chirurgia orale minore: https://pubmed.ncbi.nlm.nih.gov/34314875/ .

411. Tromboembolia venosa e trombocitopenia lieve dopo la vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34384129/
412. Esacerbazione fatale della sindrome da trombocitopenia trombotica indotta da ChadOx1-nCoV-19 dopo il successo della terapia iniziale con immunoglobuline per via endovenosa: un razionale per il monitoraggio dei livelli di immunoglobuline G: https://pubmed.ncbi.nlm.nih.gov/34382387/

413. Un caso di vasculite associata ad ANCA dopo la vaccinazione AZD1222 (Oxford-AstraZeneca) SARS-CoV-2: vittima o causalità?: https://pubmed.ncbi.nlm.nih.gov/34416184/ .
414. Emorragia intracerebrale associata a trombocitopenia trombotica indotta da vaccino dopo la vaccinazione ChAdOx1 nCOVID-19 in una donna incinta: https://pubmed.ncbi.nlm.nih.gov/34261297/
415. Trombosi venosa cerebrale massiccia dovuta a trombocitopenia trombotica immunitaria indotta dal vaccino: https://pubmed.ncbi.nlm.nih.gov/34261296/
416. Sindrome nefrosica dopo il vaccino ChAdOx1 nCoV-19 contro SARScoV-2: https://pubmed.ncbi.nlm.nih.gov/34250318/ .
417. Un caso di trombocitopenia trombotica immuno-immune indotta da vaccino con massiccia trombosi arterovenosa: https://pubmed.ncbi.nlm.nih.gov/34059191/
418. Trombosi cutanea associata a necrosi cutanea a seguito della vaccinazione Oxford-AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34189756/
419. Trombocitopenia in un adolescente con anemia falciforme dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34331506/
420. Trombocitopenia indotta da vaccino con forte mal di testa: https://pubmed.ncbi.nlm.nih.gov/34525282/
421. Miocardite associata alla vaccinazione con mRNA SARS-CoV-2 in bambini di età compresa tra 12 e 17 anni: analisi stratificata di un database nazionale: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1
422. Vaccinazione dell’mRNA COVID-19 e sviluppo di miopericardite confermata da CMR: https://www.medrxiv.org/content/10.1101/2021.09.13.21262182v1.full?s=09 .
423. Grave anemia emolitica autoimmune dopo aver ricevuto il vaccino mRNA SARS-CoV-2: https://onlinelibrary.wiley.com/doi/10.1111/trf.16672
424. L’iniezione endovenosa del vaccino mRNA della malattia di coronavirus 2019 (COVID-19) può indurre miopericardite acuta in un modello murino: https://t.co/j0IEM8cMXI
425. Un rapporto sugli eventi avversi della miocardite nello US Vaccine Adverse Event Reporting System. (VAERS) in associazione con farmaci biologici iniettabili COVID-19: https://pubmed.ncbi.nlm.nih.gov/34601006/
426. Questo studio conclude che: “Il vaccino era associato a un rischio eccessivo di miocardite (da 1 a 5 eventi ogni 100.000 persone). Il rischio di questo evento avverso potenzialmente grave e di molti altri eventi avversi gravi è aumentato sostanzialmente dopo l’infezione da SARS-CoV-2 ”: https://www.nejm.org/doi/full/10.1056/NEJMoa2110475?query=featured_home
427. Uveite bilaterale dopo inoculazione con vaccino COVID-19: un caso clinico: https://www.sciencedirect.com/science/article/pii/S1201971221007797
428. Miocardite associata alla vaccinazione con mRNA SARS-CoV-2 in bambini di età compresa tra 12 e 17 anni: analisi stratificata di un database nazionale: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1 .
429. L’epatite immuno-mediata con il vaccino Moderna non è più una coincidenza ma è confermata: https://www.sciencedirect.com/science/article/pii/S0168827821020936
430. Ampie indagini hanno rivelato consistenti alterazioni fisiopatologiche dopo la vaccinazione con i vaccini COVID-19: https://www.nature.com/articles/s41421-021-00329-3
431. Emorragia lobare con rottura ventricolare subito dopo la prima dose di un vaccino SARS-CoV-2 a base di mRNA: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8553377/
432. I vaccini Mrna COVID aumentano drasticamente i marcatori infiammatori endoteliali e il rischio di sindrome coronarica acuta come misurato dal test cardiaco PULS: un avvertimento: https://www.ahajournals.org/doi/10.1161/circ.144.suppl_1.10712
433. ChAdOx1 interagisce con CAR e PF4 con implicazioni per la trombosi con sindrome da trombocitopenia: https://www.science.org/doi/10.1126/sciadv.abl8213
434. Trombocitopenia immunitaria trombotica immunitaria indotta da vaccino letale (VITT) dopo l’annuncio 26.COV2.S: primo caso documentato al di fuori degli Stati Uniti: https://pubmed.ncbi.nlm.nih.gov/34626338/
435. Un disturbo trombocitopenico protrombotico simile alla trombocitopenia indotta da eparina dopo la vaccinazione contro il coronavirus-19: https://europepmc.org/article/PPR/PPR304469 435.
436. VITT (trombocitopenia trombotica immunitaria indotta da vaccino) dopo la vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34731555/
437. Trombocitopenia trombotica immunitaria indotta da vaccino (VITT): una nuova entità clinicopatologica con presentazioni cliniche eterogenee: https://pubmed.ncbi.nlm.nih.gov/34159588/
438. Trattamento dell’ictus ischemico acuto associato alla trombocitopenia trombotica immunitaria indotta dal vaccino ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34461442/

439. Spettro delle complicanze neurologiche dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34719776/ .
440. Trombosi del seno venoso cerebrale dopo la vaccinazione: l’esperienza nel Regno Unito: https://pubmed.ncbi.nlm.nih.gov/34370974/
441. Vena venosa cerebrale/trombosi del seno venoso con sindrome da trombocitopenia dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34373413/
442. Trombosi della vena porta dovuta a trombocitopenia immunitaria trombotica immunitaria indotta da vaccino (VITT) dopo la vaccinazione Covid con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34598301/
443. Ematuria, rash petecchiale generalizzato e mal di testa dopo la vaccinazione Oxford AstraZeneca ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34620638/
444. Infarto del miocardio e trombosi venosa azygos dopo la vaccinazione con ChAdOx1 nCoV-19 in un paziente in emodialisi: https://pubmed.ncbi.nlm.nih.gov/34650896/
445. Cardiomiopatia Takotsubo (stress) dopo la vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34625447/
446. Risposta umorale indotta dalla vaccinazione Prime-Boost con i vaccini ChAdOx1 nCoV-19 e BNT162b2 mRNA in un paziente con sclerosi multipla trattato con teriflunomide: https://pubmed.ncbi.nlm.nih.gov/34696248/
447. Sindrome di Guillain-Barré dopo la vaccinazione ChAdOx1 nCoV-19 COVID-19: una serie di casi: https://pubmed.ncbi.nlm.nih.gov/34548920/
448. Trombocitopenia trombotica immunitaria indotta da vaccino refrattaria (VITT) trattata con scambio plasmatico terapeutico ritardato (TPE): https://pubmed.ncbi.nlm.nih.gov/34672380/ .
449. Raro caso di emorragia intracranica associata al vaccino COVID-19 con trombosi del seno venoso: https://pubmed.ncbi.nlm.nih.gov/34556531/ .
450. Mal di testa ritardato dopo la vaccinazione COVID-19: un segnale di avvertimento per la trombosi venosa cerebrale indotta dal vaccino: https://pubmed.ncbi.nlm.nih.gov/34535076/ .
451. Caratteristiche cliniche della trombocitopenia indotta da vaccino e della trombosi immunitaria: https://pubmed.ncbi.nlm.nih.gov/34379914/ .
452. Predittori di mortalità nella trombocitopenia trombotica dopo la vaccinazione adenovirale COVID-19: il punteggio FAPIC: https://pubmed.ncbi.nlm.nih.gov/34545400/
453. Ictus ischemico come caratteristica di presentazione della trombocitopenia trombotica immunitaria indotta dalla vaccinazione ChAdOx1-nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34035134/
454. Studio osservazionale in ospedale sui disturbi neurologici in pazienti recentemente vaccinati con vaccini mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34688190/
455. Trattamento endovascolare per trombosi del seno venoso cerebrale indotta da vaccino e trombocitopenia dopo la vaccinazione con ChAdOx1 nCoV-19: rapporto di tre casi: https://pubmed.ncbi.nlm.nih.gov/34782400/
456. Eventi cardiovascolari, neurologici e polmonari dopo la vaccinazione con i vaccini BNT162b2, ChAdOx1 nCoV-19 e Ad26.COV2.S: un’analisi dei dati europei: https://pubmed.ncbi.nlm.nih.gov/34710832/
457. Trombosi venosa cerebrale che si sviluppa dopo la vaccinazione.

in. COVID-19: VITT, VATT, TTS e altro: https://pubmed.ncbi.nlm.nih.gov/34695859/

Trombosi venosa cerebrale e neoplasie mieloproliferative: uno studio a tre centri su 74 casi consecutivi: https://pubmed.ncbi.nlm.nih.gov/34453762/ .

459. Possibili fattori scatenanti di trombocitopenia e/o emorragia da parte del vaccino BNT162b2, Pfizer-BioNTech: https://pubmed.ncbi.nlm.nih.gov/34660652/ .
460. Siti multipli di trombosi arteriosa in un paziente di 35 anni dopo la vaccinazione con ChAdOx1 (AstraZeneca), che ha richiesto una trombectomia chirurgica femorale e carotidea d’urgenza: https://pubmed.ncbi.nlm.nih.gov/34644642/
461. Serie di casi di trombocitopenia trombotica indotta da vaccino in un ospedale universitario di Londra: https://pubmed.ncbi.nlm.nih.gov/34694650/
462. Complicanze neuro-oftalmiche con trombocitopenia e trombosi indotte dal vaccino ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34726934/
463. Eventi trombotici dopo la vaccinazione COVID-19 in età superiore ai 50 anni: risultati di uno studio di popolazione in Italia: https://pubmed.ncbi.nlm.nih.gov/34835237/
464. Emorragia intracerebrale associata a trombocitopenia trombotica indotta da vaccino dopo la vaccinazione ChAdOx1 nCOVID-19 in una donna incinta: https://pubmed.ncbi.nlm.nih.gov/34261297/

Incidenza specifica per età e sesso della trombosi del seno venoso cerebrale associata alla vaccinazione Ad26.COV2.S COVID-19: https://pubmed.ncbi.nlm.nih.gov/34724036/ .

466. Necrosi genitale con trombosi cutanea a seguito di vaccinazione con mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34839563/
467. Trombosi del seno venoso cerebrale dopo vaccinazione COVID-19 basata su mRNA: https://pubmed.ncbi.nlm.nih.gov/34783932/ .

Trombosi immunitaria indotta dal vaccino COVID-19 con trombocitopenia trombosi (VITT) e sfumature di grigio nella formazione di trombi: https://pubmed.ncbi.nlm.nih.gov/34624910/

469. Miosite infiammatoria dopo vaccinazione con ChAdOx1: https://pubmed.ncbi.nlm.nih.gov/34585145/

Infarto miocardico acuto con sopraslivellamento del segmento ST secondario a trombosi immunitaria indotta da vaccino con trombocitopenia (VITT): https://pubmed.ncbi.nlm.nih.gov/34580132/ .

471. Un raro caso di trombocitopenia trombotica indotta dal vaccino COVID-19 (VITT) che colpisce la circolazione arteriosa venosplancnica e polmonare da un ospedale generale distrettuale del Regno Unito: https://pubmed.ncbi.nlm.nih.gov/34535492/
472. Trombocitopenia trombotica indotta dal vaccino COVID-19: una serie di casi: https://pubmed.ncbi.nlm.nih.gov/34527501/
473. Trombosi con sindrome da trombocitopenia (TTS) dopo vaccinazione con AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19: un’analisi rischio-beneficio per le persone <60%.

analisi rischio-beneficio per le persone <60 anni in Australia: https://pubmed.ncbi.nlm.nih.gov/34272095/

474. Trombocitopenia immunitaria dopo immunizzazione con il vaccino Vaxzevria ChadOx1-S (AstraZeneca), Victoria, Australia: https://pubmed.ncbi.nlm.nih.gov/34756770/
475. Caratteristiche ed esiti di pazienti con trombosi del seno venoso cerebrale in trombocitopenia immunitaria trombotica indotta dal vaccino SARS-CoV-2: https://jamanetwork.com/journals/jamaneurology/fullarticle/2784622
476. Caso di studio di trombosi e sindrome da trombocitopenia dopo la somministrazione del vaccino AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34781321/
477. Trombosi con sindrome da trombocitopenia associata a vaccini COVID-19: https://pubmed.ncbi.nlm.nih.gov/34062319/
478. Trombosi del seno venoso cerebrale dopo vaccinazione con ChAdOx1: il primo caso di trombosi definita con sindrome da trombocitopenia in India: https://pubmed.ncbi.nlm.nih.gov/34706921/
479. Trombosi associata al vaccino COVID-19 con sindrome da trombocitopenia (TTS): revisione sistematica e analisi post hoc: https://pubmed.ncbi.nlm.nih.gov/34698582/ .
480. Caso clinico di trombocitopenia immunitaria dopo vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34751013/ .
481. Mielite trasversa acuta dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34684047/ .
482. Preoccupazioni per gli effetti avversi della trombocitopenia e della trombosi dopo la vaccinazione COVID-19 con vettore di adenovirus: https://pubmed.ncbi.nlm.nih.gov/34541935/
483. Ictus emorragico maggiore dopo la vaccinazione ChAdOx1 nCoV-19: un caso clinico: https://pubmed.ncbi.nlm.nih.gov/34273119/
484. Trombosi del seno venoso cerebrale dopo la vaccinazione COVID-19: gestione neurologica e radiologica: https://pubmed.ncbi.nlm.nih.gov/34327553/ .
485. Trombocitopenia con ictus ischemico acuto ed emorragia in un paziente recentemente vaccinato con un vaccino COVID-19 a base di vettore adenovirale: https://pubmed.ncbi.nlm.nih.gov/33877737/
486. Emorragia intracerebrale e trombocitopenia dopo il vaccino AstraZeneca COVID-19: sfide cliniche e diagnostiche della trombocitopenia trombotica indotta dal vaccino: https://pubmed.ncbi.nlm.nih.gov/34646685/
487. Malattia a cambiamento minimo con grave danno renale acuto dopo il vaccino Oxford-AstraZeneca COVID-19: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34242687/ .
488. Caso clinico: trombosi venosa del seno cerebrale in due pazienti con vaccino AstraZeneca SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34609603/
489. Caso clinico: eruzione cutanea simile alla pitiriasi rosea dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34557507/
490. Mielite trasversa longitudinale estesa dopo il vaccino ChAdOx1 nCOV-19: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34641797/ .
491. Polmonite eosinofila acuta associata al vaccino anti-COVID-19 AZD1222: https://pubmed.ncbi.nlm.nih.gov/34812326/ .
492. Trombocitopenia, inclusa la trombocitopenia immunitaria dopo aver ricevuto vaccini mRNA COVID-19 segnalati al Vaccine Adverse Event Reporting System (VAERS): https://pubmed.ncbi.nlm.nih.gov/34006408/
493. Un caso di vasculite associata ad ANCA dopo la vaccinazione AZD1222 (Oxford-AstraZeneca) SARS-CoV-2: vittima o causalità?: https://pubmed.ncbi.nlm.nih.gov/34416184/
494. Trombosi immunitaria indotta da vaccino e sindrome da trombocitopenia dopo la vaccinazione contro il coronavirus 2 della sindrome respiratoria acuta grave con vettore di adenovirus: una nuova ipotesi sui meccanismi e le implicazioni per lo sviluppo futuro del vaccino: https://pubmed.ncbi.nlm.nih.gov/34664303/ .

Trombosi nella malattia delle arterie periferiche e trombocitopenia trombotica a seguito della vaccinazione adenovirale COVID-19: https://pubmed.ncbi.nlm.nih.gov/34649281/ .

496. Trombocitopenia immunitaria di nuova diagnosi in una paziente incinta dopo la vaccinazione contro la malattia da coronavirus 2019: https://pubmed.ncbi.nlm.nih.gov/34420249/

Trombosi del seno venoso cerebrale ed eventi trombotici dopo vaccini COVID-19 basati su vettori: revisione sistematica e meta-analisi: https://pubmed.ncbi.nlm.nih.gov/34610990/ .

498. La sindrome di Sweet dopo il vaccino Oxford-AstraZeneca COVID-19 (AZD1222) in una donna anziana: https://pubmed.ncbi.nlm.nih.gov/34590397/
499. Perdita dell’udito neurosensoriale improvvisa dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34670143/ .

Prevalenza di eventi avversi gravi tra gli operatori sanitari dopo aver ricevuto la prima dose di vaccino contro il coronavirus ChAdOx1 nCoV-19 (Covishield) in Togo, marzo 2021: https://pubmed.ncbi.nlm.nih.gov/34819146/ .

501. Emicorea-emibalismo acuto dopo la vaccinazione COVID-19 (AZD1222): https://pubmed.ncbi.nlm.nih.gov/34581453/
502. Recidiva di alopecia areata dopo vaccinazione covid-19: un report di tre casi in Italia: https://pubmed.ncbi.nlm.nih.gov/34741583/
503. Lesione cutanea simile all’herpes zoster dopo la vaccinazione con AstraZeneca per COVID-19: un caso clinico: https://pubmed.ncbi.nlm.nih.gov/34631069/
504. Trombosi dopo vaccinazione COVID-19: possibile collegamento ai percorsi ACE: https://pubmed.ncbi.nlm.nih.gov/34479129/
505. Trombocitopenia in un adolescente con anemia falciforme dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34331506/
506. Vasculite leucocitoclastica come manifestazione cutanea del vaccino ChAdOx1 corona virus nCoV-19 (ricombinante): https://pubmed.ncbi.nlm.nih.gov/34546608/
507. Dolore addominale ed emorragia surrenale bilaterale da trombocitopenia trombotica immunitaria indotta dal vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34546343/
508. Mielite cervicale estesa longitudinalmente dopo la vaccinazione con il vaccino COVID-19 a base di virus inattivato: https://pubmed.ncbi.nlm.nih.gov/34849183/
509. Induzione della vasculite leucocitoclastica cutanea dopo il vaccino ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34853744/ .
510. Un caso di necrolisi epidermica tossica dopo vaccinazione con ChAdOx1 nCoV-19 (AZD1222): https://pubmed.ncbi.nlm.nih.gov/34751429/ .
511. Eventi avversi oculari a seguito della vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34559576/
512. Depressione dopo la vaccinazione ChAdOx1-S/nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34608345/ .
513. Tromboembolia venosa e trombocitopenia lieve dopo la vaccinazione ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34384129/ .
514. Vasculite associata ad ANCA ricorrente dopo la vaccinazione Oxford AstraZeneca ChAdOx1-S COVID-19: una serie di casi di due pazienti: https://pubmed.ncbi.nlm.nih.gov/34755433/
515. Trombosi dell’arteria maggiore e vaccinazione contro ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34839830/
516. Raro caso di linfoadenopatia sopraclavicolare controlaterale dopo vaccinazione con COVID-19: tomografia computerizzata e risultati ecografici: https://pubmed.ncbi.nlm.nih.gov/34667486/
517. Vasculite linfocitica cutanea dopo somministrazione della seconda dose di AZD1222 (Oxford-AstraZeneca) Sindrome respiratoria acuta grave Vaccino Coronavirus 2: casualità o causalità: https://pubmed.ncbi.nlm.nih.gov/34726187/ .
518. Rigetto dell’allotrapianto del pancreas dopo il vaccino ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34781027/
519. Comprensione del rischio di trombosi con sindrome da trombocitopenia a seguito della vaccinazione Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34595694/
520. Reazioni avverse cutanee di 35.229 dosi di vaccino COVID-19 Sinovac e AstraZeneca COVID-19: uno studio di coorte prospettico negli operatori sanitari: https://pubmed.ncbi.nlm.nih.gov/34661934/
521. Commenti sulla trombosi dopo la vaccinazione: la sequenza leader della proteina spike potrebbe essere responsabile della trombosi e della trombocitopenia mediata da anticorpi: https://pubmed.ncbi.nlm.nih.gov/34788138/
522. Dermatosi eosinofila dopo vaccinazione AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34753210/ .

523. Grave trombocitopenia immunitaria a seguito della vaccinazione COVID-19: rapporto di quattro casi e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34653943/ .
524. Ricaduta della trombocitopenia immunitaria dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34591991/
525. Trombosi in fase pre e post vaccinale di COVID-19; https://pubmed.ncbi.nlm.nih.gov/34650382/
526. Uno sguardo al ruolo dell’immunoistochimica post mortem nella comprensione della fisiopatologia infiammatoria della malattia COVID-19 e degli eventi avversi trombotici correlati al vaccino: una revisione narrativa: https://pubmed.ncbi.nlm.nih.gov/34769454/
527. Vaccino COVID-19 in pazienti con disturbi da ipercoagulabilità: una prospettiva clinica: https://pubmed.ncbi.nlm.nih.gov/34786893/
528. Trombocitopenia e trombosi associate al vaccino: endoteliopatia venosa che porta a micro-macrotrombosi venosa combinata: https://pubmed.ncbi.nlm.nih.gov/34833382/
529. Sindrome da trombosi e trombocitopenia che causa occlusione carotidea sintomatica isolata dopo il vaccino COVID-19 Ad26.COV2.S (Janssen): https://pubmed.ncbi.nlm.nih.gov/34670287/
530. Una presentazione insolita di trombosi venosa profonda acuta dopo il vaccino moderno COVID-19: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34790811/
531. Le immunoglobuline per via endovenosa ad alte dosi immediate seguite dal trattamento diretto con inibitori della trombina sono cruciali per la sopravvivenza nella trombocitopenia trombotica immunitaria indotta dal vaccino

Sars-Covid-19-vector adenovirale VITT con trombosi venosa del seno cerebrale e della vena porta: https://pubmed.ncbi.nlm.nih.gov/34023956/ .

532. Formazione di trombosi dopo aspetti immunologici della vaccinazione COVID-19: articolo di revisione: https://pubmed.ncbi.nlm.nih.gov/34629931/
533. Reperti di imaging ed ematologici nella trombosi e trombocitopenia dopo la vaccinazione con ChAdOx1 nCoV-19 (AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34402666/
534. Spettro dei risultati di neuroimaging nella vaccinazione post-CoVID-19: una serie di casi e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34842783/
535. Trombosi del seno venoso cerebrale, embolia polmonare e trombocitopenia dopo la vaccinazione COVID-19 in un uomo taiwanese: un caso clinico e una revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34630307/
536. Trombosi del seno venoso cerebrale fatale dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33983464/
537. Radici autoimmuni di eventi trombotici dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34508917/ .
538. Nuova trombosi della vena porta nella cirrosi: la trombofilia è esacerbata dal vaccino o dal COVID-19: https://www.jcehepatology.com/article/S0973-6883(21)00545-4/fulltext .
539. Immagini di trombocitopenia trombotica immunitaria indotta dal vaccino Oxford/AstraZeneca® COVID-19: https://pubmed.ncbi.nlm.nih.gov/33962903/ .
540. Trombosi del seno venoso cerebrale dopo la vaccinazione con COVID-19 mRNA di BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34796065/ .
541. Aumento del rischio di orticaria/angioedema dopo la vaccinazione con BNT162b2 mRNA COVID-19 negli operatori sanitari che assumono ACE inibitori: https://pubmed.ncbi.nlm.nih.gov/34579248/
542. Un caso di presentazione clinica lieve e insolita di trombocitopenia trombotica immunitaria indotta dal vaccino COVID-19 con trombosi venosa splancnica: https://pubmed.ncbi.nlm.nih.gov/34843991/
543. Trombosi del seno venoso cerebrale dopo vaccinazione con Pfizer-BioNTech COVID-19 (BNT162b2): https://pubmed.ncbi.nlm.nih.gov/34595867/
544. Un caso di porpora trombocitopenica idiopatica dopo una dose di richiamo del vaccino COVID-19 BNT162b2 (Pfizer-Biontech): https://pubmed.ncbi.nlm.nih.gov/34820240/
545. Trombocitopenia immunitaria trombotica immunitaria indotta da vaccino (VITT): mira ai meccanismi patologici con gli inibitori della tirosin-chinasi di Bruton: https://pubmed.ncbi.nlm.nih.gov/33851389/
546. Porpora trombotica trombocitopenica dopo la vaccinazione con Ad26.COV2-S: https://pubmed.ncbi.nlm.nih.gov/33980419/
547. Eventi tromboembolici nelle donne più giovani esposte ai vaccini Pfizer-BioNTech o Moderna COVID-19: https://pubmed.ncbi.nlm.nih.gov/34264151/
548. Potenziale rischio di eventi trombotici dopo la vaccinazione COVID-19 con Oxford-AstraZeneca nelle donne che ricevono estrogeni: https://pubmed.ncbi.nlm.nih.gov/34734086/
549. Trombosi dopo la vaccinazione COVID-19 con vettore di adenovirus: una preoccupazione per la malattia sottostante: https://pubmed.ncbi.nlm.nih.gov/34755555/
550. Interazioni di adenovirus con piastrine e coagulazione e sindrome da trombocitopenia immunitaria indotta da vaccino: https://pubmed.ncbi.nlm.nih.gov/34407607/

551. Porpora trombotica trombocitopenica: una nuova minaccia dopo il vaccino COVID bnt162b2: https://pubmed.ncbi.nlm.nih.gov/34264514/ .
552. Sito insolito di trombosi venosa profonda dopo la vaccinazione contro il coronavirus mRNA-2019 coronavirus disease (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34840204/
553. Effetti collaterali neurologici dei vaccini SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34750810/
554. Le coagulopatie dopo la vaccinazione SARS-CoV-2 possono derivare da un effetto combinato della proteina spike SARS-CoV-2 e delle vie di segnalazione attivate dal vettore di adenovirus: https://pubmed.ncbi.nlm.nih.gov/34639132/
555. Embolia polmonare isolata dopo la vaccinazione COVID: 2 case report e una revisione delle complicanze e del follow-up dell’embolia polmonare acuta: https://pubmed.ncbi.nlm.nih.gov/34804412/
556. Occlusione della vena retinica centrale dopo la vaccinazione con mRNA SARS-CoV-2: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34571653/ .
557. Caso complicato di trombocitopenia immunitaria trombotica indotta da vaccino a lungo termine A: https://pubmed.ncbi.nlm.nih.gov/34835275/ .
558. Trombosi venosa profonda dopo la vaccinazione con Ad26.COV2.S nei maschi adulti: xhttps: //pubmed.ncbi.nlm.nih.gov/34659839/.
559. Malattie neurologiche autoimmuni dopo la vaccinazione SARS-CoV-2: una serie di casi: https://pubmed.ncbi.nlm.nih.gov/34668274/ .
560. Grave anemia emolitica autoimmune autoimmune dopo aver ricevuto il vaccino mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34549821/
561. Presenza di varianti COVID-19 tra i destinatari del vaccino ChAdOx1 nCoV-19 (ricombinante): https://pubmed.ncbi.nlm.nih.gov/34528522/
562. Prevalenza di trombocitopenia, anticorpi anti-fattore 4 piastrinico e D-dimero elevato nei thailandesi dopo la vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/
563. Epidemiologia della miocardite/pericardite acuta negli adolescenti di Hong Kong dopo la co-vaccinazione: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/644 5179.
564. Miocardite dopo il vaccino contro l’mRNA della malattia da coronavirus del 2019: una serie di casi e determinazione del tasso di incidenza: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408
565. Miocardite e pericardite dopo vaccinazione COVID-19: disuguaglianze di età e tipi di vaccino: https://www.mdpi.com/2075-4426/11/11/1106
566. Epidemiologia e caratteristiche cliniche della miocardite/pericardite prima dell’introduzione del vaccino mRNA COVID-19 nei bambini coreani: uno studio multicentrico: https://pubmed.ncbi.nlm.nih.gov/34402230/
567. Fare luce sulla miocardite e la pericardite post-vaccinazione nei pazienti che ricevono il vaccino COVID-19 e non-COVID-19: https://pubmed.ncbi.nlm.nih.gov/34696294/
568. Miocardite in seguito al vaccino mRNA COVID-19: https://journals.lww.com/pec-online/Abstract/2021/11000/Myocarditis_Following_ mRNA_COVID_19_Vaccine.9.aspx.
569. Miocardite a seguito del vaccino mRNA Covid-19 per mRNA BNT162b2 in Israele: https://pubmed.ncbi.nlm.nih.gov/34614328/ .

Miocardite, pericardite e cardiomiopatia dopo la vaccinazione COVID-19: https://www.heartlungcirc.org/article/S1443-9506(21)01156-2/fulltext

571. Miocardite e altre complicazioni cardiovascolari dei vaccini COVID-19 basati su mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34277198/
572. Possibile associazione tra vaccino COVID-19 e miocardite: risultati clinici e CMR: https://pubmed.ncbi.nlm.nih.gov/34246586/
573. Miocardite da ipersensibilità e vaccini COVID-19: https://pubmed.ncbi.nlm.nih.gov/34856634/ .
574. Miocardite grave associata al vaccino COVID-19: zebra o unicorno?: https://www.internationaljournalofcardiology.com/article/S0167-5273(21)01477-7/fulltext .
575. Infarto miocardico acuto e miocardite dopo la vaccinazione COVID-19: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8522388/# ffn_sectitle.
576. Miocardite dopo la vaccinazione contro il Covid-19 in una grande organizzazione sanitaria: https://www.nejm.org/doi/10.1056/NEJMoa2110737?url_ver=Z39.88-2003&rfr_id= ori: rid: crossref.org & rfr_dat = cr_pub% 20% 200 pubblicato
577. Associazione della miocardite con il vaccino COVID-19 RNA messaggero BNT162b2 in una serie di casi di bambini: https://jamanetwork.com/journals/jamacardiology/fullarticle/2783052
578. Sospetto clinico di miocardite temporalmente correlata alla vaccinazione COVID-19 in adolescenti e giovani adulti: https://www.ahajournals.org/doi/abs/10.1161/CIRCULATIONAHA.121.056583?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref .org & rfr_dat = cr_pub% 20% 200pubmed
579. Mimetismo STEMI: miocardite focale in un paziente adolescente dopo vaccinazione con mRNA COVID-19 :. https://pubmed.ncbi.nlm.nih.gov/34756746/

580. Miocardite e pericardite in associazione con vaccinazione mRNA COVID-19: casi da un centro di farmacovigilanza regionale: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8587334/# ffn_sectitle.
581. Miocardite dopo vaccini mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34546329/ .
582. Pazienti con miocardite acuta dopo vaccinazione con mRNA COVID-19 :. https://jamanetwork.com/journals/jamacardiology/fullarticle/2781602 .
583. Miocardite dopo la vaccinazione COVID-19: una serie di casi: https://www.sciencedirect.com/science/article/pii/S0264410X21011725?via%3Dihub .
584. Miocardite associata alla vaccinazione COVID-19 negli adolescenti: https://publications.aap.org/pediatrics/article/148/5/e2021053427/181357/COVID-1 9-Vaccination-Associated-Myocarditis-in.
585. Risultati di miocardite sulla risonanza magnetica cardiaca dopo la vaccinazione con mRNA COVID-19 negli adolescenti:. https://pubmed.ncbi.nlm.nih.gov/34704459/
586. miocardite dopo la vaccinazione COVID-19: studio di risonanza magnetica: https://academic.oup.com/ehjcimaging/advance-article/doi/10.1093/ehjci/jeab230/6 421640.
587. Miocardite acuta dopo la somministrazione della seconda dose del vaccino BNT162b2 COVID-19: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8599115/#ffn_sectitle .
588. Miocardite dopo vaccinazione COVID-19: https://www.sciencedirect.com/science/article/pii/S2352906721001603?via%3Dihub .
589. Caso clinico: probabile miocardite dopo vaccino mRNA Covid-19 in un paziente con cardiomiopatia ventricolare sinistra aritmogena: https://pubmed.ncbi.nlm.nih.gov/34712717/ .
590. Miocardite acuta dopo la somministrazione del vaccino BNT162b2 contro COVID-19: https://www.revespcardiol.org/en-linkresolver-acute-myocarditis-after-administratio n-bnt162b2-S188558572100133X.
591. Miocardite associata alla vaccinazione contro l’mRNA del COVID-19:. https://pubs.rsna.org/doi/10.1148/radiol.2021211430?url_ver=Z39.88-2003&rfr_id= ori: rid: crossref.org & rfr_dat = cr_pub% 20% 200pubmed.
592. Miocardite acuta dopo la vaccinazione COVID-19: un caso clinico: https://www.sciencedirect.com/science/article/pii/S0248866321007098?via%3Dihu b.
593. Miopericardite acuta dopo la vaccinazione COVID-19 negli adolescenti :. https://pubmed.ncbi.nlm.nih.gov/34589238/ .
594. Perimiocardite negli adolescenti dopo la vaccinazione Pfizer-BioNTech COVID-19: https://academic.oup.com/jpids/article/10/962/6329543 .
595. Miocardite acuta associata alla vaccinazione anti-COVID-19: https://ecevr.org/DOIx.php?id=10.7774/cevr.2021.10.2.196 .
596. Miocardite associata alla vaccinazione COVID-19: risultati ecocardiografici, TC cardiaca e risonanza magnetica :. https://pubmed.ncbi.nlm.nih.gov/34428917/ .
597. Miocardite acuta sintomatica in 7 adolescenti dopo la vaccinazione Pfizer-BioNTech COVID-19 :. https://pubmed.ncbi.nlm.nih.gov/34088762/ .
598. Miocardite e pericardite negli adolescenti dopo la prima e la seconda dose di vaccini mRNA COVID-19 :. https://academic.oup.com/ehjqcco/advance-article/doi/10.1093/ehjqcco/qcab090/64 42104.
599. Vaccino COVID 19 per adolescenti. Preoccupazione per miocardite e pericardite: https://www.mdpi.com/2036-7503/13/3/61 .

Imaging cardiaco della miocardite acuta dopo la vaccinazione con mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34402228/ 600.

601. Miocardite temporaneamente associata alla vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34133885/
602. Danno miocardico acuto dopo la vaccinazione COVID-19: un caso clinico e revisione delle prove attuali dal database del sistema di segnalazione degli eventi avversi del vaccino: https://pubmed.ncbi.nlm.nih.gov/34219532/
603. Miocardite acuta associata alla vaccinazione COVID-19: rapporto di un caso: https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8639400/# ffn_sectitle
604. Miocardite dopo vaccinazione con RNA messaggero COVID-19: una serie di casi giapponesi: https://pubmed.ncbi.nlm.nih.gov/34840235/ .
605. Miocardite nel contesto di una recente vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34712497/ .
606. Miocardite acuta dopo una seconda dose di vaccino mRNA COVID-19: rapporto di due casi: https://www.clinicalimaging.org/article/S0899-7071(21)00265-5/fulltext .
607. Prevalenza di trombocitopenia, anticorpi anti-fattore 4 piastrinico e D-dimero elevato nei thailandesi dopo la vaccinazione con ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34568726/
608. Epidemiologia della miocardite/pericardite acuta negli adolescenti di Hong Kong dopo la co-vaccinazione: https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciab989/6445179

609. Miocardite dopo il vaccino mRNA della malattia da coronavirus del 2019: una serie di casi e determinazione del tasso di incidenza: https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab926/6420408 .
610. Miocardite e pericardite dopo vaccinazione COVID-19: disuguaglianze di età e tipi di vaccino: https://www.mdpi.com/2075-4426/11/11/1106
611. Epidemiologia e caratteristiche cliniche della miocardite/pericardite prima dell’introduzione del vaccino mRNA COVID-19 nei bambini coreani: uno studio multicentrico: https://pubmed.ncbi.nlm.nih.gov/34402230/
612. Fare luce sulla miocardite e la pericardite post-vaccinazione nei pazienti che ricevono il vaccino COVID-19 e non-COVID-19: https://pubmed.ncbi.nlm.nih.gov/34696294/
613. Sindrome protrombotica diffusa dopo somministrazione del vaccino ChAdOx1 nCoV-19: case report: https://pubmed.ncbi.nlm.nih.gov/34615534/
614. Tre casi di tromboembolismo venoso acuto nelle donne dopo la vaccinazione contro il coronavirus 2019: https://pubmed.ncbi.nlm.nih.gov/34352418/
615. Caratteristiche cliniche e biologiche della trombosi del seno venoso cerebrale dopo la vaccinazione con ChAdOx1 nCov-19; https://jnnp.bmj.com/content/early/2021/09/29/jnnp-2021-327340.long
616. La vaccinazione CAd26.COV2-S può rivelare trombofilia ereditaria: massiccia trombosi del seno venoso cerebrale in un giovane con conta piastrinica normale: https://pubmed.ncbi.nlm.nih.gov/34632750/
617. Risultati post mortem nella trombocitopenia trombotica indotta da vaccino: https://haematologica.org/article/view/haematol.2021.279075
618. Trombosi indotta dal vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34802488/ .
619. Infiammazione e attivazione piastrinica dopo i vaccini COVID-19: possibili meccanismi alla base della trombocitopenia e della trombosi immunitaria indotte dal vaccino: https://pubmed.ncbi.nlm.nih.gov/34887867/ .
620. Reazione anafilattoide e trombosi coronarica correlata al vaccino mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34863404/ .
621. Trombosi venosa cerebrale indotta da vaccino e trombocitopenia.

Oxford-AstraZeneca COVID-19: un’occasione mancata per un rapido ritorno all’esperienza: https://www.sciencedirect.com/science/article/pii/S235255682100093X?via%3Dihu b

622. Presenza di infarto splenico dovuto a trombosi arteriosa dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34876440/
623. Trombosi venosa profonda più di due settimane dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33928773/
624. Caso clinico: Dai una seconda occhiata: Trombosi venosa cerebrale correlata alla vaccinazione Covid-19 e sindrome da trombocitopenia trombotica: https://pubmed.ncbi.nlm.nih.gov/34880826/
625. Informazioni sulla trombocitopenia trombotica immuno-mediata indotta dal vaccino ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34587242/
626. Modifica della viscosità del sangue dopo la vaccinazione COVID-19: stima per le persone con sindrome metabolica sottostante: https://pubmed.ncbi.nlm.nih.gov/34868465/
627. Gestione di un paziente con una rara sindrome da malformazione congenita degli arti dopo trombosi e trombocitopenia indotte dal vaccino SARS-CoV-2 (VITT): https://pubmed.ncbi.nlm.nih.gov/34097311/
628. Ictus talamico bilaterale: un caso di trombocitopenia trombotica immunitaria indotta dal vaccino COVID-19 (VITT) o una coincidenza dovuta a fattori di rischio sottostanti: https://pubmed.ncbi.nlm.nih.gov/34820232/ .
629. Trombocitopenia e trombosi splancnica dopo la vaccinazione con Ad26.COV2.S trattate con successo con shunt portosistemico intraepatico intraepatico transgiugulare e trombectomia: https://onlinelibrary.wiley.com/doi/10.1002/ajh.26258
630. Incidenza di ictus ischemico acuto dopo la vaccinazione contro il coronavirus in Indonesia: serie di casi: https://pubmed.ncbi.nlm.nih.gov/34579636/
631. Trattamento di successo della trombocitopenia trombotica immunitaria indotta da vaccino in una paziente di 26 anni: https://pubmed.ncbi.nlm.nih.gov/34614491/
632. Caso clinico: trombocitopenia trombotica immunitaria indotta da vaccino in un paziente con cancro del pancreas dopo la vaccinazione con RNA-1273 messaggero: https://pubmed.ncbi.nlm.nih.gov/34790684/
633. Tromboflebite idiopatica idiopatica della vena giugulare esterna dopo la vaccinazione contro il coronavirus (COVID-19): https://pubmed.ncbi.nlm.nih.gov/33624509/ .
634. Carcinoma a cellule squamose del polmone con emottisi in seguito a vaccinazione con tozinameran (BNT162b2, Pfizer-BioNTech): https://pubmed.ncbi.nlm.nih.gov/34612003/
635. Trombocitopenia trombotica indotta da vaccino dopo vaccinazione Ad26.COV2.S in un uomo che si presenta come tromboembolismo venoso acuto: https://pubmed.ncbi.nlm.nih.gov/34096082/

Miocardite associata alla vaccinazione COVID-19 in tre ragazzi adolescenti: https://pubmed.ncbi.nlm.nih.gov/34851078/ .

637. Risultati della risonanza magnetica cardiovascolare in pazienti giovani adulti con miocardite acuta dopo la vaccinazione con mRNA COVID-19: una serie di casi: https://pubmed.ncbi.nlm.nih.gov/34496880/
638. Perimiocardite dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34866957/
639. Epidemiologia della miocardite/pericardite acuta negli adolescenti di Hong Kong dopo la co-vaccinazione: https://pubmed.ncbi.nlm.nih.gov/34849657/ .
640. Morte improvvisa indotta da miocardite dopo la vaccinazione con mRNA BNT162b2 COVID-19 in Corea: caso clinico incentrato sui risultati istopatologici: https://pubmed.ncbi.nlm.nih.gov/34664804/
641. Miocardite acuta dopo vaccinazione con mRNA COVID-19 negli adulti di età pari o superiore a 18 anni: https://pubmed.ncbi.nlm.nih.gov/34605853/
642. Recidiva di miocardite acuta temporaneamente associata alla ricezione del vaccino contro la malattia mRNA del coronavirus 2019 (COVID-19) in un maschio adolescente: https://pubmed.ncbi.nlm.nih.gov/34166671/
643. Giovane maschio con miocardite dopo vaccinazione con mRNA mRNA-1273 coronavirus disease-2019 (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34744118/
644. Miocardite acuta dopo vaccinazione SARS-CoV-2 in un maschio di 24 anni: https://pubmed.ncbi.nlm.nih.gov/34334935/ .
645. 68 Immagini PET digitali Ga-DOTATOC di infiltrati di cellule infiammatorie nella miocardite dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34746968/
646. Presenza di miocardite acuta simil-infartuale dopo la vaccinazione con COVID-19: solo una coincidenza accidentale o meglio una miocardite autoimmune associata alla vaccinazione? ”: Https://pubmed.ncbi.nlm.nih.gov/34333695/ .
647. Miocardite autolimitante che si presenta con dolore toracico ed elevazione del segmento ST negli adolescenti dopo la vaccinazione con il vaccino mRNA BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34180390/

Miocardite a seguito di immunizzazione con vaccini mRNA COVID-19 in membri delle forze armate statunitensi: https://pubmed.ncbi.nlm.nih.gov/34185045/

649. Miocardite dopo vaccinazione BNT162b2 in un maschio sano: https://pubmed.ncbi.nlm.nih.gov/34229940/
650. Miopericardite in un maschio adolescente precedentemente sano dopo la vaccinazione COVID-19: Caso clinico: https://pubmed.ncbi.nlm.nih.gov/34133825/
651. Miocardite acuta dopo la vaccinazione con mRNA-1273 per SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34308326/ .
652. Dolore toracico con riqualificazione anormale dell’elettrocardiogramma dopo l’iniezione del vaccino COVID-19 prodotto da Moderna: https://pubmed.ncbi.nlm.nih.gov/34866106/
653. Miocardite linfocitica provata da biopsia dopo la prima vaccinazione con mRNA COVID-19 in un uomo di 40 anni: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34487236/
654. Imaging multimodale e istopatologia in un giovane che si presenta con miocardite linfocitica fulminante e shock cardiogeno dopo la vaccinazione con mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34848416/
655. Report di un caso di miopericardite dopo vaccinazione con BNT162b2 COVID-19 mRNA in un giovane maschio coreano: https://pubmed.ncbi.nlm.nih.gov/34636504/
656. Miocardite acuta dopo la vaccinazione di Comirnaty in un maschio sano con precedente infezione da SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34367386/
657. Miocardite acuta in un giovane adulto due giorni dopo la vaccinazione con Pfizer: https://pubmed.ncbi.nlm.nih.gov/34709227/
658. Caso clinico: miocardite fulminante acuta e shock cardiogeno dopo la vaccinazione con coronavirus RNA messaggero nel 2019 che ha richiesto la rianimazione cardiopolmonare extracorporea: https://pubmed.ncbi.nlm.nih.gov/34778411/
659. Miocardite acuta dopo la vaccinazione contro il coronavirus del 2019: https://pubmed.ncbi.nlm.nih.gov/34734821/
660. Una serie di pazienti con miocardite dopo la vaccinazione contro SARS-CoV-2 con mRNA-1279 e BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34246585/
661. Miopericardite dopo vaccino contro la malattia da coronavirus del coronavirus dell’acido ribonucleico messaggero di Pfizer negli adolescenti: https://pubmed.ncbi.nlm.nih.gov/34228985/
662. Sindrome infiammatoria multisistemica post-vaccinazione negli adulti senza evidenza di precedente infezione da SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34852213/
663. Miocardite acuta definita dopo la vaccinazione con mRNA 2019 della malattia da coronavirus: https://pubmed.ncbi.nlm.nih.gov/34866122/
664. Disfunzione sistolica biventricolare nella miocardite acuta dopo la vaccinazione SARS-CoV-2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34601566/

665. Miocardite dopo vaccinazione COVID-19: studio MRI: https://pubmed.ncbi.nlm.nih.gov/34739045/ .
666. Miocardite acuta dopo vaccinazione COVID-19: case report: https://docs.google.com/document/d/1Hc4bh_qNbZ7UVm5BLxkRdMPnnI9zcCsl/e dice #.
667. Associazione di miocardite con il vaccino COVID-19 RNA messaggero BNT162b2 COVID-19 in una serie di casi di bambini: https://pubmed.ncbi.nlm.nih.gov/34374740/
668. Sospetto clinico di miocardite temporalmente correlata alla vaccinazione COVID-19 negli adolescenti e nei giovani adulti: https://pubmed.ncbi.nlm.nih.gov/34865500/
669. Miocardite a seguito di vaccinazione con Covid-19 in una grande organizzazione sanitaria: https://pubmed.ncbi.nlm.nih.gov/34614329/
670. Vaccino AstraZeneca COVID-19 e sindrome di Guillain-Barré in Tasmania: un nesso causale: https://pubmed.ncbi.nlm.nih.gov/34560365/
671. COVID-19, Guillain-Barré e il vaccinoUn mix pericoloso: https://pubmed.ncbi.nlm.nih.gov/34108736/ .
672. Sindrome di Guillain-Barré dopo la prima dose di vaccino Pfizer-BioNTech COVID-19: caso clinico e revisione dei casi segnalati: https://pubmed.ncbi.nlm.nih.gov/34796417/ .
673. Sindrome di Guillain-Barre dopo il vaccino BNT162b2 COVID-19: https://link.springer.com/article/10.1007%2Fs10072-021-05523-5 .
674. Vaccini adenovirus COVID-19 e sindrome di Guillain-Barré con paralisi facciale: https://onlinelibrary.wiley.com/doi/10.1002/ana.26258 .
675. Associazione di ricezione del vaccino Ad26.COV2.S COVID-19 con presunta sindrome di Guillain-Barre, febbraio-luglio 2021: https://jamanetwork.com/journals/jama/fullarticle/2785009
676. Un caso di sindrome di Guillain-Barré dopo il vaccino Pfizer COVID-19: https://pubmed.ncbi.nlm.nih.gov/34567447/
677. Sindrome di Guillain-Barré associata alla vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34648420/ .
678. Tasso di recidiva della sindrome di Guillain-Barré dopo il vaccino mRNA COVID-19 BNT162b2:

https://jamanetwork.com/journals/jamaneurology/fullarticle/2783708

679. Sindrome di Guillain-Barre dopo la vaccinazione COVID-19 in un adolescente: https://www.pedneur.com/article/S0887-8994(21)00221-6/fulltext .

Sindrome di Guillain-Barre dopo la vaccinazione ChAdOx1-S/nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34114256/ .

681. Sindrome di Guillain-Barre dopo il vaccino COVID-19 mRNA-1273: case report: https://pubmed.ncbi.nlm.nih.gov/34767184/ .
682. Sindrome di Guillain-Barre in seguito alla vaccinazione SARS-CoV-2 in 19 pazienti: https://pubmed.ncbi.nlm.nih.gov/34644738/ .
683. Sindrome di Guillain-Barre che si presenta con diplegia facciale in seguito alla vaccinazione con COVID-19 in due pazienti: https://pubmed.ncbi.nlm.nih.gov/34649856/
684. Un raro caso di sindrome di Guillain-Barré dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34671572/
685. Complicanze neurologiche di COVID-19: sindrome di Guillain-Barre dopo il vaccino Pfizer COVID-19: https://pubmed.ncbi.nlm.nih.gov/33758714/
686. Vaccino COVID-19 che causa la sindrome di Guillain-Barre, un potenziale effetto collaterale non comune: https://pubmed.ncbi.nlm.nih.gov/34484780/
687. Sindrome di Guillain-Barre dopo la prima dose di vaccinazione COVID-19: case report; https://pubmed.ncbi.nlm.nih.gov/34779385/ .
688. Sindrome di Miller Fisher dopo il vaccino Pfizer COVID-19: https://pubmed.ncbi.nlm.nih.gov/34817727/ .
689. Sindrome di Miller Fisher dopo la vaccinazione contro il coronavirus dell’mRNA BNT162b2 del 2019: https://pubmed.ncbi.nlm.nih.gov/34789193/ .
690. Debolezza facciale bilaterale con una variante della parestesia della sindrome di Guillain-Barre dopo il vaccino Vaxzevria COVID-19: https://pubmed.ncbi.nlm.nih.gov/34261746/
691. Sindrome di Guillain-Barre dopo la prima iniezione del vaccino ChAdOx1 nCoV-19: primo rapporto: https://pubmed.ncbi.nlm.nih.gov/34217513/ .
692. Un caso di sindrome sensoriale atassica di Guillain-Barre con anticorpi immunoglobulina G anti-GM1 dopo la prima dose di vaccino mRNA COVID-19 BNT162b2 (Pfizer): https://pubmed.ncbi.nlm.nih.gov/34871447/
693. Segnalazione di neuropatie infiammatorie acute con vaccini COVID-19: analisi della sproporzionalità dei sottogruppi in VigiBase: https://pubmed.ncbi.nlm.nih.gov/34579259/
694. Una variante della sindrome di Guillain-Barré dopo la vaccinazione SARS-CoV-2: AMSAN: https://pubmed.ncbi.nlm.nih.gov/34370408/ .
695. Una rara variante della sindrome di Guillain-Barré dopo la vaccinazione con Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34703690/ .
696. Sindrome di Guillain-Barré dopo la vaccinazione SARS-CoV-2 in un paziente con precedente sindrome di Guillain-Barré associata al vaccino: https://pubmed.ncbi.nlm.nih.gov/34810163/

698. Sindrome di Guillain-Barré in uno stato australiano che utilizza vaccini SARS-CoV-2 mRNA e adenovirus-vector: https://onlinelibrary.wiley.com/doi/10.1002/ana.26218 .
699. Mielite trasversa acuta dopo vaccinazione SARS-CoV-2: caso clinico e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34482455/ .
700. Sindrome di Guillain-Barré variante che si verifica dopo la vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34114269/ .
701. Sindrome di Guillian-Barre con variante assonale temporaneamente associata al vaccino moderno a base di mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34722067/
702. Sindrome di Guillain-Barre dopo la prima dose di vaccino SARS-CoV-2: un evento temporaneo, non un’associazione causale: https://pubmed.ncbi.nlm.nih.gov/33968610/
703. I vaccini SARS-CoV-2 possono essere complicati non solo dalla sindrome di Guillain-Barré ma anche dalla neuropatia delle piccole fibre distali: https://pubmed.ncbi.nlm.nih.gov/34525410/
704. Variante clinica della sindrome di Guillain-Barré con diplegia facciale prominente dopo il vaccino contro il coronavirus AstraZeneca 2019: https://pubmed.ncbi.nlm.nih.gov/34808658/
705. Segnalazione di eventi avversi e rischio di paralisi di Bell dopo la vaccinazione COVID-19: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00646-0/fullte xt.
706. Paralisi bilaterale del nervo facciale e vaccinazione COVID-19: causalità o coincidenza?: https://pubmed.ncbi.nlm.nih.gov/34522557/
707. Paralisi di Bell sinistra dopo la prima dose di vaccino mRNA-1273 SARS-CoV-2: case report: https://pubmed.ncbi.nlm.nih.gov/34763263/ .
708. Paralisi di Bell dopo la vaccinazione inattivata con COVID-19 in un paziente con una storia di paralisi di Bell ricorrente: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34621891/
709. Complicazioni neurologiche dopo la prima dose di vaccini COVID-19 e infezione da SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34697502/
710. Interferoni di tipo I come potenziale meccanismo che collega i vaccini mRNA COVID-19 con la paralisi di Bell: https://pubmed.ncbi.nlm.nih.gov/33858693/
711. Mielite trasversa acuta a seguito di vaccino COVID-19 inattivato: https://pubmed.ncbi.nlm.nih.gov/34370410/
712. Mielite trasversa acuta dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34579245/ .
713. Un caso di mielite trasversa longitudinalmente estesa a seguito della vaccinazione Covid-19: https://pubmed.ncbi.nlm.nih.gov/34182207/
714. Mielite trasversa post COVID-19; un caso clinico con revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34457267/ .
715. Attenzione al disturbo dello spettro della neuromielite ottica dopo la vaccinazione con virus inattivato per COVID-19: https://pubmed.ncbi.nlm.nih.gov/34189662/
716. Neuromielite ottica in una donna sana dopo la vaccinazione contro la sindrome respiratoria acuta grave coronavirus 2 mRNA-1273: https://pubmed.ncbi.nlm.nih.gov/34660149/
717. Neurite/chiasma ottico bilaterale bilaterale acuto con mielite trasversale estesa longitudinale nella sclerosi multipla stabile di lunga data dopo vaccinazione basata su vettori contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34131771/
718. Una serie di casi di pericardite acuta dopo la vaccinazione con COVID-19 nel contesto di recenti rapporti dall’Europa e dagli Stati Uniti: https://pubmed.ncbi.nlm.nih.gov/34635376/
719. Pericardite acuta e tamponamento cardiaco dopo vaccinazione con Covid-19: https://pubmed.ncbi.nlm.nih.gov/34749492/
720. Miocardite e pericardite negli adolescenti dopo la prima e la seconda dose di vaccini mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34849667/
721. Perimiocardite negli adolescenti dopo il vaccino Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/34319393/
722. Miopericardite acuta dopo il vaccino COVID-19 negli adolescenti: https://pubmed.ncbi.nlm.nih.gov/34589238/
723. Pericardite dopo la somministrazione del vaccino BNT162b2 mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34149145/
724. Caso clinico: pericardite sintomatica post vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34693198/ .
725. Un focolaio della malattia di Still dopo la vaccinazione contro il COVID-19 in un paziente di 34 anni: https://pubmed.ncbi.nlm.nih.gov/34797392/
726. Lezioni del mese 3: Linfoistiocitosi emofagocitica a seguito di vaccinazione COVID-19 (ChAdOx1 nCoV-19): https://pubmed.ncbi.nlm.nih.gov/34862234/
727. Miocardite dopo vaccinazione con mRNA SARS-CoV-2, una serie di casi: https://pubmed.ncbi.nlm.nih.gov/34396358/ .

728. La sindrome di Miller-Fisher e la sindrome di Guillain-Barré si sovrappongono in un paziente dopo la vaccinazione Oxford-AstraZeneca SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34848426/ .
729. Focolai di malattie immuno-mediate o malattie di nuova insorgenza in 27 soggetti dopo la vaccinazione con mRNA/DNA contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33946748/
730. Indagine post mortem sui decessi dopo la vaccinazione con i vaccini COVID-19: https://pubmed.ncbi.nlm.nih.gov/34591186/
731. Danno renale acuto con ematuria macroscopica e nefropatia da IgA dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34352309/
732. Ricaduta della trombocitopenia immunitaria dopo la vaccinazione contro il covid-19 in un giovane paziente di sesso maschile: https://pubmed.ncbi.nlm.nih.gov/34804803/ .
733. Porpora trombocitopenica immunitaria associata al vaccino mRNA COVID-19 Pfizer-BioNTech BNT16B2b2: https://pubmed.ncbi.nlm.nih.gov/34077572/
734. Emorragia retinica dopo la vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34884407/ .
735. Caso clinico: dopo la vaccinazione COVID-19 può verificarsi una vasculite associata ad anticorpi citoplasmatici anti-neutrofili con insufficienza renale acuta ed emorragia polmonare: https://pubmed.ncbi.nlm.nih.gov/34859017/
736. Emorragia intracerebrale dovuta a vasculite in seguito alla vaccinazione COVID-19: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34783899/
737. Sanguinamento cavernoso peduncolare sintomatico dopo la vaccinazione SARS-CoV-2 indotta da trombocitopenia immunitaria: https://pubmed.ncbi.nlm.nih.gov/34549178/ .
738. Morte cerebrale in un paziente vaccinato con infezione da COVID-19: https://pubmed.ncbi.nlm.nih.gov/34656887/
739. Telangiectode della porpora anulare generalizzata dopo la vaccinazione con mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34236717/ .
740. Emorragia lobare con rottura ventricolare poco dopo la prima dose di un vaccino SARS-CoV-2 basato su mRNA SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34729467/ .
741. Un caso di focolaio di ematuria macroscopica e nefropatia IgA dopo la vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/33932458/
742. Emorragia acrale dopo somministrazione della seconda dose di vaccino SARS-CoV-2. Una reazione post-vaccinazione: https://pubmed.ncbi.nlm.nih.gov/34092400/ 742.
743. Porpora trombocitopenica immunitaria grave dopo il vaccino SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34754937/
744. Ematuria macroscopica dopo la vaccinazione contro il coronavirus 2 della sindrome respiratoria acuta grave in 2 pazienti con nefropatia da IgA: https://pubmed.ncbi.nlm.nih.gov/33771584/
745. Encefalite autoimmune dopo vaccinazione ChAdOx1-S SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34846583/
746. Vaccino COVID-19 e morte: algoritmo di causalità secondo la diagnosi di ammissibilità dell’OMS: https://pubmed.ncbi.nlm.nih.gov/34073536/
747. Paralisi di Bell dopo la vaccinazione con mRNA (BNT162b2) e vaccini SARS-CoV-2 inattivati ​​(CoronaVac): una serie di casi e uno studio caso-controllo nidificato: https://pubmed.ncbi.nlm.nih.gov/34411532/
748. Epidemiologia di miocardite e pericardite in seguito a vaccini mRNA in Ontario, Canada: per prodotto vaccinale, programma e intervallo: https://www.medrxiv.org/content/10.1101/2021.12.02.21267156v1
749. Anafilassi dopo il vaccino Covid-19 in un paziente con orticaria colinergica: https://pubmed.ncbi.nlm.nih.gov/33851711/
750. Anafilassi indotta dal vaccino CoronaVac COVID-19: caratteristiche cliniche e risultati della rivaccinazione: https://pubmed.ncbi.nlm.nih.gov/34675550/ .
751. Anafilassi dopo il moderno vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34734159/ .
752. Associazione della storia autodichiarata di allergia ad alto rischio con sintomi allergici dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34698847/
753. Differenze di sesso nell’incidenza dell’anafilassi rispetto ai vaccini LNP-mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34020815/
754. Reazioni allergiche, inclusa l’anafilassi, dopo aver ricevuto la prima dose del vaccino Pfizer-BioNTech COVID-19 – Stati Uniti, dal 14 al 23 dicembre 2020: https://pubmed.ncbi.nlm.nih.gov/33641264/
755. Reazioni allergiche, inclusa l’anafilassi, dopo aver ricevuto la prima dose del vaccino Modern COVID-19 – Stati Uniti, dal 21 dicembre 2020 al 10 gennaio 2021: https://pubmed.ncbi.nlm.nih.gov/33641268/
756. Anafilassi prolungata al vaccino contro il coronavirus Pfizer 2019: un caso clinico e un meccanismo d’azione: https://pubmed.ncbi.nlm.nih.gov/33834172/
757. Reazioni di pseudo-anafilassi al vaccino Pfizer BNT162b2: segnalazione di 3 casi di anafilassi a seguito di vaccinazione con Pfizer BNT162b2: https://pubmed.ncbi.nlm.nih.gov/34579211/

757. Anafilassi bifasica dopo la prima dose del vaccino contro la malattia del coronavirus dell’RNA messaggero del 2019 con risultato positivo del test cutaneo del polisorbato 80: https://pubmed.ncbi.nlm.nih.gov/34343674/
758. Infarto miocardico acuto e miocardite dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34586408/
759. Sindrome di Takotsubo dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34539938/ .

Cardiomiopatia Takotsubo dopo la vaccinazione contro il coronavirus 2019 in un paziente in emodialisi di mantenimento: https://pubmed.ncbi.nlm.nih.gov/34731486/ .

761. Infarto miocardico prematuro o effetto collaterale del vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/33824804/
762. Infarto del miocardio, ictus ed embolia polmonare dopo il vaccino BNT162b2 mRNA COVID-19 in persone di età pari o superiore a 75 anni: https://pubmed.ncbi.nlm.nih.gov/34807248/
763. Sindrome di Kounis tipo 1 indotta dal vaccino SARS-COV-2 inattivato: https://pubmed.ncbi.nlm.nih.gov/34148772/
764. Infarto miocardico acuto entro 24 ore dalla vaccinazione COVID-19: il colpevole è la sindrome di Kounis: https://pubmed.ncbi.nlm.nih.gov/34702550/
765. Decessi associati alla vaccinazione SARS-CoV-2 lanciata di recente (Comirnaty®): https://pubmed.ncbi.nlm.nih.gov/33895650/
766. Decessi associati alla vaccinazione SARS-CoV-2 lanciata di recente: https://pubmed.ncbi.nlm.nih.gov/34425384/
767. Un caso di encefalopatia acuta e infarto miocardico senza sopraslivellamento del tratto ST dopo vaccinazione con mRNA-1273: possibile effetto avverso: https://pubmed.ncbi.nlm.nih.gov/34703815/ 767.
768. Vasculite orticarioide indotta dal vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34369046/ .
769. Vasculite associata ad ANCA dopo il vaccino Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/34280507/ .
770. Vasculite leucocitoclastica di nuova insorgenza dopo il vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34241833/
771. Vasculite cutanea dei piccoli vasi dopo il vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34529877/ .
772. Focolaio di vasculite leucocitoclastica dopo il vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/33928638/
773. Vasculite leucocitoclastica dopo esposizione al vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34836739/
774. Vasculite e borsite in [18 F] FDG-PET / CT dopo vaccino mRNA COVID-19: post hoc ergo propter hoc ?; https://pubmed.ncbi.nlm.nih.gov/34495381/ .
775. Vasculite linfocitica cutanea dopo somministrazione del vaccino mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34327795/
776. Vasculite leucocitoclastica cutanea indotta dal vaccino Sinovac COVID-19: https://pubmed.ncbi.nlm.nih.gov/34660867/ .
777. Caso clinico: vasculite associata ad ANCA che si presenta con rabdomiolisi e glomerulonefrite crescente di Pauci-Inmune dopo la vaccinazione con Pfizer-BioNTech COVID-19 mRNA: https://pubmed.ncbi.nlm.nih.gov/34659268/
778. Riattivazione della vasculite IgA dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34848431/
779. Vasculite dei piccoli vasi correlata al virus varicella-zoster dopo la vaccinazione Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/34310759/ .
780. Imaging in medicina vascolare: vasculite leucocitoclastica dopo il richiamo del vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34720009/
781. Un raro caso di porpora di Henoch-Schönlein dopo un caso clinico di vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/34518812/
782. Vasculite cutanea a seguito della vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34611627/ .
783. Possibile caso di vasculite dei piccoli vasi indotta dal vaccino mRNA COVID-19: https://pubmed.ncbi.nlm.nih.gov/34705320/ .
784. Vasculite IgA in seguito alla vaccinazione COVID-19 in un adulto: https://pubmed.ncbi.nlm.nih.gov/34779011/
785. Vasculite associata ad anticorpi citoplasmatici anti-neutrofili indotta da propiltiouracile dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34451967/
786. Vaccino contro la malattia di coronavirus 2019 (COVID-19) nel lupus eritematoso sistemico e nella vasculite associata ad anticorpi anticitoplasmatici neutrofili: https://pubmed.ncbi.nlm.nih.gov/33928459/
787. Riattivazione della vasculite IgA dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34250509/
788. Spettro clinico e istopatologico delle reazioni cutanee avverse ritardate dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34292611/ .
789. Prima descrizione della vasculite da immunocomplessi dopo la vaccinazione COVID-19 con BNT162b2: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34530771/ .
790. Sindrome nefrosica e vasculite dopo il vaccino SARS-CoV-2:

vera associazione o indizio: https://pubmed.ncbi.nlm.nih.gov/34245294/ .

791. Presenza di vasculite cutanea de novo dopo la vaccinazione contro la malattia di coronavirus (COVID-19): https://pubmed.ncbi.nlm.nih.gov/34599716/ .
792. Vasculite cutanea asimmetrica dopo vaccinazione COVID-19 con preponderanza insolita di eosinofili: https://pubmed.ncbi.nlm.nih.gov/34115904/ .
793. Porpora di Henoch-Schönlein che si verifica dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34247902/ .
794. Porpora di Henoch-Schönlein dopo la prima dose di vaccino contro il vettore virale COVID-19: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34696186/ .
795. Vasculite granulomatosa dopo il vaccino AstraZeneca anti-SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34237323/ .
796. Necrosi retinica acuta dovuta alla riattivazione del virus varicella zoster dopo la vaccinazione con mRNA BNT162b2 COVID-19: https://pubmed.ncbi.nlm.nih.gov/34851795/ .
797. Un caso di sindrome di Sweet generalizzata con vasculite innescata da una recente vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34849386/
798. Vasculite dei piccoli vasi a seguito della vaccinazione Oxford-AstraZeneca contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34310763/
799. Recidiva di poliangioite microscopica dopo la vaccinazione COVID-19: caso clinico: https://pubmed.ncbi.nlm.nih.gov/34251683/ .
800. Vasculite cutanea dopo il vaccino contro il coronavirus 2 per la sindrome respiratoria acuta grave: https://pubmed.ncbi.nlm.nih.gov/34557622/ .
801. Herpes zoster ricorrente dopo la vaccinazione COVID-19 in pazienti con orticaria cronica in trattamento con ciclosporina – Un rapporto di 3 casi: https://pubmed.ncbi.nlm.nih.gov/34510694/

Vasculite leucocitoclastica dopo la vaccinazione contro il coronavirus 2019: https://pubmed.ncbi.nlm.nih.gov/34713472/ 803.

803. Focolai di vasculite crioglobulinemia mista dopo la vaccinazione contro SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34819272/
804. Vasculite cutanea dei piccoli vasi dopo la vaccinazione con una singola dose di Janssen Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34337124/
805. Caso di vasculite da immunoglobuline A dopo la vaccinazione contro la malattia da coronavirus 2019: https://pubmed.ncbi.nlm.nih.gov/34535924/
806. Rapida progressione del linfoma angioimmunoblastico a cellule T dopo vaccinazione di richiamo dell’mRNA BNT162b2: caso clinico: https://www.frontiersin.org/articles/10.3389/fmed.2021.798095/full ?
807. La linfoadenopatia indotta dalla vaccinazione con mRNA COVID-19 imita la progressione del linfoma su FDG PET / CT: https://pubmed.ncbi.nlm.nih.gov/33591026/
808. Linfoadenopatia nei destinatari del vaccino COVID-19: dilemma diagnostico nei pazienti oncologici: https://pubmed.ncbi.nlm.nih.gov/33625300/
809. Linfoadenopatia ipermetabolica dopo somministrazione del vaccino mRNA BNT162b2 Covid-19: incidenza valutata da [18 F] FDG PET-CT e rilevanza per l’interpretazione dello studio: https://pubmed.ncbi.nlm.nih.gov/33774684/
810. Linfoadenopatia dopo la vaccinazione COVID-19: revisione dei risultati di imaging: https://pubmed.ncbi.nlm.nih.gov/33985872/
811. Evoluzione della linfoadenopatia ipermetabolica ascellare ipermetabolica bilaterale su FDG PET / CT dopo vaccinazione COVID-19 a 2 dosi: https://pubmed.ncbi.nlm.nih.gov/34735411/
812. Linfoadenopatia associata alla vaccinazione COVID-19 su FDG PET/CT: caratteristiche distintive nel vaccino adenovirus-vettoriale: https://pubmed.ncbi.nlm.nih.gov/34115709/ .
813. Linfoadenopatia indotta dalla vaccinazione COVID-19 in una clinica specializzata in imaging mammario in Israele: analisi di 163 casi: https://pubmed.ncbi.nlm.nih.gov/34257025/ .
814. Linfoadenopatia ascellare correlata al vaccino COVID-19 in pazienti con carcinoma mammario: serie di casi con revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34836672/ .
815. Il vaccino contro la malattia del coronavirus 2019 imita le metastasi linfonodali nei pazienti sottoposti a follow-up del cancro della pelle: uno studio a centro unico: https://pubmed.ncbi.nlm.nih.gov/34280870/
816. Linfoadenopatia post-vaccinazione COVID-19: rapporto sui risultati citologici della biopsia dell’aspirazione con ago sottile: https://pubmed.ncbi.nlm.nih.gov/34432391/
817. Linfoadenopatia regionale dopo la vaccinazione COVID-19: revisione della letteratura e considerazioni per la gestione del paziente nella cura del cancro al seno: https://pubmed.ncbi.nlm.nih.gov/34731748/
818. Linfoadenopatia ascellare subclinica associata alla vaccinazione COVID-19 su mammografia di screening: https://pubmed.ncbi.nlm.nih.gov/34906409/

819. Vuoi ancora più prove? Qui sono elencati 140 riferimenti agli eventi avversi dell’iniezione di COVID che possono verificarsi nei bambini. La linfoadenopatia sopraclavicolare a esordio acuto coincidente con la vaccinazione intramuscolare con mRNA contro COVID-19 può essere correlata alla tecnica di iniezione del vaccino, Spagna, gennaio e febbraio 2021: https : //pubmed.ncbi.nlm.nih.gov/33706861/
820. Linfoadenopatia sopraclavicolare dopo la vaccinazione contro il COVID-19 in Corea: follow-up seriale mediante ecografia: https://pubmed.ncbi.nlm.nih.gov/34116295/
821. Linfoadenopatia indotta dalla vaccinazione Oxford-AstraZeneca COVID-19 su [18F] colina PET / CT, non solo un risultato FDG: https://pubmed.ncbi.nlm.nih.gov/33661328/
822. Anafilassi bifasica dopo esposizione alla prima dose di vaccino mRNA Pfizer-BioNTech COVID-19 COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/
823. Adenopatia ascellare associata alla vaccinazione COVID-19: risultati di imaging e raccomandazioni di follow-up in 23 donne: https://pubmed.ncbi.nlm.nih.gov/33624520/
824. Un caso di linfoadenopatia cervicale dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34141500/
825. Risultati di imaging unici della fantasmia neurologica dopo la vaccinazione Pfizer-BioNtech COVID-19: un caso clinico: https://pubmed.ncbi.nlm.nih.gov/34096896/
826. Eventi avversi trombotici segnalati per i vaccini COVID-19 Moderna, Pfizer e Oxford-AstraZeneca: confronto tra occorrenza e risultati clinici nel database EudraVigilance: https://pubmed.ncbi.nlm.nih.gov/34835256/
827. Linfoadenopatia unilaterale dopo la vaccinazione COVID-19: un piano di gestione pratico per i radiologi di tutte le specialità: https://pubmed.ncbi.nlm.nih.gov/33713605/
828. Adenopatia ascellare unilaterale nel contesto della vaccinazione COVID-19: follow-up: https://pubmed.ncbi.nlm.nih.gov/34298342/
829. Una revisione sistematica dei casi di demielinizzazione del SNC a seguito della vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34839149/
830. Linfoadenopatia sopraclavicolare dopo la vaccinazione COVID-19: una presentazione in aumento nella clinica del nodulo del collo di attesa di due settimane: https://pubmed.ncbi.nlm.nih.gov/33685772/
831. Linfoadenopatia ascellare e cervicale correlata al vaccino COVID-19 in pazienti con carcinoma mammario attuale o precedente e altri tumori maligni: risultati di imaging trasversale su risonanza magnetica, TC e PET-TC: https://pubmed.ncbi.nlm.nih.gov/ 34719892 /
832. Adenopatia dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33625299/ .
833. Incidenza dell’adenopatia ascellare sull’imaging mammario dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34292295/ .
834. Vaccinazione COVID-19 e linfoadenopatia cervicale inferiore in una clinica di noduli al collo di due settimane: un audit di follow-up: https://pubmed.ncbi.nlm.nih.gov/33947605/ .
835. Linfoadenopatia cervicale dopo la vaccinazione contro la malattia da coronavirus 2019: caratteristiche cliniche e implicazioni per i servizi di cancro della testa e del collo: https://pubmed.ncbi.nlm.nih.gov/34526175/
836. Linfoadenopatia associata al vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/33786231/
837. Evoluzione della linfoadenopatia su PET/MRI dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33625301/ .
838. Epatite autoimmune innescata dalla vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34332438/ .
839. Sindrome nefrosica di nuova insorgenza dopo la vaccinazione Janssen COVID-19: caso clinico e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34342187/ .
840. Linfoadenopatia cervicale massiva dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34601889/
841. Glomerulonefrite ANCA a seguito della moderna vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34081948/
842. Lezioni del primo mese: mielite trasversa longitudinale estesa a seguito della vaccinazione AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34507942/ .
843. Sindrome da stravaso capillare sistemico dopo vaccinazione con ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/
844. Linfoadenopatia ascellare unilaterale correlata al vaccino COVID-19: pattern sullo screening della risonanza magnetica mammaria che consente una valutazione benigna: https://pubmed.ncbi.nlm.nih.gov/34325221/
845. Linfoadenopatia ascellare in pazienti con recente vaccinazione Covid-19: un nuovo dilemma diagnostico: https://pubmed.ncbi.nlm.nih.gov/34825530/ .
846. Malattia da cambiamento minimo e danno renale acuto dopo il vaccino Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/34000278/
847. Adenopatia ascellare unilaterale indotta dal vaccino COVID-19: valutazione di follow-up negli Stati Uniti: https://pubmed.ncbi.nlm.nih.gov/34655312/ .
848. Gastroparesi dopo la vaccinazione Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/34187985/ .
849. La linfoadenopatia sopraclaveare a esordio acuto coincidente con la vaccinazione intramuscolare con mRNA contro COVID-19 può essere correlata alla tecnica di iniezione del vaccino, Spagna, gennaio e febbraio 2021: https://pubmed.ncbi.nlm.nih.gov/33706861/
850. Linfoadenopatia sopraclavicolare dopo la vaccinazione contro il COVID-19 in Corea: follow-up seriale mediante ecografia: https://pubmed.ncbi.nlm.nih.gov/34116295/
851. Linfoadenopatia indotta dalla vaccinazione Oxford-AstraZeneca COVID-19 su [18F] colina PET / CT, non solo un risultato FDG: https://pubmed.ncbi.nlm.nih.gov/33661328/
852. Anafilassi bifasica dopo esposizione alla prima dose di vaccino mRNA Pfizer-BioNTech COVID-19 COVID-19: https://pubmed.ncbi.nlm.nih.gov/34050949/
853. Adenopatia ascellare associata alla vaccinazione COVID-19: risultati di imaging e raccomandazioni di follow-up in 23 donne: https://pubmed.ncbi.nlm.nih.gov/33624520/
854. Un caso di linfoadenopatia cervicale dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34141500/
855. Risultati di imaging unici della fantasmia neurologica dopo la vaccinazione Pfizer-BioNtech COVID-19: un caso clinico: https://pubmed.ncbi.nlm.nih.gov/34096896/
856. Eventi avversi trombotici segnalati per i vaccini COVID-19 Moderna, Pfizer e Oxford-AstraZeneca: confronto tra occorrenza e risultati clinici nel database EudraVigilance: https://pubmed.ncbi.nlm.nih.gov/34835256/
857. Linfoadenopatia unilaterale dopo la vaccinazione COVID-19: un piano di gestione pratico per i radiologi di tutte le specialità: https://pubmed.ncbi.nlm.nih.gov/33713605/
858. Adenopatia ascellare unilaterale nel contesto della vaccinazione COVID-19: follow-up: https://pubmed.ncbi.nlm.nih.gov/34298342/
859. Una revisione sistematica dei casi di demielinizzazione del SNC a seguito della vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34839149/
860. Linfoadenopatia sopraclavicolare dopo la vaccinazione COVID-19: una presentazione in aumento nella clinica del nodulo del collo di attesa di due settimane: https://pubmed.ncbi.nlm.nih.gov/33685772/
861. Linfoadenopatia ascellare e cervicale correlata al vaccino COVID-19 in pazienti con carcinoma mammario attuale o precedente e altri tumori maligni: risultati di imaging trasversale su risonanza magnetica, TC e PET-TC: https://pubmed.ncbi.nlm.nih.gov/ 34719892 /
862. Adenopatia dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33625299/ .
863. Incidenza dell’adenopatia ascellare sull’imaging mammario dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34292295/ .
864. Vaccinazione COVID-19 e linfoadenopatia cervicale inferiore in una clinica di noduli al collo di due settimane: un audit di follow-up: https://pubmed.ncbi.nlm.nih.gov/33947605/ .
865. Linfoadenopatia cervicale dopo la vaccinazione contro la malattia da coronavirus 2019: caratteristiche cliniche e implicazioni per i servizi di cancro della testa e del collo: https://pubmed.ncbi.nlm.nih.gov/34526175/
866. Linfoadenopatia associata al vaccino COVID-19: https://pubmed.ncbi.nlm.nih.gov/33786231/
867. Evoluzione della linfoadenopatia su PET/MRI dopo la vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/33625301/ .
868. Epatite autoimmune innescata dalla vaccinazione SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34332438/ .
869. Sindrome nefrosica di nuova insorgenza dopo la vaccinazione Janssen COVID-19: caso clinico e revisione della letteratura: https://pubmed.ncbi.nlm.nih.gov/34342187/ .
870. Linfoadenopatia cervicale massiva dopo la vaccinazione con COVID-19: https://pubmed.ncbi.nlm.nih.gov/34601889/
871. Glomerulonefrite ANCA a seguito della moderna vaccinazione COVID-19: https://pubmed.ncbi.nlm.nih.gov/34081948/
872. Lezioni del primo mese: mielite trasversa longitudinale estesa a seguito della vaccinazione AstraZeneca COVID-19: https://pubmed.ncbi.nlm.nih.gov/34507942/ .
873. Sindrome da stravaso capillare sistemico dopo vaccinazione con ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/
874. Linfoadenopatia ascellare unilaterale correlata al vaccino COVID-19: pattern sullo screening della risonanza magnetica mammaria che consente una valutazione benigna: https://pubmed.ncbi.nlm.nih.gov/34325221/
875. Linfoadenopatia ascellare in pazienti con recente vaccinazione Covid-19: un nuovo dilemma diagnostico: https://pubmed.ncbi.nlm.nih.gov/34825530/ .
876. Malattia da cambiamento minimo e danno renale acuto dopo il vaccino Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/34000278/
877. Adenopatia ascellare unilaterale indotta dal vaccino COVID-19: valutazione di follow-up negli Stati Uniti: https://pubmed.ncbi.nlm.nih.gov/34655312/ .
878. Gastroparesi dopo la vaccinazione Pfizer-BioNTech COVID-19: https://pubmed.ncbi.nlm.nih.gov/34187985/ .

Abbate, A., Gavin, J., Madanchi, N., Kim, C., Shah, PR, Klein, K.,. . . Danielides, S. (2021). Miocardite fulminante e iperinfiammazione sistemica temporaneamente associate alla vaccinazione con BNT162b2 mRNA COVID-19 in due pazienti. Int J Cardiol, 340 , 119-121. doi: 10.1016 / j.ijcard.2021.08.018. https://www.ncbi.nlm.nih.gov/pubmed/34416319

Abu Mouch, S., Roguin, A., Hellou, E., Ishai, A., Shoshan, U., Mahamid, L.,. . . Berar Yanay, N. (2021). Miocardite dopo vaccinazione con mRNA COVID-19. Vaccino, 39 (29), 3790-3793. doi: 10.1016 / j.vaccine.2021.05.087. https://www.ncbi.nlm.nih.gov/pubmed/34092429

Albert, E., Aurigemma, G., Saucedo, J., & Gerson, DS (2021). Miocardite a seguito di vaccinazione COVID-19. Radiol Case Rep, 16 (8), 2142-2145. doi: 10.1016 / j.radcr.2021.05.033. https://www.ncbi.nlm.nih.gov/pubmed/34025885

Sì, YN, Mai, AS, Zhang, A., Lim, OZH, Lin, N., Ng, CH,. . . Masticare, NWS (2021). Infarto miocardico acuto e miocardite a seguito di vaccinazione COVID-19. QJM . doi: 10.1093 / qjmed / hcab252. https://www.ncbi.nlm.nih.gov/pubmed/34586408

Azir, M., Inman, B., Webb, J. e Tannenbaum, L. (2021). STEMI Mimic: miocardite focale in un paziente adolescente dopo il vaccino mRNA COVID-19. J Emerg Med, 61 (6), e129-e132. doi: 10.1016 / j.jemermed.2021.09.017. https://www.ncbi.nlm.nih.gov/pubmed/34756746

Barda, N., Dagan, N., Ben-Shlomo, Y., Kepten, E., Waxman, J., Ohana, R.,. . . Balicer, RD (2021). Sicurezza del vaccino BNT162b2 mRNA Covid-19 in un ambiente nazionale. N Inglese J Med, 385 (12), 1078-1090. doi: 10.1056 / NEJMoa2110475. https://www.ncbi.nlm.nih.gov/pubmed/34432976

Bhandari, M., Pradhan, A., Vishwakarma, P. e Sethi, R. (2021). Coronavirus e manifestazioni cardiovascolari: andare al nocciolo della questione. Mondo J Cardiol, 13 (10), 556-565. doi: 10.4330 / wjc.v13.i10.556. https://www.ncbi.nlm.nih.gov/pubmed/34754400

Bozkurt, B., Kamat, I. e Hotez, PJ (2021). Miocardite con vaccini mRNA COVID-19. Circolazione, 144 (6), 471-484. doi: 10.1161 / CIRCOLAZIONEAHA.121.056135. https://www.ncbi.nlm.nih.gov/pubmed/34281357

Buchhorn, R., Meyer, C., Schulze-Forster, K., Junker, J. e Heidecke, H. (2021). Rilascio di autoanticorpi nei bambini dopo la vaccinazione con mRNA del virus Corona: un fattore di rischio della sindrome infiammatoria multisistemica? Vaccini (Basilea), 9 (11). doi: 10.3390 / vaccini9111353. https://www.ncbi.nlm.nih.gov/pubmed/34835284

Calcaterra, G., Bassareo, PP, Barilla, F., Romeo, F. e Mehta, JL (2022). Per quanto riguarda lo stato protrombotico inaspettato a seguito di alcuni vaccini contro la malattia di coronavirus 2019. J Cardiovasc Med (Hagerstown), 23 (2), 71-74. doi: 10.2459 / JCM.00000000000001232. https://www.ncbi.nlm.nih.gov/pubmed/34366403

Calcaterra, G., Mehta, JL, de Gregorio, C., Butera, G., Neroni, P., Fanos, V. e Bassareo, PP (2021). Vaccino COVID 19 per adolescenti. Preoccupazione per miocardite e pericardite. Pediatr Rep, 13 (3), 530-533. doi: 10.3390 / pediatrico13030061. https://www.ncbi.nlm.nih.gov/pubmed/34564344

Chai, Q., Nygaard, U., Schmidt, RC, Zaremba, T., Moller, AM e Thorvig, CM (2022). Sindrome infiammatoria multisistemica in un adolescente maschio dopo il suo secondo vaccino Pfizer-BioNTech COVID-19. Acta Pediatr, 111 (1), 125-127. doi: 10.1111 / apa.16141. https://www.ncbi.nlm.nih.gov/pubmed/34617315

Chamling, B., Vehof, V., Drakos, S., Weil, M., Stalling, P., Vahlhaus, C.,. . . Yilmaz, A. (2021). Presenza di miocardite acuta simil-infartuale a seguito della vaccinazione COVID-19: solo una coincidenza accidentale o piuttosto miocardite autoimmune associata alla vaccinazione? Clin Res Cardiol, 110 (11), 1850-1854. doi: 10.1007 / s00392-021-01916-w. https://www.ncbi.nlm.nih.gov/pubmed/34333695

Chang, JC e Hawley, HB (2021). Trombocitopenia e trombosi associate al vaccino: endoteliopatia venosa che porta a micro-macrotrombosi venosa combinata. Medicina (Kaunas), 57 (11). doi: 10.3390 / medicina57111163. https://www.ncbi.nlm.nih.gov/pubmed/34833382

Chelala, L., Jeudy, J., Hossain, R., Rosenthal, G., Pietris, N. e White, C. (2021). Risultati della risonanza magnetica cardiaca di miocardite dopo la vaccinazione con mRNA COVID-19 negli adolescenti. AJR Am J Roentgenol . doi: 10.2214 / AJR.21.26853. https://www.ncbi.nlm.nih.gov/pubmed/34704459

Choi, S., Lee, S., Seo, JW, Kim, MJ, Jeon, YH, Park, JH,. . . Sì, NS (2021). Morte improvvisa indotta da miocardite dopo la vaccinazione con mRNA COVID-19 BNT162b2 in Corea: caso clinico incentrato sui risultati istopatologici. J coreano Med Sci, 36 (40), e286. doi: 10.3346 / jkms.2021.36.e286. https://www.ncbi.nlm.nih.gov/pubmed/34664804

Chouchana, L., Blet, A., Al-Khalaf, M., Kafil, TS, Nair, G., Robblee, J.,. . . Liu, PP (2021). Caratteristiche delle reazioni cardiache infiammatorie dopo la vaccinazione con mRNA COVID-19 a livello globale. Clin Pharmacol Ther . doi: 10.1002 / cpt.2499. https://www.ncbi.nlm.nih.gov/pubmed/34860360

Chua, GT, Kwan, MYW, Chui, CSL, Smith, RD, Cheung, EC, Tian, ​​T.,. . . Ip, P. (2021). Epidemiologia della miocardite / pericardite acuta negli adolescenti di Hong Kong dopo la vaccinazione di Comirnaty. Clin Infect Dis . doi: 10.1093 / cid / ciab989. https://www.ncbi.nlm.nih.gov/pubmed/34849657

Clarke, R. e Ioannou, A. (2021). La mappatura T2 dovrebbe essere utilizzata nei casi di miocardite ricorrente per differenziare tra l’infiammazione acuta e la cicatrice cronica? J Pediatr . doi: 10.1016 / j.jpeds.2021.12.026. https://www.ncbi.nlm.nih.gov/pubmed/34933012

Colaneri, M., De Filippo, M., Licari, A., Marseglia, A., Maiocchi, L., Ricciardi, A.,. . . Bruno, R. (2021). Vaccinazione COVID ed esacerbazione dell’asma: potrebbe esserci un collegamento? Int J Infect Dis, 112 , 243-246. doi: 10.1016 / j.ijid.2021.09.026. https://www.ncbi.nlm.nih.gov/pubmed/34547487

Das, BB, Kohli, U., Ramachandran, P., Nguyen, HH, Greil, G., Hussain, T.,. . . Khan, D. (2021). Miopericardite dopo RNA messaggero Coronavirus Disease 2019 Vaccinazione negli adolescenti dai 12 ai 18 anni di età. J Pediatr, 238 , 26-32 e21. doi: 10.1016 / j.jpeds.2021.07.044. https://www.ncbi.nlm.nih.gov/pubmed/34339728

Das, BB, Moskowitz, WB, Taylor, MB e Palmer, A. (2021). Miocardite e pericardite dopo la vaccinazione con mRNA COVID-19: cosa sappiamo finora? Bambini (Basilea), 8 (7). doi: 10.3390 / bambini8070607. https://www.ncbi.nlm.nih.gov/pubmed/34356586

Deb, A., Abdelmalek, J., Iwuji, K. e Nugent, K. (2021). Lesione miocardica acuta a seguito della vaccinazione COVID-19: un caso clinico e una revisione delle prove attuali dal database del sistema di segnalazione degli eventi avversi del vaccino. J Prim Care Community Health, 12 , 215013272111029230. doi: 10.1177 / 21501327211029230. https://www.ncbi.nlm.nih.gov/pubmed/34219532

Dickey, JB, Albert, E., Badr, M., Laraja, KM, Sena, LM, Gerson, DS,. . . Aurigemma, GP (2021). Una serie di pazienti con miocardite a seguito di vaccinazione SARS-CoV-2 con mRNA-1279 e BNT162b2. JACC Cardiovasc Imaging, 14 (9), 1862-1863. doi: 10.1016 / j.jcmg.2021.06.003. https://www.ncbi.nlm.nih.gov/pubmed/34246585

Dimopoulou, D., Spyridis, N., Vartzelis, G., Tsolia, MN e Maritsi, DN (2021). Sicurezza e tollerabilità del vaccino mRNA COVID-19 in adolescenti con artrite idiopatica giovanile in trattamento con inibitori del TNF. Artrite reumatologica . doi: 10.1002 / art.41977. https://www.ncbi.nlm.nih.gov/pubmed/34492161

Dimopoulou, D., Vartzelis, G., Dasoula, F., Tsolia, M. e Maritsi, D. (2021). Immunogenicità del vaccino mRNA COVID-19 in adolescenti con artrite idiopatica giovanile in trattamento con inibitori del TNF. Ann Rheum Dis . doi: 10.1136 / annrheumdis-2021-221607. https://www.ncbi.nlm.nih.gov/pubmed/34844930

Ehrlich, P., Klingel, K., Ohlmann-Knafo, S., Huttinger, S., Sood, N., Pickuth, D. e Kindermann, M. (2021). Miocardite linfocitica provata da biopsia dopo la prima vaccinazione con mRNA COVID-19 in un uomo di 40 anni: caso clinico. Clin Res Cardiol, 110 (11), 1855-1859. doi: 10.1007 / s00392-021-01936-6. https://www.ncbi.nlm.nih.gov/pubmed/34487236

El Sahly, HM, Baden, LR, Essink, B., Doblecki-Lewis, S., Martin, JM, Anderson, EJ,. . . Gruppo, CS (2021). Efficacia del vaccino mRNA-1273 SARS-CoV-2 al completamento della fase in cieco. N inglese J Med, 385 (19), 1774-1785. doi: 10.1056 / NEJMoa2113017. https://www.ncbi.nlm.nih.gov/pubmed/34551225

Facetti, S., Giraldi, M., Vecchi, AL, Rogiani, S. e Nassiacos, D. (2021). [Miocardite acuta in un giovane adulto due giorni dopo la vaccinazione Pfizer]. G Ital Cardiol (Roma), 22 (11), 891-893. doi: 10.1714 / 3689.36746. https://www.ncbi.nlm.nih.gov/pubmed/34709227

Fazlollahi, A., Zahmatyar, M., Noori, M., Nejadghaderi, SA, Sullman, MJM, Shekarriz-Foumani, R.,. . . Safiri, S. (2021). Complicanze cardiache a seguito di vaccini mRNA COVID-19: una revisione sistematica di case report e serie di casi. Rev Med Virol , e2318. doi: 10.1002 / rmv.2318. https://www.ncbi.nlm.nih.gov/pubmed/34921468

Fazolo, T., Lima, K., Fontoura, JC, de Souza, PO, Hilario, G., Zorzetto, R.,. . . Bonorino, C. (2021). I pazienti pediatrici con COVID-19 nel Brasile meridionale mostrano abbondanti mRNA virali e forti risposte antivirali specifiche. Nat Commun, 12 (1), 6844. doi: 10.1038 / s41467-021-27120-y. https://www.ncbi.nlm.nih.gov/pubmed/34824230

Fikenzer, S. e Laufs, USA (2021). Correzione a: Risposta a Lettera agli editori con riferimento a Fikenzer, S., Uhe, T., Lavall, D., Rudolph, U., Falz, R., Busse, M., Hepp, P., & Laufs, U (2020). Effetti delle mascherine chirurgiche e FFP2/N95 sulla capacità di esercizio cardiopolmonare. Ricerca clinica in cardiologia: Gazzetta ufficiale della German Cardiac Society, 1-9. Pubblicazione online anticipata. https://doi.org/10.1007/s00392-020-01704-y . Clin Res Cardiol, 110 (8), 1352. doi: 10.1007 / s00392-021-01896-x. https://www.ncbi.nlm.nih.gov/pubmed/34170372

Foltran, D., Delmas, C., Flumian, C., De Paoli, P., Salvo, F., Gautier, S.,. . . Montastruc, F. (2021). Miocardite e pericardite negli adolescenti dopo la prima e la seconda dose di vaccini mRNA COVID-19. Eur Heart J Qual Care Clin Risultati . doi: 10.1093 / ehjqcco / qcab090. https://www.ncbi.nlm.nih.gov/pubmed/34849667

Forgacs, D., Jang, H., Abreu, RB, Hanley, HB, Gattiker, JL, Jefferson, AM e Ross, TM (2021). I vaccini mRNA SARS-CoV-2 suscitano risposte diverse negli esseri umani immunologicamente ingenui e pre-immuni. Immunol anteriore, 12 , 728021. doi: 10.3389 / fimmu.2021.728021. https://www.ncbi.nlm.nih.gov/pubmed/34646267

Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D.,. . . Elkayam, O. (2021). Immunogenicità e sicurezza del vaccino BNT162b2 mRNA COVID-19 in pazienti adulti con malattie reumatiche infiammatorie autoimmuni e nella popolazione generale: uno studio multicentrico. Ann Rheum Dis, 80 (10), 1330-1338. doi: 10.1136 / annrheumdis-2021-220647. https://www.ncbi.nlm.nih.gov/pubmed/34127481

Galindo, R., Chow, H. e Rongkavilit, C. (2021). COVID-19 nei bambini: manifestazioni cliniche e interventi farmacologici comprese le sperimentazioni sui vaccini. Pediatr Clin North Am, 68 (5), 961-976. doi: 10.1016 / j.pcl.2021.05.004. https://www.ncbi.nlm.nih.gov/pubmed/34538306

Gargano, JW, Wallace, M., Hadler, SC, Langley, G., Su, JR, Oster, ME,. . . Oliver, SE (2021). Uso del vaccino mRNA COVID-19 dopo segnalazioni di miocardite tra i destinatari del vaccino: aggiornamento dal comitato consultivo sulle pratiche di immunizzazione – Stati Uniti, giugno 2021.  MMWR Morb Mortal Wkly Rep, 70 (27), 977-982. doi: 10.15585 / mmwr.mm7027e2. https://www.ncbi.nlm.nih.gov/pubmed/34237049

Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E. e Diemberger, I. (2021). Vaccinazione antinfluenzale e mio-pericardite nei pazienti che ricevono inibitori del checkpoint immunitario: indagine sulla probabilità di interazione attraverso il sistema di segnalazione di eventi avversi del vaccino e VigiBase. Vaccini (Basilea), 9 (1). doi: 10.3390 / vaccini9010019. https://www.ncbi.nlm.nih.gov/pubmed/33406694

Gautam, N., Saluja, P., Fudim, M., Jambhekar, K., Pandey, T. e Al’Aref, S. (2021). Una presentazione tardiva della miocardite indotta dal vaccino COVID-19. Cureo, 13 (9), e17890. doi: 10.7759 / cureus.17890. https://www.ncbi.nlm.nih.gov/pubmed/34660088

Gellad, WF (2021). Miocardite dopo la vaccinazione contro il covid-19. BMJ, 375 , n3090. doi: 10.1136 / bmj.n3090. https://www.ncbi.nlm.nih.gov/pubmed/34916217

Greenhawt, M., Abrams, EM, Shaker, M., Chu, DK, Khan, D., Akin, C.,. . . D’oro, DBK (2021). Il rischio di reazione allergica ai vaccini SARS-CoV-2 e valutazione e gestione consigliate: una revisione sistematica, una meta-analisi, una valutazione GRADE e un approccio di consenso internazionale. J Allergy Clin Immunol Pract, 9 (10), 3546-3567. doi: 10.1016 / j.jaip.2021.06.006. https://www.ncbi.nlm.nih.gov/pubmed/34153517

Haaf, P., Kuster, GM, Mueller, C., Berger, CT, Monney, P., Burger, P.,. . . Tanner, FC (2021). Il rischio molto basso di miocardite e pericardite dopo la vaccinazione con mRNA COVID-19 non dovrebbe scoraggiare la vaccinazione. Swiss Med Wkly, 151 , w30087. doi: 10.4414 / smw.2021.w30087. https://www.ncbi.nlm.nih.gov/pubmed/34668687

Hasnie, AA, Hasnie, UA, Patel, N., Aziz, MU, Xie, M., Lloyd, SG e Prabhu, SD (2021). Perimiocardite dopo la prima dose del vaccino mRNA-1273 SARS-CoV-2 (Moderna) in un giovane maschio sano: un caso clinico. Disturbo cardiovascolare BMC, 21 (1), 375. doi: 10.1186 / s1287-021-02183-3. https://www.ncbi.nlm.nih.gov/pubmed/34348657

Hause, AM, Gee, J., Baggs, J., Abara, WE, Marquez, P., Thompson, D.,. . . Shay, DK (2021). Sicurezza del vaccino COVID-19 negli adolescenti di età compresa tra 12 e 17 anni – Stati Uniti, 14 dicembre 2020-16 luglio 2021.  MMWR Morb Mortal Wkly Rep, 70 (31), 1053-1058. doi: 10.15585 / mmwr.mm7031e1. https://www.ncbi.nlm.nih.gov/pubmed/34351881

Helms, JM, Ansteatt, KT, Roberts, JC, Kamatam, S., Foong, KS, Labayog, JS e Tarantino, MD (2021). Trombocitopenia immunitaria grave e refrattaria che si verifica dopo il vaccino SARS-CoV-2. J Blood Med, 12 , 221-224. doi: 10.2147 / JBM.S307047. https://www.ncbi.nlm.nih.gov/pubmed/33854395

Hippisley-Cox, J., Patone, M., Mei, XW, Saatci, D., Dixon, S., Khunti, K.,. . . Coupland, CAC (2021). Rischio di trombocitopenia e tromboembolismo dopo vaccinazione covid-19 e test positivo per SARS-CoV-2: studio di serie di casi autocontrollati. BMJ, 374 , n1931. doi: 10.1136 / bmj.n1931. https://www.ncbi.nlm.nih.gov/pubmed/34446426

Ho, JS, Sia, CH, Ngiam, JN, Loh, PH, Chew, NW, Kong, WK e Poh, KK (2021). Una revisione della vaccinazione COVID-19 e delle manifestazioni cardiache riportate. Singapore Med J . doi: 10.11622 / smedj.2021210. https://www.ncbi.nlm.nih.gov/pubmed/34808708

Iguchi, T., Umeda, H., Kojima, M., Kanno, Y., Tanaka, Y., Kinoshita, N. e Sato, D. (2021). Segnalazione cumulativa di eventi avversi di anafilassi dopo iniezioni di vaccino mRNA COVID-19 (Pfizer-BioNTech) in Giappone: il rapporto del primo mese. Drug Saf, 44 (11), 1209-1214. doi: 10.1007 / s40264-021-01104-9. https://www.ncbi.nlm.nih.gov/pubmed/34347278

In breve: miocardite con i vaccini Pfizer/BioNTech e Moderna COVID-19. (2021). Med Lett Drugs Ther, 63 (1629), e9. Estratto da  https://www.ncbi.nlm.nih.gov/pubmed/34544112https://www.ncbi.nlm.nih.gov/pubmed/34544112

Ioannou, A. (2021a). La miocardite dovrebbe essere considerata in quelli con un aumento della troponina e arterie coronarie non ostruite dopo la vaccinazione Pfizer-BioNTech COVID-19. QJM . doi: 10.1093 / qjmed / hcab231. https://www.ncbi.nlm.nih.gov/pubmed/34463755

Ioannou, A. (2021b). La mappatura T2 dovrebbe essere utilizzata nei casi di sospetta miocardite per confermare un processo infiammatorio acuto. QJM . doi: 10.1093 / qjmed / hcab326. https://www.ncbi.nlm.nih.gov/pubmed/34931681

Isaak, A., Feisst, A. e Luetkens, JA (2021). Miocardite dopo vaccinazione COVID-19. Radiologia, 301 (1), E378-E379. doi: 10.1148 / radiol.2021211766. https://www.ncbi.nlm.nih.gov/pubmed/34342500

Istampoulouoglou, I., Dimitriou, G., Spani, S., Cristo, A., Zimmermanns, B., Koechlin, S.,. . . Leuppi-Taegtmeyer, AB (2021). Miocardite e pericardite in associazione con vaccinazione mRNA COVID-19: casi da un centro regionale di farmacovigilanza. Glob Cardiol Sci Pract, 2021 (3), e202118. doi: 10.21542 / gcsp.2021.18. https://www.ncbi.nlm.nih.gov/pubmed/34805376

Jaafar, R., Boschi, C., Aherfi, S., Bancod, A., Le Bideau, M., Edouard, S.,. . . La Scola, B. (2021). Elevata eterogeneità individuale delle attività neutralizzanti contro il ceppo originale e nove diverse varianti di SARS-CoV-2. Virus, 13 (11). doi: 10.3390 / v13112177. https://www.ncbi.nlm.nih.gov/pubmed/34834983

Jain, SS, Steele, JM, Fonseca, B., Huang, S., Shah, S., Maskatia, SA,. . . Grosse-Wortmann, L. (2021). Miocardite associata alla vaccinazione COVID-19 negli adolescenti. Pediatria, 148 (5). doi: 10.1542/peds.2021-053427. https://www.ncbi.nlm.nih.gov/pubmed/34389692

Jhaveri, R., Adler-Shohet, FC, Blyth, CC, Chiotos, K., Gerber, JS, Green, M.,. . . Zaoutis, T. (2021). Pesare i rischi della perimiocardite con i vantaggi della vaccinazione con mRNA SARS-CoV-2 negli adolescenti. J Pediatric Infect Dis Soc, 10 (10), 937-939. doi: 10.1093 / jpids / piab061. https://www.ncbi.nlm.nih.gov/pubmed/34270752

Kaneta, K., Yokoi, K., Jojima, K., Kotooka, N. e Node, K. (2021). Giovane maschio con miocardite dopo la vaccinazione con mRNA-1273 contro la malattia di Coronavirus-2019 (COVID-19). Circ J . doi: 10.1253 / circj.CJ-21-0818. https://www.ncbi.nlm.nih.gov/pubmed/34744118

Kaul, R., Sreenivasan, J., Goel, A., Malik, A., Bandyopadhyay, D., Jin, C.,. . . Panza, JA (2021). Miocardite a seguito di vaccinazione COVID-19. Int J Cardiol Heart Vasc, 36 , 100872. doi: 10.1016 / j.ijcha.2021.100872. https://www.ncbi.nlm.nih.gov/pubmed/34568540

Khogali, F. e Abdelrahman, R. (2021). Presentazione insolita di perimiocardite acuta a seguito della vaccinazione SARS-COV-2 mRNA-1237 Moderna. Cureo, 13 (7), e16590. doi: 10.7759 / cureus.16590. https://www.ncbi.nlm.nih.gov/pubmed/34447639

Kim, HW, Jenista, ER, Wendell, DC, Azevedo, CF, Campbell, MJ, Darty, SN,. . . Kim, RJ (2021). Pazienti con miocardite acuta dopo vaccinazione con mRNA COVID-19. JAMA Cardiol, 6 (10), 1196-1201. doi: 10.1001 / jamacardio.2021.2828. https://www.ncbi.nlm.nih.gov/pubmed/34185046

Kim, IC, Kim, H., Lee, HJ, Kim, JY e Kim, JY (2021). Imaging cardiaco della miocardite acuta dopo la vaccinazione con mRNA COVID-19.  J coreano Med Sci, 36 (32), e229. doi: 10.3346 / jkms.2021.36.e229.  https://www.ncbi.nlm.nih.gov/pubmed/34402228

King, WW, Petersen, MR, Matar, RM, Budweg, JB, Cuervo Pardo, L. e Petersen, JW (2021). Miocardite dopo vaccinazione con mRNA contro SARS-CoV-2, una serie di casi.  Am Heart J Plus, 8 , 100042. doi: 10.1016 / j.ahjo.2021.100042.  https://www.ncbi.nlm.nih.gov/pubmed/34396358

Klein, NP, Lewis, N., Goddard, K., Fireman, B., Zerbo, O., Hanson, KE,. . . Weintraub, ES (2021). Sorveglianza per eventi avversi dopo la vaccinazione con mRNA COVID-19. GIAMA, 326 (14), 1390-1399. doi: 10.1001 / jama.2021.15072. https://www.ncbi.nlm.nih.gov/pubmed/34477808

Klimek, L., Bergmann, KC, Brehler, R., Pfutzner, W., Zuberbier, T., Hartmann, K.,. . . Verme, M. (2021). Gestione pratica delle reazioni allergiche ai vaccini COVID-19: un documento di sintesi delle società allergiche tedesche e austriache AeDA, DGAKI, GPA e OGAI. Allergo J Int , 1-17. doi: 10.1007 / s40629-021-00165-7. https://www.ncbi.nlm.nih.gov/pubmed/33898162

Klimek, L., Novak, N., Hamelmann, E., Werfel, T., Wagenmann, M., Taube, C.,. . . Verme, M. (2021). Gravi reazioni allergiche dopo la vaccinazione COVID-19 con il vaccino Pfizer / BioNTech in Gran Bretagna e USA: Dichiarazione di posizione delle Società tedesche di allergie: Associazione medica degli allergologi tedeschi (AeDA), Società tedesca di allergologia e immunologia clinica (DGAKI) e Società per Allergologia Pediatrica e Medicina Ambientale (GPA). Allergo J Int, 30 (2), 51-55. doi: 10.1007 / s40629-020-00160-4. https://www.ncbi.nlm.nih.gov/pubmed/33643776

Kohli, U., Desai, L., Chowdhury, D., Harahsheh, AS, Yonts, AB, Ansong, A.,. . . Ang, JY (2021). Miopericardite associata al vaccino mRNA Coronavirus-19 negli adolescenti: uno studio di indagine. J Pediatr . doi: 10.1016 / j.jpeds.2021.12.025. https://www.ncbi.nlm.nih.gov/pubmed/34952008

Kostoff, RN, Calina, D., Kanduc, D., Briggs, MB, Vlachoyiannopoulos, P., Svistunov, AA e Tsatsakis, A. (2021a). Erratum a “Perché stiamo vaccinando i bambini contro COVID-19?” [Tossico. Rappresentante. 8C (2021) 1665-1684/1193]. Toxicol Rep, 8 , 1981. doi: 10.1016 / j.toxrep.2021.10.003. https://www.ncbi.nlm.nih.gov/pubmed/34642628

Kostoff, RN, Calina, D., Kanduc, D., Briggs, MB, Vlachoyiannopoulos, P., Svistunov, AA e Tsatsakis, A. (2021b). Perché stiamo vaccinando i bambini contro il COVID-19? Rep. tossicologico, 8 , 1665-1684. doi: 10.1016 / j.toxrep.2021.08.010. https://www.ncbi.nlm.nih.gov/pubmed/34540594

Kremsner, PG, Mann, P., Kroidl, A., Leroux-Roels, I., Schindler, C., Gabor, JJ,. . . Gruppo, C.-N.-S. (2021). Sicurezza e immunogenicità di un candidato vaccino mRNA-lipidico di nanoparticelle contro SARS-CoV-2: uno studio clinico randomizzato di fase 1. Wien Klin Wochenschr, 133 (17-18), 931-941. doi: 10.1007 / s00508-021-01922-y. https://www.ncbi.nlm.nih.gov/pubmed/34378087

Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M.,. . . Stern, A. (2021). Prove per l’aumento dei tassi di innovazione delle varianti SARS-CoV-2 preoccupanti negli individui vaccinati con BNT162b2-mRNA. Nat Med, 27 (8), 1379-1384. doi: 10.1038 / s41591-021-01413-7. https://www.ncbi.nlm.nih.gov/pubmed/34127854

Kwan, MYW, Chua, GT, Chow, CB, Tsao, SSL, To, KKW, Yuen, KY,. . . Ip, P. (2021). Vaccino mRNA COVID e miocardite negli adolescenti. Hong Kong Med J, 27 (5), 326-327. doi: 10.12809 / hkmj215120. https://www.ncbi.nlm.nih.gov/pubmed/34393110

Lee, E., Chew, NWS, Ng, P. e Yeo, TJ (2021). Risposta a “Lettera all’editore: la miocardite dovrebbe essere considerata in quelli con aumento della troponina e arterie coronarie libere dopo la vaccinazione PfizerBioNTech COVID-19”. QJM . doi: 10.1093 / qjmed / hcab232. https://www.ncbi.nlm.nih.gov/pubmed/34463770

Lee, EJ, Cines, DB, Gernsheimer, T., Kessler, C., Michel, M., Tarantino, MD,. . . Bussel, JB (2021). Trombocitopenia dopo vaccinazione Pfizer e Moderna SARS-CoV-2. Am J Hematol, 96 (5), 534-537. doi: 10.1002 / ajh.26132. https://www.ncbi.nlm.nih.gov/pubmed/33606296

Levin, D., Shimon, G., Fadlon-Derai, M., Gershovitz, L., Shovali, A., Sebbag, A.,. . . Gordon, B. (2021). Miocardite a seguito di vaccinazione COVID-19 – Una serie di casi. Vaccino, 39 (42), 6195-6200. doi: 10.1016 / j.vaccine.2021.09.004. https://www.ncbi.nlm.nih.gov/pubmed/34535317

Li, J., Hui, A., Zhang, X., Yang, Y., Tang, R., Ye, H.,. . . Zhu, F. (2021). Sicurezza e immunogenicità del vaccino mRNA SARS-CoV-2 BNT162b1 negli adulti cinesi più giovani e più anziani: uno studio di fase 1 randomizzato, controllato con placebo, in doppio cieco. Nat Med, 27 (6), 1062-1070. doi: 10.1038 / s41591-021-01330-9. https://www.ncbi.nlm.nih.gov/pubmed/33888900

Li, M., Yuan, J., Lv, G., Brown, J., Jiang, X. e Lu, ZK (2021). Miocardite e pericardite a seguito di vaccinazione COVID-19: disuguaglianze nell’età e nei tipi di vaccino. J Pers Med, 11 (11). doi: 10.3390 / jpm11111106. https://www.ncbi.nlm.nih.gov/pubmed/34834458

Lim, Y., Kim, MC, Kim, KH, Jeong, IS, Cho, YS, Choi, YD e Lee, JE (2021). Caso clinico: miocardite acuta fulminante e shock cardiogeno dopo la malattia del coronavirus dell’RNA messaggero 2019 che richiede la rianimazione cardiopolmonare extracorporea. Front Cardiovasc Med, 8 , 758996. doi: 10.3389 / fcvm.2021.758996. https://www.ncbi.nlm.nih.gov/pubmed/34778411

Lungo, SS (2021). Approfondimenti importanti sulla miopericardite dopo la vaccinazione Pfizer mRNA COVID-19 negli adolescenti. J Pediatr, 238 , 5. doi: 10.1016 / j.jpeds.2021.07.057. https://www.ncbi.nlm.nih.gov/pubmed/34332972

Luk, A., Clarke, B., Dahdah, N., Ducharme, A., Krahn, A., McCrindle, B.,. . . McDonald, M. (2021). Miocardite e pericardite dopo la vaccinazione con mRNA COVID-19: considerazioni pratiche per gli operatori sanitari. Può J Cardiol, 37 (10), 1629-1634. doi: 10.1016 / j.cjca.2021.08.001. https://www.ncbi.nlm.nih.gov/pubmed/34375696

Madelon, N., Lauper, K., Breville, G., Sabater Royo, I., Goldstein, R., Andrey, DO,. . . Eberhardt, CS (2021). Risposte robuste delle cellule T in pazienti trattati con anti-CD20 dopo la vaccinazione COVID-19: uno studio di coorte prospettico. Clin Infect Dis . doi: 10.1093 / cid / ciab954. https://www.ncbi.nlm.nih.gov/pubmed/34791081

Mangat, C. e Milosavljevic, N. (2021). BNT162b2 La vaccinazione durante la gravidanza protegge sia la madre che il bambino: anticorpi anti-SARS-CoV-2 S persistentemente positivi in ​​un bambino a 6 mesi di età. Rep. Pediatr del caso, 2021 , 6901131. doi: 10.1155 / 2021/6901131. https://www.ncbi.nlm.nih.gov/pubmed/34676123

Mark, C., Gupta, S., Punnett, A., Upton, J., Orkin, J., Atkinson, A.,. . . Alexander, S. (2021). Sicurezza della somministrazione del vaccino BNT162b2 mRNA (Pfizer-BioNTech) COVID-19 in giovani e giovani adulti con una storia di leucemia linfoblastica acuta e allergia alla PEG-asparaginasi. Cancro al sangue pediatrico, 68 (11), e29295. doi: 10.1002 / pbc.29295. https://www.ncbi.nlm.nih.gov/pubmed/34398511

Martins-Filho, PR, Quintans-Junior, LJ, de Souza Araujo, AA, Sposato, KB, Souza Tavares, CS, Gurgel, RQ,. . . Santos, VS (2021). Disuguaglianze socio-economiche e incidenza e mortalità di COVID-19 nei bambini brasiliani: uno studio basato su registri a livello nazionale. Sanità pubblica, 190 , 4-6. doi: 10.1016 / j.puhe.2020.11.005. https://www.ncbi.nlm.nih.gov/pubmed/33316478

McLean, K. e Johnson, TJ (2021). Miopericardite in un maschio adolescente precedentemente sano dopo la vaccinazione COVID-19: un caso clinico. Acad Emerg Med, 28 (8), 918-921. doi: 10.1111 / acem.14322. https://www.ncbi.nlm.nih.gov/pubmed/34133825

Mevorach, D., Anis, E., Cedar, N., Bromberg, M., Haas, EJ, Nadir, E.,. . . Alroy-Preis, S. (2021). Miocardite dopo vaccino mRNA BNT162b2 contro Covid-19 in Israele. N Inglese J Med, 385 (23), 2140-2149. doi: 10.1056 / NEJMoa2109730. https://www.ncbi.nlm.nih.gov/pubmed/34614328

Minocha, PK, Better, D., Singh, RK e Hoque, T. (2021). Recidiva di miocardite acuta temporalmente associata alla ricezione del vaccino mRNA Coronavirus 2019 (COVID-19) in un adolescente maschio. J Pediatr, 238 , 321-323. doi: 10.1016 / j.jpeds.2021.06.035. https://www.ncbi.nlm.nih.gov/pubmed/34166671

Mizrahi, B., Lotan, R., Kalkstein, N., Peretz, A., Perez, G., Ben-Tov, A.,. . . Patalon, T. (2021). Correlazione delle infezioni rivoluzionarie da SARS-CoV-2 al tempo trascorso dal vaccino. Nat Commun, 12 (1), 6379. doi: 10.1038 / s41467-021-26672-3. https://www.ncbi.nlm.nih.gov/pubmed/34737312

Moffitt, K., Cheung, E., Yeung, T., Stamoulis, C. e Malley, R. (2021). Analisi del trascrittoma di Staphylococcus aureus negli ascessi dei tessuti molli pediatrici e confronto con le infezioni murine. Infect Immun, 89 (4). doi: 10.1128 / IAI.00715-20. https://www.ncbi.nlm.nih.gov/pubmed/33526560

Mohamed, L., Madsen, AMR, Schaltz-Buchholzer, F., Ostenfeld, A., Netea, MG, Benn, CS e Kofoed, PE (2021). Riattivazione delle cicatrici della vaccinazione BCG dopo la vaccinazione con vaccini mRNA-Covid: due case report. BMC Infect Dis, 21 (1), 1264. doi: 10.1186 / s12879-021-06949-0. https://www.ncbi.nlm.nih.gov/pubmed/34930152

Montgomery, J., Ryan, M., Engler, R., Hoffman, D., McClenathan, B., Collins, L.,. . . Cooper, LT, Jr. (2021). Miocardite dopo immunizzazione con vaccini mRNA COVID-19 in membri dell’esercito americano. JAMA Cardiol, 6 (10), 1202-1206. doi: 10.1001 / jamacardio.2021.2833. https://www.ncbi.nlm.nih.gov/pubmed/34185045

Murakami, Y., Shinohara, M., Oka, Y., Wada, R., Noike, R., Ohara, H.,. . . Ikeda, T. (2021). Miocardite a seguito di una vaccinazione con RNA messaggero COVID-19: una serie di casi giapponesi. Stagista Med . doi: 10.2169 / medicina interna.8731-21. https://www.ncbi.nlm.nih.gov/pubmed/34840235

Nagasaka, T., Koitabashi, N., Ishibashi, Y., Aihara, K., Takama, N., Ohyama, Y.,. . . Kaneko, Y. (2021). Miocardite acuta associata alla vaccinazione COVID-19: un caso clinico. Casi J Cardiol . doi: 10.1016 / j.jccase.2021.11.006. https://www.ncbi.nlm.nih.gov/pubmed/34876937

Ntouros, PA, Vlachogiannis, NI, Pappa, M., Nezos, A., Mavragani, CP, Tektonidou, MG,. . . Sfikakis, PP (2021). Efficace risposta al danno del DNA dopo una sfida immunitaria acuta ma non cronica: vaccino SARS-CoV-2 contro lupus eritematoso sistemico. Clin Immunol, 229 , 108765. doi: 10.1016 / j.clim.2021.108765. https://www.ncbi.nlm.nih.gov/pubmed/34089859

Nygaard, U., Holm, M., Bohnstedt, C., Chai, Q., Schmidt, LS, Hartling, UB,. . . Stensballe, LG (2022). Incidenza di miopericardite basata sulla popolazione dopo la vaccinazione COVID-19 negli adolescenti danesi. Pediatr Infect Dis J, 41 (1), e25-e28. doi: 10.1097 / INF.00000000000003389. https://www.ncbi.nlm.nih.gov/pubmed/34889875

Oberhardt, V., Luxenburger, H., Kemming, J., Schulien, I., Ciminski, K., Giese, S.,. . . Hofmann, M. (2021). Mobilitazione rapida e stabile delle cellule T CD8 (+) da parte del vaccino mRNA SARS-CoV-2. Natura, 597 (7875), 268-273. doi: 10.1038 / s41586-021-03841-4. https://www.ncbi.nlm.nih.gov/pubmed/34320609

Park, H., Yun, KW, Kim, KR, Song, SH, Ahn, B., Kim, DR,. . . Kim, YJ (2021). Epidemiologia e caratteristiche cliniche della miocardite/pericardite prima dell’introduzione del vaccino mRNA COVID-19 nei bambini coreani: uno studio multicentrico. J coreano Med Sci, 36 (32), e232. doi: 10.3346 / jkms.2021.36.e232. https://www.ncbi.nlm.nih.gov/pubmed/34402230

Park, J., Brekke, DR e Bratincsak, A. (2021). Miocardite autolimitante che si presenta con dolore toracico ed elevazione del segmento ST negli adolescenti dopo la vaccinazione con il vaccino mRNA BNT162b2. Cardiol Young , 1-4. doi: 10.1017 / S1047951121002547. https://www.ncbi.nlm.nih.gov/pubmed/34180390

Patel, YR, Louis, DW, Atalay, M., Agarwal, S. e Shah, NR (2021). Risultati della risonanza magnetica cardiovascolare in pazienti giovani adulti con miocardite acuta dopo vaccinazione con mRNA COVID-19: una serie di casi. J Cardiovasc Magn Reson, 23 (1), 101. doi: 10.1186 / s12968-021-00795-4. https://www.ncbi.nlm.nih.gov/pubmed/34496880

Patone, M., Mei, XW, Handunnetthi, L., Dixon, S., Zaccardi, F., Shankar-Hari, M.,. . . Hippisley-Cox, J. (2021). Rischi di miocardite, pericardite e aritmie cardiache associati alla vaccinazione COVID-19 o all’infezione da SARS-CoV-2. Nat Med . doi: 10.1038 / s41591-021-01630-0. https://www.ncbi.nlm.nih.gov/pubmed/34907393

Patrignani, A., Schicchi, N., Calcagnoli, F., Falchetti, E., Ciampani, N., Argalia, G., & Mariani, A. (2021). Miocardite acuta in seguito alla vaccinazione di Comirnaty in un uomo sano con precedente infezione da SARS-CoV-2. Radiol Case Rep, 16 (11), 3321-3325. doi: 10.1016 / j.radcr.2021.07.082. https://www.ncbi.nlm.nih.gov/pubmed/34367386

Perez, Y., Levy, ER, Joshi, AY, Virk, A., Rodriguez-Porcel, M., Johnson, M.,. . . Swift, MD (2021). Miocardite dopo vaccino mRNA COVID-19: una serie di casi e determinazione del tasso di incidenza. Clin Infect Dis . doi: 10.1093 / cid / ciab926. https://www.ncbi.nlm.nih.gov/pubmed/34734240

Perrotta, A., Biondi-Zoccai, G., Saade, W., Miraldi, F., Morelli, A., Marullo, AG,. . . Peruzzi, M. (2021). Un’indagine globale istantanea sugli effetti collaterali dei vaccini COVID-19 tra gli operatori sanitari e le forze armate con particolare attenzione al mal di testa. Panminerva Med, 63 (3), 324-331. doi: 10.23736 / S0031-0808.21.04435-9. https://www.ncbi.nlm.nih.gov/pubmed/34738774

Pinana, JL, Lopez-Corral, L., Martino, R., Montoro, J., Vazquez, L., Perez, A.,. . . Terapia cellulare, G. (2022). Rilevamento di anticorpi reattivi per SARS-CoV-2 dopo la vaccinazione SARS-CoV-2 in riceventi di trapianto di cellule staminali ematopoietiche: indagine prospettica del gruppo spagnolo di trapianto di cellule staminali ematopoietiche e terapia cellulare. Am J Hematol, 97 (1), 30-42. doi: 10.1002 / ajh.26385. https://www.ncbi.nlm.nih.gov/pubmed/34695229

Revon-Riviere, G., Ninove, L., Min, V., Roma, A., Coze, C., Verschuur, A.,. . . Andre, N. (2021). Il vaccino BNT162b2 mRNA COVID-19 negli adolescenti e nei giovani adulti con cancro: un’esperienza monocentrica. Eur J Cancro, 154 , 30-34. doi: 10.1016 / j.ejca.2021.06.002. https://www.ncbi.nlm.nih.gov/pubmed/34233234

Sanchez Tijmes, F., Thavendiranathan, P., Udell, JA, Seidman, MA e Hanneman, K. (2021). Valutazione della risonanza magnetica cardiaca dell’infiammazione miocardica non ischemica: revisione dello stato dell’arte e aggiornamento sulla miocardite associata alla vaccinazione COVID-19. Imaging radiologico cardiotoracico, 3 (6), e210252. doi: 10.1148 / ryct.210252. https://www.ncbi.nlm.nih.gov/pubmed/34934954

Schauer, J., Buddhe, S., Colyer, J., Sagiv, E., Law, Y., Mallenahalli Chikkabyrappa, S. e Portman, MA (2021). Miopericardite dopo il vaccino contro la malattia di coronavirus dell’acido ribonucleico Pfizer Messenger negli adolescenti. J Pediatr, 238 , 317-320. doi: 10.1016 / j.jpeds.2021.06.083. https://www.ncbi.nlm.nih.gov/pubmed/34228985

Schneider, J., Sottmann, L., Greinacher, A., Hagen, M., Kasper, HU, Kuhnen, C.,. . . Schmeling, A. (2021). Indagine post mortem sui decessi a seguito di vaccinazione con vaccini COVID-19. Int J Legal Med, 135 (6), 2335-2345. doi: 10.1007 / s00414-021-02706-9. https://www.ncbi.nlm.nih.gov/pubmed/34591186

Schramm, R., Costard-Jackle, A., Rivinius, R., Fischer, B., Muller, B., Boeken, U.,. . . Gummert, J. (2021). Scarsa risposta umorale e delle cellule T al vaccino a RNA messaggero SARS-CoV-2 a due dosi BNT162b2 nei riceventi di trapianto cardiotoracico. Clin Res Cardiol, 110 (8), 1142-1149. doi: 10.1007 / s00392-021-01880-5. https://www.ncbi.nlm.nih.gov/pubmed/34241676

Sessa, F., Salerno, M., Esposito, M., Di Nunno, N., Zamboni, P., & Pomara, C. (2021). Risultati dell’autopsia e relazione di causalità tra morte e vaccinazione COVID-19: una revisione sistematica. JClin Med, 10 (24). doi: 10.3390 / jcm10245876. https://www.ncbi.nlm.nih.gov/pubmed/34945172

Sharif, N., Alzahrani, KJ, Ahmed, SN e Dey, SK (2021). Efficacia, immunogenicità e sicurezza dei vaccini COVID-19: una revisione sistematica e una meta-analisi. Immunol anteriore, 12 , 714170. doi: 10.3389 / fimmu.2021.714170. https://www.ncbi.nlm.nih.gov/pubmed/34707602

Shay, DK, Gee, J., Su, JR, Myers, TR, Marquez, P., Liu, R.,. . . Shimabukuro, TT (2021). Monitoraggio della sicurezza del vaccino Janssen (Johnson & Johnson) COVID-19 – Stati Uniti, marzo-aprile 2021.  MMWR Morb Mortal Wkly Rep, 70 (18), 680-684. doi: 10.15585 / mmwr.mm7018e2. https://www.ncbi.nlm.nih.gov/pubmed/33956784

Shazley, O., e Alshazley, M. (2021). Un uomo di 52 anni positivo al COVID si è presentato con tromboembolismo venoso e coagulazione intravascolare disseminata dopo la vaccinazione Johnson & Johnson: un caso di studio. Cureo, 13 (7), e16383. doi: 10.7759 / cureus.16383. https://www.ncbi.nlm.nih.gov/pubmed/34408937

Shiyovich, A., Witberg, G., Aviv, Y., Eisen, A., Orvin, K., Wiessman, M.,. . . Hamdan, A. (2021). Miocardite dopo vaccinazione COVID-19: studio di risonanza magnetica. Eur Heart J Imaging cardiovascolare . doi: 10.1093 / ehjci / jeab230. https://www.ncbi.nlm.nih.gov/pubmed/34739045

Simone, A., Herald, J., Chen, A., Gulati, N., Shen, AY, Lewin, B. e Lee, MS (2021). Miocardite acuta dopo vaccinazione con mRNA COVID-19 in adulti di età pari o superiore a 18 anni. JAMA Intern Med, 181 (12), 1668-1670. doi: 10.1001 / jaminternmed.2021.5511. https://www.ncbi.nlm.nih.gov/pubmed/34605853

Cantante, ME, Taub, IB e Kaelber, DC (2021). Rischio di miocardite da infezione da COVID-19 nelle persone di età inferiore ai 20 anni: un’analisi basata sulla popolazione. medRxiv . doi: 10.1101 / 2021.07.23.21260998. https://www.ncbi.nlm.nih.gov/pubmed/34341797

Smith, C., Odd, D., Harwood, R., Ward, J., Linney, M., Clark, M.,. . . Fraser, LK (2021). Morti in bambini e giovani in Inghilterra dopo l’infezione da SARS-CoV-2 durante il primo anno di pandemia. Nat Med . doi: 10.1038 / s41591-021-01578-1. https://www.ncbi.nlm.nih.gov/pubmed/34764489

Snapiri, O., Rosenberg Danziger, C., Shirman, N., Weissbach, A., Lowenthal, A., Ayalon, I.,. . . Bilavsky, E. (2021). Danno cardiaco transitorio negli adolescenti che ricevono il vaccino BNT162b2 mRNA COVID-19. Pediatr Infect Dis J, 40 (10), e360-e363. doi: 10.1097 / INF.00000000000003235. https://www.ncbi.nlm.nih.gov/pubmed/34077949

Spinner, JA, Julien, CL, Olayinka, L., Dreyer, WJ, Bocchini, CE, Munoz, FM e Devaraj, S. (2021). Anticorpi anti-spike SARS-CoV-2 dopo la vaccinazione nel trapianto cardiaco pediatrico: un primo rapporto. Trapianto J Heart Lung . doi: 10.1016 / j.healun.2021.11.001. https://www.ncbi.nlm.nih.gov/pubmed/34911654

Starekova, J., Bluemke, DA, Bradham, WS, Grist, TM, Schiebler, ML e Reeder, SB (2021). Miocardite associata alla vaccinazione con mRNA COVID-19. Radiologia, 301 (2), E409-E411. doi: 10.1148 / radiol.2021211430. https://www.ncbi.nlm.nih.gov/pubmed/34282971

Sulemankhil, I., Abdelrahman, M. e Negi, SI (2021). Associazione temporale tra il vaccino COVID-19 Ad26.COV2.S e la miocardite acuta: un caso clinico e una revisione della letteratura. Cardiovasc Revasc Med . doi: 10.1016 / j.carrev.2021.08.012. https://www.ncbi.nlm.nih.gov/pubmed/34420869

Tailor, PD, Feighery, AM, El-Sabawi, B. e Prasad, A. (2021). Caso clinico: miocardite acuta a seguito della seconda dose di vaccino mRNA-1273 SARS-CoV-2. Rappresentante caso Eur Heart J, 5 (8), ytab319. doi: 10.1093 / ehjcr / ytab319. https://www.ncbi.nlm.nih.gov/pubmed/34514306

Takeda, M., Ishio, N., Shoji, T., Mori, N., Matsumoto, M. e Shikama, N. (2021). Miocardite eosinofila a seguito della vaccinazione contro la malattia da coronavirus 2019 (COVID-19). Circ J . doi: 10.1253 / circj.CJ-21-0935. https://www.ncbi.nlm.nih.gov/pubmed/34955479

Squadra, CC-R., Cibo e droga, A. (2021). Reazioni allergiche inclusa l’anafilassi dopo la ricezione della prima dose del vaccino Pfizer-BioNTech COVID-19 – Stati Uniti, 14-23 dicembre 2020.  MMWR Morb Mortal Wkly Rep, 70 (2), 46-51. doi: 10.15585 / mmwr.mm7002e1. https://www.ncbi.nlm.nih.gov/pubmed/33444297

Thompson, MG, Burgess, JL, Naleway, AL, Tyner, H., Yoon, SK, Meece, J.,. . . Gaglani, M. (2021). Prevenzione e attenuazione del Covid-19 con i vaccini BNT162b2 e mRNA-1273. N Inglese J Med, 385 (4), 320-329. doi: 10.1056 / NEJMoa2107058. https://www.ncbi.nlm.nih.gov/pubmed/34192428

Tinoco, M., Leite, S., Faria, B., Cardoso, S., Von Hafe, P., Dias, G.,. . . Lourenco, A. (2021). Perimiocardite dopo vaccinazione COVID-19. Clin Med Insights Cardiol, 15 , 117954682111056634. doi: 10.1177 / 11795468211056634. https://www.ncbi.nlm.nih.gov/pubmed/34866957

Truong, DT, Dionne, A., Muniz, JC, McHugh, KE, Portman, MA, Lambert, LM,. . . Newburger, JW (2021). Miocardite clinicamente sospetta correlata temporalmente alla vaccinazione COVID-19 negli adolescenti e nei giovani adulti. Circolazione . doi: 10.1161 / CIRCOLAZIONEAHA.121.056583. https://www.ncbi.nlm.nih.gov/pubmed/34865500

Tutor, A., Unis, G., Ruiz, B., Bolaji, OA e Bob-Manuel, T. (2021). Spettro di sospetta cardiomiopatia dovuta a COVID-19: una serie di casi. Curr Probl Cardiol, 46 (10), 100926. doi: 10.1016 / j.cpcardiol.2021.100926. https://www.ncbi.nlm.nih.gov/pubmed/34311983

Umei, TC, Kishino, Y., Shiraishi, Y., Inohara, T., Yuasa, S. e Fukuda, K. (2021). Recidiva di miopericardite dopo vaccinazione con mRNA COVID-19 in un adolescente maschio. CJC aperto . doi: 10.1016 / j.cjco.2021.12.002. https://www.ncbi.nlm.nih.gov/pubmed/34904134

Vidula, MK, Ambrose, M., Glassberg, H., Chokshi, N., Chen, T., Ferrari, VA e Han, Y. (2021). Miocardite e altre complicazioni cardiovascolari dei vaccini COVID-19 basati su mRNA. Cureo, 13 (6), e15576. doi: 10.7759 / cureus.15576. https://www.ncbi.nlm.nih.gov/pubmed/34277198

Visclosky, T., Theyyunni, N., Klekowski, N. e Bradin, S. (2021). Miocardite in seguito al vaccino mRNA COVID-19. Pediatr Emerg Care, 37 (11), 583-584. doi: 10.1097 / PEC.00000000000002557. https://www.ncbi.nlm.nih.gov/pubmed/34731877

Warren, CM, Snow, TT, Lee, AS, Shah, MM, Heider, A., Blomkalns, A.,. . . Nadeau, KC (2021). Valutazione delle reazioni allergiche e anafilattiche ai vaccini mRNA COVID-19 con test di conferma in un sistema sanitario regionale degli Stati Uniti. JAMA Network Open, 4 (9), e2125524. doi: 10.1001 / jamanetworkopen.2021.25524. https://www.ncbi.nlm.nih.gov/pubmed/34533570

Watkins, K., Griffin, G., Septaric, K. e Simon, EL (2021). Miocardite dopo vaccinazione BNT162b2 in un maschio sano. Am J Emerg Med, 50 , 815 e811-815 e812. doi: 10.1016 / j.ajem.2021.06.051. https://www.ncbi.nlm.nih.gov/pubmed/34229940

Weitzman, ER, Sherman, AC e Levy, O. (2021). Atteggiamenti del vaccino mRNA SARS-CoV-2 espressi nel Commento pubblico della FDA statunitense: Necessità di un partenariato pubblico-privato in un sistema di immunizzazione dell’apprendimento. Front Public Health, 9 , 695807. doi: 10.3389 / fpubh.2021.695807. https://www.ncbi.nlm.nih.gov/pubmed/34336774

Welsh, KJ, Baumblatt, J., Chege, W., Goud, R. e Nair, N. (2021). Trombocitopenia inclusa trombocitopenia immunitaria dopo aver ricevuto vaccini mRNA COVID-19 segnalati al Vaccine Adverse Event Reporting System (VAERS). Vaccino, 39 (25), 3329-3332. doi: 10.1016 / j.vaccine.2021.04.054. https://www.ncbi.nlm.nih.gov/pubmed/34006408

Witberg, G., Barda, N., Hoss, S., Richter, I., Wiessman, M., Aviv, Y.,. . . Kornowski, R. (2021). Miocardite dopo la vaccinazione contro il Covid-19 in una grande organizzazione sanitaria. N Inglese J Med, 385 (23), 2132-2139. doi: 10.1056 / NEJMoa2110737. https://www.ncbi.nlm.nih.gov/pubmed/34614329

Zimmermann, P. e Curtis, N. (2020). Perché il COVID-19 è meno grave nei bambini? Una revisione dei meccanismi proposti alla base della differenza legata all’età nella gravità delle infezioni da SARS-CoV-2. Arch Dis Child . doi: 10.1136 / archdischild-2020-320338. https://www.ncbi.nlm.nih.gov/pubmed/33262177https://cienciaysaludnatural.com/860-estudios-sobre-efectos-adversos-y-muertes-asociados-a-la-inyeccion-k0-b1t/

Fonte: https://elcolectivodeuno.wordpress.com/2021/12/29/how-much-more-evidence-do-you-need-here-is-a-list-of-860-scientific-studies-and- segnalazioni-che-collegano-vaccini-covid-a-centinaia-di-effetti-negativi-e-morti /

The great body of evidence (comparative research studies and high-quality pieces of evidence and reporting judged to be relevant to this analysis) shows that COVID-19 lockdowns, shelter-in-place policies, masks, school closures, and mask mandates have failed in their purpose of curbing transmission or reducing deaths. These restrictive policies were ineffective and devastating failures, causing immense harm especially to the poorer and vulnerable within societies. 

Nearly all governments have attempted compulsory measures to control the virus, but no government can claim success. The research indicates that mask mandates, lockdowns, and school closures have had no discernible impact of virus trajectories. 

Bendavid reported “in the framework of this analysis, there is no evidence that more restrictive nonpharmaceutical interventions (‘lockdowns’) contributed substantially to bending the curve of new cases in England, France, Germany, Iran, Italy, the Netherlands, Spain, or the United States in early 2020.” We’ve known this for a very long time now but governments continue to double down, causing misery upon people with ramifications that will likely take decades or more to repair. 

The benefits of the societal lockdowns and restrictions have been totally exaggerated and the harms to our societies and children have been severe: the harms to children, the undiagnosed illness that will result in excess mortality in years to come, depression, anxiety, suicidal ideation in our young people, drug overdoses and suicides due to the lockdown policies, the crushing isolation due to the lockdowns, psychological harms, domestic and child abuse, sexual abuse of children, loss of jobs and businesses and the devastating impact, and the massive numbers of deaths resulting from the lockdowns that will impact heavily on women and minorities. 

Now we have whispers again for the new lockdowns in response to the Omicron variant that, by my estimations, will be likely infectious but not more lethal.

How did we get here? We knew that we could never eradicate this mutable virus (that has an animal reservoir) with lockdowns and that it would likely become endemic like other circulating common cold coronaviruses. When we knew an age-risk stratified approach was optimal (focused protection as outlined in the Great Barrington Declaration) and not carte blanche policies when we had evidence of a 1,000-fold differential in risk of death between a child and an elderly person. We knew of the potency and success of early ambulatory outpatient treatment in reducing the risk of hospitalization and death in the vulnerable.

It was clear very early on that Task Forces and medical advisors and decision-makers were not reading the evidence, were not up to speed with the science or data, did not understand the evidence, did not ‘get’ the evidence, and were blinded to the science, often driven by their own prejudices, biases, arrogance, and ego. They remain ensconced in sheer academic sloppiness and laziness. It was clear that the response was not a public health one. It was a political one from day one and continues today. 

A recent study (pre-print) captures the essence and catastrophe of a lockdown society and the hollowing out of our children by looking at how children learn (3 months to 3 years old) and finding across all measures that “children born during the pandemic have significantly reduced verbal, motor, and overall cognitive performance compared to children born pre-pandemic.” Researchers also reported that “males and children in lower socioeconomic families have been most affected. Results highlight that even in the absence of direct SARS-CoV-2 infection and COVID-19 illness, the environmental changes associated with the COVID-19 pandemic is significantly and negatively affecting infant and child development.”

Perhaps Donald Luskin of the Wall Street Journal best captures what we have stably witnessed since the start of these unscientific lockdowns and school closures: “Six months into the Covid-19 pandemic, the U.S. has now carried out two large-scale experiments in public health—first, in March and April, the lockdown of the economy to arrest the spread of the virus, and second, since mid-April, the reopening of the economy. The results are in. Counterintuitive though it may be, statistical analysis shows that locking down the economy didn’t contain the disease’s spread and reopening it didn’t unleash a second wave of infections.”

The British Columbia Center for Disease Control (BCCDC) issued a full report in September 2020 on the impact of school closures on children and found para “that i) children comprise a small proportion of diagnosed COVID-19 cases, have less severe illness, and mortality is rare ii) children do not appear to be a major source of SARS-CoV-2 transmission in households or schools, a finding which has been consistent globally iii) there are important differences between how influenza and SARS-CoV-2 are transmitted. School closures may be less effective as a prevention measure for COVID-19 iv) school closures can have severe and unintended consequences for children and youth v) school closures contribute to greater family stress, especially for female caregivers, while families balance child care and home learning with employment demands vi) family violence may be on the rise during the COVID pandemic, while the closure of schools and childcare centres may create a gap in the safety net for children who are at risk of abuse and neglect.”

Now places like Austria (November 2021) have re-entered the world of lockdown lunacy only to be outmatched by Australia. Indeed, an illustration of the spurious need for these ill-informed actions is that they are being done in the face of clear scientific evidence showing that during strict prior societal lockdowns, school lockdowns, mask mandates, and additional societal restrictions, the number of positive cases went up!

The pandemic response today remains a purely political one.

What follows is the current totality of the body of evidence (available comparative studies and high-level pieces of evidence, reporting, and discussion) on COVID-19 lockdowns, masks, school closures, and mask mandates. There is no conclusive evidence supporting claims that any of these restrictive measures worked to reduce viral transmission or deaths. Lockdowns were ineffective, school closures were ineffective, mask mandates were ineffective, and masks themselves were and are ineffective and harmful. 

Table 1: Evidence showing that COVID-19 lockdowns, use of face masks, school closures, and mask mandates were largely ineffective and caused crushing harms

Study/report title, author, and year published and interactive url link	Predominant study/evidence report finding
LOCKDOWNS
1) Lockdown Effects on Sars-CoV-2 Transmission – The evidence from Northern Jutland, Kepp, 2021	“Analysis shows that while infection levels decreased, they did so before lockdown was effective, and infection numbers also decreased in neighbour municipalities without mandates…direct spill-over to neighbour municipalities or the simultaneous mass testing do not explain this…data suggest that efficient infection surveillance and voluntary compliance make full lockdowns unnecessary.”
2) A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes, Chaudhry, 2020	“Analysis was conducted to assess the impact of timing and type of national health policy/actions undertaken towards COVID-19 mortality and related health outcomes…low levels of national preparedness, scale of testing and population characteristics were associated with increased national case load and overall mortality….in our analysis, full lockdowns and wide-spread COVID-19 testing were not associated with reductions in the number of critical cases or overall mortality.”
3) Full lockdown policies in Western Europe countries have no evident impacts on the COVID-19 epidemic, Meunier, 2020	“Extrapolating pre-lockdown growth rate trends, we provide estimates of the death toll in the absence of any lockdown policies, and show that these strategies might not have saved any life in western Europe. We also show that neighboring countries applying less restrictive social distancing measures (as opposed to police-enforced home containment) experience a very similar time evolution of the epidemic.”
4) Effects of non-pharmaceutical interventions on COVID-19: A Tale of Three Models, Chin, 2020	“Inferences on effects of NPIs are non-robust and highly sensitive to model specification. Claimed benefits of lockdown appear grossly exaggerated.”
5) vvvlrNPIs). In this way, it may be possible to isolate the role of mrNPIs, net of lrNPIs and epidemic dynamics.Here, we use Sweden and South Korea as the counterfac-tuals to isolate the effects of mrNPIs in5) Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19, Bendavid, 2020	“Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19…we do not find significant benefits on case growth of more restrictive NPIs. Similar reductions in case growth may be achievable with less-restrictive interventions.”“After subtracting the epidemic and lrNPI effects, we find no clear, significant beneficial effect of mrNPIs on case growth in any country.”“In the framework of this analysis, there is no evidence that more restrictive nonpharmaceutical interventions (‘lockdowns’) contributed substantially to bending the curve of new cases in England, France, Germany, Iran, Italy, the Netherlands, Spain or the United States in early 2020.”
6) Effect of school closures on mortality from coronavirus disease 2019: old and new predictions, Rice, 2020	“We therefore conclude that the somewhat counterintuitive results that school closures lead to more deaths are a consequence of the addition of some interventions that suppress the first wave and failure to prioritise protection of the most vulnerable people.When the interventions are lifted, there is still a large population who are susceptible and a substantial number of people who are infected. This then leads to a second wave of infections that can result in more deaths, but later. Further lockdowns would lead to a repeating series of waves of infection unless herd immunity is achieved by vaccination, which is not considered in the model. A similar result is obtained in some of the scenarios involving general social distancing. For example, adding general social distancing to case isolation and household quarantine was also strongly associated with suppression of the infection during the intervention period, but then a second wave occurs that actually concerns a higher peak demand for ICU beds than for the equivalent scenario without general social distancing.”
7) Was Germany’s Corona Lockdown Necessary? Kuhbandner, 2020	“Official data from Germany’s RKI agency suggest strongly that the spread of the corona virus in Germany receded autonomously, before any interventions become effective. Several reasons for such an autonomous decline have been suggested. One is that differences in host susceptibility and behavior can result in herd immunity at a relatively low prevalence level. Accounting for individual variation in susceptibility or exposure to the coronavirus yields a maximum of 17% to 20% of the population that needs to be infected to reach herd immunity, an estimate that is empirically supported by the cohort of the Diamond Princess cruise ship. Another reason is that seasonality may also play an important role in dissipation.”
8) A First Literature Review: Lockdowns Only Had a Small Effect on COVID-19, Herby, 2021	“Lockdowns Only Had a Small Effect on COVID-19…studies which differentiate between the two types of behavioral change find that, on average, mandated behavioral changes accounts for only 9% (median: 0%) of the total effect on the growth of the pandemic stemming from behavioral changes. The remaining 91% (median: 100%) of the effect was due to voluntary behavioral changes.”
9) Trajectory of COVID-19 epidemic in Europe, Colombo, 2020	“We show that relaxing the assumption of homogeneity to allow for individual variation in susceptibility or connectivity gives a model that has better fit to the data and more accurate 14-day forward prediction of mortality. Allowing for heterogeneity reduces the estimate of “counterfactual” deaths that would have occurred if there had been no interventions from 3.2 million to 262,000, implying that most of the slowing and reversal of COVID-19 mortality is explained by the build-up of herd immunity.”
10) Modeling social distancing strategies to prevent SARS-CoV2 spread in Israel- A Cost-effectiveness analysis, Shlomai, 2020	“A national lockdown has a moderate advantage in saving lives with tremendous costs and possible overwhelming economic effects.”
11) Lockdowns and Closures vs COVID – 19: COVID Wins, Bhalla, 2020	“As we have stressed throughout, a direct test of lockdowns on cases is the most appropriate test. This direct test is a before after test i.e. a comparison of what happened post lockdown versus what would have happened. Only for 15 out of 147 economies the lockdown “worked” in making infections lower; for more than a hundred countries, post lockdown estimate of infections was more than three times higher than the counter factual. This is not evidence of success – rather it is evidence of monumental failure of lockdown policy…“we also test, in some detail, the hypothesis that early lockdowns, and more stringent lockdowns, were effective in containing the virus. We find robust results for the opposite conclusion: later lockdowns performed better, and less stringent lockdowns achieved better outcomes.” “For the first time in human history, lockdowns were used as a strategy to counter the virus. While conventional wisdom, to date, has been that lockdowns were successful (ranging from mild to spectacular) we find not one piece of evidence supporting this claim.”
12) SARS-CoV-2 waves in Europe: A 2-stratum SEIRS model solution, Djaparidze, 2020	“Found that 180-day of mandatory isolations to healthy <60 (i.e. schools and workplaces closed) produces more final deaths…e mandatory isolations have caused economic damages and since these enforced isolations were sub-optimal they involuntarily increased the risk of covid-19 disease-related damages.”
13) Government mandated lockdowns do not reduce Covid-19 deaths: implications for evaluating the stringent New Zealand response, Gibson, 2020	“Lockdowns do not reduce Covid-19 deaths. This pattern is visible on each date that key lockdown decisions were made in New Zealand. The apparent ineffectiveness of lockdowns suggests that New Zealand suffered large economic costs for little benefit in terms of lives saved.”
14) Did Lockdown Work? An Economist’s Cross-Country Comparison, Bjørnskov, 2020	“The lockdowns in most Western countries have thrown the world into the most severe recession since World War II and the most rapidly developing recession ever seen in mature market economies. They have also caused an erosion of fundamental rights and the separation of powers in a large part of the world as both democratic and autocratic regimes have misused their emergency powers and ignored constitutional limits to policy-making (Bjørnskov and Voigt, 2020). It is therefore important to evaluate whether and to which extent the lockdowns have worked as officially intended: to suppress the spread of the SARS-CoV-2 virus and prevent deaths associated with it. Comparing weekly mortality in 24 European countries, the findings in this paper suggest that more severe lockdown policies have not been associated with lower mortality. In other words, the lockdowns have not worked as intended.”
15) Inferring UK COVID-19 fatal infection trajectories from daily mortality data: were infections already in decline before the UK lockdowns ?, Wood, 2020	“A Bayesian inverse problem approach applied to UK data on first wave Covid-19 deaths and the disease duration distribution suggests that fatal infections were in decline before full UK lockdown (24 March 2020), and that fatal infections in Sweden started to decline only a day or two later. An analysis of UK data using the model of Flaxman et al. (2020, Nature 584) gives the same result under relaxation of its prior assumptions on R.”
16) The 1illusory effects of non-pharmaceutical interventions on COVID-19 in Europe, Homburg, 2020	“We show that their methods involve circular reasoning. The purported effects are pure artefacts, which contradict the data. Moreover, we demonstrate that the United Kingdom’s lockdown was both superfluous and ineffective.”
17) Child malnutrition and COVID-19: the time to act is now, Fore, 2020	“The COVID-19 pandemic is undermining nutrition across the world, particularly in low-income and middle-income countries (LMICs). The worst consequences are borne by young children. Some of the strategies to respond to COVID-19—including physical distancing, school closures, trade restrictions, and country lockdowns—are impacting food systems by disrupting the production, transportation, and sale of nutritious, fresh, and affordable foods, forcing millions of families to rely on nutrient-poor alternatives.”
18) Covid-19 Mortality: A Matter of Vulnerability Among Nations Facing Limited Margins of Adaptation, De Larochelambert, 2020	“Countries that already experienced a stagnation or regression of life expectancy, with high income and NCD rates, had the highest price to pay. This burden was not alleviated by more stringent public decisions.”
19) Impact of non-pharmaceutical interventions against COVID-19 in Europe: A quasi-experimental study, Hunter, 2020	“Closure of education facilities, prohibiting mass gatherings and closure of some non-essential businesses were associated with reduced incidence whereas stay at home orders and closure of all non-businesses was not associated with any independent additional impact.”
20) Israel: thefatemperor, 2020	“Given that the evidence reveals that the Corona disease declines even without a complete lockdown, it is recommendable to reverse the current policy and remove the lockdown.”
21) Smart Thinking, Lockdown and COVID-19: Implications for Public Policy, Altman, 2020	“The response to COVID-19 has been overwhelmingly to lockdown much the world’s economies in order to minimize death rates as well as the immediate negative effects of COVID-19. I argue that such policy is too often de-contextualized as it ignores policy externalities, assumes death rate calculations are appropriately accurate and, and as well, assumes focusing on direct Covid-19 effects to maximize human welfare is appropriate. As a result of this approach current policy can be misdirected and with highly negative effects on human welfare. Moreover, such policies can inadvertently result in not minimizing death rates (incorporating externalities) at all, especially in the long run… such misdirected and sub-optimal policy is a product of policy makers using inappropriate mental models which are lacking in a number of key areas; the failure to take a more comprehensive macro perspective to address the virus, using bad heuristics or decision-making tools, relatedly not recognizing the differential effects of the virus, and adopting herding strategy (follow-the-leader) when developing policy.”
22) The Mystery of Taiwan, Janaskie, 2020	“Another fascinating outlier – often cited as a case in which a government handled the pandemic the correct way – was Taiwan. Indeed, Taiwan presents an anomaly in the mitigation and overall handling of the Covid-19 pandemic. In terms of stringency, Taiwan ranks among the lowest in the world, with fewer controls than Sweden and far lower than the U.S….The government did test at the border and introduce some minor controls but nowhere near that of most counties. In general, Taiwan rejected lockdown in favor of maintaining social and economic functioning.” “Despite Taiwan’s closer proximity to the source of the pandemic, and its high population density, it experienced a substantially lower-case rate of 20.7 per million compared with New Zealand’s 278.0 per million. Rapid and systematic implementation of control measures, in particular effective border management (exclusion, screening, quarantine/isolation), contact tracing, systematic quarantine/isolation of potential and confirmed cases, cluster control, active promotion of mass masking, and meaningful public health communication, are likely to have been instrumental in limiting pandemic spread. Furthermore, the effectiveness of Taiwan’s public health response has meant that to date no lockdown has been implemented, placing Taiwan in a stronger economic position both during and post-COVID-19 compared with New Zealand, which had seven weeks of national lockdown (at Alert Levels 4 and 3).”
23) What They Said about Lockdowns before 2020, Gartz, 2021	“While expert consensus regarding the ineffectiveness of mass quarantine of previous years has recently been challenged, significant present-day evidence continuously demonstrates that mass quarantine is both ineffectual at preventing disease spread as well as harmful to individuals.”
24) Cost of Lockdowns: A Preliminary Report, AIER, 2020	“In the debate over coronavirus policy, there has been far too little focus on the costs of lockdowns. It’s very common for the proponents of these interventions to write articles and large studies without even mentioning the downsides…a brief look at the cost of stringencies in the United States, and around the world, including stay-at-home orders, closings of business and schools, restrictions on gatherings, shutting of arts and sports, restrictions on medical services, and interventions in the freedom of movement.”
25) Leaked Study From Inside German Government Warns Lockdown Could Kill More People Than Coronavirus, Watson, 2020 German Minister: Lockdown Will Kill More Than Covid-19 Does	“The lockdown and the measures taken by the German federal and central governments to contain the coronavirus apparently cost more lives, for example of cancer patients, than of those actually killed by it.” “Half a million more will die from tuberculosis.”
26) Evaluating the effects of shelter-in-place policies during the COVID-19 pandemic, Berry, 2021	“Previous studies have claimed that shelter-in-place orders saved thousands of lives, but we reassess these analyses and show that they are not reliable. We find that shelter-in-place orders had no detectable health benefits, only modest effects on behavior, and small but adverse effects on the economy.”
27) Study: Lockdown “Will Destroy at Least Seven Times More Years of Human Life” Than it Saves, Watson, 2020	“A study has found that the “stay at home” lockdown order in the United States will “destroy at least seven times more years of human life” than it saves and that this number is “likely” to be more than 90 times greater… Research shows that at least 16.8% of adults in the United States have suffered “major mental harm from responses to Covid-19…Extrapolating these numbers out, the figures show that “anxiety from responses to Covid-19 has impacted 42,873,663 adults and will rob them of an average of 1.3 years of life, thus destroying 55.7 million years of life.”
28) Four Stylized Facts about COVID-19, Atkeson, 2020	“Failing to account for these four stylized facts may result in overstating the importance of policy mandated NPIs for shaping the progression of this deadly pandemic… The existing literature has concluded that NPI policy and social distancing have been essential to reducing the spread of COVID-19 and the number of deaths due to this deadly pandemic. The stylized facts established in this paper challenge this conclusion.”
29) THE LONG-TERM IMPACT OF THE COVID-19 UNEMPLOYMENT SHOCK ON LIFE EXPECTANCY AND MORTALITY RATES, Bianchi, 2021	“Policy-makers should therefore consider combining lockdowns with policy interventions meant to reduce economic distress, guarantee access to health care, and facilitate effective economic reopening under health care policies to limit SARS-CoV-19 spread…assess the long-run effects of the COVID-19 economic recession on mortality and life expectancy. We estimate the size of the COVID-19-related unemployment shock to be between 2 and 5 times larger than the typical unemployment shock, depending on race and gender, resulting in a significant increase in mortality rates and drop in life expectancy. We also predict that the shock will disproportionately affect African-Americans and women, over a short horizon, while the effects for white men will unfold over longer horizons. These figures translate in more than 0.8 million additional deaths over the next 15 years.”
30) Lockdowns Do Not Control the Coronavirus: The Evidence, AIER, 2020	“The question is whether lockdowns worked to control the virus in a way that is scientifically verifiable. Based on the following studies, the answer is no and for a variety of reasons: bad data, no correlations, no causal demonstration, anomalous exceptions, and so on. There is no relationship between lockdowns (or whatever else people want to call them to mask their true nature) and virus control.”
31) Too Little of a Good Thing A Paradox of Moderate Infection Control, Cohen, 2020	“The link between limiting pathogen exposure and improving public health is not always so straightforward. Reducing the risk that each member of a community will be exposed to a pathogen has the attendant effect of increasing the average age at which infections occur. For pathogens that inflict greater morbidity at older ages, interventions that reduce but do not eliminate exposure can paradoxically increase the number of cases of severe disease by shifting the burden of infection toward older individuals.”
32) Covid Lockdown Cost/Benefits: A Critical Assessment of the Literature, Allen, 2020	“Generally speaking, the ineffectiveness of lockdown stems from voluntary changes in behavior. Lockdown jurisdictions were not able to prevent noncompliance, and non-lockdown jurisdictions benefited from voluntary changes in behavior that mimicked lockdowns. The limited effectiveness of lockdowns explains why, after one year, the unconditional cumulative deaths per million, and the pattern of daily deaths per million, is not negatively correlated with the stringency of lockdown across countries. Using a cost/benefit method proposed by Professor Bryan Caplan, and using two extreme assumptions of lockdown effectiveness, the cost/benefit ratio of lockdowns in Canada, in terms of life-years saved, is between 3.6–282. That is, it is possible that lockdown will go down as one of the greatest peacetime policy failures in Canada’s history.”
33) Covid-19: How does Belarus have one of the lowest death rates in Europe? Karáth, 2020	“Belarus’s beleaguered government remains unfazed by covid-19. President Aleksander Lukashenko, who has been in power since 1994, has flatly denied the seriousness of the pandemic, refusing to impose a lockdown, close schools, or cancel mass events like the Belarusian football league or the Victory Day parade. Yet the country’s death rate is among the lowest in Europe—just over 700 in a population of 9.5 million with over 73 000 confirmed cases.”
34) PANDA, Nell, 2020	“For each country put forward as an example, usually in some pairwise comparison and with an attendant single cause explanation, there are a host of countries that fail the expectation. We set out to model the disease with every expectation of failure. In choosing variables it was obvious from the outset that there would be contradictory outcomes in the real world. But there were certain variables that appeared to be reliable markers as they had surfaced in much of the media and pre-print papers. These included age, co-morbidity prevalence and the seemingly light population mortality rates in poorer countries than that in richer countries. Even the worst among developing nations—a clutch of countries in equatorial Latin America—have seen lighter overall population mortality than the developed world. Our aim therefore was not to develop the final answer, rather to seek common cause variables that would go some way to providing an explanation and stimulating discussion. There are some very obvious outliers in this theory, not the least of these being Japan. We test and find wanting the popular notions that lockdowns with their attendant social distancing and various other NPIs confer protection.”
35) States with the Fewest Coronavirus Restrictions, McCann, 2021	Graphics reveal no relationship in stringency level as it relates to the death rates, but finds a clear relationship between stringency and unemployment.
36) COVID-19 Lockdown Policies: An Interdisciplinary Review, Robinson, 2021	“Studies at the economic level of analysis points to the possibility that deaths associated with economic harms or underfunding of other health issues may outweigh the deaths that lockdowns save, and that the extremely high financial cost of lockdowns may have negative implications for overall population health in terms of diminished resources for treating other conditions. Research on ethics in relation to lockdowns points to the inevitability of value judgements in balancing different kinds of harms and benefits than lockdowns cause.”
37) Comedy and Tragedy in Two Americas, Tucker, 2021	“Covid unleashed a version of tyranny in the United States. Through a surreptitious and circuitous route, many public officials somehow managed to gain enormous power for themselves and demonstrate that all our vaunted limits on government are easily transgressed under the right conditions. Now they want to use that power to enact permanent change in this country. Right now, people, capital, and institutions are fleeing from them to safe and freer places, which only drives the people in power to madness. They are right now plotting to shut down the free states through any means possible.”
38) Lockdowns Worsen the Health Crisis, Younes, 2021	“We suspect that one day, the quarantining of entire societies that was carried out in response to the coronavirus pandemic, leading to vast swaths of the population becoming unhealthier overall and ironically more susceptible to severe outcomes from the virus, will be seen as the 21st century version of bloodletting.  As the epidemiologist Martin Kulldorff has observed, public health is not just about one disease, but all health outcomes.  Apparently, in 2020, the authorities forgot this obvious truth.”
39) The Damage of Lockdowns to Young People, Yang, 2021	“Biological and cultural reasons why young people, mostly referring to those under the age of 30, are particularly vulnerable to the isolation as well as lifestyle disruptions brought about by lockdowns… “Adults under 30 experienced the highest increase in suicidal thinking in the same period, with rates of suicidal ideation rising from 12.5% to 14% in people aged 18-29. For many of the young adults surveyed, these mental health challenges persisted into the summer, despite a loosening of restrictions.”
40) Lifestyle and mental health disruptions during COVID-19, Giuntella, 2021	“COVID-19 has affected daily life in unprecedented ways. Drawing on a longitudinal dataset of college students before and during the pandemic, we document dramatic changes in physical activity, sleep, time use, and mental health. We show that biometric and time-use data are critical for understanding the mental health impacts of COVID-19, as the pandemic has tightened the link between lifestyle behaviors and depression.”
41) CDC: A Quarter of Young Adults Say They Contemplated Suicide This Summer During Pandemic, Miltimore, 2020	“One in four young adults between the ages of 18 and 24 say they’ve considered suicide in the past month because of the pandemic, according to new CDC data that paints a bleak picture of the nation’s mental health during the crisis. The data also flags a surge of anxiety and substance abuse, with more than 40 percent of those surveyed saying they experienced a mental or behavioral health condition connected to the Covid-19 emergency. The CDC study analyzed 5,412 survey respondents between June 24 and 30.”
42) Global rise in childhood mental health issues amid pandemic, LEICESTER, 2021	“For doctors who treat them, the pandemic’s impact on the mental health of children is increasingly alarming. The Paris pediatric hospital caring for Pablo has seen a doubling in the number of children and young teenagers requiring treatment after attempted suicides since September.Doctors elsewhere report similar surges, with children — some as young as 8 — deliberately running into traffic, overdosing on pills and otherwise self-harming. In Japan, child and adolescent suicides hit record levels in 2020, according to the Education Ministry.”
43) Lockdowns: The Great Debate, AIER, 2020	“The global lockdowns, on this scale with this level of stringency, have been without precedent. And yet we have examples of a handful of countries and US states that did not do this, and their record in minimizing the cost of the pandemic is better than the lockdown countries and states. The evidence that the lockdowns have done net good in terms of public health is still lacking.”
44) COVID-19 containment policies through time may cost more lives at metapopulation level, Wells, 2020	“Show that temporally restricted containment efforts, that have the potential to flatten epidemic curves, can result in wider disease spread and larger epidemic sizes in metapopulations.”
45) The Covid-19 Emergency Did Not Justify Lockdowns, Boudreaux, 2021	“Yet there was no such careful calculation for the lockdowns imposed in haste to combat Covid-19. Lockdowns were simply assumed not only to be effective at significantly slowing the spread of SARS-CoV-2, but also to impose only costs that are acceptable. Regrettably, given the novelty of the lockdowns, and the enormous magnitude of their likely downsides, this bizarrely sanguine attitude toward lockdowns was – and remains – wholly unjustified.”
46) Death and Lockdowns, Tierney, 2021	“Now that the 2020 figures have been properly tallied, there’s still no convincing evidence that strict lockdowns reduced the death toll from Covid-19. But one effect is clear: more deaths from other causes, especially among the young and middle-aged, minorities, and the less affluent.The best gauge of the pandemic’s impact is what statisticians call “excess mortality,” which compares the overall number of deaths with the total in previous years. That measure rose among older Americans because of Covid-19, but it rose at an even sharper rate among people aged 15 to 54, and most of those excess deaths were not attributed to the virus.”
47) The COVID Pandemic Could Lead to 75,000 Additional Deaths from Alcohol and Drug Misuse and Suicide, Well Being Trust, 2021	“The brief notes that if the country fails to invest in solutions that can help heal the nation’s isolation, pain, and suffering, the collective impact of COVID-19 will be even more devastating. Three factors, already at work, are exacerbating deaths of despair: unprecedented economic failure paired with massive unemployment, mandated social isolation for months and possible residual isolation for years, and uncertainty caused by the sudden emergence of a novel, previously unknown microbe…the deadly impact of lockdowns will grow in future years, due to the lasting economic and educational consequences. The United States will experience more than 1 million excess deaths in the United States during the next two decades as a result of the massive “unemployment shock” last year… lockdowns are the single worst public health mistake in the last 100 years,” says Dr. Jay Bhattacharya, a professor at Stanford Medical School. “We will be counting the catastrophic health and psychological harms, imposed on nearly every poor person on the face of the earth, for a generation.”
48) Professor Explains Flaw in Many Models Used for COVID-19 Lockdown Policies, Chen, 2021	“Economics professor Doug Allen wanted to know why so many early models used to create COVID-19 lockdown policies turned out to be highly incorrect. What he found was that a great majority were based on false assumptions and “tended to over-estimate the benefits and under-estimate the costs.” He found it troubling that policies such as total lockdowns were based on those models. “They were built on a set of assumptions. Those assumptions turned out to be really important, and the models are very sensitive to them, and they turn out to be false,” said Allen, the Burnaby Mountain Professor of Economics at Simon Fraser University, in an interview.”“Furthermore, “The limited effectiveness of lockdowns explains why, after one year, the unconditional cumulative deaths per million, and the pattern of daily deaths per million, is not negatively correlated with the stringency of lockdown across countries,” writes Allen. In other words, in his assessment, heavy lockdowns do not meaningfully reduce the number of deaths in the areas where they are implemented, when compared to areas where lockdowns were not implemented or as stringent.”
49) The Anti-Lockdown Movement Is Large and Growing, Tucker, 2021	“The lesson: lockdown policies failed to protect the vulnerable and otherwise did little to nothing actually to suppress or otherwise control the virus. AIER has assembled fully 35 studies revealing no connection between lockdowns and disease outcomes. In addition, the Heritage Foundation has published an outstanding roundup of the Covid experience, revealing that lockdowns were largely political theater distracting from what should have been good public health practice.”
50) The Ugly Truth About The Covid-19 Lockdowns, Hudson, 2021	“By following the data and official communications from global organisations, PANDA unravels what transpired that led us into deleterious lockdowns, which continue to have enormous negative impacts across the world.”
51) The Catastrophic Impact of Covid Forced Societal Lockdowns, Alexander, 2020	“It is also noteworthy that these irrational and unreasonable restrictive actions are not limited to any one jurisdiction such as the US, but shockingly have occurred across the globe. It is stupefying as to why governments, whose primary roles are to protect their citizens, are taking these punitive actions despite the compelling evidence that these policies are misdirected and very harmful; causing palpable harm to human welfare on so many levels. It’s tantamount to insanity what governments have done to their populations and largely based on no scientific basis. None! In this, we have lost our civil liberties and essential rights, all based on spurious ‘science’ or worse, opinion, and this erosion of fundamental freedoms and democracy is being championed by government leaders who are disregarding the Constitutional (USA) and Charter (Canada) limits to their right to make and enact policy. These unconstitutional and unprecedented restrictions have taken a staggering toll on our health and well-being and also target the very precepts of democracy; particularly given the fact that this viral pandemic is no different in overall impact on society than any previous pandemics. There is simply no defensible rationale to treat this pandemic any differently.”
52) Cardiovascular and immunological implications of social distancing in the context of COVID-19, D’Acquisto, 2020	“It is clear that social distancing measures such as lockdown during the COVID-19 pandemic will have subsequent effects on the body including the immune and cardiovascular systems, the extent of which will be dependent on the duration of such measures. The take-home message of these investigations is that social interaction is an integral part of a wide range of conditions that influence cardiovascular and immunological homeostasis.”
53) A Statistical Analysis of COVID-19 and Government Protection Measures in the U.S., Dayaratna, 2021	“Our analysis demonstrates that the time from a state’s first case to voluntary changes in residence mobility, which occurred before the imposition of shelter-in-place orders in 43 states, indeed quelled the time to reach the maximum growth in per capita cases. On the other hand, our analysis also indicates that these behavioral changes were not significantly effective in quelling mortality… our simulations find a negative effect of the time from a state’s first case to the imposition of shelter-in-place orders on the time to reach the specified per capita mortality thresholds. Our analysis also finds a slightly smaller negative effect on the time from a state’s first case to the imposition of prohibitions on gatherings above 500 people…. shelter-in-place orders can also have negative unforeseen health-related consequences, including the capacity to cause patients to avoid visits to doctors’ offices and emergency rooms. In addition, these policies can result in people, including those with chronic illnesses, skipping routine medical appointments, not seeking routine procedures to diagnose advanced cancer, not pursuing cancer screening colonoscopies, postponing non-emergency cardiac catheterizations, being unable to seek routine care if they experience chronic pain, and suffering mental health effects, among others…drug overdose deaths, alcohol consumption, and suicidal ideation have also been noted to have increased in 2020 compared to prior years.”
54) Lockdowns in Taiwan: Myths Versus Reality, Gartz, 2021	“Articles citing a “tightening” of rules only briefly acknowledge that Taiwan never locked down. Instead, they blame the increase in cases on a loosening of travel restrictions and on people’s becoming “more relaxed or careless as time goes by.” A closer look reveals that this harsh turn in restrictions consists of capping gatherings at 500 for outdoors and 100 for indoors to 10 and 5 respectively — more in line with gathering limits imposed by Western nations.The reality is that the hyperbolic 124 action items misrepresent the Taiwanese approach. Relative to other countries, Taiwan serves as a beacon of freedom: children still attended school, professionals continued to go to work, and businesspeople were able to keep their businesses open.”
55) Lockdowns Need to Be Intellectually Discredited Once and For All, Yang, 2021	“Lockdowns do not provide any meaningful benefit and they cause unnecessary collateral damage. Voluntary actions and light-handed accommodations to protect the vulnerable according to comprehensive analysis, not cherry-picked studies with overly short timelines, provide similar, if not better, virus mitigation compared to lockdown policies. Furthermore, contrary to what many keep trying to say, it is lockdowns that are the causal factor behind the unprecedented economic and social damage that has been dealt to society.”
56) Canada’s COVID-19 Strategy is an Assault on the Working Class, Kulldorff, 2020	“The Canadian COVID-19 lockdown strategy is the worst assault on the working class in many decades. Low-risk college students and young professionals are protected; such as lawyers, government employees, journalists, and scientists who can work from home; while older high-risk working-class people must work, risking their lives generating the population immunity that will eventually help protect everyone. This is backwards, leading to many unnecessary deaths from both COVID-19 and other diseases.”
57) Our COVID-19 Plan would Minimize Mortality and Lockdown-induced Collateral Damage, Kulldorff, 2020	“While mortality is inevitable during a pandemic, the COVID-19 lockdown strategy has led to more than 220,000 deaths, with the urban working class carrying the heaviest burden. Many older workers have been forced to accept high mortality risk or increased poverty, or both. While the current lockdowns are less strict than in March, the lockdown and contact tracing strategy is the worst assault on the working class since segregation and the Vietnam War.Lockdown policies have closed schools, businesses and churches, while not enforcing strict protocols to protect high-risk nursing home residents. University closures and the economic displacement caused by lockdowns have led millions of young adults to live with older parents, increasing regular close interactions across generations.”
58) The costs are too high; the scientist who wants lockdown lifted faster; Gupta, 2021	“It’s becoming clear that a lot of people have been exposed to the virus and that the death rate in people under 65 is not something you would lock down the economy for,” she says. “We can’t just think about those who are vulnerable to the disease. We have to think about those who are vulnerable to lockdown too. The costs of lockdown are too high at this point.”
59) Review of the Impact of COVID-19 First Wave Restrictions on Cancer Care, Collateral Global, Heneghan; 2021	“Restrictive measures in the first wave of the COVID19 pandemic in 2019-20 led to wide-scale, global disruption of cancer care. Future restrictions should consider disruptions to the cancer care pathways and plan to prevent unnecessary harms.”
60) German Study Finds Lockdown ‘Had No Effect’ on Stopping Spread of Coronavirus, Watson, 2021	“Stanford researchers found “no clear, significant beneficial effect of [more restrictive measures] on case growth in any country.”
61) Lockdown will claim the equivalent of 560,000 lives because of the health impact of the ‘deep and prolonged recession it will cause’, expert warns, Adams/Thomas/Daily Mail, 2020	“Lockdowns will end up claiming the equivalent of more than 500,000 lives because of the health impact of the ‘deep and prolonged recession it will cause.”
62) Anxiety From Reactions to Covid-19 Will Destroy At Least Seven Times More Years of Life Than Can Be Saved by Lockdowns, Glen, 2021	“Likewise, a 2020 paper about quarantines published in The Lancet states: “Separation from loved ones, the loss of freedom, uncertainty over disease status, and boredom can, on occasion, create dramatic effects. Suicide has been reported, substantial anger generated, and lawsuits brought following the imposition of quarantine in previous outbreaks. The potential benefits of mandatory mass quarantine need to be weighed carefully against the possible psychological costs.”Yet, when dealing with Covid-19 and other issues, politicians sometimes ignore this essential principle of sound decision-making. For a prime example, NJ Governor Phil Murphy recently insisted that he must maintain a lockdown or “there will be blood on our hands.” What that statement fails to recognize is that lockdowns also kill people via the mechanisms detailed above… In other words, the anxiety from reactions to Covid-19—such as business shutdowns, stay-at-home orders, media exaggerations, and legitimate concerns about the virus—will extinguish at least seven times more years of life than can possibly be saved by the lockdowns.Again, all of these figures minimize deaths from anxiety and maximize lives saved by lockdowns. Under the more moderate scenarios documented above, anxiety will destroy more than 90 times the life saved by lockdowns.”
63) The psychological impact of quarantine and how to reduce it: rapid review of the evidence, Brooks, 2020	“Reported negative psychological effects including post-traumatic stress symptoms, confusion, and anger. Stressors included longer quarantine duration, infection fears, frustration, boredom, inadequate supplies, inadequate information, financial loss, and stigma. Some researchers have suggested long-lasting effects. In situations where quarantine is deemed necessary, officials should quarantine individuals for no longer than required, provide clear rationale for quarantine and information about protocols, and ensure sufficient supplies are provided. Appeals to altruism by reminding the public about the benefits of quarantine to wider society can be favourable.”
64) Lockdown ‘had no effect’ on coronavirus pandemic in Germany, Huggler, 2021	“A new study by German scientists claims to have found evidence that lockdowns may have had little effect on controlling the coronavirus pandemic. Statisticians at Munich University found “no direct connection” between the German lockdown and falling infection rates in the country.”
65) Swedish researchers: Anti-corona restrictions have killed as many people as the virus itself, Peterson, 2021	“The restrictions against the coronavirus have killed as many people as the virus itself. The restrictions have first and foremost hit the poorer parts of the world and struck young people, the researchers believe, pointing to children who died of malnutrition and various diseases. They also pointed to adults who died of diseases that could have been treated. “These deaths we see in poor countries are related to women who die in childbirth, newborns who die early, children who die of pneumonia, diarrhea, and malaria because they are malnourished or not vaccinated,” Peterson said.”
66) Lockdowns Leave London Broken, Burden, 2021	“In normal times, London runs on a sprawling network of trains and buses that bring in millions of commuters to work and spend. Asking those people to work from home ripped the heart out of the economy, leaving the U.K. capital more like a ghost town than a thriving metropolis.The city is now emerging from a year of lockdowns with deeper scars than much of the rest of the U.K. Many restaurants, theaters and shops remain shuttered, and the migrant workers that staffed them fled to their birth countries in the tens of thousands. Even when most of the rules expire in June, new border restrictions since the U.K. left the European Union will make it harder for many to return. As a result, the city’s business model focused on population density is in upheaval, and many of London’s strengths have turned to weaknesses.”
67) Lockdowns Are a Step Too Far in Combating Covid-19, Nocera, 2020	“The truth is that using lockdowns to halt the spread of the coronavirus was never a good idea. If they have any utility at all, it is short term: to help ensure that hospitals aren’t overwhelmed in the early stages of the pandemic. But the long-term shutdowns of schools and businesses, and the insistence that people stay indoors — which almost every state imposed at one point or another — were examples of terribly misguided public policy. It is likely that when the history of this pandemic is told, lockdowns will be viewed as one of the worst mistakes the world made.”
68) Stop the Lies: Lockdowns Did Not and Do Not Protect the Vulnerable, Alexander, 2021	“Lockdowns didn’t protect the vulnerable, but rather harmed them and shifted the morbidity and mortality burden to the underprivileged.”
69) Why Shutdowns and Masks Suit the Elite, Swaim, 2021	“The dispute over masks—like those over school closures, business shutdowns, social-distancing guidelines and all the rest—should always properly have been a discussion of acceptable versus unacceptable risk. But the preponderance of America’s cultural and political leaders showed no ability to think about risk in a helpful way.”
70) The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality, Agrawal, 2021	“Find that following the implementation of SIP policies, excess mortality increases. The increase in excess mortality is statistically significant in the immediate weeks following SIP implementation for the international comparison only and occurs despite the fact that there was a decline in the number of excess deaths prior to the implementation of the policy… failed to find that countries or U.S. states that implemented SIP policies earlier, and in which SIP policies had longer to operate, had lower excess deaths than countries/U.S. states that were slower to implement SIP policies. We also failed to observe differences in excess death trends before and after the implementation of SIP policies based on pre-SIP COVID-19 death rates.”
71) COVID-19 Lockdowns Over 10 Times More Deadly Than Pandemic Itself, Revolver, 2020	“We have drawn upon existing economic studies on the health effects of unemployment to calculate an estimate of how many years of life will have been lost due to the lockdowns in the United States, and have weighed this against an estimate of how many years of life will have been saved by the lockdowns. The results are nothing short of staggering, and suggest that the lockdowns will end up costing Americans over 10 times as many years of life as they will save from the virus itself.”
72) The Impact of Interruptions in Childhood Vaccination, Collateral Global, 2021	“COVID-19 pandemic measures caused significant disruption to childhood vaccination services and uptake. In future pandemics, and for the remainder of the current one, policymakers must ensure access to vaccination services and provide catch-up programs to maintain high levels of immunisation, especially in those most vulnerable to childhood diseases in order to avoid further inequalities.”
73) Shelter-in-place orders didn’t save lives during the pandemic, research paper concludes, Howell, 2021 COVID-19 lockdowns caused more deaths instead of reducing them, study finds	“Researchers from the RAND Corporation and the University of Southern California studied excess mortality from all causes, the virus or otherwise, in 43 countries and the 50 U.S. states that imposed shelter-in-place, or “SIP,” policies. In short, the orders didn’t work. “We fail to find that SIP policies saved lives. To the contrary, we find a positive association between SIP policies and excess deaths. We find that following the implementation of SIP policies, excess mortality increases,” the researchers said in a working paper for the National Bureau of Economic Research (NBER).”
74) Experts Said Ending Lockdowns Would Be Worse for the Economy than the Lockdowns Themselves. They Were Wrong, MisesInstitute, 2021	“There is no indication whatsoever that states with longer periods of lockdown and forced social distancing fared better economically than states that abandoned covid restrictions much earlier. Rather, many states that ended lockdowns early—or didn’t have them at all—now show less unemployment and more economic growth than states that imposed lockdowns and social distancing rules much longer. The complete lack of any correlation between economic success and covid lockdowns illustrates yet again that the confident predictions of the experts—who insisted that states without long lockdowns would endure bloodbaths and economic destruction—were very wrong.”
75) The Harms of Lockdowns, The Dangers of Censorship, And A Path Forward, AIER, 2020	“When you read about failures of intelligence, probably the most spectacular being the weapons of mass destruction fiasco, the lesson that they were supposed to learn from that, and maybe have learned, is that you need to encourage cognitive dissonance. You need to encourage critical thinking. You need to have people who are looking at things differently than your mainstream view, because it will help to prevent you from making catastrophic errors. It will help to keep you honest.And we’ve done exactly the opposite instead of encouraging critical thinking, different ideas, we’ve stifled it. That’s what makes the actions of the Ontario College of Physicians and Surgeons towards you so shocking because it’s absolute the opposite of what we need to do. And it’s been that absence of critical thinking of incorporating critical thinking in our decision-making that has led to one mistake after another in handling COVID-19.”
76) UNDERSTANDING INTER-REGIONAL DIFFERENCES IN COVID-19 MORTALITY RATES, PANDA, 2021	“We cannot argue that the phased adoption of these measures has any impact on risk mitigation. This is an important consideration for policy makers who must carefully balance the benefits of a phased lockdown strategy with the economic harm caused by such an intervention.”
77) Potential lessons from the Taiwan and New Zealand health responses to the COVID-19 pandemic, Summers, 2020	“Extensive public health infrastructure established in Taiwan pre-COVID-19 enabled a fast coordinated response, particularly in the domains of early screening, effective methods for isolation/quarantine, digital technologies for identifying potential cases and mass mask use. This timely and vigorous response allowed Taiwan to avoid the national lockdown used by New Zealand. Many of Taiwan’s pandemic control components could potentially be adopted by other jurisdictions.”
78) 5 Times More Children Committed Suicide Than Died of COVID-19 During Lockdown: UK Study, Phillips, 2021	“Five times more children and young people committed suicide than died of COVID-19 during the first year of the pandemic in the United Kingdom, according to a study, which also concluded that lockdowns are more detrimental to children’s health than the virus itself.”
79) Study Indicates Lockdowns Have Increased Deaths of Despair, Yang, 2021	“Deaths of despair due in large part to social isolation. Regardless of whether they think lockdowns work, policymakers must be cognizant of the fact shutting down society also leads to excess deaths. Whether it’s from the government policies themselves or the willful compliance of society enforcing the soft despotism of popular hysteria, social isolation is taking its toll on the lives of many.”
80) DEATHS OF DESPAIR AND THE INCIDENCE OF EXCESS MORTALITY IN 2020, Mulligan, 2020	“Presumably social isolation is part of the mechanism that turns a pandemic into a wave of deaths of despair. However, the results in this paper do not say how much, if any, comes from government stay-at-home orders versus various actions individual households and private businesses have taken to encourage social distancing.”
81) Effects of the lockdown on the mental health of the general population during the COVID-19 pandemic in Italy: Results from the COMET collaborative network, Fiorillo, 2020	“Although physical isolation and lockdown represent essential public health measures for containing the spread of the COVID-19 pandemic, they are a serious threat for mental health and well-being of the general population. As an integral part of COVID-19 response, mental health needs should be addressed.”
Mental Health and the Covid-19 Pandemic, Pfefferbaum, 2020	“The Covid-19 pandemic has alarming implications for individual and collective health and emotional and social functioning. In addition to providing medical care, already stretched health care providers have an important role in monitoring psychosocial needs and delivering psychosocial support to their patients, health care providers, and the public — activities that should be integrated into general pandemic health care.”
82) Why Government Lockdowns Mostly Harm the Poor, Peterson, 2021	“For developed countries, lockdowns undoubtedly imposed significant economic and health costs. Many workers in the service sector, like the food industry, for example, were left unemployed and had to rely on government stimulus checks to get them through the bumpiest stages of the pandemic. Some businesses had to shutter their doors entirely, leaving many employers without jobs as well. This is to say nothing of the severe mental health consequences of government lockdown orders…These irresponsible government actions are especially acute and more harmful in developing countries and among the poor because most workers can’t afford to sacrifice weeks or perhaps months of income, only to be confined to what is effectively house arrest.”
83) Cost of Lockdowns: A Preliminary Report, AIER, 2020	“In the debate over coronavirus policy, there has been far too little focus on the costs of lockdowns. It’s very common for the proponents of these interventions to write articles and large studies without even mentioning the downsides.”
84) In Africa, social distancing is a privilege few can afford, Noko, 2020	“Social distancing could probably work in China and in Europe – but in many African countries, it is a privilege only a minority can afford.”
85) Teargas, beatings and bleach: the most extreme Covid-19 lockdown controls around the world, Ratcliff, 2020	“Violence and humiliation used to police coronavirus curfews around globe, often affecting the poorest and more vulnerable.”
86) “Shoot them dead”: Philippine President Rodrigo Duterte orders police and military to kill citizens who defy coronavirus lockdown, Capatides, 2020	“Later that night, Philippine President Rodrigo Duterte took to the airwaves with a chilling warning for his citizens: Defy the lockdown orders again and the police will shoot you dead.”
87) Colombia’s Capital Locks Down as Cases Surge, Vyas, 2021 Colombia Protests Turn Deadly Amid Covid-19 Hardships	“Bogotá, which has logged a quarter of the nation’s cases, had already applied restrictions on mobility and alcohol sales in order to contain gatherings and the spread of the virus before expanding the measures.”“The nationwide unrest was triggered by a proposed tax-collection overhaul and stringent pandemic lockdowns that have been blamed for causing mass unemployment and throwing some four million people into poverty.”
88) Argentina receives AstraZeneca jabs amid anti-lockdown protests, AL JAZEERA, 2021	“New COVID-19 restrictions have been imposed in and around Buenos Aires in effort to stem recent rise in infections…Argentines took to the streets on Saturday, however, to protest against new coronavirus-related restrictions in and around the capital, Buenos Aires, that came into effect on Friday… Horacio Rodriguez Larreta, head of the city government, said last week that Buenos Aires “totally disagree[s] with the decision of the national government to close schools.”
89) Lives vs. Livelihoods Revisited: Should Poorer Countries with Younger Populations Have Equally Strict Lockdowns? Von Carnap, 2020	“Economists in the rich world have largely supported stringent containment measures, rejecting any trade-off between lives and livelihoods…strict lockdowns in countries where a significant share of the population is poor are likely to have more severe consequences on welfare than in richer countries. From a macro perspective, any negative economic effect of a lockdown is reducing a budget with already fewer resources in a poor country.”
90) Responding to the COVID-19 Pandemic in Developing Countries: Lessons from Selected Countries of the Global South, Chowdhury, 2020	“If testing, contact tracing and other early containment measures had been adequately done in a timely manner to stem viral transmission, nationwide lockdowns would not have been necessary, and only limited areas would have had to be locked down for quarantine purposes. The effectiveness of containment measures, including lockdowns, are typically judged primarily by their ability to quickly reduce new infections, ‘flatten the curve’ and avoid subsequent waves of infections. However, lockdowns can have many effects, depending on context, and typically incur huge economic costs, unevenly distributed in economies and societies.”
91) Battling COVID-19 with dysfunctional federalism: Lessons from India, Choutagunta, 2021	“Find that India’s centralized lockdown was at best a partial success in a handful of states, while imposing enormous economic costs even in areas where few were affected by the pandemic.”
92) The 2006 Origins of the Lockdown Idea, Tucker, 2020	“Now begins the grand effort, on display in thousands of articles and news broadcasts daily, somehow to normalize the lockdown and all its destruction of the last two months. We didn’t lock down almost the entire country in 1968/69, 1957, or 1949-1952, or even during 1918. But in a terrifying few days in March 2020, it happened to all of us, causing an avalanche of social, cultural, and economic destruction that will ring through the ages.”
93) Young People Are Particularly Vulnerable To Lockdowns, Yang, 2021	“The damage to society was certainly extensive, with a 3.5 percent annualized economic retraction record in 2020 and a 32.9 percent decline in Q2 of 2020, making this one of the sharpest economic declines in modern history. However, the level of suffering and trauma caused by these policies cannot be appropriately expressed by economic data alone. Lockdown policies may have caused a substantial amount of financial damage but the social damage is just as concerning, if not more so. Across the board, there have been increased reports of mental health issues, such as depression and anxiety, that are linked to social isolation, substantial life disruptions, and existential dread over the state of the world. Unlike lost dollars, mental health problems leave real and lasting damage which could lead to complications later in life, if not self-harm or suicide. For young people, a drastic increase in suicides has claimed more lives than Covid-19. That is because they are far less vulnerable to Covid than older segments of the population but far more negatively impacted by lockdowns.”
94) More “Covid Suicides” than Covid Deaths in Kids, Gartz, 2021	“Before Covid, an American youth died by suicide every six hours. Suicide is a major public health threat and a leading cause of death for those aged under 25 — one far bigger than Covid. And it is something that we have only made worse as we, led by politicians and ‘the science,’ deprived our youngest members of society — who constitute one-third of the US population — of educational, emotional and social development without their permission or consent for over a year… the biggest increase in youth deaths occurred in the 15-24 age bracket — the age group most susceptible to committing suicide, and which constitutes 91% of youth suicides… such “deaths of despair” tend to be higher among youths, particularly for those about to graduate or enter the workforce. With economic shrinkage due to lockdowns and forced closures of universities, youths face both less economic opportunity and limited social support — which plays an important role in reporting and preventing self-harm — through social networks.”
95) Comparison of COVID-19 outcomes among shielded and non-shielded populations, Jani, 2021	“Linked family practitioner, prescribing, laboratory, hospital and death records and compared COVID-19 outcomes among shielded and non-shielded individuals in the West of Scotland. Of the 1.3 million population, 27,747 (2.03%) were advised to shield, and 353,085 (26.85%) were classified a priori as moderate risk…in spite of the shielding strategy, high risk individuals were at increased risk of death.”
96) Sweden: Despite Variants, No Lockdowns, No Daily Covid Deaths, Fumento, 2021	““Locking down is saving time,” he said last year. “It’s not solving anything.” In essence the country “front-loaded” its deaths and decreased those deaths later on…Despite Sweden inevitably feeling undertow from economies that did lock down, “Covid-19 has had a rather limited impact on its economy compared with most other European countries,” according to the Nordetrade.com consulting firm. “Softer preventative restrictions against Covid-19 earlier in the year and a strong recovery in the third quarter contained the GDP contraction,” it said.Thus, the country the media loved to hate is reaping the best of all worlds: Few current cases and deaths, stronger economic growth than the lockdown countries, and its people never experienced the yoke of tyranny.”
97) Lockdown lessons, Ross, 2021	“Never take radical action without overwhelming evidence that it will work. The authorities took all manner of drastic actions and weren’t the least bit interested in offering evidence and they still aren’t. Unelected bureaucrats, who know nothing about us, dictated how we live our lives down to the tiniest details. The authorities coerced hundreds of millions of people to wear masks. They assumed that would reduce transmission. There is now evidence that masks are worse than useless.Be extremely reluctant to commit sweeping violations of the Constitution. The Constitution is our country’s greatest asset and our north star. Ignoring it or trampling on it is never a good idea. The Constitution is what makes us who we are. We ought to treat it like the treasure it is.Always consider both costs and benefits and make best-effort projections of both. The costs of virtually every aspect of the lockdown were more than the benefits, usually far more…it has increased the amount of depression and number of suicides, especially among those age 18 and younger. The postponement and cancellation of medical appointments have resulted in thousands of premature deaths.”
98) Prof. Sunetra Gupta — New Lockdown is a Terrible Mistake, Gupta, 2020	“I would beg to disagree. I think there is an alternative, and that alternative involves reducing the deaths that this pandemic might cause by diverting our energies to protecting the vulnerables. Now, why would I say that? The main reason to say that is because the costs of alternative strategies such as lockdown are so profound that we are left with a contemplation of how to go ahead, go forwards, in this current sort of situation without inflicting harm, not just to those who are vulnerable to COVID, but to the general population in a way that meets with those standards that we set ourselves from the moment we were, maybe not born, but from the moment that we became cognizant of those responsibilities towards society.”
99) The harms of lockdown will vastly outweigh the benefits, Hinton, 2021	“Nearly 1.2 m people waiting at least six months for vital services.”
100) Lockdowns don’t work, Stone/AEI, 2020	“Lockdowns don’t work. That simple sentence is enough to ignite a firestorm of controversy these days, whether you say it in public (to someone at least six feet away, of course) or online. As soon as the words leave your lips, they begin to be interpreted in extraordinary ways. Why do you want to kill old people? Why do you think the economy is more important than saving lives? Why do you hate science? Are you a shill for Trump? Why are you spreading misinformation about the severity of COVID? But here’s the thing: there’s no evidence of lockdowns working. If strict lockdowns actually saved lives, I would be all for them, even if they had large economic costs. But, put simply, the scientific and medical case for strict lockdowns is paper-thin… If you’re going to essentially cancel the civil liberties of the entire population for a few weeks, you should probably have evidence that the strategy will work.”
101) Science Killed itself over COVID-19, Raleigh/Federalist/Atlas, 2021	“Lockdowns destroyed people, Atlas said, by “shutting down medical care, stopping people from seeking emergency medical care, increasing drug abuse, increasing death by suicide, more psychological damage, particularly among the younger generation. Hundreds and thousands of child abuse cases went unreported. Teenagers’ self-harm cases have tripled… Mortality data showing that anywhere from a third or half of the deaths during the pandemic were not due to COVID-19,” Atlas said. “They were extra deaths due to the lockdowns…we should offer targeted protections for high-risk people but no lockdowns of low-risk people.”
102) Assembling Covid Jigsaw Pieces Into a Complete Pandemic Picture, Brookes, 2021	“Overall there is a minimal positive impact from quarantine policy, isolation requirements, Test and Trace regimes, social distancing, masking or other non-pharmaceutical interventions. Initially, these were the only tools in the tool-box of interventionist politicians and scientists. At best they slightly delayed the inevitable, but they also caused considerable collateral harms.”
103) Covid Lockdowns Signal the Rise of Public Policy by Ransom, O’Neill/MisesInstitute, 2021	“Public policy by ransom occurs when a government imposes a behavioral requirement on individuals and enforces this by punishing the general public in aggregate until a stipulated level of compliance is attained. The method relies on members of the public and public commentators—like Marcotte—who will attribute blame for these negative consequences to recalcitrant citizens who fail to adopt the preferred behaviors of the governing class. In the weltanschauung that underpins this type of governance, government reactions to public behaviors are “metaphysically given” and are treated as a mere epiphenomenon of the actions of individual members of the public who dare to behave in ways disliked by public authorities… what has emerged as an ominous mode of thinking in this atmosphere is the reflexive attribution of blame to recalcitrant members of the public for any subsequent negative consequences imposed on the public by government policies. If the government chooses to impose a negative consequence on the public—even conditionally on the behavior of the public—that consequence is a chosen policy of the government and must be viewed as a policy choice.”
104) Sweden Saw Lower Mortality Rate Than Most of Europe in 2020, Despite No Lockdown, Miltimore, 2021	“I think people will probably think very carefully about these total shutdowns, how good they really were…t hey may have had an effect in the short term, but when you look at it throughout the pandemic, you become more and more doubtful…data published by Reuters that show Sweden, which shunned the strict lockdowns embraced by most nations around the world, experienced a smaller increase in its mortality rate than most European countries in 2020.”
105) Weighing the Costs of COVID Versus the Costs of Lockdowns, Leef/National Review, 2021	“Yet there was no such careful calculation for the lockdowns imposed in haste to combat Covid-19. Lockdowns were simply assumed not only to be effective at significantly slowing the spread of SARS-CoV-2, but also to impose only costs that are acceptable. Regrettably, given the novelty of the lockdowns, and the enormous magnitude of their likely downsides, this bizarrely sanguine attitude toward lockdowns was – and remains – wholly unjustified. And the unjustness of this reaction is further highlighted by the fact that, in a free society, the burden of proof is on those who would restrict freedom and not on those who resist such restrictions… policy-makers should be just as interested in the costs of the problem as in the costs of any proposed solution to it.”
106) Increase in preterm stillbirths and reduction in iatrogenic preterm births for fetal compromise: a multi-centre cohort study of COVID-19 lockdown effects in Melbourne, Australia, Hui, 2021	“Lockdown restrictions in a high-income setting, in the absence of high rates of COVID-19 disease, were associated with a significant increase in preterm stillbirths, and a significant reduction in iatrogenic PTB for suspected fetal compromise.”
107) Impact of the COVID19 pandemic on cardiovascular mortality and catherization activity during the lockdown in central Germany: an observational study, Nef, 2021	“During the COVID-19-related lockdown a significant increase in cardiovascular mortality was observed in central Germany, whereas catherization activities were reduced.”
108) Editor’s Note – Cancer Review Issue, Collateral Global, 2021	“Before the lockdowns, we had made so much progress in the war on cancer.  Between 1999 and 2019, cancer mortality dropped by an astonishing 27% in the United States, down to 600,000 deaths in 2019.  Worldwide, the age-standardized death rate from cancer has decreased by 15% since 1990.  Cancer, like COVID-19, is by proportion an old person’s disease, with 27% of cases afflicting people 70 and over and over 70% of cases afflicting people 50 and over.  Despite progress against the disease, 18.1 million new cases were diagnosed worldwide in 2018, and 9.6 million people died from cancer… N\nearly eight out of ten cancer patients reported delays in care, with almost six out ten skipping doctor visits, one in four skipping imaging, and one in six missing surgery…the toll from cancer, exacerbated by lockdown and panic, will continue into the indefinite future.”
109) Impact of COVID-19 and partial lockdown on access to care, self-management and psychological well-being among people with diabetes: A cross-sectional study, Yeoh, 2021	“COVID-19 and lockdown had mixed impacts on self-care and management behaviours. Greater clinical care and attention should be provided to people with diabetes with multiple comorbidities and previous mental health disorders during the pandemic and lockdown…the pandemic and quarantine measures may have led to many losses including a loss of loved ones, employment, financial security, direct social contacts, educational opportunities, recreation and social support. A review of the psychological impact of quarantine demonstrated a high prevalence of psychological symptoms and emotional disturbance.”
110) Mental Health During the COVID-19 Pandemic in the United States: Online Survey, Jewell, 2020	“Findings suggest that many US residents are experiencing high stress, depressive, and anxiety symptomatology, especially those who are underinsured, uninsured, or unemployed.”
111) Mental health in the UK during the COVID-19 pandemic: cross-sectional analyses from a community cohort study, Jia, 2020	“Increased psychological morbidity was evident in this UK sample and found to be more common in younger people, women and in individuals who identified as being in recognised COVID-19 risk groups. Public health and mental health interventions able to ameliorate perceptions of risk of COVID-19, worry about COVID-19 loneliness and boost positive mood may be effective.”
112) The psychological impact of quarantine on coronavirus disease 2019 (COVID-19), Luo, 2020	“Based on these studies, a great amount of psychologic symptoms or problems developed during the quarantine period, including anxiety (228/649, 35.1%), depression (110/649, 16.9%), loneliness (37/649, 5.7%) and despair (6/649, 0.9%). One study (Dong et al., 2020) reported that people quarantined had suicidal tendencies or ideas than those not quarantined.”
113) COVID-19 pandemic leads to major backsliding on childhood vaccinations, new WHO, UNICEF data shows, WHO, 2021	“23 million children missed out on basic childhood vaccines through routine health services in 2020, the highest number since 2009 and 3.7 million more than in 2019”
114) Virus-linked hunger tied to 10,000 child deaths each month, Hinnant, 2020	“All around the world, the coronavirus and its restrictions are pushing already hungry communities over the edge, cutting off meager farms from markets and isolating villages from food and medical aid. Virus-linked hunger is leading to the deaths of 10,000 more children a month over the first year of the pandemic, according to an urgent call to action from the United Nations shared with The Associated Press ahead of its publication in the Lancet medical journal…The parents of the children are without work,” said Annelise Mirabal, who works with a foundation that helps malnourished children in Maracaibo, the city in Venezuela thus far hardest hit by the pandemic. “How are they going to feed their kids?…in May, Nieto recalled, after two months of quarantine in Venezuela, 18-month-old twins arrived at his hospital with bodies bloated from malnutrition.”
115) CG REPORT 3: The Impact of Pandemic Restrictions on Childhood Mental Health, Collateral Global, 2021	“The evidence shows the overall impact of COVID-19 restrictions on the mental health and well-being of children and adolescents is likely to be severe… Eight out of ten children and adolescents report worsening of behaviour or any psychological symptoms or an increase in negative feelings due to the COVID-19 pandemic. School closures contributed to increased anxiety, loneliness and stress; negative feelings due to COVID-19 increased with the duration of school closures. Deteriorating mental health was found to be worse in females and older adolescents.”
116) Unintended Consequences of Lockdowns: COVID-19 and the Shadow Pandemic, Ravindran, 2021	“Using variation in the intensity of government-mandated lock-downs in India, we show that domestic violence complaints increase 0.47 SD in districts with the strictest lockdown rules. We find similarly large increases in cyber-crime complaints.”
117) Projected increases in suicide in Canada as a consequence of COVID-19, McIntyre, 2020	“A percentage point increase in unemployment was associated with a 1.0% increase in suicide between 2000 and 2018. In the first scenario, the rise in unemployment rates resulted in a projected total of 418 excess suicides in 2020-2021 (suicide rate per 100,000: 11.6 in 2020). In the second scenario, the projected suicide rates per 100,000 increased to 14.0 in 2020 and 13.6 in 2021, resulting in 2114 excess suicides in 2020-2021. These results indicate that suicide prevention in the context of COVID-19-related unemployment is a critical priority.”
118) COVID-19, unemployment, and suicide, Kawohl, 2020	“In the high scenario, the worldwide unemployment rate would increase from 4·936% to 5·644%, which would be associated with an increase in suicides of about 9570 per year. In the low scenario, the unemployment would increase to 5·088%, associated with an increase of about 2135 suicides… expect an extra burden for our mental health system, and the medical community should prepare for this challenge now. Mental health providers should also raise awareness in politics and society that rising unemployment is associated with an increased number of suicides. The downsizing of the economy and the focus of the medical system on the COVID-19 pandemic can lead to unintended long-term problems for a vulnerable group on the fringes of society.”
119) The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study, Maringe, 2020	“Substantial increases in the number of avoidable cancer deaths in England are to be expected as a result of diagnostic delays due to the COVID-19 pandemic in the UK.”
120) Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK, Gheorghe, 2021	“Premature cancer deaths resulting from diagnostic delays during the first wave of the COVID-19 pandemic in the UK will result in significant economic losses. On a per-capita basis, this impact is, in fact, greater than that of deaths directly attributable to COVID-19. These results emphasise the importance of robust evaluation of the trade-offs of the wider health, welfare and economic effects of NPI to support both resource allocation and the prioritisation of time-critical health services directly impacted in a pandemic, such as cancer care.”
121) Cancer during the COVID-19 pandemic: did we shout loudly enough and did anyone listen? A lasting legacy for nations, Price, 2021	“In just four cancer types (breast, colon, lung and oesophagus), studies during the first wave of the COVID-19 pandemic (published July 2020 [3]) predicted 60,000 lost life years. The quality-adjusted life years and the productivity losses due to these excess cancer deaths have been estimated in this new article to be 32,700 and £104 million over 5 years, respectively. This is nearly 1.5 times higher per capita than that of deaths directly related to COVID-19 in that time. The authors confirm that this is a conservative estimate for these cancer groups as it does not take into account additional productivity losses due to delays or reduction in quality of treatment and stage migration.”
122) Donation and transplantation activity in the UK during the COVID-19 lockdown, Manara, 2020	“Compared with 2019, the number of deceased donors decreased by 66% and the number of deceased donor transplants decreased by 68%, larger decreases than we estimated.”
123) Rapid Systematic Review: The Impact of Social Isolation and Loneliness on the Mental Health of Children and Adolescents in the Context of COVID-19, Loades, 2020	“Children and adolescents are probably more likely to experience high rates of depression and most likely anxiety during and after enforced isolation ends. This may increase as enforced isolation continues.”
124) The Costs and Benefits of Covid-19 Lockdowns in New Zealand, Lally, 2021	“Using data available up to 28 June 2021, the estimated additional deaths from a mitigation strategy are 1,750 to 4,600, implying a Cost per Quality Adjusted Life Year saved by locking down in March 2020 of at least 13 times the generally employed threshold figure of $62,000 for health interventions in New Zealand; the lockdowns do not then seem to have been justified by reference to the standard benchmark. Using only data available to the New Zealand government in March 2020, the ratio is similar and therefore the same conclusion holds that the nation-wide lockdown strategy was not warranted.”
125) Trends in suicidal ideation over the first three months of COVID-19 lockdowns, Killgore, 2020	“The percentage of respondents endorsing suicidal ideation was greater with each passing month for those under lockdown or shelter-in-place restrictions due to the novel coronavirus, but remained relatively stable and unchanged for those who reported no such restrictions.”
126) Cardiovascular Mortality during the COVID-19 Pandemics in a Large Brazilian City: a Comprehensive Analysis, Brant, 2021	“The greater occurrence of CVD deaths at home, in parallel with lower hospitalization rates, suggests that CVD care was disrupted during the COVID-19 pandemics, which more adversely affected older and more socially vulnerable individuals, exacerbating health inequities in BH.”
127) Excess Deaths in People with Cardiovascular Diseases during the COVID-19 Pandemic, Banerjee, 2021	“Mortality data suggest indirect effects on CVD will be delayed rather than contemporaneous (peak RR 1.14). CVD service activity decreased by 60–100% compared with pre-pandemic levels in eight hospitals across China, Italy, and England.”
128) Cardiovascular Deaths During the COVID-19 Pandemic in the United States, Wadhera, 2021	“Hospitalizations for acute cardiovascular conditions have declined, raising concern that patients may be avoiding hospitals because of fear of contracting severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2)…there was an increase in deaths caused by ischemic heart disease and hypertensive diseases in some regions of the United States during the initial phase of the COVID-19 pandemic.”
129) Lockdowns of Young People Lead to More Deaths from Covid-19, Berdine, 2020	“On April 1, 2020 Dr Anthony Fauci indicated that lockdowns would have to continue until there were zero new cases. This policy indicated a strategy whose goal was eradication of the virus through lockdown. The premise that the virus could be eradicated was a false one. While individual virus particles can certainly be killed, the Covid-19 virus cannot be eradicated. If the virus could be eradicated, then Australia would have already succeeded with its brutal lockdown. All of the scientific data, as opposed to the wishful thinking coming out of Garbage In Garbage Out models, indicates that the virus is here forever – much like influenza. Given the fact that the virus will eventually spread to the entire young and economically active population, lockdowns of the young cannot possibly achieve reduced mortality compared to voluntary action.”
130) A second lockdown would break South Africans, Griffiths, 2020	“It is likely that soon there will be increased calls for a second hard lockdown as it gets worse, either countrywide or in particular provinces. Should such a decision be implemented it will probably take many South Africans over their breaking point as some may well lose what they so desperately attempted to save during the initial lockdown.”
131) CDC, Longitudinal Trends in Body Mass Index Before and During the COVID-19 Pandemic Among Persons Aged 2–19 Years — United States, 2018–2020, Lange, 2021	“During the COVID-19 pandemic, children and adolescents spent more time than usual away from structured school settings, and families who were already disproportionally affected by obesity risk factors might have had additional disruptions in income, food, and other social determinants of health.† As a result, children and adolescents might have experienced circumstances that accelerated weight gain, including increased stress, irregular mealtimes, less access to nutritious foods, increased screen time, and fewer opportunities for physical activity (e.g., no recreational sports) (2,3).”
132) The Truth About Lockdowns, Rational Ground, 2021	“1.4 million additional tuberculosis deaths due to lockdown disruptions, 500,000 additional deaths related to HIV, Malaria deaths could double to 770,000 total per year, 65 percent decrease in all cancer screenings, Breast cancer screenings dropped 89 percent, Colorectal screenings dropped 85 percent, At least 1/3 of excess deaths in the U.S. are already not related to COVID-19, Increase in cardiac arrests but decrease in EMS calls for them, Significant increase in stress-related cardiomyopathy during lockdowns, 132 million additional people in sub-Saharan Africa are projected to be undernourished due to lockdown disruptions, Study estimates up to 2.3 million additional child deaths in the next year from lockdowns, Millions of girls have been deprived of access to food, basic healthcare, and protection and thousands exposed to abuse and exploitation.”
133) The Backward Art of Slowing the Spread? Congregation Efficiencies during COVID-19, Mulligan, 2021	“Micro evidence contradicts the public-health ideal in which households would be places of solitary confinement and zero transmission. Instead, the evidence suggests that “households show the highest transmission rates” and that “households are high-risk settings for the transmission of [COVID-19].”
134) The Failed Experiment of Covid Lockdowns, Luskin, 2020	“Six months into the Covid-19 pandemic, the U.S. has now carried out two large-scale experiments in public health—first, in March and April, the lockdown of the economy to arrest the spread of the virus, and second, since mid-April, the reopening of the economy. The results are in. Counterintuitive though it may be, statistical analysis shows that locking down the economy didn’t contain the disease’s spread and reopening it didn’t unleash a second wave of infections.”
135) An Interview with Gigi Foster, Warrior Against Lockdowns, Brownstone, 2021	“Well, I mean, we thought that was necessary because we were just surrounded by people who have bought into the lockdown ideology. And they will have in their minds, a very facile sort of reason why lockdowns should work. And so, we addressed that very directly in that section as you know. We say, “Look, on the surface of it, the idea is that you prevent people from interacting with each other and therefore, transmitting the virus. That’s what people believe. That’s what they think when they think lockdown, they think, “That’s what I’m doing.” But they don’t realize how many other collateral problems are happening and also how little that particular objective is actually being serviced, because of the fact that we live in these interdependent societies now. And we also are trapping people often in large buildings, sharing air together, and not able to go outside as much and so we’re actually potentially increasing the spread of the virus, at least within communities, our communities. So, it basically is an example of trying to engage with the people we feel are misguided on this issue in a calm way, not screaming at each other, not sort of taking the radical position on either side and just saying, “I’m going to play gotcha with you” because that’s not productive.”
136) The Politicisation of Science Funding in the US, Carl, 2021	Regarding Sweden: “As an aside, the report clearly states: “The best way of comparing the mortality impact of the coronavirus (COVID-19) pandemic internationally is by looking at all-cause mortality compared with the five-year average.” So what do the new numbers show? Sweden has had negative excess mortality. In other words, the level of mortality between January 2020 and June 2021 was lower than the five-year average. If this isn’t a vindication of Anders Tegnell’s approach, I don’t know what is.”
137) Pandemic lockdown, healthcare policies and human rights: integrating opposed views on COVID-19 public health mitigation measures, Burlacu, 2020	“Starting from the rationale of the lockdown, in this paper we explored and exposed the other consequences of the COVID-19 pandemic measures such as the use or abuse of human rights and freedom restrictions, economic issues, marginalized groups and eclipse of all other diseases. Our scientific attempt is to coagulate a stable position and integrate current opposing views by advancing the idea that rather than applying the uniform lockdown policy, one could recommend instead an improved model targeting more strict and more prolonged lockdowns to vulnerable risk/age groups while enabling less stringent measures for the lower-risk groups, minimizing both economic losses and deaths. Rigorous (and also governed by freedom) debating may be able to synchronize the opposed perspectives between those advocating an extreme lockdown (e.g., most of the epidemiologists and health experts), and those criticizing all restrictive measures (e.g., economists and human rights experts). Confronting the multiple facets of the public health mitigation measures is the only way to avoid contributing to history with yet another failure, as seen in other past epidemics.”
138) Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic — United States, June 24–30, 2020, Czeisler, 2020	25.5% of persons 18 to 24 years old seriously considered suicide in the prior 30 days (Table 1).CDC: A Quarter of Young Adults Say They Contemplated Suicide This Summer During Pandemic – Foundation for Economic Education (fee.org)
139) Will the Truth on COVID Restrictions Really Prevail?, Atlas, 2021	“Separate from their limited value in containing the virus — efficacy that has often been “grossly exaggerated” in published papers — lockdown policies have been extraordinarily harmful.  The harms to children of closing in-person schooling are dramatic, including poor learning, school dropouts, social isolation, and suicidal ideation, most of which are far worse for lower income groups. A recent study confirms that up to 78% of cancers were never detected due to missed screening over three months. If one extrapolates to the entire country, where about 150,000 new cancers are diagnosed per month, three-fourths to over a million new cases over nine months will have gone undetected. That health disaster adds to missed critical surgeries, delayed presentations of pediatric illnesses, heart attack and stroke patients too afraid to call emergency services, and others all well documented… Beyond hospital care, CDC reported four-fold increases in depression, three-fold increases in anxiety symptoms, and a doubling of suicidal ideation, particularly among young adults after the first few months of lockdowns, echoing the AMA reports of drug overdoses and suicides. Domestic abuse and child abuse have been skyrocketing due to the isolation and specifically to the loss of jobs, particularly in the strictest lockdowns.”
140) With Low Vaccination Rates, Africa’s Covid Deaths Remain Far below Europe and the US, Mises Wire, 2021	“Since the very beginning of the covid panic, the narrative has been this: implement severe lockdowns or your population will experience a bloodbath. Morgues will be overwhelmed, the death total toll will be astounding. On the other hand, we were assured those jurisdictions that do lock down would see only a fraction of the death toll… The lockdown narrative, of course, has already been thoroughly overturned. Jurisdictions that did not lock down or adopted only weak and short lockdowns ended up with covid death tolls that were either similar to—or even better than—death tolls in countries that adopted draconian lockdowns. Lockdown advocates said locked-down countries would be overwhelmingly better off. These people were clearly wrong.”
141) Rethinking lockdowns, Joffe, 2020	“Lockdowns have also resulted in a wide-range of unintended ramifications. Economic damage, delays in “non-urgent” surgeries, diagnoses, and treatments, and excess deaths arising from the “collateral effects” of lockdown measures should all be considered as policy-makers weigh future measures.Dr. Joffe argues that Canadians have been essentially presented with a “false dichotomy” – between a choice of either economically-damaging lockdowns or lethal inaction. However, his analysis finds that the costs of the lockdown measures compare poorly against their purported benefits when measured by Quality Adjusted Life Years, or QALY. “Various cost-benefit analyses from different countries, including some of these costs, have consistently estimated the cost in lives from lockdowns to be at least five to 10 times higher than the benefit, and likely far higher.”
142) Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza, WHO, 2020	“Home quarantine of exposed individuals to reduce transmission is not recommended because there is no obvious rationale for this measure, and there would be considerable difficulties in implementing it.”
143) Projected deaths of despair from COVID-19, Well Being Trust, 2020	“More Americans could lose their lives to deaths of despair, deaths due to drug, alcohol, and suicide, if we do not do something immediately. Deaths of despair have been on the rise for the last decade, and in the context of COVID-19, deaths of despair should be seen as the epidemic within the pandemic.”
144) Dr Matthew Owens: Undoing the untold harms of COVID-19 on young people: a call to action, 2020	“A sense of proportion is now needed to help mitigate the negative impact of the ‘lockdown’ measures and encourage the healthy development and wellbeing of all young people.”
145) Stay at Home, Protect the National Health Service, Save Lives”: A cost benefit analysis of the lockdown in the United Kingdom, Miles, 2020	“The costs of continuing severe restrictions are so great relative to likely benefits in lives saved that a rapid easing in restrictions is now warranted.”
146) Great Barrington Declaration, Gupta, Kulldorff, Bhattacharya, 2020	“Both COVID-19 itself and the lockdown policy reactions have had enormous adverse consequences for patients in the US and around the world. While the harm from COVID-19 infections are well represented in news stories every day, the harms from lockdowns themselves are less well advertised, but no less important. The patients hurt by missed medical visits and hospitalizations due to lockdowns are as worthy of attention and policy response as are patients afflicted by COVID-19 infection.”
147) Sweden saw lower 2020 death spike than much of Europe – data, Ahlander, 2021	“Sweden, which has shunned the strict lockdowns that have choked much of the global economy, emerged from 2020 with a smaller increase in its overall mortality rate than most European countries, an analysis of official data sources showed.”
148) Open Letter from Medical Doctors and Health Professionals to All Belgian Authorities and All Belgian Media, AIER, 2020	“If we compare the waves of infection in countries with strict lockdown policies to countries that did not impose lockdowns (Sweden, Iceland …), we see similar curves.  So there is no link between the imposed lockdown and the course of the infection. Lockdown has not led to a lower mortality rate.”
149) Will Months of Remote Learning Worsen Students’ Attention Problems? Harwin, 2020	“Robert is working from home again, along with over 50 million students, as schools in 48 states have shut down in-person classes to curb the spread of the novel coronavirus. How will the long absence from traditional school routines affect Robert and the millions of other students across the country who struggle with self-control, focus, or mental flexibility?”
150) COVID-19 Mandates Will Not Work for the Delta Variant, Alexander, 2021	“Yet the elites are far removed from the ramifications of their nonsensical, illogical, specious policies and edicts. Dictates that do not apply to them or their families or friends. The ‘laptop’ affluent class could vacate, work remotely, walk their dogs and pets, catch up on reading their books, and do tasks they could not do had they been in the workplace daily. They could hire extra teachers for their children etc. Remote working was a boon. The actions of our governments however, devastated and long-term hurt the poor in societies and terribly and perversely so, and many could not hold on and committed suicide. AIER’s Ethan Yang’s analysis showed that deaths of despair skyrocketed. Poor children, especially in richer western nations such as the US and Canada, self-harmed and ended their lives, not due to the pandemic virus, but due to the lockdowns and school closures. Many children took their own lives out of despair, depression, and hopelessness due to the lockdowns and school closures.”
151) Open letter from medical doctors and health professionals to all Belgian authorities and all Belgian media, The American Institute of Stress, 2020	“If we compare the waves of infection in countries with strict lockdown policies to countries that did not impose lockdowns (Sweden, Iceland …), we see similar curves.  So there is no link between the imposed lockdown and the course of the infection. Lockdown has not led to a lower mortality rate. If we look at the date of application of the imposed lockdowns we see that the lockdowns were set after the peak was already over and the number of cases decreasing. The drop was therefore not the result of the taken measures.”
152) Lockdown Scepticism Was Never a ‘Fringe’ Viewpoint, Carl, 2021	“Whether or not lockdowns are justifiable on public-health grounds, they certainly represent the greatest infringement on civil liberties in modern history. In the UK, lockdowns have contributed to the largest economic contraction in more than 300 years, as well as countless bankruptcies, and a dramatic rise in public borrowing.”
153) Actuaries warn Ramaphosa of a ‘humanitarian disaster to dwarf Covid-19′ if restrictive lockdown is not lifted, Bell, 2020	“The frequently voiced government mantra that lives are being prioritised and that the issue is “lives versus the economy” is described in the Panda report as a false dichotomy. The report notes: “Viruses kill. But the economy sustains lives, and poverty kills too.”It points out that the admitted intention of the lockdown is to “flatten the curve”, to spread expected virus deaths over time, so as not to overburden hospital systems. This “saves lives to the extent that avoidable deaths are prevented, but merely shifts the timing of the rest by some weeks.”
154) THE STATE OF THE NATION: A 50-STATE COVID-19 SURVEY REPORT #23: DEPRESSION AMONG YOUNG ADULTS, Perlis, 2020	“In line with our May results, our survey indicates that the next administration will lead a country where unprecedented numbers of younger individuals are experiencing depression, anxiety, and, for some, thoughts of suicide. These symptoms are not concentrated among any particular subgroup or region in our survey; they are elevated in every group we examined. Our survey results also strongly suggest that those with direct economic and property losses resulting from COVID-19 appear to be at particular risk, so strategies focusing on these individuals may be critical.”
155) COVID-19 to Add as Many as 150 Million Extreme Poor by 2021, The World Bank, 2020	“Global extreme poverty is expected to rise in 2020 for the first time in over 20 years as the disruption of the COVID-19 pandemic compounds the forces of conflict and climate change, which were already slowing poverty reduction progress, the World Bank said today.The COVID-19 pandemic is estimated to push an additional 88 million to 115 million people into extreme poverty this year, with the total rising to as many as 150 million by 2021, depending on the severity of the economic contraction. Extreme poverty, defined as living on less than $1.90 a day, is likely to affect between 9.1% and 9.4% of the world’s population in 2020, according to the biennial Poverty and Shared Prosperity Report. This would represent a regression to the rate of 9.2% in 2017. Had the pandemic not convulsed the globe, the poverty rate was expected to drop to 7.9% in 2020.”
156) The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic, Bromage, 2020	“Incident AHF hospitalization significantly declined in our centre during the COVID-19 pandemic, but hospitalized patients had more severe symptoms at admission. Further studies are needed to investigate whether the incidence of AHF declined or patients did not present to hospital while the national lockdown and social distancing restrictions were in place. From a public health perspective, it is imperative to ascertain whether this will be associated with worse long-term outcomes.”
157) For the Greater Good? The Devastating Ripple Effects of the Covid-19 Crisis, Schippers, 2020	The side effects so far seem to outweigh the positive effects and a recent historical overview of outbreaks concludes that: “History suggests that we are actually at much greater risk of exaggerated fears and misplaced priorities” (Jones D. S., 2020; p. 1683). The main side effects are: Excess mortality from causes other such as hunger, delayed health care, increase in effects mental health issues, suicide, increase in diseases such as measles, and increased inequalities due to school closures and job loss. These have ripple effects throughout society. In many countries emergency admissions, e.g., for cardiac chest pain and transient ischemic attacks, are decreased by about 50%, as people are avoiding hospital visits, which eventually will lead to higher death rates from other causes, such as heart attack and strokes (Sarner, 2020). Also, many medical treatments such as chemotherapy have not been given and were postponed (Sud et al., 2020). In terms of mental health effects, vulnerable groups, such as people with prior mental health issues might be at especially high risk (Jeong et al., 2016). Indeed, a survey by Young Minds revealed that up to 80% of young people with a history of mental health issues reported a worsening of their condition as a result of the pandemic and lockdown measures (Sarner, 2020). The mental health effects arguably affect the general population as a whole, and it has been suggested that this will be a global catastrophe (Izaguirre-Torres and Siche, 2020).
158) COVID-19 emergency measures and the impending authoritarian pandemic, Thomson, 2020	“Yet, as this Article demonstrates—with diverse examples drawn from across the world—there are unmistakable regressions into authoritarianism in governmental efforts to contain the virus. Despite the unprecedented nature of this challenge, there is no sound justification for systemic erosion of rights-protective democratic ideals and institutions beyond that which is strictly demanded by the exigencies of the pandemic. A Wuhan-inspired all-or-nothing approach to viral containment sets a dangerous precedent for future pandemics and disasters, with the global copycat response indicating an impending ‘pandemic’ of a different sort, that of authoritarianization. With a gratuitous toll being inflicted on democracy, civil liberties, fundamental freedoms, healthcare ethics, and human dignity, this has the potential to unleash humanitarian crises no less devastating than COVID-19 in the long run.”
159) Falling living standards during the COVID-19 crisis: Quantitative evidence from nine developing countries, Egger, 2021	“Document declines in employment and income in all settings beginning March 2020. The share of households experiencing an income drop ranges from 8 to 87% (median, 68%). Household coping strategies and government assistance were insufficient to sustain precrisis living standards, resulting in widespread food insecurity and dire economic conditions even 3 months into the crisis. We discuss promising policy responses and speculate about the risk of persistent adverse effects, especially among children and other vulnerable groups.”
160) COVID-19 and the Political Economy of Mass Hysteria, Bagus, 2021	“The violation of basic human rights in the form of curfews, lockdowns, and coercive closure of business has been amply illustrated during the COVID-19 crisis. Naturally, the COVID-19 example is indicative rather than representative and its lessons cannot be generalized. During the COVID-19 crisis, several authors have argued that from a public health point of view, these invasive interventions such as lockdowns have been unnecessary and, indeed, detrimental to overall public health. In fact, prior scientific research on disease mitigation measures during a possible influenza pandemic had warned against such invasive interventions and recommended a more normal social functioning.”
161) COVID-19 mortalities in England and Wales and the Peltzman offsetting effect, Williams, 2021	“Our results suggest: (i) a refined estimate of mean weekly COVID-19 excess deaths that is 63% of standard excess deaths; and (ii) a positive net excess mortality impact of the lockdown. We make a case that (ii) is due to the Peltzman offsetting effect, i.e. the intended mortality impact of the lockdown was more than offset by the unintended impact.”
162) Progression of COVID-19 under the highly restrictive measures imposed in Argentina, Sagripanti, 2021	“The number of yearly deaths caused by respiratory diseases and influenza in Argentina before the pandemic was similar to the total number of deaths attributed to COVID-19 cumulated on April 25, 2021, more than a year after the pandemic started. The failure to detect any benefit on ameliorating COVID-19 by the long and strict nation-wide lock-downs in Argentina should raise world-wide concerns about mandating costly and ineffective restrictive measures during ongoing or future pandemics.”
163) COVID-19 in South Africa, Broadbent, 2020	“This does not show that locking down made no difference relative to a counterfactual scenario (and a full analysis would need to consider provincial trajectories too), but it does mean that a detailed (and provincial) analysis needs to be undertaken before we can evaluate the effectiveness of lockdown measures in the South African context. Were we to try to “read off” the effect of the interventions from the shape of the epidemic, we would have to conclude they had no effect. Likewise we would have to attribute the slow progress of the epidemic in the country to background features (e.g. the relative youthfulness of the population). This is a caution against such “reading off” both in this context and others.”
164) The effects of non-pharmaceutical interventions on SARS-CoV-2 transmission in different socioeconomic populations in Kuwait: a modeling study, Khadadah, 2021	“Our simulated epidemic trajectories show that the partial curfew measure greatly reduced and delayed the height of the peak in P1, yet significantly elevated and hastened the peak in P2. Modest cross-transmission between P1 and P2 greatly elevated the height of the peak in P1 and brought it forward in time closer to the peak of P2.”
165) Hard, not early: putting the New Zealand Covid-19 response in context, Gibson, 2020	“The cross-country evidence shows that restrictions imposed after the inflection point in infections is reached are ineffective in reducing total deaths. Even restrictions imposed earlier have just a modest effect.”
166) The SARS-CoV-2 Pandemic in High Income Countries Such as Canada: A Better Way Forward Without Lockdowns, Joffe, 2021	“Specifically, there are three priorities including the following: first, protect those most at risk by separating them from the threat (mitigation); second, ensure critical infrastructure is ready for people who get sick (preparation and response); and third, shift the response from fear to confidence (recovery). We argue that, based on Emergency Management principles, the age-dependent risk from SARS-CoV-2, the minimal (at best) efficacy of lockdowns, and the terrible cost-benefit trade-offs of lockdowns, we need to reset the pandemic response. We can manage risk and save more lives from both COVID-19 and lockdowns, thus achieving far better outcomes in both the short- and long-term.”
167) On the effectiveness of COVID-19 restrictions and lockdowns: Pan metron ariston, Spiliopoulos, 2021	“Governments conditioned policy choice on recent pandemic dynamics, and were found to de-escalate the associated stringency of implemented NPIs more cautiously than in their escalation, i.e., policy mixes exhibited significant hysteresis. Finally, at least 90% of the maximum effectiveness of NPIs can be achieved by policies with an average Stringency index of 31–40, without restricting internal movement or imposing stay at home measures, and only recommending (not enforcing) closures on workplaces and schools, accompanied by public informational campaigns. Consequently, the positive effects on case and death growth rates of voluntary behavioral changes in response to beliefs about the severity of the pandemic, generally trumped those arising from mandatory behavioral restrictions.”
168) Covid-19: Comparisons by Country and Implications for Future Pandemics, Mehl-Madrona, 2021	“While no lockdown resulted in higher mortality, the difference between strict lockdown and lax lockdown was not terribly different and favored lax lockdown. Only one of the top 44 countries had long and strict restrictions. Strict restrictions were more common in the worst performing countries in terms of Covid mortality. The United States had both the largest economic growth coupled with the largest rate of mortality. Those who did well economically, had lower mortality and less pressure on their population. Yet they had less mortality than average and less than their neighbors.”
169) Does Social Isolation Really Curb COVID-19 Deaths? Direct Evidence from Brazil that it Might do the Exact Opposite, de Souza, 2020	“There appears to be strong empirical evidence that, in Brazil, the adoption of restrictive measures increasing social isolation have worsened the pandemic in that country instead of mitigating it, likely as a higher-order effect emerging from a combination of factors.”
170) The tiered restrictions enforced in November 2020 did not impact the epidemiology of the second wave of COVID-19 in Italy, Rainisio, 2021	“The trend of R(t) tending to increase shortly after the measures became effective does not allow to exclude that the enforcement of such restrictions might have been counterproductive. These results are instrumental in informing public health efforts aimed at attempting to manage the epidemic efficiently. Planning further use of the tiered restrictions and the associated containment measures should be carefully and critically revised to avoid a useless burden to the population with no advantage for the containment of the epidemic or a possible worsening.”
SCHOOL CLOSURES
1) Suffering in silence: How COVID-19 school closures inhibit the reporting of child maltreatment, Baron, 2020	“While one would expect the financial, mental, and physical stress due to COVID-19 to result in additional child maltreatment cases, we find that the actual number of reported allegations was approximately 15,000 lower (27%) than expected for these two months. We leverage a detailed dataset of school district staffing and spending to show that the observed decline in allegations was largely driven by school closures.”
2) Association of routine school closures with child maltreatment reporting and substantiation in the United States; 2010-2017, Puls, 2021	“Results suggest that the detection of child maltreatment may be diminished during periods of routine school closure.”
3) Reporting of child maltreatment during the SARS-CoV-2 pandemic in New York City from March to May 2020, Rapoport, 2021	“Precipitous drops in child maltreatment reporting and child welfare interventions coincided with social distancing policies designed to mitigate COVID-19 transmission.”
4) Calculating the impact of COVID-19 pandemic on child abuse and neglect in the U.S, Nguyen, 2021	“The COVID-19 pandemic has led to a precipitous drop in CAN investigations where almost 200,000 children are estimated to have been missed for prevention services and CAN in a 10-month period.”
5) Effect of school closures on mortality from coronavirus disease 2019: old and new predictions, Rice, 2020	“We therefore conclude that the somewhat counterintuitive results that school closures lead to more deaths are a consequence of the addition of some interventions that suppress the first wave and failure to prioritise protection of the most vulnerable people. When the interventions are lifted, there is still a large population who are susceptible and a substantial number of people who are infected. This then leads to a second wave of infections that can result in more deaths, but later. Further lockdowns would lead to a repeating series of waves of infection unless herd immunity is achieved by vaccination, which is not considered in the model. A similar result is obtained in some of the scenarios involving general social distancing. For example, adding general social distancing to case isolation and household quarantine was also strongly associated with suppression of the infection during the intervention period, but then a second wave occurs that actually concerns a higher peak demand for ICU beds than for the equivalent scenario without general social distancing.”
6) Schools Closures during the COVID-19 Pandemic: A Catastrophic Global Situation, Buonsenso, 2020	“This extreme measure provoked a disruption of the educational system involving hundreds of million children worldwide. The return of children to school has been variable and is still an unresolved and contentious issue. Importantly the process has not been directly correlated to the severity of the pandemic s impact and has fueled the widening of disparities, disproportionately affecting the most vulnerable populations. Available evidence shows SC added little benefit to COVID-19 control whereas the harms related to SC severely affected children and adolescents. This unresolved issue has put children and young people at high risk of social, economic and health-related harm for years to come, triggering severe consequences during their lifespan.”
7) The Impact of COVID-19 School Closure on Child and Adolescent Health: A Rapid Systematic Review, Chaabane, 2021	“COVID-19-related school closure was associated with a significant decline in the number of hospital admissions and pediatric emergency department visits. However, a number of children and adolescents lost access to school-based healthcare services, special services for children with disabilities, and nutrition programs. A greater risk of widening educational disparities due to lack of support and resources for remote learning were also reported among poorer families and children with disabilities. School closure also contributed to increased anxiety and loneliness in young people and child stress, sadness, frustration, indiscipline, and hyperactivity. The longer the duration of school closure and reduction of daily physical activity, the higher was the predicted increase of Body Mass Index and childhood obesity prevalence.”
8) School Closures and Social Anxiety During the COVID-19 Pandemic, Morrissette, 2020	“Reported on the effects that social isolation and loneliness may have on children and adolescents during the global 2019 novel coronavirus disease (COVID-19) pandemic, with their findings suggesting associations between social anxiety and loneliness/social isolation.”
9) Parental job loss and infant health, Lindo, 2011	“Husbands’ job losses have significant negative effects on infant health. They reduce birth weights by approximately four and a half percent.”
10) Closing schools is not evidence based and harms children, Lewis, 2021	“For some children education is their only way out of poverty; for others school offers a safe haven away from a dangerous or chaotic home life. Learning loss, reduced social interaction, isolation, reduced physical activity, increased mental health problems, and potential for increased abuse, exploitation, and neglect have all been associated with school closures. Reduced future income6 and life expectancy are associated with less education. Children with special educational needs or who are already disadvantaged are at increased risk of harm.”
11) Impacts of school closures on physical and mental health of children and young people: a systematic review, Viner, 2021	“School closures as part of broader social distancing measures are associated with considerable harms to CYP health and wellbeing. Available data are short-term and longer-term harms are likely to be magnified by further school closures. Data are urgently needed on longer-term impacts using strong research designs, particularly amongst vulnerable groups. These findings are important for policy-makers seeking to balance the risks of transmission through school-aged children with the harms of closing schools.”
12) School Closure: A Careful Review of the Evidence, Alexander, 2020	“Based on the existing reviewed evidence, the predominant finding is that children (particularly young children) are at very low risk of acquiring SARS-CoV-2 infection, and if they do become infected, are at very low risk of spreading it among themselves or to other children in the school setting, of spreading it to their teachers, or of spreading it to other adults or to their parents, or of taking it into the home setting; children typically become infected from the home setting/clusters and adults are typically the index case; children are at very low risk of severe illness or death from COVID-19 disease except in very rare circumstances; children do not drive SARS-CoV-2/COVID-19 as they do seasonal influenza; an age gradient as to susceptibility and transmission capacity exists whereby older children should not be treated the same as younger children in terms of ability to transmit e.g. a 6 year-old versus a 17 year-old (as such, public health measures would be different in an elementary school versus a high/secondary school); ‘very low risk’ can also be considered ‘very rare’ (not zero risk, but negligible, very rare); we argue that masking and social distancing for young children is unsound policy and not needed and if social distancing is to be used, that 3-feet is suitable over 6-feet and will address the space limitations in schools; we argue that we are well past the point where we must replace hysteria and fear with knowledge and fact.  The schools must be immediately re-opened for in-person instruction as there is no reason to do otherwise.”
13) Children, school and COVID-19, RIVM, 2021	“If we look at all hospital admissions reported by the NICE Foundation between 1 January and 16 November 2021, 0.7% were younger than 4 years old. 0.1% were aged 4-11 years and 0.2% were aged 12-17 years. The vast majority (99.0%) of all people admitted to hospital with COVID-19 were aged 18 years or older.”
14) FEW CARRIERS, FEW TRANSMITTERS”: A STUDY CONFIRMS THE MINIMAL ROLE OF CHILDREN IN THE COVID-19 EPIDEMIC, Vincendon, 2020	“Children are few carriers, few transmitters, and when they are contaminated, it is almost always adults in the family who have contaminated them.”
15) Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany, Ehrhardt, 2020	“Investigated data from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected 0-19 year olds, who attended schools/childcare facilities, to assess their role in SARS-CoV-2 transmission after these establishments’ reopening in May 2020 in Baden-Württemberg, Germany. Child-to-child transmission in schools/childcare facilities appeared very uncommon.”
16) Australian Health Protection Principal Committee (AHPPC) coronavirus (COVID-19) statements on 24 April 2020, Australian government, 2020	“AHPPC continues to note that there is very limited evidence of transmission between children in the school environment; population screening overseas has shown very low incidence of positive cases in school-aged children. In Australia, 2.4 per cent of confirmed cases have been in children aged between 5 and 18 years of age (as at 6am, 22 April 2020).  AHPPC believes that adults in the school environment should practice room density measures (such as in staff rooms) given the greater risk of transmission between adults.”
17) AN EVIDENCE SUMMARY OF PAEDIATRIC COVID-19 LITERATURE, Boast, 2021	“Critical illness is very rare (~1%). In data from China, the USA and Europe, there is a “U shaped” risk gradient, with infants and older adolescents appear most likely to be hospitalised and to suffer from more severe disease. Deaths in children remain extremely rare from COVID-19, with only 4 deaths in the UK as of May 2020 in children <15 years, all in children with serious comorbidities.”
18) Transmission dynamics of SARS-CoV-2 within families with children in Greece: A study of 23 clusters,  Maltezou, 2020	“While children become infected by SARS-CoV-2, they do not appear to transmit infection to others.”
19) No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020, Heavey, 2020	“Children are thought to be vectors for transmission of many respiratory diseases including influenza. It was assumed that this would be true for COVID-19 also. To date however, evidence of widespread paediatric transmission has failed to emerge. School closures create childcare issues for parents. This has an impact on the workforce, including the healthcare workforce. There are also concerns about the impact of school closures on children’s mental and physical health… examination of all Irish paediatric cases of COVID-19 attending school during the pre-symptomatic and symptomatic periods of infection (n = 3) identified no cases of onward transmission to other children or adults within the school and a variety of other settings. These included music lessons (woodwind instruments) and choir practice, both of which are high-risk activities for transmission. Furthermore, no onward transmission from the three identified adult cases to children was identified.”
20) COVID-19, school closures, and child poverty: a social crisis in the making, Van Lancker, 2020	“The UN Educational, Scientific and Cultural Organization estimates that 138 countries have closed schools nationwide, and several other countries have implemented regional or local closures. These school closures are affecting the education of 80% of children worldwide. Although scientific debate is ongoing with regard to the effectiveness of school closures on virus transmission, the fact that schools are closed for a long period of time could have detrimental social and health consequences for children living in poverty, and are likely to exacerbate existing inequalities.”
21) Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study, Bayham, 2020	“School closures come with many trade-offs, and can create unintended child-care obligations. Our results suggest that the potential contagion prevention from school closures needs to be carefully weighted with the potential loss of health-care workers from the standpoint of reducing cumulative mortality due to COVID-19, in the absence of mitigating measures.”
22) The Truth About Kids, School, and COVID-19, Thompson/The Atlantic, 2021	“The CDC’s judgment comes at a particularly fraught moment in the debate about kids, schools, and COVID-19. Parents are exhausted. Student suicides are surging. Teachers’ unions are facing national opprobrium for their reluctance to return to in-person instruction. And schools are already making noise about staying closed until 2022… Research from around the world has, since the beginning of the pandemic, indicated that people under 18, and especially younger kids, are less susceptible to infection, less likely to experience severe symptoms, and far less likely to be hospitalized or die…in May 2020, a small Irish study of young students and education workers with COVID-19 interviewed more than 1,000 contacts and found “no case of onward transmission” to any children or adults. In June 2020, a Singapore study of three COVID-19 clusters found that “children are not the primary drivers” of outbreaks and that “the risk of SARS-CoV-2 transmission among children in schools, especially preschools, is likely to be low.”
23) Feared coronavirus outbreaks in schools yet to arrive, early data shows, Meckler/The Washington Post, 2020	“This early evidence, experts say, suggests that opening schools may not be as risky as many have feared and could guide administrators as they chart the rest of what is already an unprecedented school year. Everyone had a fear there would be explosive outbreaks of transmission in the schools. In colleges, there have been. We have to say that, to date, we have not seen those in the younger kids, and that is a really important observation.”
24) Three studies highlight low COVID risk of in-person school, CIDRAP, 2021	“A trio of new studies demonstrate low risk of COVID-19 infection and spread in schools, including limited in-school COVID-19 transmission in North Carolina, few cases of the coronavirus-associated multisystem inflammatory syndrome in children (MIS-C) in Swedish schools, and minimal spread of the virus from primary school students in Norway.”
25) Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools, Zimmerman, 2021	“In the first 9 weeks of in-person instruction in North Carolina schools, we found extremely limited within-school secondary transmission of SARS-CoV-2, as determined by contact tracing.”
26) Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden, Ludvigsson, 2020	“Of the 1,951,905 children aged 1 to 16 years in Sweden as of Dec 31, 2019, 65 died in the pre-pandemic period of November 2019 to February 2020, compared with 69 in the pandemic period of March through June 2020. None of the deaths were caused by COVID-19. Fifteen children diagnosed as having COVID-19, including seven with MIS-C, were admitted to an intensive care unit (ICU) from March to June 2020 (0.77 per 100,000 children in this age-group). Four children required mechanical ventilation. Four children were 1 to 6 years old (0.54 per 100,000), and 11 were 7 to 16 (0.90 per 100,000). Four of the children had an underlying illness: 2 with cancer, 1 with chronic kidney disease, and 1 with a hematologic disease). Of the country’s 103,596 preschool teachers and 20 schoolteachers, fewer than 10 were admitted to an ICU by Jun 30, 2020 (an equivalent of 19 per 100,000).”
27) Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020, Brandal, 2021	“This prospective study shows that transmission of SARS-CoV-2 from children under 14 years of age was minimal in primary schools in Oslo and Viken, the two Norwegian counties with the highest COVID-19 incidence and in which 35% of the Norwegian population resides. In a period of low to medium community transmission (a 14-day incidence of COVID-19 of < 150 cases per 100,000 inhabitants), when symptomatic children were asked to stay home from school, there were < 1% SARS-CoV-2–positive test results among child contacts and < 2% positive results in adult contacts in 13 contract tracings in Norwegian primary schools. In addition, self-collection of saliva for SARS-CoV-2 detection was efficient and sensitive (85% (11/13); 95% confidence interval: 55–98)…use of face masks is not recommended in schools in Norway. We found that with the IPC measures implemented there is low to no transmission from SARS-CoV-2–infected children in schools.”
28) Children are unlikely to be the main drivers of the COVID-19 pandemic – A systematic review, Ludvigsson, 2020	“Identified 700 scientific papers and letters and 47 full texts were studied in detail. Children accounted for a small fraction of COVID-19 cases and mostly had social contacts with peers or parents, rather than older people at risk of severe disease…Children are unlikely to be the main drivers of the pandemic. Opening up schools and kindergartens is unlikely to impact COVID-19 mortality rates in older people.”
29) Science Brief: Transmission of SARS-CoV-2 in K-12 Schools and Early Care and Education Programs – Updated, CDC, 2021	“Findings from several studies suggest that SARS-CoV-2 transmission among students is relatively rare, particularly when prevention strategies are in place…several studies have also concluded that students are not the primary sources of exposure to SARS-CoV-2 among adults in school setting.”
30) Children under 10 less likely to drive COVID-19 outbreaks, research review says, Dobbins/McMaster, 2020	“The bottom line thus far is that children under 10 years of age are unlikely to drive outbreaks of COVID-19 in daycares and schools and that, to date, adults were much more likely to be the transmitter of infection than children.”
31) Role of children in the transmission of the COVID-19 pandemic: a rapid scoping review, Rajmil, 2020	“Children are not transmitters to a greater extent than adults. There is a need to improve the validity of epidemiological surveillance to solve current uncertainties, and to take into account social determinants and child health inequalities during and after the current pandemic.”
32) COVID-19 in schools – the experience in NSW, NCIRS, 2020	“SARS-CoV-2 transmission in children in schools appears considerably less than seen for other respiratory viruses, such as influenza. In contrast to influenza, data from both virus and antibody testing to date suggest that children are not the primary drivers of COVID-19 spread in schools or in the community. This is consistent with data from international studies showing low rates of disease in children and suggesting limited spread among children and from children to adults.”
33) Spread of SARS-CoV-2 in the Icelandic Population, Gudbjartsson, 2020	“In a population-based study in Iceland, children under 10 years of age and females had a lower incidence of SARS-CoV-2 infection than adolescents or adults and males.”
34) Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy, Onder, 2020	Infected children and females were less likely to have severe disease.
35) BC Center for Disease Control, BC Children’s hospital, 2020	“BC families reported impaired learning, increased child stress, and decreased connection during COVID-19 school closures, while global data show increased loneliness and declining mental health, including anxiety and depression… Provincial child protection reports have also declined significantly despite reported increased domestic violence globally. This suggests decreased detection of child neglect and abuse without reporting from schools… The impact of school closures is likely to be experienced disproportionately by families subject to social inequities, and those with children with health conditions or special learning needs. Interrupted access to school-based resources, connections, and support compounds the broader societal impact of the pandemic. In particular, there are likely to be greater effects on single parent families, families in poverty, working mothers, and those with unstable employment and housing.”
36) Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study, Macartney, 2020	“SARS-CoV-2 transmission rates were low in NSW educational settings during the first COVID-19 epidemic wave, consistent with mild infrequent disease in the 1·8 million child population.”
37) COVID-19 Cases and Transmission in 17 K–12 Schools — Wood County, Wisconsin, August 31–November 29, 2020, CDC/Falk, 2021	“In a setting of widespread community SARS-CoV-2 transmission, few instances of in-school transmission were identified among students and staff members, with limited spread among children within their cohorts and no documented transmission to or from staff members.”
38) COVID-19 in children and the role of school settings in transmission – second update, ECDC, 2021	“Children aged between 1-18 years have much lower rates of hospitalisation, severe disease requiring intensive hospital care, and death than all other age groups, according to surveillance data…the decision to close schools to control the COVID-19 pandemic should be used as a last resort. The negative physical, mental and educational impacts of proactive school closures on children, as well as the economic impact on society more broadly, would likely outweigh the benefits.”“Investigations of cases identified in school settings suggest that child to child transmission in schools is uncommon and not the primary cause of SARS-CoV-2 infection in children whose onset of infection coincides with the period during which they are attending school, particularly in preschools and primary school.”
39) COVID-19 in children and young people, Snape, 2020	“The near-global closure of schools in response to the pandemic reflected the reasonable expectation from previous respiratory virus outbreaks that children would be a key component of the transmission chain. However, emerging evidence suggests that this is most likely not the case. A minority of children experience a postinfectious inflammatory syndrome, the pathology and long-term outcomes of which are poorly understood. However, relative to their risk of contracting disease, children and adolescents have been disproportionately affected by lockdown measures, and advocates of child health need to ensure that children’s rights to health and social care, mental health support, and education are protected throughout subsequent pandemic waves…There are many other areas of potential indirect harm to children, including an increase in home injuries (accidental and nonaccidental) when children have been less visible to social protection systems because of lockdowns. In Italy, hospitalizations for accidents at home increased markedly during the COVID-19 lockdown and potentially posed a higher threat to children’s health than COVID-19. UK pediatricians report that delay in presentations to hospital or disrupted services contributed to the deaths of equal numbers of children that were reported to have died with SARS-CoV-2 infection. Many countries are seeing evidence that mental health in young people has been adversely affected by school closures and lockdowns. For example, preliminary evidence suggests that deaths by suicide of young people under 18 years old increased during lockdown in England.”
40) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study, Swann, 2020	“Children and young people have less severe acute covid-19 than adults.”
41) The Dangers of Keeping the Schools Closed, Yang, 2020	“The data from a range of countries shows that children rarely, and in many countries never, have died from this infection. Children appear to get infected at a much lower rate than those who are older… there is no evidence that children are important in transmitting the disease…What we know about social distancing policies is based largely on models of influenza, where children are a vulnerable group. However, preliminary data on COVID-19 suggests that children are a small fraction of cases and may be less vulnerable than older adults.”
42) SARS-CoV-2 Infection in Children, Lu, 2020	“In contrast with infected adults, most infected children appear to have a milder clinical course. Asymptomatic infections were not uncommon.”
43) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, Wu, 2020	Less than 1% of the cases were in children younger than 10 years of age.
44) Risk for COVID-19 Infection, CDC, 2021	A CDC report on hospitalization and death in children, found that when compared to persons 18 to 29 years old, children 0 to 4 years had a 4x lower rate of hospitalization and a 9x lower rate of death. Children 5 to 17 years old had a 9x lower rate of hospitalization and a 16x lower rate of death.
45) Children are unlikely to have been the primary source of household SARS-CoV-2 infections, Zhu, 2020	“Whilst SARS-CoV-2 can cause mild disease in children, the data available to date suggests that children have not played a substantive role in the intra-household transmission of SARS-CoV-2.”
46) Characteristics of Household Transmission of COVID-19, Li, 2020	“The secondary attack rate to children was 4% compared with 17.1% for adults.”
47) Are The Risks Of Reopening Schools Exaggerated?, Kamenetz/NPR, 2020	“Despite widespread concerns, two new international studies show no consistent relationship between in-person K-12 schooling and the spread of the coronavirus. And a third study from the United States shows no elevated risk to childcare workers who stayed on the job…As a pediatrician, I am really seeing the negative impacts of these school closures on children,” Dr. Danielle Dooley, a medical director at Children’s National Hospital in Washington, D.C., told NPR. She ticked off mental health problems, hunger, obesity due to inactivity, missing routine medical care and the risk of child abuse — on top of the loss of education. “Going to school is really vital for children. They get their meals in school, their physical activity, their health care, their education, of course.”
48) Child care not associated with spread of COVID-19, Yale study finds, YaleNews, 2020	“Findings show child care programs that remained open throughout the pandemic did not contribute to the spread of the virus to providers, lending valuable insight to parents, policymakers, and providers alike.”
49) Reopening US Schools in the Era of COVID-19: Practical Guidance From Other Nations, Tanmoy Das, 2020	“There is evidence that, compared with adults, children are 3-fold less susceptible to infection, more likely to be asymptomatic, and less likely to be hospitalized and die. While rare reports of pediatric multi-inflammatory syndrome need to be monitored, its association with COVID-19 is extremely low and typically treatable.”
50) Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US, Dooley, 2020	“Restrictions imposed because of the coronavirus make these challenges more formidable. While school districts are engaging in distance learning, reports indicate wide variability in access to quality educational instruction, digital technology, and internet access. Students in rural and urban school districts are faced with challenges accessing the internet. In some urban areas, as many as one-third of students are not participating in online classes.  Chronic absenteeism, or missing 10% or more of the school year, affects educational outcomes, including reading levels, grade retention, graduation rates, and high school dropout rates. Chronic absenteeism already disproportionately affects children living in poverty. The consequences of missing months of school will be even more marked.”
51) COVID-19 and school return: The need and necessity, Betz, 2020	“Of particular concern are the consequences for children who live in poverty. These children live in homes that have inadequate resources for virtual learning that will contribute to learning deficits, and thereby falling further behind with expected academic performance for grade level. Children from low-resourced homes are likely to have limited space for doing school work, inadequate temperature controls for heating and cooling and safe outdoor space for exercise (Van Lancker & Parolin, 2020). Furthermore, this group of children are at high risk for food insecurity as they may not have access to school lunches/breakfasts with school closures.”
52) Children are not COVID-19 super spreaders: time to go back to school, Munro, 2020	“Evidence is therefore emerging that children could be significantly less likely to become infected than adults…At the current time, children do not appear to be super spreaders.”
53) Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020, Danis, 2020	“The index case stayed 4 days in the chalet with 10 English tourists and a family of 5 French residents; SARS-CoV-2 was detected in 5 individuals in France, 6 in England (including the index case), and 1 in Spain (overall attack rate in the chalet: 75%). One pediatric case, with picornavirus and influenza A coinfection, visited 3 different schools while symptomatic. One case was asymptomatic, with similar viral load as that of a symptomatic case…The fact that an infected child did not transmit the disease despite close interactions within schools suggests potential different transmission dynamics in children.”
54) COVID-19 – research evidence summaries, RCPCH, 2020	“In children, the evidence is now clear that COVID-19 is associated with a considerably lower burden of morbidity and mortality compared to that seen in the elderly. There is evidence of critical illness and death in children, but it is rare. There is also some evidence that children may be less likely to acquire the infection. The role of children in transmission, once they have acquired the infection, is unclear, although there is no clear evidence that they are any more infectious than adults. Symptoms are non-specific and most commonly cough and fever.”
55) Impact of COVID-19 and lockdown on mental health of children and adolescents: A narrative review with recommendations, Singh, 2020	“On these grounds, since January, 2020, various countries started implementing regional and national containment measures or lockdowns. In this backdrop one of the principal measures taken during lockdown has been closure of schools, educational institutes and activity areas. These inexorable circumstances which are beyond normal experience, lead to stress, anxiety and a feeling of helplessness in all.”
56) Absence of SARS-CoV-2 Transmission from Children in Isolation to Guardians, South Korea, Lee/EID, 2021	“Did not observe SARS-CoV-2 transmission from children to guardians in isolation settings in which close proximity would seem to increase transmission risk. Recent studies have suggested that children are not the main drivers of the COVID-19 pandemic, although the reasons remain unclear.”
57) COVID-19 National Emergency Response Center, Epidemiology and Case Management Team. Contact tracing during coronavirus disease outbreak, South Korea, 2020, Park/EID, 2020	“A large study on contacts of COVID-19 case-patients in South Korea observed that household transmission was lowest when the index case-patient was 0–9 years of age.”
58) COVID-19 in Children and the Dynamics of Infection in Families, Posfay-Barbe, 2020	“In 79% of households, ≥1 adult family member was suspected or confirmed for COVID-19 before symptom onset in the study child, confirming that children are infected mainly inside familial clusters.  Surprisingly, in 33% of households, symptomatic HHCs tested negative despite belonging to a familial cluster with confirmed SARS-CoV-2 cases, suggesting an underreporting of cases. In only 8% of households did a child develop symptoms before any other HHC, which is in line with previous data in which it is shown that children are index cases in <10% of SARS-CoV-2 familial clusters.”
59) COVID-19 Transmission and Children: The Child Is Not to Blame, Lee, 2020	“Report on the dynamics of COVID-19 within families of children with reverse-transcription polymerase chain reaction–confirmed SARS-CoV-2 infection in Geneva, Switzerland. From March 10 to April 10, 2020, all children <16 years of age diagnosed at Geneva University Hospital (N = 40) underwent contact tracing to identify infected household contacts (HHCs). Of 39 evaluable households, in only 3 (8%) was a child the suspected index case, with symptom onset preceding illness in adult HHCs. In all other households, the child developed symptoms after or concurrent with adult HHCs, suggesting that the child was not the source of infection and that children most frequently acquire COVID-19 from adults, rather than transmitting it to them.”“In intriguing study from France, a 9-year-old boy with respiratory symptoms associated with picornavirus, influenza A, and SARS-CoV-2 coinfection was found to have exposed over 80 classmates at 3 schools; no secondary contacts became infected, despite numerous influenza infections within the schools, suggesting an environment conducive to respiratory virus transmission.”“In New South Wales, Australia, 9 students and 9 staff infected with SARS-CoV-2 across 15 schools had close contact with a total of 735 students and 128 staff. Only 2 secondary infections were identified, none in adult staff; 1 student in primary school was potentially infected by a staff member, and 1 student in high school was potentially infected via exposure to 2 infected schoolmates.”
60) Role of children in household transmission of COVID-19, Kim, 2020	“A total of 107 paediatric COVID-19 index cases and 248 of their household members were identified. One pair of paediatric index-secondary household case was identified, giving a household SAR of 0.5% (95% CI 0.0% to 2.6%).”
61) Secondary attack rate in household contacts of COVID-19 Paediatric index cases: a study from Western India, Shah, 2021	“The household SAR from pediatric patients is low.”
62) Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis, Madewell, 2021	“Household secondary attack rates were increased from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) than from asymptomatic index cases (0.7%; 95% CI, 0%-4.9%), to adult contacts (28.3%; 95% CI, 20.2%-37.1%) than to child contacts (16.8%; 95% CI, 12.3%-21.7%).”
63) Children and Adolescents With SARS-CoV-2 Infection, Maltezou, 2020	“Child-to-adult transmission was found in one occasion only.”
64) Severe Acute Respiratory Syndrome-Coronavirus-2 Transmission in an Urban Community: The Role of Children and Household Contacts, Pitman-Hunt, 2021	“A household sick contact was identified in fewer than half (42%) of patients and no child-to-adult transmission was identified.”
65) A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission Clusters, Zhu, 2020	“The secondary attack rate in pediatric household contacts was lower than in adult household contacts (RR, 0.62; 95% CI, 0.42-0.91). These data have important implications for the ongoing management of the COVID-19 pandemic, including potential vaccine prioritization strategies.”
66) The role of children in transmission of SARS-CoV-2: A rapid review, Li, 2020	“Preliminary results from population-based and school-based studies suggest that children may be less frequently infected or infect others.”
67) Novel Coronavirus 2019 Transmission Risk in Educational Settings, Yung, 2020	“The data suggest that children are not the primary drivers of SARS-CoV-2 transmission in schools and could help inform exit strategies for lifting of lockdowns.”
68) INTERPOL report highlights impact of COVID-19 on child sexual abuse, Interpol, 2020	“Key environmental, social and economic factor changes due to COVID-19 which have impacted child sexual exploitation and abuse (CSEA) across the world include:closure of schools and subsequent movement to virtual learning environments;increased time children spend online for entertainment, social and educational purposes;restriction of international travel and the repatriation of foreign nationals;limited access to community support services, child care and educational personnel who often play a key role in detecting and reporting cases of child sexual exploitation.”
69) Do school closures reduce community transmission of COVID-19? A systematic review of observational studies, Walsh, 2021	“With such varied evidence on effectiveness, and the harmful effects, policymakers should take a measured approach before implementing school closures.”
70) Association between living with children and outcomes from COVID-19: an OpenSAFELY cohort study of 12 million adults in England, Forbes, 2020	“For adults living with children there is no evidence of an increased risk of severe COVID-19 outcomes. These findings have implications for determining the benefit-harm balance of children attending school in the COVID-19 pandemic.”
71) School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review, Viner, 2020	“Data from the SARS outbreak in mainland China, Hong Kong, and Singapore suggest that school closures did not contribute to the control of the epidemic.”
72) Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza, WHO, 2020	“The effect of reactive school closure in reducing influenza transmission varied but was generally limited.”
73) New research finds no evidence that schools are playing a significant role in driving spread of the Covid-19 virus in the community, Warwick, 2021	“New research led by epidemiologists at the University of Warwick has found that there is no significant evidence that schools are playing a significant role in driving the spread of the Covid-19 disease in the community, particularly in primary schools…our analysis of recorded school absences as a result of infection with COVID-19 suggest that the risk is much lower in primary than secondary schools and we do not find evidence to suggest that school attendance is a significant driver of outbreaks in the community.”
74) When schools shut: New UNESCO study exposes failure to factor gender in COVID-19 education responses, UNESCO, 2021	“As governments brought remote learning solutions to scale to respond to the pandemic, speed, rather than equity in access and outcomes, appears to have been the priority. Initial COVID-19 responses seem to have been developed with little attention to inclusiveness, raising the risk of increased marginalization… Most countries across all income groups report providing teachers with different forms of support. Few programmes, however, helped teachers recognize the gender risks, disparities and inequalities that emerged during COVID-19 closures. Female teachers also have been largely expected to take on a dual role to ensure continuity of learning for their students, while facing additional childcare and unpaid domestic responsibilities in their homes during school closures.”
75) School Closures Have Failed America’s Children, Kristof, 2021	“Flags are flying at half-staff across the United States to commemorate the half-million American lives lost to the coronavirus. But there’s another tragedy we haven’t adequately confronted: Millions of American schoolchildren will soon have missed a year of in-person instruction, and we may have inflicted permanent damage on some of them, and on our country… But the educational losses are disproportionately the fault of Democratic governors and mayors who too often let schools stay closed even as bars opened.”
76) The effects of school closures on SARS-CoV-2 among parents and teachers, Vlachos, 2020	“The results for parents indicate that keeping lower-secondary schools open had minor consequences for the overall transmission of SARS-CoV-2 in society.”
77) The Effects of School Reopenings on COVID-19 Hospitalizations, Harris, 2021	“We find no effect of in-person school reopening on COVID-19 hospitalization rates.”
78) Shut and re-open: the role of schools in the spread of COVID-19 in Europe, Stage, 2021	“Limited school attendance, such as older students sitting exams or the partial return of younger year groups, does not appear to significantly affect community transmission. In countries where community transmission is generally low, such as Denmark or Norway, a large-scale reopening of schools while controlling or suppressing the epidemic appears feasible.”
79) COVID-19 incidence, hospitalizations and mortality trends in Croatia and school closures, Simetin, 2021	“The observed inconsistent pattern indicates that there were no association of school openings and COVID-19 morbidity and mortality trends in Croatia and that other factors were leading to increasing and decreasing numbers. This emphasizes the need to consider the introduction of other effective and less harmful measures by stakeholders, or at least to use school closures as a last resort.”
80) A cross-sectional and prospective cohort study of the role of schools in the SARS-CoV-2 second wave in Italy, Gandini, 2021	“This analysis does not support a role for school opening as a driver of the second COVID-19 wave in Italy, a large European country with high SARS-CoV-2 incidence.”
81) The Role of Schools in Transmission of the SARS-CoV-2 Virus: Quasi-Experimental Evidence from Germany, Bismarck-Osten, 2021	“Show that neither the summer closures nor the closures in the fall had a significant containing effect on the spread of SARS-CoV-2 among children or a spill-over effect on older generations. There is also no evidence that the return to school at full capacity after the summer holidays increased infections among children or adults. Instead, we find that the number of children infected increased during the last weeks of the summer holiday and decreased in the first weeks after schools reopened, a pattern we attribute to travel returnees.”
82) No causal effect of school closures in Japan on the spread of COVID-19 in spring 2020, Fukumoto, 2021	“We do not find any evidence that school closures in Japan reduced the spread of COVID-19. Our null results suggest that policies on school closures should be reexamined given the potential negative consequences for children and parents.”
83) Transmission of SARS-CoV-2 in Norwegian schools: A population-wide register-based cohort study on characteristics of the index case and secondary attack rates, Rotevatn, 2021	“Results confirm that schools have not been an important arena of transmission of SARS-CoV-2 in Norway and therefore support that schools can be kept open with IPC measures in place.”
84) COVID-19 Mitigation Practices and COVID-19 Rates in Schools: Report on Data from Florida, New York and Massachusetts, Oster, 2021	“Find higher student COVID-19 rates in schools and districts with lower in-person density but no correlations in staff rates. Ventilation upgrades are correlated with lower rates in Florida but not in New York. We do not find any correlations with mask mandates.”
MASKS-INEFFECTIVENESS
1) Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers, Bundgaard, 2021	“Infection with SARS-CoV-2 occurred in 42 participants recommended masks (1.8%) and 53 control participants (2.1%). The between-group difference was −0.3 percentage point (95% CI, −1.2 to 0.4 percentage point; P = 0.38) (odds ratio, 0.82 [CI, 0.54 to 1.23]; P = 0.33). Multiple imputation accounting for loss to follow-up yielded similar results…the recommendation to wear surgical masks to supplement other public health measures did not reduce the SARS-CoV-2 infection rate among wearers by more than 50% in a community with modest infection rates, some degree of social distancing, and uncommon general mask use.”
2) SARS-CoV-2 Transmission among Marine Recruits during Quarantine, Letizia, 2020	“Our study showed that in a group of predominantly young male military recruits, approximately 2% became positive for SARS-CoV-2, as determined by qPCR assay, during a 2-week, strictly enforced quarantine. Multiple, independent virus strain transmission clusters were identified…all recruits wore double-layered cloth masks at all times indoors and outdoors.”
3) Physical interventions to interrupt or reduce the spread of respiratory viruses, Jefferson, 2020	“There is low certainty evidence from nine trials (3507 participants) that wearing a mask may make little or no difference to the outcome of influenza‐like illness (ILI) compared to not wearing a mask (risk ratio (RR) 0.99, 95% confidence interval (CI) 0.82 to 1.18. There is moderate certainty evidence that wearing a mask probably makes little or no difference to the outcome of laboratory‐confirmed influenza compared to not wearing a mask (RR 0.91, 95% CI 0.66 to 1.26; 6 trials; 3005 participants)…the pooled results of randomised trials did not show a clear reduction in respiratory viral infection with the use of medical/surgical masks during seasonal influenza.”
4) The Impact of Community Masking on COVID-19: A Cluster-Randomized Trial in Bangladesh, Abaluck, 2021 Heneghan et al.	A cluster-randomized trial of community-level mask promotion in rural Bangladesh from November 2020 to April 2021 (N=600 villages, N=342,126 adults. Heneghan writes: “In a Bangladesh study, surgical masks reduced symptomatic COVID infections by between 0 and 22 percent, while the efficacy of cloth masks led to somewhere between an 11 percent increase to a 21 percent decrease. Hence, based on these randomized studies, adult masks appear to have either no or limited efficacy.”
5) Evidence for Community Cloth Face Masking to Limit the Spread of SARS-CoV-2: A Critical Review, Liu/CATO, 2021	“The available clinical evidence of facemask efficacy is of low quality and the best available clinical evidence has mostly failed to show efficacy, with fourteen of sixteen identified randomized controlled trials comparing face masks to no mask controls failing to find statistically significant benefit in the intent-to-treat populations. Of sixteen quantitative meta-analyses, eight were equivocal or critical as to whether evidence supports a public recommendation of masks, and the remaining eight supported a public mask intervention on limited evidence primarily on the basis of the precautionary principle.”
6) Nonpharmaceutical Measures for Pandemic Influenza in Nonhealthcare Settings—Personal Protective and Environmental Measures, CDC/Xiao, 2020	“Evidence from 14 randomized controlled trials of these measures did not support a substantial effect on transmission of laboratory-confirmed influenza…none of the household studies reported a significant reduction in secondary laboratory-confirmed influenza virus infections in the face mask group…the overall reduction in ILI or laboratory-confirmed influenza cases in the face mask group was not significant in either studies.”
7) CIDRAP: Masks-for-all for COVID-19 not based on sound data, Brosseau, 2020	“We agree that the data supporting the effectiveness of a cloth mask or face covering are very limited. We do, however, have data from laboratory studies that indicate cloth masks or face coverings offer very low filter collection efficiency for the smaller inhalable particles we believe are largely responsible for transmission, particularly from pre- or asymptomatic individuals who are not coughing or sneezing…though we support mask wearing by the general public, we continue to conclude that cloth masks and face coverings are likely to have limited impact on lowering COVID-19 transmission, because they have minimal ability to prevent the emission of small particles, offer limited personal protection with respect to small particle inhalation, and should not be recommended as a replacement for physical distancing or reducing time in enclosed spaces with many potentially infectious people.”
8) Universal Masking in Hospitals in the Covid-19 Era, Klompas/NEJM, 2020	“We know that wearing a mask outside health care facilities offers little, if any, protection from infection. Public health authorities define a significant exposure to Covid-19 as face-to-face contact within 6 feet with a patient with symptomatic Covid-19 that is sustained for at least a few minutes (and some say more than 10 minutes or even 30 minutes). The chance of catching Covid-19 from a passing interaction in a public space is therefore minimal. In many cases, the desire for widespread masking is a reflexive reaction to anxiety over the pandemic…The calculus may be different, however, in health care settings. First and foremost, a mask is a core component of the personal protective equipment (PPE) clinicians need when caring for symptomatic patients with respiratory viral infections, in conjunction with gown, gloves, and eye protection…universal masking alone is not a panacea. A mask will not protect providers caring for a patient with active Covid-19 if it’s not accompanied by meticulous hand hygiene, eye protection, gloves, and a gown. A mask alone will not prevent health care workers with early Covid-19 from contaminating their hands and spreading the virus to patients and colleagues. Focusing on universal masking alone may, paradoxically, lead to more transmission of Covid-19 if it diverts attention from implementing more fundamental infection-control measures.”
9) Masks for prevention of viral respiratory infections among health care workers and the public: PEER umbrella systematic review, Dugré, 2020	“This systematic review found limited evidence that the use of masks might reduce the risk of viral respiratory infections. In the community setting, a possible reduced risk of influenza-like illness was found among mask users. In health care workers, the results show no difference between N95 masks and surgical masks on the risk of confirmed influenza or other confirmed viral respiratory infections, although possible benefits from N95 masks were found for preventing influenza-like illness or other clinical respiratory infections. Surgical masks might be superior to cloth masks but data are limited to 1 trial.”
10) Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis, Saunders-Hastings, 2017	“Facemask use provided a non-significant protective effect (OR = 0.53; 95% CI 0.16–1.71; I2 = 48%) against 2009 pandemic influenza infection.”
11) Experimental investigation of indoor aerosol dispersion and accumulation in the context of COVID-19: Effects of masks and ventilation, Shah, 2021	“Nevertheless, high-efficiency masks, such as the KN95, still offer substantially higher apparent filtration efficiencies (60% and 46% for R95 and KN95 masks, respectively) than the more commonly used cloth (10%) and surgical masks (12%), and therefore are still the recommended choice in mitigating airborne disease transmission indoors.”
12) Exercise with facemask; Are we handling a devil’s sword?- A physiological hypothesis, Chandrasekaran, 2020	“Exercising with facemasks may reduce available Oxygen and increase air trapping preventing substantial carbon dioxide exchange. The hypercapnic hypoxia may potentially increase acidic environment, cardiac overload, anaerobic metabolism and renal overload, which may substantially aggravate the underlying pathology of established chronic diseases. Further contrary to the earlier thought, no evidence exists to claim the facemasks during exercise offer additional protection from the droplet transfer of the virus.”
13) Surgical face masks in modern operating rooms–a costly and unnecessary ritual?, Mitchell, 1991	“Following the commissioning of a new suite of operating rooms air movement studies showed a flow of air away from the operating table towards the periphery of the room. Oral microbial flora dispersed by unmasked male and female volunteers standing one metre from the table failed to contaminate exposed settle plates placed on the table. The wearing of face masks by non-scrubbed staff working in an operating room with forced ventilation seems to be unnecessary.”
14) Facemask against viral respiratory infections among Hajj pilgrims: A challenging cluster-randomized trial, Alfelali, 2020	“By intention-to-treat analysis, facemask use did not seem to be effective against laboratory-confirmed viral respiratory infections (odds ratio [OR], 1.4; 95% confidence interval [CI], 0.9 to 2.1, p = 0.18) nor against clinical respiratory infection (OR, 1.1; 95% CI, 0.9 to 1.4, p = 0.40).”
15) Simple respiratory protection–evaluation of the filtration performance of cloth masks and common fabric materials against 20-1000 nm size particles, Rengasamy, 2010	“Results obtained in the study show that common fabric materials may provide marginal protection against nanoparticles including those in the size ranges of virus-containing particles in exhaled breath.”
16) Respiratory performance offered by N95 respirators and surgical masks: human subject evaluation with NaCl aerosol representing bacterial and viral particle size range, Lee, 2008	“The study indicates that N95 filtering facepiece respirators may not achieve the expected protection level against bacteria and viruses. An exhalation valve on the N95 respirator does not affect the respiratory protection; it appears to be an appropriate alternative to reduce the breathing resistance.”
17) Aerosol penetration and leakage characteristics of masks used in the health care industry, Weber, 1993	“We conclude that the protection provided by surgical masks may be insufficient in environments containing potentially hazardous sub-micrometer-sized aerosols.”
18) Disposable surgical face masks for preventing surgical wound infection in clean surgery, Vincent, 2016	“We included three trials, involving a total of 2106 participants. There was no statistically significant difference in infection rates between the masked and unmasked group in any of the trials…from the limited results it is unclear whether the wearing of surgical face masks by members of the surgical team has any impact on surgical wound infection rates for patients undergoing clean surgery.”
19) Disposable surgical face masks: a systematic review, Lipp, 2005	“From the limited results it is unclear whether wearing surgical face masks results in any harm or benefit to the patient undergoing clean surgery.”
20) Comparison of the Filter Efficiency of Medical Nonwoven Fabrics against Three Different Microbe Aerosols, Shimasaki , 2018	“We conclude that the filter efficiency test using the phi-X174 phage aerosol may overestimate the protective performance of nonwoven fabrics with filter structure compared to that against real pathogens such as the influenza virus.”
21) The use of masks and respirators to preventtransmission of influenza: a systematic review of thescientific evidence21) The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence, Bin-Reza, 2012	The use of masks and respirators to preventtransmission of influenza: a systematic review of thescientific evidence“None of the studies established a conclusive relationship between mask/respirator use and protection against influenza infection. Some evidence suggests that mask use is best undertaken as part of a package of personal protection especially hand hygiene.”
22) Facial protection for healthcare workers during pandemics: a scoping review, Godoy, 2020	“Compared with surgical masks, N95 respirators perform better in laboratory testing, may provide superior protection in inpatient settings and perform equivalently in outpatient settings. Surgical mask and N95 respirator conservation strategies include extended use, reuse or decontamination, but these strategies may result in inferior protection. Limited evidence suggests that reused and improvised masks should be used when medical-grade protection is unavailable.”
23) Assessment of Proficiency of N95 Mask Donning Among the General Public in Singapore, Yeung, 2020	“These findings support ongoing recommendations against the use of N95 masks by the general public during the COVID-19 pandemic.5 N95 mask use by the general public may not translate into effective protection but instead provide false reassurance. Beyond N95 masks, proficiency among the general public in donning surgical masks needs to be assessed.”
24) Evaluating the efficacy of cloth facemasks in reducing particulate matter exposure, Shakya, 2017	“Standard N95 mask performance was used as a control to compare the results with cloth masks, and our results suggest that cloth masks are only marginally beneficial in protecting individuals from particles<2.5 μm.”
25) Use of surgical face masks to reduce the incidence of the common cold among health care workers in Japan: a randomized controlled trial, Jacobs, 2009	“Face mask use in health care workers has not been demonstrated to provide benefit in terms of cold symptoms or getting colds.”
26) N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel, Radonovich, 2019	“Among outpatient health care personnel, N95 respirators vs medical masks as worn by participants in this trial resulted in no significant difference in the incidence of laboratory-confirmed influenza.”
27) Does Universal Mask Wearing Decrease or Increase the Spread of COVID-19?, Watts up with that? 2020	“A survey of peer-reviewed studies shows that universal mask wearing (as opposed to wearing masks in specific settings) does not decrease the transmission of respiratory viruses from people wearing masks to people who are not wearing masks.”
28) Masking: A Careful Review of the Evidence, Alexander, 2021	“In fact, it is not unreasonable at this time to conclude that surgical and cloth masks, used as they currently are, have absolutely no impact on controlling the transmission of Covid-19 virus, and current evidence implies that face masks can be actually harmful.”
29) Community and Close Contact Exposures Associated with COVID-19 Among Symptomatic Adults ≥18 Years in 11 Outpatient Health Care Facilities — United States, July 2020, Fisher, 2020	Reported characteristics of symptomatic adults ≥18 years who were outpatients in 11 US academic health care facilities and who received positive and negative SARS-CoV-2 test results (N = 314)* — United States, July 1–29, 2020, revealed that 80% of infected persons wore face masks almost all or most of the time.
30) Impact of non-pharmaceutical interventions against COVID-19 in Europe: a quasi-experimental study, Hunter, 2020	Face masks in public was not associated with reduced incidence.
31) Masking lack of evidence with politics, CEBM, Heneghan, 2020	“It would appear that despite two decades of pandemic preparedness, there is considerable uncertainty as to the value of wearing masks. For instance, high rates of infection with cloth masks could be due to harms caused by cloth masks, or benefits of medical masks.  The numerous systematic reviews that have been recently published all include the same evidence base so unsurprisingly broadly reach the same conclusions.”
32) Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study, Marks, 2021	“We observed no association of risk of transmission with reported mask usage by contacts, with the age or sex of the index case, or with the presence of respiratory symptoms in the index case at the initial study visit.”
33) Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza, WHO, 2020	“Ten RCTs were included in the meta-analysis, and there was no evidence that face masks are effective in reducing transmission of laboratory-confirmed influenza.”
34) The Strangely Unscientific Masking of America, Younes, 2020	“One report reached its conclusion based on observations of a “dummy head attached to a breathing simulator.”  Another analyzed use of surgical masks on people experiencing at least two symptoms of acute respiratory illness. Incidentally, not one of these studies involved cloth masks or accounted for real-world mask usage (or misusage) among lay people, and none established efficacy of widespread mask-wearing by people not exhibiting symptoms.  There was simply no evidence whatsoever that healthy people ought to wear masks when going about their lives, especially outdoors.”
35) Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review, Brainard, 2020	“31 eligible studies (including 12 RCTs). Narrative synthesis and random-effects meta-analysis of attack rates for primary and secondary prevention in 28 studies were performed. Based on the RCTs we would conclude that wearing facemasks can be very slightly protective against primary infection from casual community contact, and modestly protective against household infections when both infected and uninfected members wear facemasks. However, the RCTs often suffered from poor compliance and controls using facemasks.”
36) The Year of Disguises, Koops, 2020	“The healthy people in our society should not be punished for being healthy, which is exactly what lockdowns, distancing, mask mandates, etc. do…Children should not be wearing face coverings. We all need constant interaction with our environments and that is especially true for children. This is how their immune system develops. They are the lowest of the low-risk groups. Let them be kids and let them develop their immune systems… The “Mask Mandate” idea is a truly ridiculous, knee-jerk reaction and needs to be withdrawn and thrown in the waste bin of disastrous policy, along with lockdowns and school closures. You can vote for a person without blindly supporting all of their proposals!”
37) Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden, Ludvigsson, 2020	“1,951,905 children in Sweden (as of December 31, 2019) who were 1 to 16 years of age, were examined…social distancing was encouraged in Sweden, but wearing face masks was not…No child with Covid-19 died.”
38) Double-Masking Benefits Are Limited, Japan Supercomputer Finds, Reidy, 2021	“Wearing two masks offers limited benefits in preventing the spread of droplets that could carry the coronavirus compared to one well-fitted disposable mask, according to a Japanese study that modeled the dispersal of droplets on a supercomputer.”
39) Physical interventions to interrupt or reduce the spread of respiratory viruses. Part 1 – Face masks, eye protection and person distancing: systematic review and meta-analysis, Jefferson, 2020	“There was insufficient evidence to provide a recommendation on the use of facial barriers without other measures. We found insufficient evidence for a difference between surgical masks and N95 respirators and limited evidence to support effectiveness of quarantine.”
40) Should individuals in the community without respiratory symptoms wear facemasks to reduce the spread of COVID-19?, NIPH, 2020	“Non-medical facemasks include a variety of products. There is no reliable evidence of the effectiveness of non-medical facemasks in community settings. There is likely to be substantial variation in effectiveness between products. However, there is only limited evidence from laboratory studies of potential differences in effectiveness when different products are used in the community.”
41) Is a mask necessary in the operating theatre?, Orr, 1981	“It would appear that minimum contamination can best be achieved by not wearing a mask at all but operating in silence. Whatever its relation to contamination, bacterial counts, or the dissemination of squames, there is no direct evidence that the wearing of masks reduces wound infection.”
42) The surgical mask is a bad fit for risk reduction, Neilson, 2016	“As recently as 2010, the US National Academy of Sciences declared that, in the community setting, “face masks are not designed or certified to protect the wearer from exposure to respiratory hazards.” A number of studies have shown the inefficacy of the surgical mask in household settings to prevent transmission of the influenza virus.”
43) Facemask versus No Facemask in Preventing Viral Respiratory Infections During Hajj: A Cluster Randomised Open Label Trial, Alfelali, 2019	“Facemask use does not prevent clinical or laboratory-confirmed viral respiratory infections among Hajj pilgrims.”
44) Facemasks in the COVID-19 era: A health hypothesis, Vainshelboim, 2021	“The existing scientific evidences challenge the safety and efficacy of wearing facemask as preventive intervention for COVID-19. The data suggest that both medical and non-medical facemasks are ineffective to block human-to-human transmission of viral and infectious disease such SARS-CoV-2 and COVID-19, supporting against the usage of facemasks. Wearing facemasks has been demonstrated to have substantial adverse physiological and psychological effects. These include hypoxia, hypercapnia, shortness of breath, increased acidity and toxicity, activation of fear and stress response, rise in stress hormones, immunosuppression, fatigue, headaches, decline in cognitive performance, predisposition for viral and infectious illnesses, chronic stress, anxiety and depression.”
45) The use of masks and respirators to prevent transmission of influenza: a systematic review of the scientific evidence, Bin-Reza, 2011	“None of the studies established a conclusive relationship between mask/respirator use and protection against influenza infection. Some evidence suggests that mask use is best undertaken as part of a package of personal protection especially hand hygiene.”
46) Are Face Masks Effective? The Evidence., Swiss Policy Research, 2021	“Most studies found little to no evidence for the effectiveness of face masks in the general population, neither as personal protective equipment nor as a source control.”
47) Postoperative wound infections and surgical face masks: A controlled study, Tunevall, 1991	“These results indicate that the use of face masks might be reconsidered. Masks may be used to protect the operating team from drops of infected blood and from airborne infections, but have not been proven to protect the patient operated by a healthy operating team.”
48) Mask mandate and use efficacy in state-level COVID-19 containment, Guerra, 2021	“Mask mandates and use are not associated with slower state-level COVID-19 spread during COVID-19 growth surges.”
49) Twenty Reasons Mandatory Face Masks are Unsafe, Ineffective and Immoral, Manley, 2021	“A CDC-funded review on masking in May 2020 came to the conclusion: “Although mechanistic studies support the potential effect of hand hygiene or face masks, evidence from 14 randomized controlled trials of these measures did not support a substantial effect on transmission of laboratory-confirmed influenza… None of the household studies reported a significant reduction in secondary laboratory-confirmed influenza virus infections in the face mask group.” If masks can’t stop the regular flu, how can they stop SAR-CoV-2?”
50) A cluster randomised trial of cloth masks compared with medical masks in healthcare workers, MacIntyre, 2015	“First RCT of cloth masks, and the results caution against the use of cloth masks. This is an important finding to inform occupational health and safety. Moisture retention, reuse of cloth masks and poor filtration may result in increased risk of infection…the rates of all infection outcomes were highest in the cloth mask arm, with the rate of ILI statistically significantly higher in the cloth mask arm (relative risk (RR)=13.00, 95% CI 1.69 to 100.07) compared with the medical mask arm. Cloth masks also had significantly higher rates of ILI compared with the control arm. An analysis by mask use showed ILI (RR=6.64, 95% CI 1.45 to 28.65) and laboratory-confirmed virus (RR=1.72, 95% CI 1.01 to 2.94) were significantly higher in the cloth masks group compared with the medical masks group. Penetration of cloth masks by particles was almost 97% and medical masks 44%.”
51) Horowitz: Data from India continues to blow up the ‘Delta’ fear narrative, Blazemedia, 2021	“Rather than proving the need to sow more panic, fear, and control over people, the story from India — the source of the “Delta” variant — continues to refute every current premise of COVID fascism…Masks failed to stop the spread there.”
52) An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021, Hetemäki, 2021	Reporting on a nosocomial hospital outbreak in Finland, Hetemäli et al. observed that “both symptomatic and asymptomatic infections were found among vaccinated health care workers, and secondary transmission occurred from those with symptomatic infections despite use of personal protective equipment.”
53) Nosocomial outbreak caused by the SARS-CoV-2 Delta variant in a highly vaccinated population, Israel, July 2021, Shitrit, 2021	In a hospital outbreak investigation in Israel, Shitrit et al. observed “high transmissibility of the SARS-CoV-2 Delta variant among twice vaccinated and masked individuals.” They added that “this suggests some waning of immunity, albeit still providing protection for individuals without comorbidities.” Again, despite use of personal protective equipment.
54) 47 studies confirm ineffectiveness of masks for COVID and 32 more confirm their negative health effects, Lifesite news staff, 2021	“No studies were needed to justify this practice since most understood viruses were far too small to be stopped by the wearing of most masks, other than sophisticated ones designed for that task and which were too costly and complicated for the general public to properly wear and keep changing or cleaning. It was also understood that long mask wearing was unhealthy for wearers for common sense and basic science reasons.”
55) Are EUA Face Masks Effective in Slowing the Spread of a Viral Infection?, Dopp, 2021	The vast evidence shows that masks are ineffective.
56) CDC Study finds overwhelming majority of people getting coronavirus wore masks, Boyd/Federalist, 2021	“A Centers for Disease Control report released in September shows that masks and face coverings are not effective in preventing the spread of COVID-19, even for those people who consistently wear them.”
57) Most Mask Studies Are Garbage, Eugyppius, 2021	“The other kind of study, the proper kind, would be a randomised controlled trial. You compare the rates of infection in a masked cohort against rates of infection in an unmasked cohort. Here things have gone much, much worse for mask brigade. They spent months trying to prevent the publication of the Danish randomised controlled trial, which found that masks do zero. When that paper finally squeaked into print, they spent more months trying desperately to poke holes in it. You could feel their boundless relief when the Bangladesh study finally appeared to save them in early September. Every last Twitter blue-check could now proclaim that Science Shows Masks Work. Such was their hunger for any scrap of evidence to prop up their prior convictions, that none of them noticed the sad nature of the Science in question. The study found a mere 10% reduction in seroprevalence among the masked cohort, an effect so small that it fell within the confidence interval. Even the study authors couldn’t exclude the possibility that masks in fact do zero.”
58) Using face masks in the community: first update, ECDC, 2021	“No high-quality evidence in favor of face masks and recommended their use only based on the ‘precautionary principle.”
59) Do physical measures such as hand-washing or wearing masks stop or slow down the spread of respiratory viruses?, Cochrane, 2020	“Seven studies took place in the community, and two studies in healthcare workers. Compared with wearing no mask, wearing a mask may make little to no difference in how many people caught a flu-like illness (9 studies; 3507 people); and probably makes no difference in how many people have flu confirmed by a laboratory test (6 studies; 3005 people). Unwanted effects were rarely reported, but included discomfort.”
60) Mouth-nose protection in public: No evidence of effectiveness, Thieme/ Kappstein, 2020	“The use of masks in public spaces is questionable simply because of the lack of scientific data. If one also considers the necessary precautions, masks must even be considered a risk of infection in public spaces according to the rules known from hospitals… If masks are worn by the population, the risk of infection is potentially increased, regardless of whether they are medical masks or whether they are so-called community masks designed in any way. If one considers the precautionary measures that the RKI as well as the international health authorities have pronounced, all authorities would even have to inform the population that masks should not be worn in public spaces at all. Because no matter whether it is a duty for all citizens or voluntarily borne by the citizens who want it for whatever reason, it remains a fact that masks can do more harm than good in public.”
61) US mask guidance for kids is the strictest across the world,  Skelding, 2021	“Kids need to see faces,” Jay Bhattacharya, a professor of medicine at Stanford University, told The Post. Youngsters watch people’s mouths to learn to speak, read and understand emotions, he said.“We have this idea that this disease is so bad that we must adopt any means necessary to stop it from spreading,” he said. “It’s not that masks in schools have no costs. They actually do have substantial costs.”
62) Masking young children in school harms language acquisition, Walsh, 2021	“This is important because children and/or students do not have the speech or language ability that adults have — they are not equally able and the ability to see the face and especially the mouth is critical to language acquisition which children and/or students are engaged in at all times. Furthermore, the ability to see the mouth is not only essential to communication but also essential to brain development.”
63) The Case Against Masks for Children, Makary, 2021	“It’s abusive to force kids who struggle with them to sacrifice for the sake of unvaccinated adults… Do masks reduce Covid transmission in children? Believe it or not, we could find only a single retrospective study on the question, and its results were inconclusive. Yet two weeks ago the Centers for Disease Control and Prevention sternly decreed that 56 million U.S. children and adolescents, vaccinated or not, should cover their faces regardless of the prevalence of infection in their community. Authorities in many places took the cue to impose mandates in schools and elsewhere, on the theory that masks can’t do any harm. That isn’t true. Some children are fine wearing a mask, but others struggle. Those who have myopia can have difficulty seeing because the mask fogs their glasses. (This has long been a problem for medical students in the operating room.) Masks can cause severe acne and other skin problems. The discomfort of a mask distracts some children from learning. By increasing airway resistance during exhalation, masks can lead to increased levels of carbon dioxide in the blood. And masks can be vectors for pathogens if they become moist or are used for too long.”
64) Face Covering Mandates, Peavey, 2021	“Face Covering Mandates And Why They AREN’T Effective.”
65) Do masks work? A Review of the evidence, Anderson, 2021	“In truth, the CDC’s, U.K.’s, and WHO’s earlier guidance was much more consistent with the best medical research on masks’ effectiveness in preventing the spread of viruses. That research suggests that Americans’ many months of mask-wearing has likely provided little to no health benefit and might even have been counterproductive in preventing the spread of the novel coronavirus.”
66) Most face masks won’t stop COVID-19 indoors, study warns, Anderer, 2021	“New research reveals that cloth masks filter just 10% of exhaled aerosols, with many people not wearing coverings that fit their face properly.”
67) How face masks and lockdowns failed/the face mask folly in retrospect, Swiss Policy Research, 2021	“Mask mandates and lockdowns have had no discernible impact.”
68) CDC Releases School COVID Transmission Study But Buries One of the Most Damning Parts, Davis, 2021	“The 21% lower incidence in schools that required mask use among students was not statistically significant compared with schools where mask use was optional… With tens of millions of American kids headed back to school in the fall, their parents and political leaders owe it to them to have a clear-sighted, scientifically rigorous discussion about which anti-COVID measures actually work and which might put an extra burden on vulnerable young people without meaningfully or demonstrably slowing the spread of the virus…that a masking requirement of students failed to show independent benefit is a finding of consequence and great interest.”
69) World Health Organization internal meeting, COVID-19 – virtual press conference – 30 March 2020, 2020	“This is a question on Austria. The Austrian Government has a desire to make everyone wear a mask who’s going into the shops. I understood from our previous briefings with you that the general public should not wear masks because they are in short supply. What do you say about the new Austrian measures?… I’m not specifically aware of that measure in Austria. I would assume that it’s aimed at people who potentially have the disease not passing it to others. In general WHO recommends that the wearing of a mask by a member of the public is to prevent that individual giving the disease to somebody else. We don’t generally recommend the wearing to masks in public by otherwise well individuals because it has not been up to now associated with any particular benefit.”
70) Face masks to prevent transmission of influenza virus: a systematic review, Cowling, 2010	“Review highlights the limited evidence base supporting the efficacy or effectiveness of face masks to reduce influenza virus transmission.”“None of the studies reviewed showed a benefit from wearing a mask, in either HCW or community members in households (H).”
71) Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis, Smith, 2016	“Although N95 respirators appeared to have a protective advantage over surgical masks in laboratory settings, our meta-analysis showed that there were insufficient data to determine definitively whether N95 respirators are superior to surgical masks in protecting health care workers against transmissible acute respiratory infections in clinical settings.”
72) Effectiveness of Masks and Respirators Against Respiratory Infections in Healthcare Workers: A Systematic Review and Meta-Analysis, Offeddu, 2017	“We found evidence to support universal medical mask use in hospital settings as part of infection control measures to reduce the risk of CRI and ILI among HCWs. Overall, N95 respirators may convey greater protection, but universal use throughout a work shift is likely to be less acceptable due to greater discomfort…Our analysis confirms the effectiveness of medical masks and respirators against SARS. Disposable, cotton, or paper masks are not recommended. The confirmed effectiveness of medical masks is crucially important for lower-resource and emergency settings lacking access to N95 respirators. In such cases, single-use medical masks are preferable to cloth masks, for which there is no evidence of protection and which might facilitate transmission of pathogens when used repeatedly without adequate sterilization…We found no clear benefit of either medical masks or N95 respirators against pH1N1…Overall, the evidence to inform policies on mask use in HCWs is poor, with a small number of studies that is prone to reporting biases and lack of statistical power.”
73) N95 Respirators vs Medical Masks for Preventing Influenza Among Health Care Personnel, Radonovich, 2019	“Use of N95 respirators, compared with medical masks, in the outpatient setting resulted in no significant difference in the rates of laboratory-confirmed influenza.”
Effectiveness of N95 respirators versus surgical masks againstinfluenza: A systematic review and meta-analysis74) Masks Don’t Work: A Review of Science Relevant to COVID-19 Social Policy, Rancourt, 2020	The use of N95 respirators compared with surgical masks is not associated with alower risk of laboratory-confirmed influenza. It suggests that N95 respirators should not be rec-ommended for general public and nonhigh-risk medical staff those are not in close contact withinfluenza patients or suspected patients. “No RCT study with verified outcome shows a benefit for HCW or community members in households to wearing a mask or respirator. There is no such study. There are no exceptions. Likewise, no study exists that shows a benefit from a broad policy to wear masks in public (more on this below). Furthermore, if there were any benefit to wearing a mask, because of the blocking power against droplets and aerosol particles, then there should be more benefit from wearing a respirator (N95) compared to a surgical mask, yet several large meta-analyses, and all the RCT, prove that there is no such relative benefit.”
75) More Than a Dozen Credible Medical Studies Prove Face Masks Do Not Work Even In Hospitals!, Firstenberg, 2020	“Mandating masks has not kept death rates down anywhere. The 20 U.S. states that have never ordered people to wear face masks indoors and out have dramatically lower COVID-19 death rates than the 30 states that have mandated masks. Most of the no-mask states have COVID-19 death rates below 20 per 100,000 population, and none have a death rate higher than 55. All 13 states that have death rates higher 55 are states that have required the wearing of masks in all public places. It has not protected them.”
76) Does evidence based medicine support the effectiveness of surgical facemasks in preventing postoperative wound infections in elective surgery?, Bahli, 2009	“From the limited randomized trials it is still not clear that whether wearing surgical face masks harms or benefit the patients undergoing elective surgery.”
77) Peritonitis prevention in CAPD: to mask or not?, Figueiredo, 2000	“The current study suggests that routine use of face masks during CAPD bag exchanges may be unnecessary and could be discontinued.”
78) The operating room environment as affected by people and the surgical face mask, Ritter, 1975	“The wearing of a surgical face mask had no effect upon the overall operating room environmental contamination and probably work only to redirect the projectile effect of talking and breathing. People are the major source of environmental contamination in the operating room.”
79) The efficacy of standard surgical face masks: an investigation using “tracer particles, Ha’eri, 1980	“Particle contamination of the wound was demonstrated in all experiments. Since the microspheres were not identified on the exterior of these face masks, they must have escaped around the mask edges and found their way into the wound.”
80) Wearing of caps and masks not necessary during cardiac catheterization, Laslett, 1989	“Prospectively evaluated the experience of 504 patients undergoing percutaneous left heart catheterization, seeking evidence of a relationship between whether caps and/or masks were worn by the operators and the incidence of infection. No infections were found in any patient, regardless of whether a cap or mask was used. Thus, we found no evidence that caps or masks need to be worn during percutaneous cardiac catheterization.”
81) Do anaesthetists need to wear surgical masks in the operating theatre? A literature review with evidence-based recommendations, Skinner, 2001	“A questionnaire-based survey, undertaken by Leyland’ in 1993 to assess attitudes to the use of masks, showed that 20% of surgeons discarded surgical masks for endoscopic work. Less than 50% did not wear the mask as recommended by the Medical Research Council. Equal numbers of surgeons wore the mask in the belief they were protecting themselves and the patient, with 20% of these admitting that tradition was the only reason for wearing them.”
82) Mask mandates for children are not backed by data, Faria, 2021	“Even if you want to use the 2018-19 flu season to avoid overlap with the start of the COVID-19 pandemic, the CDC paints a similar picture: It estimated 480 flu deaths among children during that period, with 46,000 hospitalizations. COVID-19, mercifully, is simply not as deadly for children. According to the American Academy of Pediatrics, preliminary data from 45 states show that between 0.00%-0.03% of child COVID-19 cases resulted in death. When you combine these numbers with the CDC study that found mask mandates for students — along with hybrid models, social distancing, and classroom barriers — did not have a statistically significant benefit in preventing the spread of COVID-19 in schools, the insistence that we force students to jump through these hoops for their own protection makes no sense.”
83) The Downsides of Masking Young Students Are Real, Prasad, 2021	“The benefits of mask requirements in schools might seem self-evident—they have to help contain the coronavirus, right?—but that may not be so. In Spain, masks are used in kids ages 6 and older. The authors of one study there examined the risk of viral spread at all ages. If masks provided a large benefit, then the transmission rate among 5-year-olds would be far higher than the rate among 6-year-olds. The results don’t show that. Instead, they show that transmission rates, which were low among the youngest kids, steadily increased with age—rather than dropping sharply for older children subject to the face-covering requirement. This suggests that masking kids in school does not provide a major benefit and might provide none at all. And yet many officials prefer to double down on masking mandates, as if the fundamental policy were sound and only the people have failed.”
84) Masks In Schools: Scientific American Fumbles Report On Childhood COVID Transmission, English/ACSH, 2021	“Masking is a low-risk, inexpensive intervention. If we want to recommend it as a precautionary measure, especially in situations where vaccination isn’t an option, great. But that’s not what the public has been told. “Florida governor Ron DeSantis and politicians in Texas say research does not support mask mandates,” SciAm’s sub-headline bellowed. “Many studies show they are wrong.”If that’s the case, demonstrate that the intervention works before you mandate its use in schools. If you can’t, acknowledged what UC San Francisco hematologist-oncologist and Associate Professor of Epidemiology Vinay Prasad wrote over at the Atlantic:”No scientific consensus exists about the wisdom of mandatory-masking rules for schoolchildren … In mid-March 2020, few could argue against erring on the side of caution. But nearly 18 months later, we owe it to children and their parents to answer the question properly: Do the benefits of masking kids in school outweigh the downsides? The honest answer in 2021 remains that we don’t know for sure.”
85) Masks ‘don’t work,’ are damaging health and are being used to control population: Doctors panel, Haynes, 2021	“The only randomized control studies that have ever been done on masks show that they don’t work,” began Dr. Nepute. He referred to Dr. Anthony Fauci’s “noble lie,” in which Fauci “changed his tune,” from his March 2020 comments, where he downplayed the need and efficacy of mask wearing, before urging Americans to use masks later in the year. “Well, he lied to us. So if he lied about that, what else has he lied to you about?” questioned Nepute.Masks have become commonplace in almost every setting, whether indoors or outdoors, but Dr. Popper mentioned how there have been “no studies” which actually examine the “effect of wearing a mask during all your waking hours.”“There’s no science to back any of this and particularly no science to back the fact that wearing a mask twenty four-seven or every waking minute, is health promoting,” added Popper.”
86) Aerosol penetration through surgical masks, Chen, 1992	“The mask that has the highest collection efficiency is not necessarily the best mask from the perspective of the filter-quality factor, which considers not only the capture efficiency but also the air resistance. Although surgical mask media may be adequate to remove bacteria exhaled or expelled by health care workers, they may not be sufficient to remove the sub-micrometer-sized aerosols containing pathogens to which these health care workers are potentially exposed.”
87) CDC: Schools With Mask Mandates Didn’t See Statistically Significant Different Rates of COVID Transmission From Schools With Optional Policies, Miltimore, 2021	“The CDC did not include its finding that “required mask use among students was not statistically significant compared with schools where mask use was optional” in the summary of its report.”
88) Horowitz: Data from India continues to blow up the ‘Delta’ fear narrative, Howorwitz, 2021	“Rather than proving the need to sow more panic, fear, and control over people, the story from India — the source of the “Delta” variant — continues to refute every current premise of COVID fascism…Unless we do that, we must return to the very effective lockdowns and masks. In reality, India’s experience proves the opposite true; namely:1) Delta is largely an attenuated version, with a much lower fatality rate, that for most people is akin to a cold.2) Masks failed to stop the spread there.3) The country has come close to the herd immunity threshold with just 3% vaccinated.
89) Transmission of SARS-CoV-2 Delta Variant Among Vaccinated Healthcare Workers, Vietnam, Chau, 2021	While not definitive in the LANCET publication, it can be inferred that the nurses were all masked up and had PPE etc. as was the case in Finland and Israel nosocomial outbreaks, indicating the failure of PPE and masks to constrain Delta spread.
90) Aerosol penetration through surgical masks, Willeke, 1992	“The mask that has the highest collection efficiency is not necessarily the best mask from the perspective of the filter-quality factor, which considers not only the capture efficiency but also the air resistance. Although surgical mask media may be adequate to remove bacteria exhaled or expelled by health care workers, they may not be sufficient to remove the submicrometer-size aerosols containing pathogens to which these health care workers are potentially exposed.”
91) The efficacy of standard surgical face masks: an investigation using “tracer particles”, Wiley, 1980	“Particle contamination of the wound was demonstrated in all aexperiments. Since the microspheres were not identified on the exterior of these face masks, they must have escped around the mask edges and found their way into the wound. The wearing of the mask beneath the headgear curtails this route of contamination.”
92) An Evidence Based Scientific Analysis of Why Masks are Ineffective, Unnecessary, and Harmful, Meehan, 2020	“Decades of the highest-level scientific evidence (meta-analyses of multiple randomized controlled trials) overwhelmingly conclude that medical masks are ineffective at preventing the transmission of respiratory viruses, including SAR-CoV-2…those arguing for masks are relying on low-level evidence (observational retrospective trials and mechanistic theories), none of which are powered to counter the evidence, arguments, and risks of mask mandates.”
93) Open Letter from Medical Doctors and Health Professionals to All Belgian Authorities and All Belgian Media, AIER, 2020	“Oral masks in healthy individuals are ineffective against the spread of viral infections.”
94) Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis, Long, 2020	“The use of N95 respirators compared with surgical masks is not associated with a lower risk of laboratory-confirmed influenza. It suggests that N95 respirators should not be recommended for general public and nonhigh-risk medical staff those are not in close contact with influenza patients or suspected patients.”
95) Advice on the use of masks in the context of COVID-19, WHO, 2020	“However, the use of a mask alone is insufficient to provide an adequate level of protection or source control, and other personal and community level measures should also be adopted to suppress transmission of respiratory viruses.”
96) Farce mask: it’s safe for only 20 minutes, The Sydney Morning Herald, 2003	“Health authorities have warned that surgical masks may not be an effective protection against the virus.”Those masks are only effective so long as they are dry,” said Professor Yvonne Cossart of the Department of Infectious Diseases at the University of Sydney.”As soon as they become saturated with the moisture in your breath they stop doing their job and pass on the droplets.”Professor Cossart said that could take as little as 15 or 20 minutes, after which the mask would need to be changed. But those warnings haven’t stopped people snapping up the masks, with retailers reporting they are having trouble keeping up with demand.”
97) Study: Wearing A Used Mask Is Potentially Riskier Than No Mask At All, Boyd, 2020 Effects of mask-wearing on the inhalability and deposition of airborne SARS-CoV-2 aerosols in human upper airway	“According to researchers from the University of Massachusetts Lowell and California Baptist University, a three-layer surgical mask is 65 percent efficient in filtering particles in the air. That effectiveness, however, falls to 25 percent once it is used.“It is natural to think that wearing a mask, no matter new or old, should always be better than nothing,” said author Jinxiang Xi.“Our results show that this belief is only true for particles larger than 5 micrometers, but not for fine particles smaller than 2.5 micrometers,” he continued.”
MASK MANDATES
1) Mask mandate and use efficacy for COVID-19 containment in US States, Guerra, 2021	“Calculated total COVID-19 case growth and mask use for the continental United States with data from the Centers for Disease Control and Prevention and Institute for Health Metrics and Evaluation. We estimated post-mask mandate case growth in non-mandate states using median issuance dates of neighboring states with mandates…did not observe association between mask mandates or use and reduced COVID-19 spread in US states.”
2) These 12 Graphs Show Mask Mandates Do Nothing To Stop COVID, Weiss, 2020	“Masks can work well when they’re fully sealed, properly fitted, changed often, and have a filter designed for virus-sized particles. This represents none of the common masks available on the consumer market, making universal masking much more of a confidence trick than a medical solution…Our universal use of unscientific face coverings is therefore closer to medieval superstition than it is to science, but many powerful institutions have too much political capital invested in the mask narrative at this point, so the dogma is perpetuated. The narrative says that if cases go down it’s because masks succeeded. It says that if cases go up it’s because masks succeeded in preventing more cases. The narrative simply assumes rather than proves that masks work, despite overwhelming scientific evidence to the contrary.”
3) Mask Mandates Seem to Make CCP Virus Infection Rates Climb, Study Says, Vadum, 2020	“Protective-mask mandates aimed at combating the spread of the CCP virus that causes the disease COVID-19 appear to promote its spread, according to a report from RationalGround.com, a clearinghouse of COVID-19 data trends that’s run by a grassroots group of data analysts, computer scientists, and actuaries.”
4) Horowitz: Comprehensive analysis of 50 states shows greater spread with mask mandates, Howorwitz, 2020 Justin Hart	“How long do our politicians get to ignore the results?… The results: When comparing states with mandates vs. those without, or periods of times within a state with a mandate vs. without, there is absolutely no evidence the mask mandate worked to slow the spread one iota. In total, in the states that had a mandate in effect, there were 9,605,256 confirmed COVID cases over 5,907 total days, an average of 27 cases per 100,000 per day. When states did not have a statewide order (which includes the states that never had them and the period of time masking states did not have the mandate in place) there were 5,781,716 cases over 5,772 total days, averaging 17 cases per 100,000 people per day.”
5) The CDC’s Mask Mandate Study: Debunked, Alexander, 2021	“Thus, it is not surprising that the CDC’s own recent conclusion on the use of nonpharmaceutical measures such as face masks in pandemic influenza, warned that scientific “evidence from 14 randomized controlled trials of these measures did not support a substantial effect on transmission…” Moreover, in the WHO’s 2019 guidance document on nonpharmaceutical public health measures in a pandemic, they reported as to face masks that “there is no evidence that this is effective in reducing transmission…” Similarly, in the fine print to a recent double-blind, double-masking simulation the CDC stated that “The findings of these simulations [supporting mask usage] should neither be generalized to the effectiveness …nor interpreted as being representative of the effectiveness of these masks when worn in real-world settings.”
6) Phil Kerpin, tweet, 2021 The Spectator	“The first ecological study of state mask mandates and use to include winter data: “Case growth was independent of mandates at low and high rates of community spread, and mask use did not predict case growth during the Summer or Fall-Winter waves.”
7) How face masks and lockdowns failed, SPR, 2021	“Infections have been driven primarily by seasonal and endemic factors, whereas mask mandates and lockdowns have had no discernible impact”
8) Analysis of the Effects of COVID-19 Mask Mandates on Hospital Resource Consumption and Mortality at the County Level, Schauer, 2021	“There was no reduction in per-population daily mortality, hospital bed, ICU bed, or ventilator occupancy of COVID-19-positive patients attributable to the implementation of a mask-wearing mandate.”
9) Do we need mask mandates, Harris, 2021	“But masks proved far less useful in the subsequent 1918 Spanish flu, a viral disease spread by pathogens smaller than bacteria. California’s Department of Health, for instance, reported that the cities of Stockton, which required masks, and Boston, which did not, had scarcely different death rates, and so advised against mask mandates except for a few high-risk professions such as barbers….Randomized controlled trials (RCTs) on mask use, generally more reliable than observational studies, though not infallible, typically show that cloth and surgical masks offer little protection. A few RCTs suggest that perfect adherence to an exacting mask protocol may guard against influenza, but meta-analyses find little on the whole to suggest that masks offer meaningful protection. WHO guidelines from 2019 on influenza say that despite “mechanistic plausibility for the potential effectiveness” of masks, studies showed a benefit too small to be established with any certainty. Another literature review by researchers from the University of Hong Kong agrees. Its best estimate for the protective effect of surgical masks against influenza, based on ten RCTs published through 2018, was just 22 percent, and it could not rule out zero effect.”
MASK HARMS
1) Corona children studies: Co-Ki: First results of a German-wide registry on mouth and nose covering (mask) in children, Schwarz, 2021	“The average wearing time of the mask was 270 minutes per day. Impairments caused by wearing the mask were reported by 68% of the parents. These included irritability (60%), headache (53%), difficulty concentrating (50%), less happiness (49%), reluctance to go to school/kindergarten (44%), malaise (42%) impaired learning (38%) and drowsiness or fatigue (37%).”
2) Dangerous pathogens found on children’s face masks, Cabrera, 2021	“Masks were contaminated with bacteria, parasites, and fungi, including three with dangerous pathogenic and pneumonia-causing bacteria.”
3) Masks, false safety and real dangers, Part 2: Microbial challenges from masks, Borovoy, 2020/2021	“Laboratory testing of used masks from 20 train commuters revealed that 11 of the 20 masks tested contained over 100,000 bacterial colonies. Molds and yeasts were also found. Three of the masks contained more than one million bacterial colonies… The outside surfaces of surgical masks were found to have high levels of the following microbes, even in hospitals, more concentrated on the outside of masks than in the environment. Staphylococcus species (57%) and Pseudomonas spp (38%) were predominant among bacteria, and Penicillium spp (39%) and Aspergillus spp. (31%) were the predominant fungi.”
4) Preliminary report on surgical mask induced deoxygenation during major surgery, Beder, 2008	“Considering our findings, pulse rates of the surgeon’s increase and SpO2 decrease after the first hour. This early change in SpO2 may be either due to the facial mask or the operational stress. Since a very small decrease in saturation at this level, reflects a large decrease in PaO2, our findings may have a clinical value for the health workers and the surgeons.”
5) Mask mandates may affect a child’s emotional, intellectual development, Gillis, 2020	“The thing is we really don’t know for sure what the effect may or may not be. But what we do know is that children, especially in early childhood, they use the mouth as part of the entire face to get a sense of what’s going on around them in terms of adults and other people in their environment as far as their emotions. It also has a role in language development as well… If you think about an infant, when you interact with them you use part of your mouth. They are interested in your facial expressions. And if you think about that part of the face being covered up, there is that possibility that it could have an effect. But we don’t know because this is really an unprecedented time. What we wonder about is if this could play a role and how can we stop it if it would affect child development.”
6) Headaches and the N95 face-mask amongst healthcare providers, Lim, 2006	“Healthcare providers may develop headaches following the use of the N95 face-mask.”
7) Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021, Brooks, 2021	“Although use of double masking or knotting and tucking are two of many options that can optimize fit and enhance mask performance for source control and for wearer protection, double masking might impede breathing or obstruct peripheral vision for some wearers, and knotting and tucking can change the shape of the mask such that it no longer covers fully both the nose and the mouth of persons with larger faces.”
8) Facemasks in the COVID-19 era: A health hypothesis, Vainshelboim, 2021	“Wearing facemasks has been demonstrated to have substantial adverse physiological and psychological effects. These include hypoxia, hypercapnia, shortness of breath, increased acidity and toxicity, activation of fear and stress response, rise in stress hormones, immunosuppression, fatigue, headaches, decline in cognitive performance, predisposition for viral and infectious illnesses, chronic stress, anxiety and depression.”
9) Wearing a mask can expose children to dangerous levels of carbon dioxide in just THREE MINUTES, study finds, Shaheen/Daily Mail, 2021	“European study found that children wearing masks for only minutes could be exposed to dangerous carbon dioxide levels…Forty-five children were exposed to carbon dioxide levels between three to twelve times healthy levels.”
10) How many children must die? Shilhavy, 2020	“How long are parents going to continue masking their children causing great harm to them, even to the point of risking their lives? Dr. Eric Nepute in St. Louis took time to record a video rant that he wants everyone to share, after the 4-year-old child of one of his patients almost died from a bacterial lung infection caused by prolonged mask use.”
11) Medical Doctor Warns that “Bacterial Pneumonias Are on the Rise” from Mask Wearing, Meehan, 2021	“I’m seeing patients that have facial rashes, fungal infections, bacterial infections. Reports coming from my colleagues, all over the world, are suggesting that the bacterial pneumonias are on the rise…Why might that be? Because untrained members of the public are wearing medical masks, repeatedly… in a non-sterile fashion… They’re becoming contaminated. They’re pulling them off of their car seat, off the rear-view mirror, out of their pocket, from their countertop, and they’re reapplying a mask that should be worn fresh and sterile every single time.”
12) Open Letter from Medical Doctors and Health Professionals to All Belgian Authorities and All Belgian Media, AIER, 2020	“Wearing a mask is not without side effects. Oxygen deficiency (headache, nausea, fatigue, loss of concentration) occurs fairly quickly, an effect similar to altitude sickness. Every day we now see patients complaining of headaches, sinus problems, respiratory problems and hyperventilation due to wearing masks. In addition, the accumulated CO2 leads to a toxic acidification of the organism which affects our immunity. Some experts even warn of an increased transmission of the virus in case of inappropriate use of the mask.”
13) Face coverings for covid-19: from medical intervention to social practice, Peters, 2020	“At present, there is no direct evidence (from studies on Covid19 and in healthy people in the community) on the effectiveness of universal masking of healthy people in the community to prevent infection with respiratory viruses, including Covid19. Contamination of the upper respiratory tract by viruses and bacteria on the outside of medical face masks has been detected in several hospitals. Another research shows that a moist mask is a breeding ground for (antibiotic resistant) bacteria and fungi, which can undermine mucosal viral immunity. This research advocates the use of medical / surgical masks (instead of homemade cotton masks) that are used once and replaced after a few hours.”
14) Face masks for the public during the covid-19 crisis, Lazzarino, 2020	“The two potential side effects that have already been acknowledged are: (1) Wearing a face mask may give a false sense of security and make people adopt a reduction in compliance with other infection control measures, including social distancing and hands washing. (2) Inappropriate use of face mask: people must not touch their masks, must change their single-use masks frequently or wash them regularly, dispose them correctly and adopt other management measures, otherwise their risks and those of others may increase. Other potential side effects that we must consider are: (3) The quality and the volume of speech between two people wearing masks is considerably compromised and they may unconsciously come closer. While one may be trained to counteract side effect n.1, this side effect may be more difficult to tackle. (4) Wearing a face mask makes the exhaled air go into the eyes. This generates an uncomfortable feeling and an impulse to touch your eyes. If your hands are contaminated, you are infecting yourself.”
15) Contamination by respiratory viruses on outer surface of medical masks used by hospital healthcare workers, Chughtai, 2019	“Respiratory pathogens on the outer surface of the used medical masks may result in self-contamination. The risk is higher with longer duration of mask use (> 6 h) and with higher rates of clinical contact. Protocols on duration of mask use should specify a maximum time of continuous use, and should consider guidance in high contact settings.”
16) Reusability of Facemasks During an Influenza Pandemic, Bailar, 2006	“After considering all the testimony and other information we received, the committee concluded that there is currently no simple, reliable way to decontaminate these devices and enable people to use them safely more than once. There is relatively little data available about how effective these devices are against flu even the first time they are used. To the extent they can help at all, they must be used correctly, and the best respirator or mask will do little to protect a person who uses it incorrectly. Substantial research must be done to increase our understanding of how flu spreads, to develop better masks and respirators, and to make it easier to decontaminate them. Finally, the use of face coverings is only one of many strategies that will be needed to slow or halt a pandemic, and people should not engage in activities that would increase their risk of exposure to flu just because they have a mask or respirator.”
17) Exhalation of respiratory viruses by breathing, coughing, and talking, Stelzer-Braid, 2009	“The exhaled aerosols generated by coughing, talking, and breathing were sampled in 50 subjects using a novel mask, and analyzed using PCR for nine respiratory viruses. The exhaled samples from a subset of 10 subjects who were PCR positive for rhinovirus were also examined by cell culture for this virus. Of the 50 subjects, among the 33 with symptoms of upper respiratory tract infections, 21 had at least one virus detected by PCR, while amongst the 17 asymptomatic subjects, 4 had a virus detected by PCR. Overall, rhinovirus was detected in 19 subjects, influenza in 4 subjects, parainfluenza in 2 subjects, and human metapneumovirus in 1 subject. Two subjects were co-infected. Of the 25 subjects who had virus-positive nasal mucus, the same virus type was detected in 12 breathing samples, 8 talking samples, and in 2 coughing samples. In the subset of exhaled samples from 10 subjects examined by culture, infective rhinovirus was detected in 2.”
18) [Effect of a surgical mask on six minute walking distance], Person, 2018	“Wearing a surgical mask modifies significantly and clinically dyspnea without influencing walked distance.”
19) Protective masks reduce resilience, Science ORF, 2020	“The German researchers used two types of face masks for their study – surgical masks and so-called FFP2 masks, which are mainly used by medical personnel. The measurements were carried out with the help of spiroergometry, in which patients or in this case the test persons exert themselves physically on a stationary bicycle – a so-called ergometer – or a treadmill. The subjects were examined without a mask, with surgical masks and with FFP2 masks. The masks therefore impair breathing, especially the volume and the highest possible speed of the air when exhaling. The maximum possible force on the ergometer was significantly reduced.”
20) Wearing masks even more unhealthy than expected, Coronoa transition, 2020	“They contain microplastics – and they exacerbate the waste problem…”Many of them are made of polyester and so you have a microplastic problem.” Many of the face masks would contain polyester with chlorine compounds: “If I have the mask in front of my face, then of course I breathe in the microplastic directly and these substances are much more toxic than if you swallow them, as they get directly into the nervous system,” Braungart continues.”
21) Masking Children: Tragic, Unscientific, and Damaging, Alexander, 2021	“Children do not readily acquire SARS-CoV-2 (very low risk), spread it to other children or teachers, or endanger parents or others at home. This is the settled science. In the rare cases where a child contracts Covid virus it is very unusual for the child to get severely ill or die. Masking can do positive harm to children – as it can to some adults. But the cost benefit analysis is entirely different for adults and children – particularly younger children. Whatever arguments there may be for consenting adults – children should not be required to wear masks to prevent the spread of Covid-19. Of course, zero risk is not attainable – with or without masks, vaccines, therapeutics, distancing or anything else medicine may develop or government agencies may impose.”
22) The Dangers of Masks, Alexander, 2021	“With that clarion call, we pivot and refer here to another looming concern and this is the potential danger of the chlorine, polyester, and microplastic components of the face masks (surgical principally but any of the mass-produced masks) that have become part of our daily lives due to the Covid-19 pandemic. We hope those with persuasive power in the government will listen to this plea. We hope that the necessary decisions will be made to reduce the risk to our populations.”
23) 13-year-old mask wearer dies for inexplicable reasons, Corona Transition, 2020	“The case is not only causing speculation in Germany about possible poisoning with carbon dioxide. Because the student “was wearing a corona protective mask when she suddenly collapsed and died a little later in the hospital,” writes Wochenblick.Editor’s Review: The fact that no cause of death was communicated nearly three weeks after the girl’s death is indeed unusual. The carbon dioxide content of the air is usually about 0.04 percent. From a proportion of four percent, the first symptoms of hypercapnia, i.e. carbon dioxide poisoning, appear. If the proportion of the gas rises to more than 20 percent, there is a risk of deadly carbon dioxide poisoning. However, this does not come without alarm signals from the body. According to the medical portal netdoktor, these include “sweating, accelerated breathing, accelerated heartbeat, headaches, confusion, loss of consciousness”. The unconsciousness of the girl could therefore be an indication of such poisoning.”
24) Student Deaths Lead Chinese Schools to Change Mask Rules, that’s, 2020	“During the month of April, three cases of students suffering sudden cardiac death (SCD) while running during gym class have been reported in Zhejiang, Henan and Hunan provinces. Beijing Evening News noted that all three students were wearing masks at the time of their deaths, igniting a critical discussion over school rules on when students should wear masks.”
25) Blaylock: Face Masks Pose Serious Risks To The Healthy, 2020	“As for the scientific support for the use of face mask, a recent careful examination of the literature, in which 17 of the best studies were analyzed, concluded that, “ None of the studies established a conclusive relationship between mask/respirator use and protection against influenza infection.”1   Keep in mind, no studies have been done to demonstrate that either a cloth mask or the N95 mask has any effect on transmission of the COVID-19 virus. Any recommendations, therefore, have to be based on studies of influenza virus transmission. And, as you have seen, there is no conclusive evidence of their efficiency in controlling flu virus transmission.”
26) The mask requirement is responsible for severe psychological damage and the weakening of the immune system, Coronoa Transition, 2020	“In fact, the mask has the potential to “trigger strong psychovegetative stress reactions via emerging aggression, which correlate significantly with the degree of stressful after-effects”. Prousa is not alone in her opinion. Several psychologists dealt with the mask problem — and most came to devastating results. Ignoring them would be fatal, according to Prousa.”
27) The physiological impact of wearing an N95 mask during hemodialysis as a precaution against SARS in patients with end-stage renal disease, Kao, 2004	“Wearing an N95 mask for 4 hours during HD significantly reduced PaO2 and increased respiratory adverse effects in ESRD patients.”
28) Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?, Kisielinski, 2021	“We objectified evaluation evidenced changes in respiratory physiology of mask wearers with significant correlation of O2 drop and fatigue (p < 0.05), a clustered co-occurrence of respiratory impairment and O2 drop (67%), N95 mask and CO2 rise (82%), N95 mask and O2 drop (72%), N95 mask and headache (60%), respiratory impairment and temperature rise (88%), but also temperature rise and moisture (100%) under the masks. Extended mask-wearing by the general population could lead to relevant effects and consequences in many medical fields.”“Here are the pathophysiological changes and subjective complaints: 1) Increase in blood carbon dioxide 2) Increase in breathing resistance 3) Decrease in blood oxygen saturation 4) Increase in heart rate 5) Decrease in cardiopulmonary capacity 6) Feeling of exhaustion 7) Increase in respiratory rate 8) Difficulty breathing and shortness of breath 9) Headache 10) Dizziness 11) Feeling of dampness and heat 12) Drowsiness (qualitative neurological deficits) 13) Decrease in empathy perception 14) Impaired skin barrier function with acne, itching and skin lesions”
29) Is N95 face mask linked to dizziness and headache?, Ipek, 2021	“Respiratory alkalosis and hypocarbia were detected after the use of N95. Acute respiratory alkalosis can cause headache, anxiety, tremor, muscle cramps. In this study, it was quantitatively shown that the participants’ symptoms were due to respiratory alkalosis and hypocarbia.”
30) COVID-19 prompts a team of engineers to rethink the humble face mask, Myers, 2020	“But in filtering those particles, the mask also makes it harder to breathe. N95 masks are estimated to reduce oxygen intake by anywhere from 5 to 20 percent. That’s significant, even for a healthy person. It can cause dizziness and lightheadedness. If you wear a mask long enough, it can damage the lungs. For a patient in respiratory distress, it can even be life threatening.”
31) 70 doctors in open letter to Ben Weyts: ‘Abolish mandatory mouth mask at school’ – Belgium, World Today News, 2020	“In an open letter to the Flemish Minister of Education Ben Weyts (N-VA), 70 doctors ask to abolish the mandatory mouth mask at school, both for the teachers and for the students. Weyts does not intend to change course. The doctors ask that Minister Ben Weyts immediately reverses his working method: no mouth mask obligation at school, only protect the risk group and only the advice that people with a possible risk profile should consult their doctor.”
32) Face masks pose dangers for babies, toddlers during COVID-19 pandemic, UC Davis Health, 2020	“Masks may present a choking hazard for young children. Also, depending on the mask and the fit, the child may have trouble breathing. If this happens, they need to be able to take it off,” said UC Davis pediatrician Lena van der List. “Children less than 2 years of age will not reliably be able to remove a face mask and could suffocate. Therefore, masks should not routinely be used for young children…“The younger the child, the more likely they will be to not wear the mask properly, reach under the mask and touch potentially contaminated masks,” said Dean Blumberg, chief of pediatric infectious diseases at UC Davis Children’s Hospital. “Of course, this depends on the developmental level of the individual child. But I think masks are not likely to provide much potential benefit over risk until the teen years.”
33) Covid-19: Important potential side effects of wearing face masks that we should bear in mind, Lazzarino, 2020	“Other potential side effects that we must consider, however, are 1) The quality and volume of speech between people wearing masks is considerably compromised and they may unconsciously come closer2) Wearing a mask makes the exhaled air go into the eyes. This generates an impulse to touch the eyes. 3) If your hands are contaminated, you are infecting yourself, 4) Face masks make breathing more difficult. Moreover, a fraction of carbon dioxide previously exhaled is inhaled at each respiratory cycle. Those phenomena increase breathing frequency and deepness, and they may worsen the burden of covid-19 if infected people wearing masks spread more contaminated air. This may also worsen the clinical condition of infected people if the enhanced breathing pushes the viral load down into their lungs, 5) The innate immunity’s efficacy is highly dependent on the viral load. If masks determine a humid habitat where SARS-CoV-2 can remain active because of the water vapour continuously provided by breathing and captured by the mask fabric, they determine an increase in viral load (by re-inhaling exhaled viruses) and therefore they can cause a defeat of the innate immunity and an increase in infections.”
34) Risks of N95 Face Mask Use in Subjects With COPD, Kyung, 2020	“Of the 97 subjects, 7 with COPD did not wear the N95 for the entire test duration. This mask-failure group showed higher British modified Medical Research Council dyspnea scale scores and lower FEV1 percent of predicted values than did the successful mask use group. A modified Medical Research Council dyspnea scale score ≥ 3 (odds ratio 167, 95% CI 8.4 to >999.9; P = .008) or a FEV1 < 30% predicted (odds ratio 163, 95% CI 7.4 to >999.9; P = .001) was associated with a risk of failure to wear the N95. Breathing frequency, blood oxygen saturation, and exhaled carbon dioxide levels also showed significant differences before and after N95 use.”
35) Masks too dangerous for children under 2, medical group warns, The Japan Times, 2020	“Children under the age of 2 shouldn’t wear masks because they can make breathing difficult and increase the risk of choking, a medical group has said, launching an urgent appeal to parents as the nation reopens from the coronavirus crisis…Masks can make breathing difficult because infants have narrow air passages,” which increases the burden on their hearts, the association said, adding that masks also raise the risk of heat stroke for them.”
36) Face masks can be problematic, dangerous to health of some Canadians: advocates, Spenser, 2020	“Face masks are dangerous to the health of some Canadians and problematic for some others…Asthma Canada president and CEO Vanessa Foran said simply wearing a mask could create risk of an asthma attack.”
37) COVID-19 Masks Are a Crime Against Humanity and Child Abuse, Griesz-Brisson, 2020	“The rebreathing of our exhaled air will without a doubt create oxygen deficiency and a flooding of carbon dioxide. We know that the human brain is very sensitive to oxygen depravation. There are nerve cells for example in the hippocampus, that can’t be longer than 3 minutes without oxygen – they cannot survive. The acute warning symptoms are headaches, drowsiness, dizziness, issues in concentration, slowing down of the reaction time – reactions of the cognitive system. However, when you have chronic oxygen depravation, all of those symptoms disappear, because you get used to it. But your efficiency will remain impaired and the undersupply of oxygen in your brain continues to progress. We know that neurodegenerative diseases take years to decades to develop. If today you forget your phone number, the breakdown in your brain would have already started 20 or 30 years ago…The child needs the brain to learn, and the brain needs oxygen to function.  We don’t need a clinical study for that. This is simple, indisputable physiology. Conscious and purposely induced oxygen deficiency is an absolutely deliberate health hazard, and an absolute medical contraindication.”
38) Study shows how masks are harming children, Mercola, 2021	“Data from the first registry to record children’s experiences with masks show physical, psychological and behavioral issues including irritability, difficulty concentrating and impaired learning.Since school shutdowns in spring 2020, an increasing number of parents are seeking drug treatment for attention deficit hyperactivity disorder (ADHD) for their children.Evidence from the U.K. shows schools are not the super spreaders health officials said they were; measured rates of infection in schools were the same as the community, not higher.A large randomized controlled trial showed wearing masks does not reduce the spread of SARS-CoV-2.”
39) New Study Finds Masks Hurt Schoolchildren Physically, Psychologically, and Behaviorally, Hall, 2021 https://www.researchsquare.com/article/rs-124394/v2	“A new study, involving over 25,000 school-aged children, shows that masks are harming schoolchildren physically, psychologically, and behaviorally, revealing 24 distinct health issues associated with wearing masks…Though these results are concerning, the study also found that 29.7% of children experienced shortness of breath, 26.4% experienced dizziness, and hundreds of the participants experiencing accelerated respiration, tightness in chest, weakness, and short-term impairment of consciousness.”
40) Protective Face Masks: Effect on the Oxygenation and Heart Rate Status of Oral Surgeons during Surgery, Scarano, 2021	“In all 20 surgeons wearing FFP2 covered by surgical masks, a reduction in arterial O2 saturation from around 97.5% before surgery to 94% after surgery was recorded with increase of heart rates. A shortness of breath and light-headedness/headaches were also noted.”
41) Effects of surgical and FFP2/N95 face masks on cardiopulmonary exercise capacity, Fikenzer, 2020	“Ventilation, cardiopulmonary exercise capacity and comfort are reduced by surgical masks and highly impaired by FFP2/N95 face masks in healthy individuals. These data are important for recommendations on wearing face masks at work or during physical exercise.”
42) Headaches Associated With Personal Protective Equipment – A Cross-Sectional Study Among Frontline Healthcare Workers During COVID-19, Ong, 2020	“Most healthcare workers develop de novo PPE-associated headaches or exacerbation of their pre-existing headache disorders.”
43) Open letter from medical doctors and health professionals to all Belgian authorities and all Belgian media, The American Institute of Stress, 2020	“Wearing a mask is not without side effects.  Oxygen deficiency (headache, nausea, fatigue, loss of concentration) occurs fairly quickly, an effect similar to altitude sickness. Every day we now see patients complaining of headaches, sinus problems, respiratory problems, and hyperventilation due to wearing masks. In addition, the accumulated CO2 leads to a toxic acidification of the organism which affects our immunity. Some experts even warn of increased transmission of the virus in case of inappropriate use of the mask.”
44) Reusing masks may increase your risk of coronavirus infection, expert says, Laguipo, 2020	“For the public, they should not wear facemasks unless they are sick, and if a healthcare worker advised them.”For the average member of the public walking down a street, it is not a good idea,” Dr. Harries said.”What tends to happen is people will have one mask. They won’t wear it all the time, they will take it off when they get home, they will put it down on a surface they haven’t cleaned,” she added.Further, she added that behavioral issues could adversely put themselves at more risk of getting the infection. For instance, people go out and don’t wash their hands, they touch parts of the mask or their face, and they get infected.”
45) What’s Going On Under the Masks?, Wright, 2021	“Americans today have pretty good chompers on average, at least relative to most other people, past and present. Nevertheless, we do not think enough about oral health as evidenced by the almost complete lack of discussion regarding the effect of lockdowns and mandatory masking on our mouths.”
46) Experimental Assessment of Carbon Dioxide Content in Inhaled Air With or Without Face Masks in Healthy ChildrenA Randomized Clinical Trial, Walach, 2021	“A large-scale survey in Germany of adverse effects in parents and children using data of 25 930 children has shown that 68% of the participating children had problems when wearing nose and mouth coverings.”
47) NM Kids forced to wear masks while running in 100-degree heat; Parents are striking back, Smith, 2021	“Nationally, children have a 99.997% survival rate from COVID-19.  In New Mexico, only 0.7% of child COVID-19 cases have resulted in hospitalization. It is clear that children have an extremely low risk of severe illness or death from COVID-19, and mask mandates are placing a burden upon kids which is detrimental to their own health and well-being.”
48) Health Canada issues advisory for disposable masks with graphene, CBC, 2021	“Health Canada is advising Canadians not to use disposable face masks that contain graphene. Health Canada issued the notice on Friday and said wearers could inhale graphene, a single layer of carbon atoms. Masks containing the toxic particles may have been distributed in some health-care facilities.”
49) COVID-19: Performance study of microplastic inhalation risk posed by wearing masks, Li, 2021 Is graphene safe?	“Wearing masks considerably reduces the inhalation risk of particles (e.g., granular microplastics and unknown particles) even when they are worn continuously for 720 h. Surgical, cotton, fashion, and activated carbon masks wearing pose higher fiber-like microplastic inhalation risk, while all masks generally reduced exposure when used under their supposed time (<4 h). N95 poses less fiber-like microplastic inhalation risk. Reusing masks after they underwent different disinfection pre-treatment processes can increase the risk of particle (e.g., granular microplastics) and fiber-like microplastic inhalation. Ultraviolet disinfection exerts a relatively weak effect on fiber-like microplastic inhalation, and thus, it can be recommended as a treatment process for reusing masks if proven effective from microbiological standpoint. Wearing an N95 mask reduces the inhalation risk of spherical-type microplastics by 25.5 times compared with not wearing a mask.”
50) Manufacturers have been using nanotechnology-derived graphene in face masks — now there are safety concerns, Maynard, 2021	“Early concerns around graphene were sparked by previous research on another form of carbon — carbon nanotubes. It turns out that some forms of these fiber-like materials can cause serious harm if inhaled. And following on from research here, a natural next-question to ask is whether carbon nanotubes’ close cousin graphene comes with similar concerns.Because graphene lacks many of the physical and chemical aspects of carbon nanotubes that make them harmful (such as being long, thin, and hard for the body to get rid of), the indications are that the material is safer than its nanotube cousins. But safer doesn’t mean safe. And current research indicates that this is not a material that should be used where it could potentially be inhaled, without a good amount of safety testing first…As a general rule of thumb, engineered nanomaterials should not be used in products where they might inadvertently be inhaled and reach the sensitive lower regions of the lungs.”
51) Masking young children in school harms language acquisition, Walsh, 2021	“This is important because children and/or students do not have the speech or language ability that adults have — they are not equally able and the ability to see the face and especially the mouth is critical to language acquisition which children and/or students are engaged in at all times. Furthermore, the ability to see the mouth is not only essential to communication but also essential to brain development.“Studies show that by age four, kids from low-income households will hear 30 million less words than their more affluent counterparts, who get more quality face-time with caretakers.”  (https://news.stanford.edu/news/2014/november/language-toddlers-fernald-110514.html).”
52) Dangerous pathogens found on children’s face masks, Rational Ground, 2021	“A group of parents in Gainesville, FL, sent 6 face masks to a lab at the University of Florida, requesting an analysis of contaminants found on the masks after they had been worn. The resulting report found that five masks were contaminated with bacteria, parasites, and fungi, including three with dangerous pathogenic and pneumonia-causing bacteria. Although the test is capable of detecting viruses, including SARS-CoV-2, only one virus was found on one mask (alcelaphine herpesvirus 1)…Half of the masks were contaminated with one or more strains of pneumonia-causing bacteria. One-third were contaminated with one or more strains of meningitis-causing bacteria. One-third were contaminated with dangerous, antibiotic-resistant bacterial pathogens. In addition, less dangerous pathogens were identified, including pathogens that can cause fever, ulcers, acne, yeast infections, strep throat, periodontal disease, Rocky Mountain Spotted Fever, and more.”
53) Face mask dermatitis” due to compulsory facial masks during the SARS-CoV-2 pandemic: data from 550 health care and non-health care workers in Germany, Niesert, 2021	“The duration of wearing masks showed a significant impact on the prevalence of symptoms (p < 0.001). Type IV hypersensitivity was significantly more likely in participants with symptoms compared to those without symptoms (p = 0.001), whereas no increase in symptoms was observed in participants with atopic diathesis. HCWs used facial skin care products significantly more often than non-HCWs (p = 0.001).”
54) Effect of Wearing Face Masks on the Carbon Dioxide Concentration in the Breathing Zone, AAQR/Geiss, 2020	“Detected carbon dioxide concentrations ranged from 2150 ± 192 to 2875 ± 323 ppm. The concentrations of carbon dioxide while not wearing a face mask varied from 500–900 ppm. Doing office work and standing still on the treadmill each resulted in carbon dioxide concentrations of around 2200 ppm. A small increase could be observed when walking at a speed of 3 km h–1 (leisurely walking pace)…concentrations in the detected range can cause undesirable symptoms, such as fatigue, headache, and loss of concentration.”
55) Surgical masks as source of bacterial contamination during operative procedures, Zhiqing, 2018	“The source of bacterial contamination in SMs was the body surface of the surgeons rather than the OR environment. Moreover, we recommend that surgeons should change the mask after each operation, especially those beyond 2 hours.”
56) The Damage of Masking Children Could be Irreparable, Hussey, 2021	“When we surround children with mask-wearers for a year at a time, are we impairing their face barcode recognition during a period of hot neural development, thus putting full development of the FFA at risk? Does the demand for separation from others, reducing social interaction, add to the potential consequences as it might in autism? When can we be sure that we won’t interfere with visual input to the face recognition visual neurology so we don’t interfere with brain development? How much time with stimulus interference can we allow without consequences? Those are all questions currently without answers; we don’t know. Unfortunately, the science implies that if we mess up brain development for faces, we may not currently have therapies to undo everything we’ve done.”
57) Masks can be Murder, Grossman, 2021	“Wearing masks can create a sense of anonymity for an aggressor, while also dehumanizing the victim. This prevents empathy, empowering violence, and murder.” Masking helps remove empathy and compassion, allowing others to commit unspeakable acts on the masked person.”
58) London high school teacher calls face masks an ‘egregious and unforgivable form of child abuse, Butler, 2020	“In his email, Farquharson called the campaign to legislate mask wearing a “shameful farce, a charade, an act of political theatre” that’s more about enforcing “obedience and compliance” than it is about public health. He also likened children wearing masks to “involuntary self-torture,” calling it “an egregious and unforgivable form of child abuse and physical assault.”
59) UK Government Advisor Admits Masks Are Just “Comfort Blankets” That Do Virtually Nothing, ZeroHedge, 2021	“As the UK Government heralds “freedom day” today, which is anything but, a prominent government scientific advisor has admitted that face masks do very little to protect from coronavirus and are basically just “comfort blankets…the professor noted that “those aerosols escape masks and will render the mask ineffective,” adding “The public were demanding something must be done, they got masks, it is just a comfort blanket. But now it is entrenched, and we are entrenching bad behaviour…all around the world you can look at mask mandates and superimpose on infection rates, you cannot see that mask mandates made any effect whatsoever,” Axon further noted, adding that “The best thing you can say about any mask is that any positive effect they do have is too small to be measured.”
60) Masks, false safety and real dangers, Part 1: Friable mask particulate and lung vulnerability, Borovoy, 2020	“Surgical personnel are trained to never touch any part of a mask, except the loops and the nose bridge. Otherwise, the mask is considered useless and is to be replaced. Surgical personnel are strictly trained not to touch their masks otherwise. However, the general public may be seen touching various parts of their masks. Even the masks just removed from manufacturer packaging have been shown in the above photos to contain particulate and fiber that would not be optimal to inhale… Further concerns of macrophage response and other immune and inflammatory and fibroblast response to such inhaled particles specifically from facemasks should be the subject of more research. If widespread masking continues, then the potential for inhaling mask fibers and environmental and biological debris continues on a daily basis for hundreds of millions of people. This should be alarming for physicians and epidemiologists knowledgeable in occupational hazards.”
61) Medical Masks, Desai, 2020	“Face masks should be used only by individuals who have symptoms of respiratory infection such as coughing, sneezing, or, in some cases, fever. Face masks should also be worn by health care workers, by individuals who are taking care of or are in close contact with people who have respiratory infections, or otherwise as directed by a doctor. Face masks should not be worn by healthy individuals to protect themselves from acquiring respiratory infection because there is no evidence to suggest that face masks worn by healthy individuals are effective in preventing people from becoming ill.”

Based on the existing body of evidence from March 2020 to present, the predominant finding is that children (particularly young children) are at very low risk of acquiring SARS-CoV-2 infection in the first place (limited ACE 2 receptors in the nasopharynx of children (Patel and Bunyavanich) and a pre-activated innate immune system (research (August 2021) by Loske)), and if they do become infected. 

They are at vanishingly low risk of spreading it among themselves or to other children in the school setting, of spreading it to their teachers, or of spreading it to other adults or to their parents, or of taking it into the home setting; children typically become infected from the home setting/clusters and adults are typically the index case. 

Children are at very low risk of severe illness or death from COVID-19 disease except in very rare circumstances; children do not drive COVID-19 as they do seasonal influenza. 

These lockdown and school closure policies caused (and are still causing) serious harm with long term consequences, especially among those least able to afford them! Governments caused the death of many children due to the lockdowns and school closures. 

Here we provide the body of evidence below that reveals the catastrophic failures of school closures (comprised of comparative effectiveness studies as well as relevant pieces of evidence).

Table 1: Failed COVID school closure policies 

Study/report title, author, and year published and interactive url link	Predominant study/evidence report finding
1) Open Schools, Covid-19, and Child and Teacher Morbidity in Sweden, Ludvigsson, 2020	“Of the 1,951,905 children aged 1 to 16 years in Sweden as of Dec 31, 2019, 65 died in the pre-pandemic period of November 2019 to February 2020, compared with 69 in the pandemic period of March through June 2020. None of the deaths were caused by COVID-19. Fifteen children diagnosed as having COVID-19, including seven with MIS-C, were admitted to an intensive care unit (ICU) from March to June 2020 (0.77 per 100,000 children in this age-group). Four children required mechanical ventilation. Four children were 1 to 6 years old (0.54 per 100,000), and 11 were 7 to 16 (0.90 per 100,000). Four of the children had an underlying illness: 2 with cancer, 1 with chronic kidney disease, and 1 with a hematologic disease). Of the country’s 103,596 preschool teachers and 20 schoolteachers, fewer than 10 were admitted to an ICU by Jun 30, 2020 (an equivalent of 19 per 100,000).”
2) Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020, Danis, 2020	“The index case stayed 4 days in the chalet with 10 English tourists and a family of 5 French residents; SARS-CoV-2 was detected in 5 individuals in France, 6 in England (including the index case), and 1 in Spain (overall attack rate in the chalet: 75%). One pediatric case, with picornavirus and influenza A coinfection, visited 3 different schools while symptomatic. One case was asymptomatic, with similar viral load as that of a symptomatic case…The fact that an infected child did not transmit the disease despite close interactions within schools suggests potential different transmission dynamics in children.”
3) COVID-19 Cases and Transmission in 17 K–12 Schools — Wood County, Wisconsin, August 31–November 29, 2020, CDC/Falk, 2021	“In a setting of widespread community SARS-CoV-2 transmission, few instances of in-school transmission were identified among students and staff members, with limited spread among children within their cohorts and no documented transmission to or from staff members.”
4) Calculating the impact of COVID-19 pandemic on child abuse and neglect in the U.S, Nguyen, 2021	“The COVID-19 pandemic has led to a precipitous drop in CAN investigations where almost 200,000 children are estimated to have been missed for prevention services and CAN in a 10-month period.”
5) Effect of school closures on mortality from coronavirus disease 2019: old and new predictions, Rice, 2020	“We therefore conclude that the somewhat counterintuitive results that school closures lead to more deaths are a consequence of the addition of some interventions that suppress the first wave and failure to prioritise protection of the most vulnerable people. When the interventions are lifted, there is still a large population who are susceptible and a substantial number of people who are infected. This then leads to a second wave of infections that can result in more deaths, but later. Further lockdowns would lead to a repeating series of waves of infection unless herd immunity is achieved by vaccination, which is not considered in the model. A similar result is obtained in some of the scenarios involving general social distancing. For example, adding general social distancing to case isolation and household quarantine was also strongly associated with suppression of the infection during the intervention period, but then a second wave occurs that actually concerns a higher peak demand for ICU beds than for the equivalent scenario without general social distancing.”
6) Schools Closures during the COVID-19 Pandemic: A Catastrophic Global Situation, Buonsenso, 2020	“This extreme measure provoked a disruption of the educational system involving hundreds of million children worldwide. The return of children to school has been variable and is still an unresolved and contentious issue. Importantly the process has not been directly correlated to the severity of the pandemic s impact and has fueled the widening of disparities, disproportionately affecting the most vulnerable populations. Available evidence shows SC added little benefit to COVID-19 control whereas the harms related to SC severely affected children and adolescents. This unresolved issue has put children and young people at high risk of social, economic and health-related harm for years to come, triggering severe consequences during their lifespan.”
7) The Impact of COVID-19 School Closure on Child and Adolescent Health: A Rapid Systematic Review, Chaabane, 2021	“COVID-19-related school closure was associated with a significant decline in the number of hospital admissions and pediatric emergency department visits. However, a number of children and adolescents lost access to school-based healthcare services, special services for children with disabilities, and nutrition programs. A greater risk of widening educational disparities due to lack of support and resources for remote learning were also reported among poorer families and children with disabilities. School closure also contributed to increased anxiety and loneliness in young people and child stress, sadness, frustration, indiscipline, and hyperactivity. The longer the duration of school closure and reduction of daily physical activity, the higher was the predicted increase of Body Mass Index and childhood obesity prevalence.”
8) School Closures and Social Anxiety During the COVID-19 Pandemic, Morrissette, 2020	“Reported on the effects that social isolation and loneliness may have on children and adolescents during the global 2019 novel coronavirus disease (COVID-19) pandemic, with their findings suggesting associations between social anxiety and loneliness/social isolation.”
9) Parental job loss and infant health, Lindo, 2011	“Husbands’ job losses have significant negative effects on infant health. They reduce birth weights by approximately four and a half percent.”
10) Closing schools is not evidence based and harms children, Lewis, 2021	“For some children education is their only way out of poverty; for others school offers a safe haven away from a dangerous or chaotic home life. Learning loss, reduced social interaction, isolation, reduced physical activity, increased mental health problems, and potential for increased abuse, exploitation, and neglect have all been associated with school closures. Reduced future income6 and life expectancy are associated with less education. Children with special educational needs or who are already disadvantaged are at increased risk of harm.”
11) Impacts of school closures on physical and mental health of children and young people: a systematic review, Viner, 2021	“School closures as part of broader social distancing measures are associated with considerable harms to CYP health and wellbeing. Available data are short-term and longer-term harms are likely to be magnified by further school closures. Data are urgently needed on longer-term impacts using strong research designs, particularly amongst vulnerable groups. These findings are important for policy-makers seeking to balance the risks of transmission through school-aged children with the harms of closing schools.”
12) School Closure: A Careful Review of the Evidence, Alexander, 2020	“Based on the existing reviewed evidence, the predominant finding is that children (particularly young children) are at very low risk of acquiring SARS-CoV-2 infection, and if they do become infected, are at very low risk of spreading it among themselves or to other children in the school setting, of spreading it to their teachers, or of spreading it to other adults or to their parents, or of taking it into the home setting; children typically become infected from the home setting/clusters and adults are typically the index case; children are at very low risk of severe illness or death from COVID-19 disease except in very rare circumstances; children do not drive SARS-CoV-2/COVID-19 as they do seasonal influenza; an age gradient as to susceptibility and transmission capacity exists whereby older children should not be treated the same as younger children in terms of ability to transmit e.g. a 6 year-old versus a 17 year-old (as such, public health measures would be different in an elementary school versus a high/secondary school); ‘very low risk’ can also be considered ‘very rare’ (not zero risk, but negligible, very rare); we argue that masking and social distancing for young children is unsound policy and not needed and if social distancing is to be used, that 3-feet is suitable over 6-feet and will address the space limitations in schools; we argue that we are well past the point where we must replace hysteria and fear with knowledge and fact.  The schools must be immediately re-opened for in-person instruction as there is no reason to do otherwise.”
13) Children, school and COVID-19, RIVM, 2021	“If we look at all hospital admissions reported by the NICE Foundation between 1 January and 16 November 2021, 0.7% were younger than 4 years old. 0.1% were aged 4-11 years and 0.2% were aged 12-17 years. The vast majority (99.0%) of all people admitted to hospital with COVID-19 were aged 18 years or older.”
14) FEW CARRIERS, FEW TRANSMITTERS”: A STUDY CONFIRMS THE MINIMAL ROLE OF CHILDREN IN THE COVID-19 EPIDEMIC, Vincendon, 2020	“Children are few carriers, few transmitters, and when they are contaminated, it is almost always adults in the family who have contaminated them.”
15) Transmission of SARS-CoV-2 in children aged 0 to 19 years in childcare facilities and schools after their reopening in May 2020, Baden-Württemberg, Germany, Ehrhardt, 2020	“Investigated data from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected 0-19 year olds, who attended schools/childcare facilities, to assess their role in SARS-CoV-2 transmission after these establishments’ reopening in May 2020 in Baden-Württemberg, Germany. Child-to-child transmission in schools/childcare facilities appeared very uncommon.”
16) Australian Health Protection Principal Committee (AHPPC) coronavirus (COVID-19) statements on 24 April 2020, Australian government, 2020	“AHPPC continues to note that there is very limited evidence of transmission between children in the school environment; population screening overseas has shown very low incidence of positive cases in school-aged children. In Australia, 2.4 per cent of confirmed cases have been in children aged between 5 and 18 years of age (as at 6am, 22 April 2020).  AHPPC believes that adults in the school environment should practice room density measures (such as in staff rooms) given the greater risk of transmission between adults.”
17) AN EVIDENCE SUMMARY OF PAEDIATRIC COVID-19 LITERATURE, Boast, 2021	“Critical illness is very rare (~1%). In data from China, the USA and Europe, there is a “U shaped” risk gradient, with infants and older adolescents appear most likely to be hospitalised and to suffer from more severe disease. Deaths in children remain extremely rare from COVID-19, with only 4 deaths in the UK as of May 2020 in children <15 years, all in children with serious comorbidities.”
18) Transmission dynamics of SARS-CoV-2 within families with children in Greece: A study of 23 clusters,  Maltezou, 2020	“While children become infected by SARS-CoV-2, they do not appear to transmit infection to others.”
19) No evidence of secondary transmission of COVID-19 from children attending school in Ireland, 2020, Heavey, 2020	“Children are thought to be vectors for transmission of many respiratory diseases including influenza. It was assumed that this would be true for COVID-19 also. To date however, evidence of widespread paediatric transmission has failed to emerge. School closures create childcare issues for parents. This has an impact on the workforce, including the healthcare workforce. There are also concerns about the impact of school closures on children’s mental and physical health… examination of all Irish paediatric cases of COVID-19 attending school during the pre-symptomatic and symptomatic periods of infection (n = 3) identified no cases of onward transmission to other children or adults within the school and a variety of other settings. These included music lessons (woodwind instruments) and choir practice, both of which are high-risk activities for transmission. Furthermore, no onward transmission from the three identified adult cases to children was identified.”
20) COVID-19, school closures, and child poverty: a social crisis in the making, Van Lancker, 2020	“The UN Educational, Scientific and Cultural Organization estimates that 138 countries have closed schools nationwide, and several other countries have implemented regional or local closures. These school closures are affecting the education of 80% of children worldwide. Although scientific debate is ongoing with regard to the effectiveness of school closures on virus transmission, the fact that schools are closed for a long period of time could have detrimental social and health consequences for children living in poverty, and are likely to exacerbate existing inequalities.”
21) Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study, Bayham, 2020	“School closures come with many trade-offs, and can create unintended child-care obligations. Our results suggest that the potential contagion prevention from school closures needs to be carefully weighted with the potential loss of health-care workers from the standpoint of reducing cumulative mortality due to COVID-19, in the absence of mitigating measures.”
22) The Truth About Kids, School, and COVID-19, Thompson/The Atlantic, 2021	“The CDC’s judgment comes at a particularly fraught moment in the debate about kids, schools, and COVID-19. Parents are exhausted. Student suicides are surging. Teachers’ unions are facing national opprobrium for their reluctance to return to in-person instruction. And schools are already making noise about staying closed until 2022… Research from around the world has, since the beginning of the pandemic, indicated that people under 18, and especially younger kids, are less susceptible to infection, less likely to experience severe symptoms, and far less likely to be hospitalized or die…in May 2020, a small Irish study of young students and education workers with COVID-19 interviewed more than 1,000 contacts and found “no case of onward transmission” to any children or adults. In June 2020, a Singapore study of three COVID-19 clusters found that “children are not the primary drivers” of outbreaks and that “the risk of SARS-CoV-2 transmission among children in schools, especially preschools, is likely to be low.”
23) Feared coronavirus outbreaks in schools yet to arrive, early data shows, Meckler/The Washington Post, 2020	“This early evidence, experts say, suggests that opening schools may not be as risky as many have feared and could guide administrators as they chart the rest of what is already an unprecedented school year. Everyone had a fear there would be explosive outbreaks of transmission in the schools. In colleges, there have been. We have to say that, to date, we have not seen those in the younger kids, and that is a really important observation.”
24) Three studies highlight low COVID risk of in-person school, CIDRAP, 2021	“A trio of new studies demonstrate low risk of COVID-19 infection and spread in schools, including limited in-school COVID-19 transmission in North Carolina, few cases of the coronavirus-associated multisystem inflammatory syndrome in children (MIS-C) in Swedish schools, and minimal spread of the virus from primary school students in Norway.”
25) Incidence and Secondary Transmission of SARS-CoV-2 Infections in Schools, Zimmerman, 2021	“In the first 9 weeks of in-person instruction in North Carolina schools, we found extremely limited within-school secondary transmission of SARS-CoV-2, as determined by contact tracing.”
26) Suffering in silence: How COVID-19 school closures inhibit the reporting of child maltreatment, Baron, 2020	“While one would expect the financial, mental, and physical stress due to COVID-19 to result in additional child maltreatment cases, we find that the actual number of reported allegations was approximately 15,000 lower (27%) than expected for these two months. We leverage a detailed dataset of school district staffing and spending to show that the observed decline in allegations was largely driven by school closures.”
27) Minimal transmission of SARS-CoV-2 from paediatric COVID-19 cases in primary schools, Norway, August to November 2020, Brandal, 2021	“This prospective study shows that transmission of SARS-CoV-2 from children under 14 years of age was minimal in primary schools in Oslo and Viken, the two Norwegian counties with the highest COVID-19 incidence and in which 35% of the Norwegian population resides. In a period of low to medium community transmission (a 14-day incidence of COVID-19 of < 150 cases per 100,000 inhabitants), when symptomatic children were asked to stay home from school, there were < 1% SARS-CoV-2–positive test results among child contacts and < 2% positive results in adult contacts in 13 contract tracings in Norwegian primary schools. In addition, self-collection of saliva for SARS-CoV-2 detection was efficient and sensitive (85% (11/13); 95% confidence interval: 55–98)…use of face masks is not recommended in schools in Norway. We found that with the IPC measures implemented there is low to no transmission from SARS-CoV-2–infected children in schools.”
28) Children are unlikely to be the main drivers of the COVID-19 pandemic – A systematic review, Ludvigsson, 2020	“Identified 700 scientific papers and letters and 47 full texts were studied in detail. Children accounted for a small fraction of COVID-19 cases and mostly had social contacts with peers or parents, rather than older people at risk of severe disease…Children are unlikely to be the main drivers of the pandemic. Opening up schools and kindergartens is unlikely to impact COVID-19 mortality rates in older people.”
29) Science Brief: Transmission of SARS-CoV-2 in K-12 Schools and Early Care and Education Programs – Updated, CDC, 2021	“Findings from several studies suggest that SARS-CoV-2 transmission among students is relatively rare, particularly when prevention strategies are in place…several studies have also concluded that students are not the primary sources of exposure to SARS-CoV-2 among adults in school setting.”
30) Children under 10 less likely to drive COVID-19 outbreaks, research review says, Dobbins/McMaster, 2020	“The bottom line thus far is that children under 10 years of age are unlikely to drive outbreaks of COVID-19 in daycares and schools and that, to date, adults were much more likely to be the transmitter of infection than children.”
31) Role of children in the transmission of the COVID-19 pandemic: a rapid scoping review, Rajmil, 2020	“Children are not transmitters to a greater extent than adults. There is a need to improve the validity of epidemiological surveillance to solve current uncertainties, and to take into account social determinants and child health inequalities during and after the current pandemic.”
32) COVID-19 in schools – the experience in NSW, NCIRS, 2020	“SARS-CoV-2 transmission in children in schools appears considerably less than seen for other respiratory viruses, such as influenza. In contrast to influenza, data from both virus and antibody testing to date suggest that children are not the primary drivers of COVID-19 spread in schools or in the community. This is consistent with data from international studies showing low rates of disease in children and suggesting limited spread among children and from children to adults.”
33) Spread of SARS-CoV-2 in the Icelandic Population, Gudbjartsson, 2020	“In a population-based study in Iceland, children under 10 years of age and females had a lower incidence of SARS-CoV-2 infection than adolescents or adults and males.”
34) Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy, Onder, 2020	Infected children and females were less likely to have severe disease.
35) BC Center for Disease Control, BC Children’s hospital, 2020	“BC families reported impaired learning, increased child stress, and decreased connection during COVID-19 school closures, while global data show increased loneliness and declining mental health, including anxiety and depression… Provincial child protection reports have also declined significantly despite reported increased domestic violence globally. This suggests decreased detection of child neglect and abuse without reporting from schools… The impact of school closures is likely to be experienced disproportionately by families subject to social inequities, and those with children with health conditions or special learning needs. Interrupted access to school-based resources, connections, and support compounds the broader societal impact of the pandemic. In particular, there are likely to be greater effects on single parent families, families in poverty, working mothers, and those with unstable employment and housing.”
36) Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study, Macartney, 2020	“SARS-CoV-2 transmission rates were low in NSW educational settings during the first COVID-19 epidemic wave, consistent with mild infrequent disease in the 1·8 million child population.”
37) Reporting of child maltreatment during the SARS-CoV-2 pandemic in New York City from March to May 2020, Rapoport, 2021	“Precipitous drops in child maltreatment reporting and child welfare interventions coincided with social distancing policies designed to mitigate COVID-19 transmission.”
38) COVID-19 in children and the role of school settings in transmission – second update, ECDC, 2021	“Children aged between 1-18 years have much lower rates of hospitalisation, severe disease requiring intensive hospital care, and death than all other age groups, according to surveillance data…the decision to close schools to control the COVID-19 pandemic should be used as a last resort. The negative physical, mental and educational impacts of proactive school closures on children, as well as the economic impact on society more broadly, would likely outweigh the benefits.”“Investigations of cases identified in school settings suggest that child to child transmission in schools is uncommon and not the primary cause of SARS-CoV-2 infection in children whose onset of infection coincides with the period during which they are attending school, particularly in preschools and primary school.”
39) COVID-19 in children and young people, Snape, 2020	“The near-global closure of schools in response to the pandemic reflected the reasonable expectation from previous respiratory virus outbreaks that children would be a key component of the transmission chain. However, emerging evidence suggests that this is most likely not the case. A minority of children experience a postinfectious inflammatory syndrome, the pathology and long-term outcomes of which are poorly understood. However, relative to their risk of contracting disease, children and adolescents have been disproportionately affected by lockdown measures, and advocates of child health need to ensure that children’s rights to health and social care, mental health support, and education are protected throughout subsequent pandemic waves…There are many other areas of potential indirect harm to children, including an increase in home injuries (accidental and nonaccidental) when children have been less visible to social protection systems because of lockdowns. In Italy, hospitalizations for accidents at home increased markedly during the COVID-19 lockdown and potentially posed a higher threat to children’s health than COVID-19. UK pediatricians report that delay in presentations to hospital or disrupted services contributed to the deaths of equal numbers of children that were reported to have died with SARS-CoV-2 infection. Many countries are seeing evidence that mental health in young people has been adversely affected by school closures and lockdowns. For example, preliminary evidence suggests that deaths by suicide of young people under 18 years old increased during lockdown in England.”
40) Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study, Swann, 2020	“Children and young people have less severe acute covid-19 than adults.”
41) The Dangers of Keeping the Schools Closed, Yang, 2020	“The data from a range of countries shows that children rarely, and in many countries never, have died from this infection. Children appear to get infected at a much lower rate than those who are older… there is no evidence that children are important in transmitting the disease…What we know about social distancing policies is based largely on models of influenza, where children are a vulnerable group. However, preliminary data on COVID-19 suggests that children are a small fraction of cases and may be less vulnerable than older adults.”
42) SARS-CoV-2 Infection in Children, Lu, 2020	“In contrast with infected adults, most infected children appear to have a milder clinical course. Asymptomatic infections were not uncommon.”
43) Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention, Wu, 2020	Less than 1% of the cases were in children younger than 10 years of age.
44) Risk for COVID-19 Infection, CDC, 2021	A CDC report on hospitalization and death in children, found that when compared to persons 18 to 29 years old, children 0 to 4 years had a 4x lower rate of hospitalization and a 9x lower rate of death. Children 5 to 17 years old had a 9x lower rate of hospitalization and a 16x lower rate of death.
45) Children are unlikely to have been the primary source of household SARS-CoV-2 infections, Zhu, 2020	“Whilst SARS-CoV-2 can cause mild disease in children, the data available to date suggests that children have not played a substantive role in the intra-household transmission of SARS-CoV-2.”
46) Characteristics of Household Transmission of COVID-19, Li, 2020	“The secondary attack rate to children was 4% compared with 17.1% for adults.”
47) Are The Risks Of Reopening Schools Exaggerated?, Kamenetz/NPR, 2020	“Despite widespread concerns, two new international studies show no consistent relationship between in-person K-12 schooling and the spread of the coronavirus. And a third study from the United States shows no elevated risk to childcare workers who stayed on the job…As a pediatrician, I am really seeing the negative impacts of these school closures on children,” Dr. Danielle Dooley, a medical director at Children’s National Hospital in Washington, D.C., told NPR. She ticked off mental health problems, hunger, obesity due to inactivity, missing routine medical care and the risk of child abuse — on top of the loss of education. “Going to school is really vital for children. They get their meals in school, their physical activity, their health care, their education, of course.”
48) Child care not associated with spread of COVID-19, Yale study finds, YaleNews, 2020	“Findings show child care programs that remained open throughout the pandemic did not contribute to the spread of the virus to providers, lending valuable insight to parents, policymakers, and providers alike.”
49) Reopening US Schools in the Era of COVID-19: Practical Guidance From Other Nations, Tanmoy Das, 2020	“There is evidence that, compared with adults, children are 3-fold less susceptible to infection, more likely to be asymptomatic, and less likely to be hospitalized and die. While rare reports of pediatric multi-inflammatory syndrome need to be monitored, its association with COVID-19 is extremely low and typically treatable.”
50) Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US, Dooley, 2020	“Restrictions imposed because of the coronavirus make these challenges more formidable. While school districts are engaging in distance learning, reports indicate wide variability in access to quality educational instruction, digital technology, and internet access. Students in rural and urban school districts are faced with challenges accessing the internet. In some urban areas, as many as one-third of students are not participating in online classes.  Chronic absenteeism, or missing 10% or more of the school year, affects educational outcomes, including reading levels, grade retention, graduation rates, and high school dropout rates. Chronic absenteeism already disproportionately affects children living in poverty. The consequences of missing months of school will be even more marked.”
51) COVID-19 and school return: The need and necessity, Betz, 2020	“Of particular concern are the consequences for children who live in poverty. These children live in homes that have inadequate resources for virtual learning that will contribute to learning deficits, and thereby falling further behind with expected academic performance for grade level. Children from low-resourced homes are likely to have limited space for doing school work, inadequate temperature controls for heating and cooling and safe outdoor space for exercise (Van Lancker & Parolin, 2020). Furthermore, this group of children are at high risk for food insecurity as they may not have access to school lunches/breakfasts with school closures.”
52) Children are not COVID-19 super spreaders: time to go back to school, Munro, 2020	“Evidence is therefore emerging that children could be significantly less likely to become infected than adults…At the current time, children do not appear to be super spreaders.”
53) Association of routine school closures with child maltreatment reporting and substantiation in the United States; 2010-2017, Puls, 2021	“Results suggest that the detection of child maltreatment may be diminished during periods of routine school closure.”
54) COVID-19 – research evidence summaries, RCPCH, 2020	“In children, the evidence is now clear that COVID-19 is associated with a considerably lower burden of morbidity and mortality compared to that seen in the elderly. There is evidence of critical illness and death in children, but it is rare. There is also some evidence that children may be less likely to acquire the infection. The role of children in transmission, once they have acquired the infection, is unclear, although there is no clear evidence that they are any more infectious than adults. Symptoms are non-specific and most commonly cough and fever.”
56) Absence of SARS-CoV-2 Transmission from Children in Isolation to Guardians, South Korea, Lee/EID, 2021	“Did not observe SARS-CoV-2 transmission from children to guardians in isolation settings in which close proximity would seem to increase transmission risk. Recent studies have suggested that children are not the main drivers of the COVID-19 pandemic, although the reasons remain unclear.”
57) COVID-19 National Emergency Response Center, Epidemiology and Case Management Team. Contact tracing during coronavirus disease outbreak, South Korea, 2020, Park/EID, 2020	“A large study on contacts of COVID-19 case-patients in South Korea observed that household transmission was lowest when the index case-patient was 0–9 years of age.”
58) COVID-19 in Children and the Dynamics of Infection in Families, Posfay-Barbe, 2020	“In 79% of households, ≥1 adult family member was suspected or confirmed for COVID-19 before symptom onset in the study child, confirming that children are infected mainly inside familial clusters.  Surprisingly, in 33% of households, symptomatic HHCs tested negative despite belonging to a familial cluster with confirmed SARS-CoV-2 cases, suggesting an underreporting of cases. In only 8% of households did a child develop symptoms before any other HHC, which is in line with previous data in which it is shown that children are index cases in <10% of SARS-CoV-2 familial clusters.”
59) COVID-19 Transmission and Children: The Child Is Not to Blame, Lee, 2020	“Report on the dynamics of COVID-19 within families of children with reverse-transcription polymerase chain reaction–confirmed SARS-CoV-2 infection in Geneva, Switzerland. From March 10 to April 10, 2020, all children <16 years of age diagnosed at Geneva University Hospital (N = 40) underwent contact tracing to identify infected household contacts (HHCs). Of 39 evaluable households, in only 3 (8%) was a child the suspected index case, with symptom onset preceding illness in adult HHCs. In all other households, the child developed symptoms after or concurrent with adult HHCs, suggesting that the child was not the source of infection and that children most frequently acquire COVID-19 from adults, rather than transmitting it to them.”“In intriguing study from France, a 9-year-old boy with respiratory symptoms associated with picornavirus, influenza A, and SARS-CoV-2 coinfection was found to have exposed over 80 classmates at 3 schools; no secondary contacts became infected, despite numerous influenza infections within the schools, suggesting an environment conducive to respiratory virus transmission.”“In New South Wales, Australia, 9 students and 9 staff infected with SARS-CoV-2 across 15 schools had close contact with a total of 735 students and 128 staff. Only 2 secondary infections were identified, none in adult staff; 1 student in primary school was potentially infected by a staff member, and 1 student in high school was potentially infected via exposure to 2 infected schoolmates.”
60) Role of children in household transmission of COVID-19, Kim, 2020	“A total of 107 paediatric COVID-19 index cases and 248 of their household members were identified. One pair of paediatric index-secondary household case was identified, giving a household SAR of 0.5% (95% CI 0.0% to 2.6%).”
61) Secondary attack rate in household contacts of COVID-19 Paediatric index cases: a study from Western India, Shah, 2021	“The household SAR from pediatric patients is low.”
62) Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis, Madewell, 2021	“Household secondary attack rates were increased from symptomatic index cases (18.0%; 95% CI, 14.2%-22.1%) than from asymptomatic index cases (0.7%; 95% CI, 0%-4.9%), to adult contacts (28.3%; 95% CI, 20.2%-37.1%) than to child contacts (16.8%; 95% CI, 12.3%-21.7%).”
63) Children and Adolescents With SARS-CoV-2 Infection, Maltezou, 2020	“Child-to-adult transmission was found in one occasion only.”
64) Severe Acute Respiratory Syndrome-Coronavirus-2 Transmission in an Urban Community: The Role of Children and Household Contacts, Pitman-Hunt, 2021	“A household sick contact was identified in fewer than half (42%) of patients and no child-to-adult transmission was identified.”
65) A Meta-analysis on the Role of Children in Severe Acute Respiratory Syndrome Coronavirus 2 in Household Transmission Clusters, Zhu, 2020	“The secondary attack rate in pediatric household contacts was lower than in adult household contacts (RR, 0.62; 95% CI, 0.42-0.91). These data have important implications for the ongoing management of the COVID-19 pandemic, including potential vaccine prioritization strategies.”
66) The role of children in transmission of SARS-CoV-2: A rapid review, Li, 2020	“Preliminary results from population-based and school-based studies suggest that children may be less frequently infected or infect others.”
67) Novel Coronavirus 2019 Transmission Risk in Educational Settings, Yung, 2020	“The data suggest that children are not the primary drivers of SARS-CoV-2 transmission in schools and could help inform exit strategies for lifting of lockdowns.”
68) INTERPOL report highlights impact of COVID-19 on child sexual abuse, Interpol, 2020	“Key environmental, social and economic factor changes due to COVID-19 which have impacted child sexual exploitation and abuse (CSEA) across the world include:closure of schools and subsequent movement to virtual learning environments;increased time children spend online for entertainment, social and educational purposes;restriction of international travel and the repatriation of foreign nationals;limited access to community support services, child care and educational personnel who often play a key role in detecting and reporting cases of child sexual exploitation.”
69) Do school closures reduce community transmission of COVID-19? A systematic review of observational studies, Walsh, 2021	“With such varied evidence on effectiveness, and the harmful effects, policymakers should take a measured approach before implementing school closures.”
70) Association between living with children and outcomes from COVID-19: an OpenSAFELY cohort study of 12 million adults in England, Forbes, 2020	“For adults living with children there is no evidence of an increased risk of severe COVID-19 outcomes. These findings have implications for determining the benefit-harm balance of children attending school in the COVID-19 pandemic.”
71) School closure and management practices during coronavirus outbreaks including COVID-19: a rapid systematic review, Viner, 2020	“Data from the SARS outbreak in mainland China, Hong Kong, and Singapore suggest that school closures did not contribute to the control of the epidemic.”
72) Non-pharmaceutical public health measures for mitigating the risk and impact of epidemic and pandemic influenza, WHO, 2020	“The effect of reactive school closure in reducing influenza transmission varied but was generally limited.”
73) New research finds no evidence that schools are playing a significant role in driving spread of the Covid-19 virus in the community, Warwick, 2021	“New research led by epidemiologists at the University of Warwick has found that there is no significant evidence that schools are playing a significant role in driving the spread of the Covid-19 disease in the community, particularly in primary schools…our analysis of recorded school absences as a result of infection with COVID-19 suggest that the risk is much lower in primary than secondary schools and we do not find evidence to suggest that school attendance is a significant driver of outbreaks in the community.”
74) When schools shut: New UNESCO study exposes failure to factor gender in COVID-19 education responses, UNESCO, 2021	“As governments brought remote learning solutions to scale to respond to the pandemic, speed, rather than equity in access and outcomes, appears to have been the priority. Initial COVID-19 responses seem to have been developed with little attention to inclusiveness, raising the risk of increased marginalization… Most countries across all income groups report providing teachers with different forms of support. Few programmes, however, helped teachers recognize the gender risks, disparities and inequalities that emerged during COVID-19 closures. Female teachers also have been largely expected to take on a dual role to ensure continuity of learning for their students, while facing additional childcare and unpaid domestic responsibilities in their homes during school closures.”
75) School Closures Have Failed America’s Children, Kristof, 2021	“Flags are flying at half-staff across the United States to commemorate the half-million American lives lost to the coronavirus. But there’s another tragedy we haven’t adequately confronted: Millions of American schoolchildren will soon have missed a year of in-person instruction, and we may have inflicted permanent damage on some of them, and on our country… But the educational losses are disproportionately the fault of Democratic governors and mayors who too often let schools stay closed even as bars opened.”